activity_type,unit,count,cumulative_prop,manual_curation
POTENCY,umol.L-1,4465197,0.186,-1
IC50,umol.L-1,3346464,0.325,-1
GI50,umol.L-1,2537503,0.43,-1
INHIBITION,%,1926847,0.511,1
PERCENTEFFECT,%,1328350,0.566,1
KOFF,s-1,824799,0.6,-1
KON,,824153,0.634,1
KI,umol.L-1,754747,0.666,-1
MIC,umol.L-1,751833,0.697,-1
ACTIVITY,,666654,0.725,0
ACTIVITY,%,590341,0.749,1
EC50,umol.L-1,579534,0.774,-1
AC50,umol.L-1,239973,0.784,-1
KD,umol.L-1,204750,0.792,-1
IC50,,191326,0.8,-1
ZSCORE,,147589,0.806,0
RATIOIC50,,142064,0.812,0
TISSUESEVERITYSCORE,,124751,0.817,1
KI,,119453,0.822,-1
RATIO,,117835,0.827,0
GI,%,103041,0.831,1
CC50,umol.L-1,100279,0.836,-1
IZ,mm,91302,0.839,1
T12,s,89296,0.843,0
RESIDUALACTIVITY,%,76434,0.846,-1
FC,,73539,0.849,0
SOLUBILITY,umol.L-1,58909,0.852,0
STABILITY,%,56157,0.854,0
ED50,ug.mg-1,51999,0.856,-1
LC50,umol.L-1,50788,0.858,-1
%CONTROL,%,50544,0.86,
BACTERIALBIOTRANSFORMATION,,47351,0.862,1
AC50,,45120,0.864,-1
CL,mL.min-1.kg-1,44837,0.866,0
TGI,umol.L-1,43994,0.868,-1
RATIOKI,,43154,0.87,0
GROWTHRATE,,38336,0.871,
EMAX,%,38319,0.873,1
AUC,ng.h.mL-1,38183,0.875,0
MIC90,umol.L-1,38026,0.876,-1
ED50,umol.L-1,37217,0.878,-1
CONTROLDMSOTUBULINPHENOTYPEDIFFERENTCELLS(%),%,32783,0.879,
TOTALCELLCOUNT,,32783,0.88,0
CONTROLDMSOMITOTICCELLS(%),%,32783,0.882,
CONTROLDMSOMITOCHONDRIADIFFERENT-PHENOTYPECELLS(%),%,32783,0.883,
CONTROLDMSOMEMBRANEPERMEABLE-PHENOTYPECELLS(%),%,32783,0.885,
POPULATIONFRAGMENTEDNUCLEI(%),%,32783,0.886,
CONTROLDMSOHEALTHYNUCLEI(%),%,32783,0.887,
POPULATIONAPOPTOTIC(%),%,32783,0.889,
POPULATIONHEALTHYNUCLEI(%),%,32783,0.89,
POPULATIONPYKNOSEDNUCLEI(%),%,32783,0.891,
POPULATIONNORMAL(%),%,32783,0.893,
POPULATIONMITOTICCELLS(%),%,32783,0.894,
CONTROLDMSOFRAGMENTEDNUCLEI%,%,32783,0.895,
CONTROLDMSOPYKNOSEDNUCLEI(%),%,32783,0.897,
POPULATIONHOECHSTHIGHINTENSITYOBJECTS(%),%,32783,0.898,
POPULATIONTUBULIN-DIFFERENT-PHENOTYPE(%),%,32782,0.9,
POPULATIONMITOCHONDRIADIFFERENT-PHENOTYPE(%),%,32782,0.901,
POPULATIONMEMBRANEPERMEABLE-PHENOTYPE(%),%,32782,0.902,
F,%,31040,0.904,0
LOGD,,30412,0.905,0
MIC50,umol.L-1,28590,0.906,-1
ACTIVITY,umol.L-1,28463,0.907,-1
CMAX,umol.L-1,26775,0.908,
SELECTIVITYINDEX,,26619,0.909,
CL,mL.min-1.g-1,26600,0.911,0
GI,,26461,0.912,
DELTATM,C,24914,0.913,
CONTROLDMSOTOTALCELLS,,22319,0.914,
SELECTIVITYRATIO,,22199,0.914,
RATIOEC50,,22141,0.915,
EFFICACY,%,21679,0.916,1
RATIOCC50EC50,,21405,0.917,
LOGP,,20404,0.918,
EC50,,19688,0.919,
IFI,%,19227,0.92,
MIC,,19060,0.92,
WEIGHT,mg,18621,0.921,
MIC80,umol.L-1,18515,0.922,-1
MBC,umol.L-1,18444,0.923,
DELTATM,Cel,17605,0.924,
TIME,s,17221,0.924,0
MORTALITY,%,16577,0.925,1
DRUGMETABOLISM,,16015,0.926,
VDSS,L.kg-1,15439,0.926,
CONTROLDMSOAPOPTOTICCELLS(%),%,14544,0.927,
PPB,%,14111,0.927,
TMAX,s,14091,0.928,
RATIOCC50IC50,,13782,0.929,
SURVIVAL,%,13775,0.929,-1
XC50,umol.L-1,13705,0.93,
DRUGUPTAKE,,13622,0.93,
FU,,13505,0.931,
PKA,,13290,0.931,
CELLVIABILITY,%,13086,0.932,
%INHIB(MEAN),%,12829,0.932,
DRUGUPTAKE,% ID/g,12781,0.933,
IC90,umol.L-1,11580,0.933,-1
SELECTIVITY,,11183,0.934,
TC,%,11121,0.934,
CONTROLDMSOTOTALCELLS,%,10464,0.935,
CONTROLDMSOGROWTHRATE,%,10464,0.935,
ID50,umol.L-1,10441,0.936,
MIC99,umol.L-1,10417,0.936,-1
%OFCONTROL,%,10334,0.937,
HEPG2TOXASSAY-CC50,umol.L-1,9992,0.937,
LUCIFERASEINFECTIONASSAY-IC50,umol.L-1,9992,0.937,
HEPG2TOXASSAY-CC90,umol.L-1,9992,0.938,
LUCIFERASEINFECTIONASSAY-IC90,umol.L-1,9992,0.938,
LUCIFERASEEXPRESSIONCONTROL-IC50,umol.L-1,9992,0.939,
LUCIFERASEEXPRESSIONCONTROL-IC90,umol.L-1,9992,0.939,
ED50,umol.mg-1,9766,0.939,
KM,umol.L-1,9536,0.94,
CP,umol.L-1,9417,0.94,
ACTIVITY,mg,9067,0.941,
THERMALMELTINGCHANGE,Cel,8894,0.941,
DRUGMETABOLISM,%,8728,0.941,
CHANGE,%,8622,0.942,
CLH,uL/min,8422,0.942,
MFC,umol.L-1,8383,0.942,
PHOS,umol.L-1,8339,0.943,
CHOL,umol.L-1,8339,0.943,
GLUC,umol.L-1,8339,0.943,
CREAT,umol.L-1,8339,0.944,
BUN,umol.L-1,8339,0.944,
ALB,umol.L-1,8339,0.945,
HCT,%,8338,0.945,
RBC,cells.uL-1,8338,0.945,
MCV,fL,8338,0.946,
PROT,umol.L-1,8338,0.946,
WBC,cells.uL-1,8337,0.946,
MCH,pg,8335,0.947,
POTASSIUM,meq.L-1,8335,0.947,
HGB,umol.L-1,8335,0.947,
SODIUM,meq.L-1,8335,0.948,
PLAT,cells.uL-1,8319,0.948,
LYMLE,%,8308,0.948,
NEUTLE,%,8308,0.949,
MONOLE,%,8308,0.949,
BASOLE,%,8308,0.949,
EOSLE,%,8308,0.95,
BILI,umol.L-1,8264,0.95,
SOLUBILITY,,8111,0.95,
INHIBITION(MEAN),%,7427,0.951,
CONTROL,%,7368,0.951,
IMAX,%,7323,0.951,
%MAX(MEAN),%,7141,0.952,
EC90,umol.L-1,6960,0.952,
TI,,6911,0.952,
LD50,ug.mg-1,6818,0.952,
DIZ,,6807,0.953,
PKB,,6754,0.953,
%MAX,%,6681,0.953,
TGI,%,6638,0.954,-1
REDUCTION,%,6309,0.954,
MED,ug.mg-1,6235,0.954,
KB,umol.L-1,6076,0.954,
DRUGUPTAKE,umol.L-1,5985,0.955,
LOG2FC,,5791,0.955,
FICI,,5427,0.955,
GI50,,5244,0.955,
INTRINSICACTIVITY,,5152,0.956,
MCC,umol.L-1,5147,0.956,
KD,,5117,0.956,
ILS,%,5058,0.956,
TC50,umol.L-1,5011,0.956,
APTT,s,5006,0.957,
RELATIVEPOTENCY,,4997,0.957,
MRT,s,4848,0.957,
PAPP,10^-6 cm/s,4790,0.957,
PT,s,4759,0.957,
VD,L.kg-1,4745,0.958,
LD50,umol.L-1,4730,0.958,
ID50,ug.mg-1,4698,0.958,
ALBGLOB,,4661,0.958,
ALT,[IU].L-1,4661,0.958,
GGT,[IU].L-1,4661,0.959,
TRIG,umol.L-1,4661,0.959,
TERMBW,mg,4661,0.959,
CALCIUM,umol.L-1,4661,0.959,
CL,meg.L-1,4661,0.959,
AST,[IU].L-1,4661,0.96,
PHOSLPD,umol.L-1,4661,0.96,
RETIRBC,%,4661,0.96,
LDH,[IU].L-1,4661,0.96,
ALP,[IU].L-1,4661,0.96,
MCHC,%,4661,0.96,
BILDIR,umol.L-1,4637,0.961,
LOGD74,,4557,0.961,
PAPP,10'-6 cm/s,4553,0.961,
FIBRINO,umol.L-1,4525,0.961,
ABSAC40UM,umol.L-1,4485,0.961,
INH,umol.L-1,4466,0.962,
ACTIVITY,mm,4463,0.962,
PAPP,ucm.s-1,4240,0.962,
RETENTIONTIME,s,4160,0.962,
%OFINHIBITION,%,4072,0.962,
CC50,,4048,0.963,
MIC100,umol.L-1,4033,0.963,
PERMEABILITY,10'-6 cm/s,4009,0.963,
MST,d,3907,0.963,
-LOGMIC,,3898,0.963,
EMAX,,3834,0.963,-1
HEPATOTOXICITY,,3811,0.963,
IZ,,3767,0.964,
T12,,3742,0.964,
CLOGP,,3694,0.964,
MCHC,umol.L-1,3681,0.964,
ALT,U.L-1,3678,0.964,
ALP,U.L-1,3678,0.964,
AST,U.L-1,3678,0.965,
CHLORIDE,meq.L-1,3674,0.965,
MEC,umol.L-1,3667,0.965,
RBA,,3557,0.965,
CK,U.L-1,3527,0.965,
KCAT,s-1,3513,0.965,
ACTIVITY,mmHg,3465,0.965,
KE,umol.L-1,3432,0.966,
CONCENTRATION,umol.L-1,3409,0.966,
RBA,%,3357,0.966,
CI,,3356,0.966,
PERMEABILITY,nm/s,3345,0.966,
LIPASE,U.L-1,3277,0.966,
URATE,umol.L-1,3276,0.966,
LDH,U.L-1,3255,0.967,
DRUGUPTAKE,%,3250,0.967,
BPR,,3236,0.967,
CO2,umol.L-1,3235,0.967,
PERMEABILITY,10^-6 cm/s,3220,0.967,
INTRINSICACTIVITY,%,3192,0.967,
LOGK,,3192,0.967,
TC,,3192,0.967,
ED50,,3177,0.968,
BASO,cells.uL-1,3164,0.968,
LYM,cells.uL-1,3140,0.968,
EOS,cells.uL-1,3140,0.968,
MONO,cells.uL-1,3140,0.968,
IDG,%,3133,0.968,
DC50,umol.L-1,3117,0.968,
AUTOPHAGYINDUCTION,%,3052,0.969,
NEUTSG,cells.uL-1,3034,0.969,
RBCNUC,/100WBC,2992,0.969,
%CTRL,%,2885,0.969,
RATIO,/mol.L-1.s-1,2851,0.969,
RATIOGI50,,2822,0.969,
PAPP,nm/s,2773,0.969,
ABSAC35UM,umol.L-1,2735,0.969,
ACTIVITY,ug.mg-1,2731,0.969,
DECREASE,%,2725,0.97,
ACTIVITY,s,2701,0.97,
MIC95,umol.L-1,2691,0.97,
KA,umol.L-1,2671,0.97,
KCATKM,/mol.L-1.s-1,2648,0.97,
TM,Cel,2623,0.97,
HC50,umol.L-1,2574,0.97,
ACTIVITYINDEX,,2574,0.97,
PERMEABILITY,ucm.s-1,2572,0.97,
TD50,ug.mg-1,2531,0.971,
PD50,ug.mg-1,2521,0.971,
PERMEABILITY,,2507,0.971,
DRUGUPTAKE,%ID,2501,0.971,
TOXICITY,,2460,0.971,
IC95,umol.L-1,2405,0.971,
%CELLDEATH,,2400,0.971,
INHIBITION,umol.L-1,2390,0.971,
PD2,,2304,0.971,
LOG(ACTIVITY),,2290,0.971,
RELATIVEACTIVITY,,2284,0.972,
LOG1C,,2253,0.972,
DIET,%,2246,0.972,
K,s-1,2227,0.972,
PROTECTION,%,2205,0.972,
EC,umol.L-1,2190,0.972,
CLH,,2183,0.972,
KINACT,umol.L-1,2176,0.972,
ACTIVITY,pg/ml,2130,0.972,
DOSE,ug.mg-1,2095,0.972,
PIC50,,2092,0.972,
LOG(1C),,2056,0.973,
DRUGUPTAKE,ng/g,2037,0.973,
PXC50,,1984,0.973,
EFFICACY,,1950,0.973,
SURVIVORS,,1895,0.973,
SURVIVAL,d,1876,0.973,
DRUGDEGRADATION,%,1863,0.973,
ACTIVITY,umol,1831,0.973,
MAXACTIVATION,%,1804,0.973,
IC50RATIO,,1783,0.973,
PKD,,1771,0.973,
RATIOED50,,1760,0.973,
ACTIVITY,ml,1750,0.974,
CL,uL.min-1.(10^6cells)-1,1737,0.974,
IC50RELATIVE,umol.L-1,1729,0.974,
DRUGRECOVERY,%,1720,0.974,
ERH,,1716,0.974,
ACTIVITY,mU/ml,1694,0.974,
KOBS1,/mol.L-1.s-1,1690,0.974,
TGI,,1673,0.974,
INCREASE,%,1662,0.974,
ACTIVITY,pm/min/mg,1662,0.974,
HITSCORE,,1660,0.974,
MIC,mg,1658,0.974,
DELTATM,,1617,0.974,
K,/mol.L-1.s-1,1603,0.974,
SI,,1601,0.974,
INHIBITIONINDEX,,1601,0.975,
MOTILITY,%,1597,0.975,
MTD,ug.mg-1,1596,0.975,
LOG10CFU,,1564,0.975,
DELTAMST,d,1559,0.975,
MORTALITY,,1550,0.975,
AUC,,1542,0.975,
CYTOTOXICITY,,1530,0.975,
RATIOIC50EC50,,1512,0.975,
PAPP,,1493,0.975,
ABSAC35,umol.L-1,1480,0.975,
CL,,1467,0.975,
DELTAT,Cel,1442,0.975,
PEC50,,1438,0.975,
POTENCY,,1412,0.975,
SUV,,1397,0.975,
ABSAC26UM,umol.L-1,1390,0.976,
FOLDCHANGE,,1389,0.976,
ACTIVITY,equiv,1377,0.976,
PI,,1364,0.976,
KINACT,s-1,1363,0.976,
GI,umol.L-1,1362,0.976,
RM,,1355,0.976,
DISPLACEMENT,%,1337,0.976,
ACTIVITY,U/L,1332,0.976,
RATIOTD50ED50,,1330,0.976,
DURATION,s,1297,0.976,
C50,umol.L-1,1289,0.976,
ABSAC40,umol.L-1,1263,0.976,
RELATIVEGROWTH,,1253,0.976,
MBC,,1251,0.976,
CT,umol.L-1,1248,0.976,
CONCENTRATION@MAXI,mm,1244,0.976,
CLH,ml/min,1231,0.976,
%INHIBITION,umol.L-1,1230,0.977,
EFFECT,,1190,0.977,
BP,mmHg,1187,0.977,
LOGPAPP,,1185,0.977,
LC50,,1180,0.977,
IC80,umol.L-1,1166,0.977,
LC50,[ppm],1162,0.977,
KA,L.umol-1,1144,0.977,
RESPONSE,%,1130,0.977,
HEPATOTOXICITY(MODERATE),%,1120,0.977,
HEPATOTOXICITY(MODERATE),,1120,0.977,
HEPATOTOXICITY(MECHANISM),,1120,0.977,
HEPATOTOXICITY(TIMETOONSET),,1120,0.977,
HEPATOTOXICITY(SUCCESSFULREINTRODUCTION),,1120,0.977,
HEPATOTOXICITY(MALIGNANTTUMOUR),,1120,0.977,
HEPATOTOXICITY(GRANULOMATOUSHEPATITIS),,1120,0.977,
HEPATOTOXICITY(STEATOSIS),,1120,0.977,
HEPATOTOXICITY(CHOLEOSTASIS),,1120,0.977,
HEPATOTOXICITY(ANIMALTOXICITYKNOWN),,1120,0.977,
HEPATOTOXICITY(CYTOLYTIC),,1120,0.977,
HEPATOTOXICITY(COMMENT),,1120,0.977,
HEPATOTOXICITY(ACUTE),,1120,0.978,
HEPATOTOXICITY(SEVEREHEPATITIS),,1120,0.978,
HEPATOTOXICITY(CIRRHOSIS),,1120,0.978,
HEPATOTOXICITY(BENIGNTUMOUR),,1120,0.978,
HEPATOTOXICITY(CHRONICLIVERDISEASE),,1120,0.978,
HEPATOTOXICITY(ASSOCIATIONWITHVASCULARDISEASE),,1120,0.978,
HEPATOTOXICITY(ACUTE),%,1120,0.978,
RATIOAUC,,1111,0.978,
MAX,%,1100,0.978,
MBC999,umol.L-1,1094,0.978,
SURVIVAL,,1082,0.978,
UI,,1074,0.978,
PEFF,10'-6 cm/s,1067,0.978,
CYTOTOXICITY,%,1059,0.978,
"K(P,UU,BRAIN)",,1045,0.978,
CONC@MAXFOLDINCR,mm,1040,0.978,
DRUGMETABOLISM,umol.L-1,1037,0.978,
TD50,umol.L-1,1027,0.978,
ACTIVITY,bpm,1027,0.978,
LOGPE,,1019,0.978,
LOGIC50,,1014,0.978,
GROWTH,%,1012,0.978,
HC10,umol.L-1,1000,0.978,
DRUGEXCRETION,%,994,0.979,
DOSEG,%,988,0.979,
ID50,umol.mg-1,971,0.979,
CURES,,970,0.979,
FIC,,965,0.979,
MSD,d,960,0.979,
ACTIVITY,mm3,957,0.979,
LOG10CFUML,,952,0.979,
FLUINTENSITY,,952,0.979,
RF,,951,0.979,
CD,umol.L-1,946,0.979,
STIMULATION,%,942,0.979,
IMAX,,939,0.979,
CP(F),umol.L-1,917,0.979,
DILICONCERN,,915,0.979,
DILISEVERITYCLASS,,915,0.979,
MPE,%,909,0.979,
TDI,,908,0.979,
AD50,ug.mg-1,907,0.979,
CD50,umol.L-1,907,0.979,
KP,,904,0.979,
DISTRIBUTION,%,896,0.979,
MBC>999,umol.L-1,885,0.979,
NT,,881,0.979,
DELTATM,K,873,0.979,
HEPSELIVERDISEASE,,861,0.979,
HEPSEHEPATOMEGALY,,861,0.98,
HEPSELIVERFUNCTIONTESTSABNORMAL,,861,0.98,
HEPSELIVERFATTY,,861,0.98,
HEPSEELEVATEDLIVERFUNCTIONTESTS,,861,0.98,
HEPSEHEPATICFAILURE,,861,0.98,
HEPSECHOLELITHIASIS,,861,0.98,
HEPSEJAUNDICE,,861,0.98,
HEPSECOMBINEDSCORES,,861,0.98,
HEPSEHEPATICNECROSIS,,861,0.98,
HEPSECIRRHOSIS,,861,0.98,
HEPSEHEPATITIS,,861,0.98,
HEPSEBILIRUBINEMIA,,861,0.98,
HEPSECHOLECYSTITIS,,861,0.98,
PC50,umol.L-1,857,0.98,
OD,,856,0.98,
STABILITY,microL/min/mg,847,0.98,
MTC,umol.L-1,845,0.98,
DOSE,%,842,0.98,
PHOSPHOLIPIDOSIS,,841,0.98,
PERMEABILITY,%,838,0.98,
THERAPEUTICINDEX,,829,0.98,
LOGKI,,814,0.98,
ACTIVITY,mmol/L,811,0.98,
LD50,umol.mg-1,811,0.98,
ER-PHAGYSUPPRESSION,%,808,0.98,
ED30,ug.mg-1,805,0.98,
LOG1D50,,792,0.98,
MED,,789,0.98,
LOG1LD10,,776,0.981,
ACTIVITY,cm,774,0.981,
RATIOPKI,,773,0.981,
RLU,,772,0.981,
RATIOLC50,,771,0.981,
K,,752,0.981,
BIODISTRIBUTION,%,750,0.981,
DOSEORGAN,%,747,0.981,
PKI,,745,0.981,
ILS,,744,0.981,
CLRENAL,mL.min-1.kg-1,743,0.981,
EC15,umol.L-1,742,0.981,
ACTIVATION,%,736,0.981,
POTENCYRATIO,,736,0.981,
K,L.umol-1,736,0.981,
ACTIVITY,umol.min-1,730,0.981,
IP,umol.L-1,726,0.981,
RATIO,%,723,0.981,
EFFECT,%,721,0.981,
%RESIDUALKINASEACTIVITY,%,716,0.981,
MBEC,umol.L-1,712,0.981,
INJECTEDDOSEG,%,711,0.981,
OD,ug.mg-1,705,0.981,
RMAX,%,704,0.981,
REVERSAL,%,699,0.981,
CONCENTRATION,,699,0.981,
ACTIVITY,log10[CFU].ml-1,694,0.981,
PA2,,693,0.981,
KINETICSOLUBILITY,,693,0.981,
COMPOUNDRECOVERY,%,690,0.981,
VMAX,umol.min-1,687,0.981,
CMIN,umol.L-1,683,0.981,
DELTATC,%,682,0.981,
ACTIVITY,log10[CFU],680,0.982,
DELTAG,kcal.mol-1,679,0.982,
MIC50,,679,0.982,
NAN,,674,0.982,
AC40,umol.L-1,669,0.982,
ID50,,669,0.982,
KE,,668,0.982,
DECREASEINBLOODPRESSURE,%,666,0.982,
KIS,umol.L-1,658,0.982,
CHI,,656,0.982,
MIC90,,652,0.982,
ACTIVITY,U.mg-1,651,0.982,
DELTAMEANSURVIVALTIME,,649,0.982,
FT>MIC,%,643,0.982,
VMAX,%,642,0.982,
MAXACTIVITY,umol.L-1,638,0.982,
FCMAX,umol.L-1,637,0.982,
NOOFSURVIVORS,,636,0.982,
RELATIVEBINDINGAFFINITY,,634,0.982,
MPC,umol.L-1,633,0.982,
ACTIVITY,d,632,0.982,
REMAINING,%,632,0.982,
MST,,629,0.982,
ILSMAX,%,625,0.982,
BINDING,%,625,0.982,
%INHIBITIONOFCONTROLSPECIFICBINDING(MEANN=2),%,623,0.982,
LOGKS,,614,0.982,
CYTOTOXICITY,umol.L-1,612,0.982,
LOG1MMIC,,612,0.982,
REDUCTION,,611,0.982,
RATEOFINHIBITION,%,609,0.982,
ANIMALS,%,608,0.982,
LOGS,,607,0.982,
MFC,,606,0.982,
DELTAMST,,604,0.982,
RATIOPIC50,,603,0.982,
ACTIVITY,umol.min-1.mg-1,603,0.982,
KB,L.umol-1,599,0.982,
ED50,mg.kg-1.d-1,599,0.983,
ED90,ug.mg-1,597,0.983,
LOGK',,588,0.983,
DRUGUPTAKE,ug.mg-1,588,0.983,
CLF,mL.min-1.kg-1,579,0.983,
PCC50,,579,0.983,
ZONEOFINHIBITION,umol.L-1,576,0.983,
K,umol.L-1,572,0.983,
GROWTHINHIBITION,%,571,0.983,
KAPP,L.umol-1,569,0.983,
VARIATION,%,567,0.983,
ACTIVITY,U,566,0.983,
DRUGUPTAKE,umol,565,0.983,
ID,%,563,0.983,
MBIC50,umol.L-1,562,0.983,
SUPPRESSION,%,558,0.983,
LD10,ug.mg-1,554,0.983,
K3KI,/mol.L-1.s-1,552,0.983,
IA,,551,0.983,
DIURETICACTIVITY,,549,0.983,
MRT(T),s,544,0.983,
LOG2MIC,,543,0.983,
VIABILITY,%,541,0.983,
OCC,%,540,0.983,
T,Cel,538,0.983,
KAPP,umol.L-1,537,0.983,
NOOFCUREDMICE,,534,0.983,
MAXRESPONSE,%,534,0.983,
LD50,,532,0.983,
MFC995,umol.L-1,532,0.983,
MIC,[ppm],528,0.983,
IC90,,528,0.983,
2PT,umol.L-1,525,0.983,
WEIGHTCHANGE,%,523,0.983,
ACTIVITY,IU/L,522,0.983,
MNCC,umol.L-1,519,0.983,
CC10,umol.L-1,515,0.983,
AFI,%,512,0.983,
IC20,umol.L-1,507,0.983,
ABSAC1000UM,umol.L-1,505,0.983,
IC100,umol.L-1,504,0.983,
VIRUSRATING,,503,0.983,
EDMIN,ug.mg-1,501,0.983,
DRUGMETABOLISM,umol.min-1,499,0.983,
KA,/mol.L-1.s-1,494,0.983,
DELTAIOP,mmHg,494,0.984,
MOTILITYREDUCTIONCYTOTOXICITY,%,491,0.984,
LDHINCREASE-INDEXVALUE,,489,0.984,
GGTINCREASE-INDEXVALUE,,489,0.984,
ACTIVITY,mV,489,0.984,
COMPOSITEACTIVITY-MARGINAL,,489,0.984,
SGPTINCREASE-NUMBEROFREPORTS,,489,0.984,
GGTINCREASE-ACTIVITYSCORE,,489,0.984,
LDHINCREASE-NUMBEROFREPORTS,,489,0.984,
ALKALINEPHOSPHATASEINCREASE-NUMBEROFREPORTS,,489,0.984,
LDHINCREASE-ACTIVITYSCORE,,489,0.984,
SGOTINCREASE-ACTIVITYSCORE,,489,0.984,
GGTINCREASE-NUMBEROFREPORTS,,489,0.984,
ALKALINEPHOSPHATASEINCREASE-ACTIVITYSCORE,,489,0.984,
SGPTINCREASE-INDEXVALUE,,489,0.984,
SGOTINCREASE-INDEXVALUE,,489,0.984,
SGOTINCREASE-NUMBEROFREPORTS,,489,0.984,
COMPOSITEACTIVITY-SCORE,,489,0.984,
SGPTINCREASE-ACTIVITYSCORE,,489,0.984,
COMPOSITEACTIVITY-ACTIVE,,489,0.984,
ALKALINEPHOSPHATASEINCREASE-INDEXVALUE,,489,0.984,
PGI50,,488,0.984,
ACTIVITY,ms,487,0.984,
MBIC,umol.L-1,485,0.984,
PEFF,ucm.s-1,484,0.984,
RATIOKE,,483,0.984,
RATIOKI(APP),,481,0.984,
PLASMACONCENTRATION,umol.L-1,479,0.984,
KASS,l M-1,479,0.984,
DRUGUPTAKE,nmol/g,474,0.984,
DRUGUPTAKE,mg,472,0.984,
MBC995,umol.L-1,472,0.984,
CONCENTRATION,%,472,0.984,
LOG(RATIO),,470,0.984,
PLASMALEVEL,umol.L-1,468,0.984,
KOBS,s-1,468,0.984,
ACTIVITY,Cel,467,0.984,
GI90,umol.L-1,467,0.984,
-LOG(SOLUBILITY),,466,0.984,
VMAX,,465,0.984,
DELTACT,,464,0.984,
RECOVERY,%,462,0.984,
CMAX,,462,0.984,
LOCOMOTORACTIVITY,,461,0.984,
ACTIVITY,s-1,460,0.984,
MED,g/acre,459,0.984,
LOG1KIAPP,,458,0.984,
COMPOUNDRECOVERY,,458,0.984,
C0,umol.L-1,456,0.984,
IA,%,454,0.984,
ED50,mg,454,0.985,
%BINDING,%,454,0.985,
PED50,,450,0.985,
MIC>95,umol.L-1,448,0.985,
MFC999,umol.L-1,447,0.985,
KIRATIO,,442,0.985,
DRUGUPTAKE(FREE),umol.L-1,441,0.985,
KM,,440,0.985,
CLH,%,439,0.985,
RADIOACTIVITY,%,438,0.985,
DELTAH,kcal.mol-1,434,0.985,
LD50,mg,433,0.985,
ANTICONVULSANTACTIVITY,,431,0.985,
MIC=>50,umol.L-1,429,0.985,
KB,,428,0.985,
MLC,umol.L-1,428,0.985,
REMAINING(WITHOUTCOFACTOR),%,427,0.985,
CL,L/hr,422,0.985,
EC25,umol.L-1,421,0.985,
LOGEC50,,420,0.985,
MIC,ug cm**-2,420,0.985,
CT,ng/g,419,0.985,
RFU,,419,0.985,
MBC90,umol.L-1,418,0.985,
SCORE,,415,0.985,
DRUGEXCRETION,,415,0.985,
ACTIVITY,micromol/min,415,0.985,
EC90,,415,0.985,
LCK,,414,0.985,
VDF,L.kg-1,414,0.985,
CL,%,413,0.985,
INCREASE,,411,0.985,
PHYTOTOXICITY,%,411,0.985,
NOOFANIMALS,,410,0.985,
CD50,ug.mg-1,410,0.985,
INVITROACTIVITY,,409,0.985,
LOG(1MIC),,407,0.985,
CP,,406,0.985,
DELTATMSTAUROSPORINEPOSITIVECONTROL,,406,0.985,
ERH,%,405,0.985,
AUC,umol.L-1,402,0.985,
QH,%,401,0.985,
MAXACTIVITYCONCENT,umol.L-1,400,0.985,
EC50,[ppm],400,0.985,
PERMEABILITY,nm s-1,400,0.985,
CMAX,ng/g,398,0.985,
BLOCK,%,397,0.985,
ABSAC1,umol.L-1,395,0.985,
WEIGHTCHANGE,mg,394,0.985,
PD'2,,394,0.985,
EC30,umol.L-1,392,0.985,
FLUORESCENCE,,391,0.985,
ED50,umol,391,0.985,
IC30,umol.L-1,390,0.985,
KON,/mol.L-1.s-1,389,0.985,
KD,s-1,389,0.985,
2APTT,umol.L-1,387,0.985,
BIODISTRIBUTION,%ID/g,387,0.985,
IDORGAN,%,383,0.986,
RADIOLABELRECOVERY,ngequiv/g,382,0.986,
MOTILITY,,380,0.986,
HEARTRATE,beats min-1,378,0.986,
PAWSWELLING,umol.L-1,375,0.986,
IG50,umol.L-1,375,0.986,
CLH,ml/min.g,375,0.986,
LOG(ILSMAX),,374,0.986,
SOLUBILITYRATIO,,373,0.986,
KCATKM,,372,0.986,
KON,Ms-1,372,0.986,
LOGIC50,umol.L-1,371,0.986,
-LOGKB,,370,0.986,
CONCENTRATION,ug g-1,369,0.986,
DRUGMETABOLISM,umol,368,0.986,
KA,,366,0.986,
MBC,umol.ml-1,366,0.986,
DTM,K,365,0.986,
EC80,umol.L-1,363,0.986,
CURED,%,361,0.986,
FPDC,,361,0.986,
ED20,ug.mg-1,359,0.986,
ACTIVITY,mg dl-1,358,0.986,
KII,umol.L-1,356,0.986,
ACTIVITY,g/dl,355,0.986,
NOOFMICECURED,,355,0.986,
RELATIVEAFFINITY,,354,0.986,
RUMAX,%,354,0.986,
PEFF,10^-6 cm/s,353,0.986,
HILLCOEFFICIENT,,353,0.986,
MIC80,,353,0.986,
VMAX,umol.min-1.mg-1,352,0.986,
FA,,352,0.986,
COOPERATIVITY,,350,0.986,
RELATIVEIC50,,350,0.986,
MHC,umol.L-1,348,0.986,
CL,uL/min,348,0.986,
SDL,%,346,0.986,
ACTIVITY,RFU,345,0.986,
INHIBITION,mm,345,0.986,
LOG(%),,344,0.986,
K05,umol.L-1,342,0.986,
ED,nM kg-1,339,0.986,
ACTIVITY,microM/min,336,0.986,
TD50,,336,0.986,
%RESIDUALACTIVITYWITHSKEPINONE-L,%,333,0.986,
OPTIMALDOSE,ug.mg-1,332,0.986,
DELTABLOODPRESSURE,mmHg,332,0.986,
RELATIVEPOTENCY,%,332,0.986,
THERMSOLUBILITY,,331,0.986,
MIC99,,331,0.986,
MTC,ug.mg-1,331,0.986,
DISTRIBUTIONOFRADIOACTIVITY,dose g-1,330,0.986,
LD99,umol.L-1,330,0.986,
PKA2,,329,0.986,
K',,329,0.986,
ACTIVITY,V,328,0.986,
RELEASE,%,328,0.986,
MPC8,umol.L-1,328,0.986,
IC70,umol.L-1,328,0.986,
ACTIVITY,umol.mg-1,328,0.986,
MBC50,umol.L-1,328,0.986,
MIC,umol,328,0.986,
MNTD,umol.L-1,327,0.986,
HD50,umol.L-1,325,0.986,
MAXFALLINBLOODPRESSURE,mmHg,324,0.986,
-LOG(1MIC),,324,0.986,
RADIOLABELRECOVERY,ugequiv,324,0.986,
PFA,,323,0.986,
CTD50,umol.L-1,323,0.987,
CHANGE,,323,0.987,
CL,ml/min,322,0.987,
SAFETYRATIO,,322,0.987,
FPDMEASUREMENT,,321,0.987,
ACTIVITY,a.u.,321,0.987,
NOOFREVERTANTSPERPLATE,,320,0.987,
HR,beats min-1,320,0.987,
MEANFOLDSTIMULATION,,318,0.987,
DRUGMETABOLISM,umol.min-1.mg-1,317,0.987,
AFFINITY,,316,0.987,
SCHIZONTSIZE,mm,315,0.987,
PAE,s,315,0.987,
RADIOLABELRECOVERY,%,314,0.987,
IC25,umol.L-1,314,0.987,
ACTIVITYRATING,,314,0.987,
ACTIVITY,mm2,312,0.987,
STABILITY,s,312,0.987,
RATIO,umol.L-1,311,0.987,
ED,ug.mg-1,311,0.987,
DECREASEINSBP,%,311,0.987,
DELTAH,kJ.mol-1,310,0.987,
MAX,,310,0.987,
FG,,309,0.987,
PKA1,,309,0.987,
FH,,309,0.987,
INHIBITIONZONE,umol.L-1,309,0.987,
ACTIVITY,uEq/min,308,0.987,
PF50,,307,0.987,
%ACTIVITYREMAINING,%,307,0.987,
FFRACTION,,307,0.987,
MEANINJECTEDDOSEG,,307,0.987,
-LOGC,umol.L-1.ml-1,306,0.987,
INJECTEDDOSE,%,305,0.987,
LOGKW,,305,0.987,
INHIBITION,,304,0.987,
RELATIVEACTIVITY,%,303,0.987,
MIC999,umol.L-1,303,0.987,
MEANSURVIVALTIME,d,303,0.987,
ACTIVITY,[CFU],303,0.987,
KEL,h-1,302,0.987,
CT,%,302,0.987,
KOBS1,,302,0.987,
IC12,umol.L-1,301,0.987,
IZ,umol.L-1,300,0.987,
BIODISTRIBUTION,,299,0.987,
ED50RATIO,,299,0.987,
KS,umol.L-1,299,0.987,
CMC,umol.L-1,298,0.987,
LOG(10^6IC50),,297,0.987,
CC90,umol.L-1,294,0.987,
EC150,umol.L-1,294,0.987,
ED50,10'-1 ug/ml,293,0.987,
ACTIVITY,ml-1,293,0.987,
FIC50,umol.L-1,291,0.987,
LOGRA,,291,0.987,
LOG1M,,291,0.987,
FAUC,ng.h.mL-1,290,0.987,
EC100,umol.L-1,290,0.987,
REPELLENCY,%,290,0.987,
GR80,[ppm],289,0.987,
VR,,289,0.987,
INJECTED,%,288,0.987,
TC50,,288,0.987,
DRUGUPTAKE,kBq/ml,287,0.987,
CCIC50,umol.L-1,287,0.987,
AUCDOSE,uM.hr.kg/mg,286,0.987,
-TDELTAS,kcal.mol-1,286,0.987,
CELLSURVIVAL,%,284,0.987,
EC99,umol.L-1,282,0.987,
RADIOLABELRECOVERY,ugequiv/g,282,0.987,
LTKBBDDILISEVERITYSCORE,,281,0.987,
VIABLECELLS,%,280,0.987,
MAC,umol.L-1,280,0.987,
APD95,%,280,0.987,
MIC=<90,umol.L-1,278,0.987,
CC20,umol.L-1,278,0.987,
IC50,ug.mg-1,277,0.987,
GROWTHINDEX,,276,0.987,
AUC,umol.h.L-1,275,0.987,
ACTIVITY,mol/mol,274,0.988,
RECOVERYATOB(MEAN),%,274,0.988,
INHIBITORYACTIVITY,,273,0.988,
ILSMAX,,273,0.988,
RATIOLC50IC50,,273,0.988,
AVERAGEIC90,umol.L-1,273,0.988,
DELTALOGD,,272,0.988,
ORALACTIVITY,,272,0.988,
RELAXATION,%,272,0.988,
LOG(1I50),,271,0.988,
DELTAG,kJ.mol-1,271,0.988,
LOGKI,umol.L-1,270,0.988,
ED90,umol.L-1,270,0.988,
COMPLEXFORMATION,%,270,0.988,
EC50,ug.mg-1,269,0.988,
%MAX,,268,0.988,
TIME,,267,0.988,
MTD,umol.L-1,267,0.988,
ACTIVITY,[ppm],267,0.988,
D40,ug.mg-1,266,0.988,
KIC,umol.L-1,266,0.988,
RESPONSE,,266,0.988,
FOLDACTIVATION,,266,0.988,
MABP,mmHg,265,0.988,
EC50,mgAi/L,265,0.988,
ACTIVITY,pg,265,0.988,
STABILITY,umol.L-1,264,0.988,
DIAMETEROFINHIBITIONZONE,umol.L-1,264,0.988,
ACTIVITY,Zone units,264,0.988,
TDI,%,263,0.988,
PKAB1,,261,0.988,
LOG(RBA),,261,0.988,
LOG(43000KI),umol.L-1,260,0.988,
LOG(1ID50),,260,0.988,
VMAX,umol.L-1.s-1,260,0.988,
POLYAMINE,%,258,0.988,
FOLDREVERSION,,258,0.988,
ACTIVITY,g/L,256,0.988,
ACTIVITY,umolequiv/umol,256,0.988,
MIC,ug.mg-1,255,0.988,
GIC50,umol.L-1,255,0.988,
DILIPOSITIVENEGATIVE,,255,0.988,
EC20,umol.L-1,254,0.988,
ACTIVITY,IU/ml,254,0.988,
T-C,d,254,0.988,
IOP,mmHg,253,0.988,
STABILITY,umol.min-1,252,0.988,
BBR,,252,0.988,
CMAXDOSE,umol.L-1,251,0.988,
EMIN,%,251,0.988,
ACTIVITY,h-1,251,0.988,
ED25,ug.mg-1,251,0.988,
AMNESIAREVERSAL,%,251,0.988,
EC200,umol.L-1,250,0.988,
EMAX,umol.L-1,249,0.988,
BLOODGLUCOSE,%,249,0.988,
FU,umol.L-1,248,0.988,
FABS,%,247,0.988,
RATIOAUCMIC,,247,0.988,
FORMATION,%,246,0.988,
DRUGUPTAKE,umol.mg-1,246,0.988,
ALD50,ug.mg-1,246,0.988,
LTS,,246,0.988,
MITC95,umol.L-1,245,0.988,
RELATIVEVMAX,,245,0.988,
ACTIVITY,10'2mEq,244,0.988,
MFC,umol.ml-1,244,0.988,
PAPPATOB(MEAN),1E-6 cm/s,244,0.988,
KE(APP),umol.L-1,243,0.988,
ACTIVITY,deltalog10[CFU],242,0.988,
ED50,10'-2 ug/ml,242,0.988,
MAXINHIBITION,%,241,0.988,
CFU,ml-1,241,0.988,
ED50,g ml-1,240,0.988,
IC50,mg,240,0.988,
ED50,10'-3 ug/ml,240,0.988,
NOOFMICE,,238,0.988,
MRC,umol.L-1,237,0.988,
LC99,umol.L-1,237,0.988,
DIET,,237,0.988,
ANTAGONISTPOTENCY,,237,0.988,
ACTIVITY,micromol/kg/min,237,0.988,
TCS50,umol.L-1,235,0.988,
STABILITY,ml/min.kg,235,0.988,
K,hr-1,235,0.988,
GROWTHINHIBITION,,234,0.988,
EC2,umol.L-1,234,0.988,
%OFENGAGEMENT,%,233,0.988,
RATIOLD50ED50,,233,0.988,
LED,umol.L-1,232,0.988,
MEANSURVIVALDAYS,d,232,0.988,
MHC10,umol.L-1,231,0.988,
FAUCMIC,,231,0.988,
BODYWEIGHT,mg,231,0.988,
LEVEL,,229,0.988,
SOLUBILITY(MEAN),umol.L-1,229,0.989,
DECREASE,,228,0.989,
DRUGRELEASE,%,228,0.989,
IC50,[ppm],228,0.989,
DELTAA,,228,0.989,
LC90,[ppm],227,0.989,
DRUGDEGRADATION,,227,0.989,
ACTIVITY,meq,227,0.989,
TOXICITY,%,227,0.989,
HILLSLOPE,,227,0.989,
MOLEFRACTION,,227,0.989,
ACTIVITY,[CFU].ml-1,226,0.989,
BINDINGAFFINITY,,226,0.989,
R,%,226,0.989,
MED50,ug.mg-1,226,0.989,
OD,mg.kg-1.d-1,226,0.989,
ACTIVITY,c.p.m. 50ul-1,225,0.989,
TOXICDEATHS,,225,0.989,
AP,umol.L-1,224,0.989,
AUC,uM.hr.Kg/mg,224,0.989,
POTENCY,%,224,0.989,
MNEC,umol.L-1,224,0.989,
INH,s,223,0.989,
KINETIC,ug/ml,223,0.989,
MED,umol.L-1,222,0.989,
MAXFALLINBLOODPRESSURE,%,222,0.989,
WEIGHTCHANGE,,221,0.989,
DECREASEINBLOODPRESSURE,,221,0.989,
MEC,[ppm],221,0.989,
PTC50,,221,0.989,
PKAA1,,221,0.989,
SMAX,%,220,0.989,
DNAUC,kg.min/L,220,0.989,
FALL,,219,0.989,
CONTROL,,219,0.989,
I,%,218,0.989,
D,%,218,0.989,
RI,,218,0.989,
SALURETICACTIVITY,m equiv 5hr-1 kg-1,217,0.989,
ACTIVITYRATING,%,217,0.989,
LOGSP,,217,0.989,
ACTIVITY,cpm,216,0.989,
RETENTION,%,215,0.989,
CLF,L/hr,214,0.989,
WEIGHTDIFFERENCE,mg,213,0.989,
ACTIVITY,U/ml,213,0.989,
PK,,213,0.989,
KDISS,s-1,213,0.989,
ANTAGONISM,%,212,0.989,
ED15,ug.mg-1,211,0.989,
LOGKP,,211,0.989,
NH,,211,0.989,
DC50,,210,0.989,
MES,,209,0.989,
ALPHAMAX,,208,0.989,
AGONISTPOTENCY,,208,0.989,
PKI,umol.L-1,207,0.989,
FPDMEASUREMENT,FPDc,206,0.989,
BOTTOM,,206,0.989,
TOP,,206,0.989,
NI,,205,0.989,
IC50,molar ratio,205,0.989,
ACTIVITY,10'-2mm,204,0.989,
KINACT,,204,0.989,
BLOODPRESSURE,mmHg,204,0.989,
CC100,umol.L-1,204,0.989,
MEANSURVIVAL,d,204,0.989,
HYPOGLYCEMICACTIVITY,%,204,0.989,
ACTIVITY,uMequiv/uM,203,0.989,
PARASITAEMIA,%,203,0.989,
ACTIVITY,mg.kg-1.d-1,203,0.989,
WEIGHTCHANGE,g mouse-1,203,0.989,
CF,,203,0.989,
BASALUPTAKE,%,202,0.989,
ACTIVITY,pg/hr,202,0.989,
DELTALOG(TAUKA),,202,0.989,
C10,umol.L-1,201,0.989,
FAUC,umol.h.L-1,201,0.989,
RESISTANCEINDEX,,201,0.989,
LOG(RATIOIC50),,200,0.989,
CLOGD,,200,0.989,
K,h-1,200,0.989,
DELTAPIC50WT-MUTANT,,200,0.989,
ACQUISITIONTIME,s,199,0.989,
LC90,umol.L-1,199,0.989,
GLUCOSENORMALISATION,%,198,0.989,
ACTIVITY,MU,198,0.989,
TASTECHARACTER,,198,0.989,
LOG1K,,198,0.989,
ACTIVITY,/mol.L-1.s-1,197,0.989,
DELTALOG10CFUML,,196,0.989,
KBAPP,umol.L-1,196,0.989,
ACTIVITY,10^-2mm,196,0.989,
DOSEORGAN,,196,0.989,
SURVIVALTIME,d,196,0.989,
K2,/mol.L-1.s-1,196,0.989,
TDS,,195,0.989,
EFFICIENCY,%,194,0.989,
PEFF,,194,0.989,
KCAT,,193,0.989,
AD50,,193,0.989,
CHANGEINAMPLITUDERESPONSE,%,193,0.989,
IC99,umol.L-1,192,0.989,
SALURETICACTIVITY,m equiv kg-1,192,0.989,
MIC100,,192,0.989,
IZ,%,192,0.989,
ACTIVITY,IU/mg,192,0.989,
RELATIVEVIABILITY,%,192,0.989,
ACTIVITY,nmol/g,192,0.989,
ACTIVITY,ml/min,192,0.989,
RELATIVESEAPACTIVITY,%,192,0.989,
MAXSTIMULATION,%,191,0.989,
%ACTIVITY,%,191,0.989,
IZ,Zone units,191,0.989,
MFC90,umol.L-1,190,0.989,
ACTIVITY,milliequivalent/kg,190,0.989,
CFUML,,190,0.99,
FDI,%,190,0.99,
RA,,189,0.99,
DELTAAMIN,,188,0.99,
LOGKILL,,188,0.99,
LOGKA,,187,0.99,
ACTIVITY,pg/microg/hr,187,0.99,
PERMEABILITY,10'6cm/s,187,0.99,
EMETICEPISODES,,187,0.99,
MBIC90,umol.L-1,187,0.99,
IC5,umol.L-1,186,0.99,
ED90,gAi/ha,186,0.99,
CELLVIABILITYRATIO,,186,0.99,
MFC,umol,186,0.99,
AUCDOSE,nM.hr,185,0.99,
HC50,,185,0.99,
FA,%,185,0.99,
AUC,ng.hr/g,184,0.99,
EMR,,183,0.99,
ACTIVITY,RU,183,0.99,
SURVIVALS,,183,0.99,
PAPP,10'6cm/s,183,0.99,
BINDINGENERGY,kCal mol-1,183,0.99,
HD50,uM kg-1,182,0.99,
LOGPNALK,,182,0.99,
EC50RATIO,,182,0.99,
IC10,umol.L-1,182,0.99,
VMAXKM,,181,0.99,
PLD50,,181,0.99,
IC,umol.L-1,181,0.99,
AUCDOSE,ng.hr/ml,181,0.99,
AUCDOSE,umol.h.L-1,180,0.99,
DRUGUPTAKE,%IDKg/g,180,0.99,
BOUND,%,180,0.99,
PI,%,179,0.99,
BP,,179,0.99,
LOGKD,,179,0.99,
PERMEABILITY,10'-7 cm/s,178,0.99,
ACTIVITY,ng g-1,178,0.99,
ACTIVITY,mmol,178,0.99,
PARTITIONCOEFFICIENT,,178,0.99,
IZ,mm2,178,0.99,
MTL,umol.L-1,177,0.99,
LOG1T,,177,0.99,
ED50,[ppm],177,0.99,
MAXACTIVATION,,177,0.99,
I50,,176,0.99,
MIC50,mmol.ml-1,175,0.99,
LOG1IC50,,175,0.99,
LOGPEFF,,175,0.99,
SOLUBILITY,%,175,0.99,
MIC=>95,umol.L-1,174,0.99,
KINACT,/mol.L-1.s-1,174,0.99,
P,,174,0.99,
TAQINHIBITION,,174,0.99,
GC50,umol.L-1,174,0.99,
HR,%,174,0.99,
MEDIANSURVIVALTIME,,173,0.99,
LOG1MIC,,173,0.99,
R%,%,173,0.99,
GABARATIO,,173,0.99,
PIC25,,173,0.99,
EC40,umol.L-1,172,0.99,
REVERSION,%,172,0.99,
"%ENZYMEACTIVITY(RELATIVETODMSOCONTROLS,AVERAGEN=2)",%,172,0.99,
CONTROLCOMPOUNDIC50,umol.L-1,172,0.99,
VD,l,171,0.99,
AGGREGATION,%,171,0.99,
TISSUEDISTRIBUTION,,171,0.99,
CT,ug.mg-1,171,0.99,
ACTIVITY,dose ratio,171,0.99,
DELTAHR,%,171,0.99,
GE,%,171,0.99,
AB50,ug.mg-1,171,0.99,
SLEEPINGTIME,s,171,0.99,
CELLGROWTH,%,170,0.99,
NOAEL,umol.L-1,170,0.99,
FALL,%,170,0.99,
GABASHIFT,,169,0.99,
MPR,,169,0.99,
DRUGABSORPTION,%,169,0.99,
ABSORBANCE,,169,0.99,
FREE,%,168,0.99,
ACTIVITYINDEX,%,168,0.99,
K3KI,1/m/s,167,0.99,
CHANGEINBP,mmHg,167,0.99,
GEOMETRICMEAN,,167,0.99,
THERMALMELTINGCHANGE,,166,0.99,
PGI,%,166,0.99,
AVERAGEWEIGHTCHANGE,mg,166,0.99,
AVERAGESKINREACTION,,166,0.99,
PROTECTED,%,165,0.99,
LOGLC50,,165,0.99,
SOLUBILITY,uL,164,0.99,
FRP,%,164,0.99,
LOGBB,,164,0.99,
ABSAC30UM,umol.L-1,164,0.99,
PT,umol.L-1,164,0.99,
NORMALIZATION,%,163,0.99,
RRT,s,163,0.99,
VDSS,,163,0.99,
LOG(PERMEABILITY),,163,0.99,
ANALGESIA,%,162,0.99,
FEC50,umol.L-1,162,0.99,
MRTLAST,s,162,0.99,
RESPONSERATIO,,162,0.99,
IDXKGOFBODYWEIGHTGOFTISSUE,%,162,0.99,
MFC50,umol.L-1,161,0.99,
CSS,umol.L-1,161,0.99,
ACTIVITY,g/day,161,0.99,
ENHANCEMENT,%,161,0.99,
INDEX,,160,0.99,
RADIALGROWTHINHIBITIONOFFUNGI(Ā)(MM),mm,160,0.99,
NOOFSURVIVALS,,159,0.99,
ACTIVITY,MT/ha,159,0.99,
DOSE,umol.L-1,159,0.99,
PMIC50,,159,0.99,
SURVIVORS,%,159,0.99,
CFU,,159,0.99,
AFFINITY,%,158,0.99,
REMAININGACTIVITY,,158,0.99,
RIS,%,158,0.99,
MBC,umol,158,0.99,
LOGKON,,158,0.99,
VMAX,microM/min,158,0.99,
INHIBITION,radii.mm-1,157,0.99,
DRUGEXCRETION,%ID,157,0.99,
IC50,%,157,0.99,
RELATIVEED50,,157,0.99,
LOG10(%HIA+10),,157,0.99,
CONVERSION,%,157,0.99,
MISSTC,,156,0.99,
HYDROLYSIS,%,156,0.99,
RESIDUALINSULINRELEASE,%,156,0.99,
INCORPORATION,,156,0.99,
PROLIFERATIVERESPONSE,,156,0.99,
IRONCHANGE,%,156,0.99,
DELTABLOODPRESSURE,,156,0.99,
RELATIVEEFFICACY,,155,0.99,
CMAX,ug.mg-1,155,0.99,
FDI,,155,0.99,
PEFF,nm/s,155,0.991,
SC50,umol.L-1,155,0.991,
LOGKOH-,,155,0.991,
MEANARTERIALBLOODPRESSURE,mmHg,154,0.991,
DECREASEINSBP,,154,0.991,
KD(APP),,154,0.991,
AVERAGEWEIGHT,%,154,0.991,
MID,umol.L-1,154,0.991,
HACUIMPROVEMENT,%,153,0.991,
DISEASECONTROL,%,152,0.991,
REDUCTIONOFLIVEWORMS,%,152,0.991,
KOX,M-1 min-1,152,0.991,
MAD,ug.mg-1,152,0.991,
FOLDSELECTIVITY,,152,0.991,
ZONESIZE,umol.L-1,151,0.991,
K2,s-1,151,0.991,
NEUROTOXICITY,,151,0.991,
NOOFCURES,,151,0.991,
DRUGUPTAKE,%ID/cc,151,0.991,
CURESTOTAL,,151,0.991,
MAXEFFECT,%,151,0.991,
VDSS,l,150,0.991,
CULTURE,%,150,0.991,
P50,mmHg,150,0.991,
PRA,,150,0.991,
SELECTIVITY,umol.L-1,150,0.991,
SURVIVALTIME,,150,0.991,
RELATIVEACTIVATION,%,150,0.991,
MIC>98,umol.L-1,149,0.991,
MAP,mmHg,149,0.991,
SURVIVORSATDAY4,,149,0.991,
ED40,ug.mg-1,148,0.991,
BINDINGAFFINITY,umol.L-1,148,0.991,
LC80,[ppm],148,0.991,
LOG(KINETICSOLUBILITY),,147,0.991,
HF,,147,0.991,
POTENTIATION,%,147,0.991,
XI50,molar excess,146,0.991,
RA,%,146,0.991,
RADIOLABELRECOVERY,,146,0.991,
ID50,mg,146,0.991,
PTGI,,145,0.991,
LETHALITY,%,145,0.991,
FMAX,%,145,0.991,
ED90,mg.kg-1.d-1,145,0.991,
PDC50,,145,0.991,
TD50,umol.mg-1,145,0.991,
-LOGMIC,umol.L-1,144,0.991,
ACTIVITY,radii.mm-1,144,0.991,
MEANRELATIVEPOTENCY,,144,0.991,
V12,mV,143,0.991,
KHOX,M-1 min-1,143,0.991,
SWELLING,%,143,0.991,
TT,s,143,0.991,
ACTIVITY,cm2,143,0.991,
PH,,142,0.991,
AUCDOSE,microM.hr/mg/kg,142,0.991,
RELATIVEIC50,umol.L-1,142,0.991,
BBC,umol.L-1,142,0.991,
D10,ug.mg-1,142,0.991,
DELTABG,%,142,0.991,
BEHAVIOR,,142,0.991,
SELECTIVITYINDEX,umol.L-1,141,0.991,
INCORPORATION,%,141,0.991,
RATIOKI,umol.L-1,141,0.991,
CC25,umol.L-1,141,0.991,
RATIO,/M/min,141,0.991,
LC30,umol.L-1,141,0.991,
ACTIVITY,mmolequiv/mmol,141,0.991,
CONCENTRATION,nM g-1,141,0.991,
FLUORESCENCEINTENSITY,,141,0.991,
SUV,%,140,0.991,
RADIOACTIVITY,%ID/g,140,0.991,
MAXCONCENTRATION,umol.L-1,140,0.991,
TOXICITY,umol.L-1,139,0.991,
PKI(UM),,139,0.991,
LC100,umol.L-1,139,0.991,
ACTIVITY,ng/L,139,0.991,
HCR,,139,0.991,
ED100,ug.mg-1,139,0.991,
LEISHMANICIDALACTIVITY,,138,0.991,
DC50,microg/cm2,138,0.991,
HD50,ug.mg-1,138,0.991,
LOG(1ED50),,138,0.991,
CPEINDEX,,138,0.991,
AVERAGESURVIVAL,d,138,0.991,
DRUGTRANSPORT,,138,0.991,
P50E,mmHg,138,0.991,
LD90,umol.L-1,138,0.991,
MLD,umol,138,0.991,
EFFECTIVEDOSE,nM kg-1,137,0.991,
CIRATIO,,137,0.991,
ACTIVITY,10^9/L,137,0.991,
ACTIVITY,/m2,137,0.991,
ACTIVITY,mol,136,0.991,
LC70,[ppm],136,0.991,
CROPYIELD,tons/ha,136,0.991,
MTD,uM kg-1,136,0.991,
NOOFTOXICDEATHS,,135,0.991,
CLH,ug/min,135,0.991,
NORMALBEATS,%,135,0.991,
KI,umol.L-1.min-1,135,0.991,
PAPP,cm s-1,135,0.991,
ED40,uM kg-1,135,0.991,
PI50,umol.L-1,135,0.991,
CELLPROLIFERATIONEC50,umol.L-1,135,0.991,
UTC,%,135,0.991,
AUCDOSE,hr.Kg/L,134,0.991,
%OFACTIVITY,%,134,0.991,
AUCDOSE,,134,0.991,
CHANGEINIOP,mmHg,134,0.991,
LOGKOFF,,134,0.991,
TLAST,s,134,0.991,
KDPPH,/mol.L-1.s-1,134,0.991,
PF,,134,0.991,
HEARTRATE,,134,0.991,
ACTIVITY,tons/ha,134,0.991,
TUMORS,%,134,0.991,
FIC50,,133,0.991,
PARASITEMIA,%,133,0.991,
NOOFPOSITIVECASES,,133,0.991,
CLEAVAGE,%,133,0.991,
HYPERSENSITIVITYFACTOR,,133,0.991,
GR50,gAi/ha,132,0.991,
ENZYMEACTIVITY,%,132,0.991,
ED50,mg 2kg-1,132,0.991,
DIURETICEFFECT,,132,0.991,
CONCENTRATION,ng/mL,132,0.991,
ALLOSTEICENHANER(AE),%,132,0.991,
FOLDINCREASE,,131,0.991,
2XAPTT,umol.L-1,131,0.991,
SPECIFICITY,,131,0.991,
KAPP,,131,0.991,
NE,,131,0.991,
ABSAC200UM,umol.L-1,131,0.991,
MIC,uL.ml-1,131,0.991,
ED,umol.L-1,131,0.991,
EQUIEFFECTIVEDOSE,ug.mg-1,131,0.991,
LOGBR,,130,0.991,
MMC,umol.L-1,130,0.991,
KB,10^7/M,129,0.991,
KIUC,umol.L-1,129,0.991,
DRUGUPTAKE,umol.min-1,128,0.991,
KL,umol.L-1,128,0.991,
CRCCRC0,umol.L-1,128,0.991,
ACTIVITY,mEq/L,128,0.991,
FR50,,127,0.991,
K,10'-2/s,127,0.991,
DECREASEINACTIVITY,%,127,0.991,
APOPTOSIS,%,127,0.991,
RELATIVEEFFICACY,%,127,0.991,
TOXICITYRATIO,,127,0.991,
LOGFU,,127,0.991,
MAXSALTTOLERANCE,,126,0.991,
MCC,,126,0.991,
MEC,%,126,0.991,
TUMORVOLUME,mm**3,126,0.991,
MFC99,umol.L-1,126,0.991,
RANGE,,125,0.991,
P[A50],,125,0.991,
PROTECTION,,125,0.991,
LOG(1MLD),,125,0.991,
MBP,,125,0.991,
BMAX,fmol,125,0.991,
MFC<=999,umol.L-1,124,0.991,
ACTIVITY,mU,124,0.991,
RECOVERED,%,124,0.991,
FLUINTENSITY,a.u.,124,0.991,
KREL,,124,0.991,
ED10,ug.mg-1,124,0.991,
ABSORPTION,%,124,0.991,
LOGP(LUNG),,124,0.991,
TOXIC,,124,0.991,
ED80,gAi/ha,124,0.991,
VDSS,mL/min/kg,124,0.992,
MBC999,,123,0.992,
HEARTRATE,%,123,0.992,
ACTIVITY,nmol/min/ml,123,0.992,
LOGGI50,,123,0.992,
HI,,123,0.992,
CLH,L/min,123,0.992,
NOAEL,ug.mg-1,123,0.992,
KI(APP),,123,0.992,
TR,,123,0.992,
MLD,ug.mg-1,123,0.992,
NS,,123,0.992,
DISTRIBUTION(DOSEG),%,122,0.992,
A50,umol.L-1,122,0.992,
LOG1MEC,,122,0.992,
DIZ,%,122,0.992,
WEIGHTCHANGEDIFFERENCE,mg,121,0.992,
ACCUMULATION,%,121,0.992,
LYSIS,%,121,0.992,
DECREASEINSYSTOLICBLOODPRESSURE,%,121,0.992,
LEVEL,nM (mg of protein)-1,121,0.992,
PROLIFERATION,%,121,0.992,
LOG(1KM),,121,0.992,
AVERAGEWEIGHT,g mouse-1,121,0.992,
KIAPP,,120,0.992,
APTT,umol.L-1,120,0.992,
CT,,120,0.992,
NUMBER,,120,0.992,
MTD,g/acre,120,0.992,
RELATIVEPOTENCY,fold,120,0.992,
VMAX,pmol/min/mg protein,120,0.992,
PAPP,cm/s * 10E6,119,0.992,
NOOFMICEPROTECTED,,119,0.992,
PROLIFERATION,,119,0.992,
CCH,%,119,0.992,
ABSAC50UM,umol.L-1,119,0.992,
DOSE,uM kg-1,118,0.992,
NOOFANIMALSPROTECTEDANIMALSTESTED,,118,0.992,
LIPOPHILICITY,,118,0.992,
ND50,ug.mg-1,118,0.992,
LOG1KM,,117,0.992,
PA2(APP),,117,0.992,
PC,,117,0.992,
ACTIVITY,mol/L,117,0.992,
LOG10CFUG,,117,0.992,
DRUGUPTAKE,ngequiv/g,116,0.992,
DELTAG,,116,0.992,
SALURETICPOTENCY,u equiv,116,0.992,
ECMAX,umol.L-1,116,0.992,
ED20,mM kg-1,116,0.992,
D50,ug.mg-1,116,0.992,
RESISTANCE,,116,0.992,
EC95,umol.L-1,116,0.992,
STIMULATIONINDEX,,116,0.992,
NOOFTUMORS,,116,0.992,
BWD,mg,115,0.992,
CHANGEINCL-CURRENT,,115,0.992,
IC50,10^2 uM,115,0.992,
RELATIVEAMPLITUDE,%,115,0.992,
RATIO,10^3/M/min,115,0.992,
SD90,mg.kg-1.d-1,114,0.992,
DRUGTRANSPORT,%,114,0.992,
RATING,,114,0.992,
AMOUNTEXCRETED,%,114,0.992,
MCD,ug.mg-1,114,0.992,
-LOGED50,M acre-1,114,0.992,
LD50,[ppm],114,0.992,
FIC,umol.L-1,114,0.992,
URINEVOLUME,ml,114,0.992,
T50,s,114,0.992,
CHOLESTEROLREDUCTION,%,113,0.992,
CHANGEINHEARTRATE,%,113,0.992,
DELTALOG10CFU,,113,0.992,
HEMOLYSIS,%,113,0.992,
ACTIVITYSCALE,umol.L-1,113,0.992,
ACTIVITY,log10[CFU].g-1,113,0.992,
KBIND,umol.L-1,113,0.992,
MAXRESPONSE,,113,0.992,
LC50,mgAi/L,113,0.992,
URINEVOLUME,ml 6hr-1 100g-1,113,0.992,
FC,%,113,0.992,
DURATIONOFACTION,s,112,0.992,
UPTAKE,%ID/g,112,0.992,
LICKINGLATENCY,s,112,0.992,
SUSCEPTIBILITY,,112,0.992,
MAX,mmHg s-1,112,0.992,
LD10,mg.kg-1.d-1,112,0.992,
PAPP,10'-7 cm/s,112,0.992,
LOGI50,,112,0.992,
GLUCOSEUTILIZATION,umol.L-1,112,0.992,
SELECTIVITYQUOTIENT,,112,0.992,
AUC,hr.ng/g,112,0.992,
DRUGMETABOLISM,ug.mg-1,111,0.992,
"K(P,UU,CSF)",,111,0.992,
MECHANISMBASEDINHIBITION,,111,0.992,
PTD50,,111,0.992,
Q,umol.L-1,111,0.992,
EFFECTIVEDOSE,,110,0.992,
ENTRYLATENCY,s,110,0.992,
LOWERING,%,110,0.992,
-LOGC,mM kg-1,110,0.992,
ACTIVITY,mg-1.g-1,109,0.992,
PKA3,,109,0.992,
TDELTAS,kcal.mol-1,109,0.992,
UTERINEWEIGHT,mg,109,0.992,
TD50,uM kg-1,109,0.992,
EXCRETION,%,109,0.992,
NA,m equiv 6hr-1 100g-1,108,0.992,
UPTAKEVALUE,,108,0.992,
RELATIVEHYDROLYSISRATE,,108,0.992,
MGM,,108,0.992,
ACTIVITY,ug/mg/day,108,0.992,
TOTALIRONOUTPUT,ug.mg-1,108,0.992,
INJECTEDDOSEORGAN,%,108,0.992,
NA+K+,,108,0.992,
TASTECLASS,,108,0.992,
EXPRESSION,%,107,0.992,
CONVERSIONRATE,%,107,0.992,
TPE,s,107,0.992,
TIMECONSTANT,ms,107,0.992,
IVP,,107,0.992,
SAFETYINDEX,,107,0.992,
SECRETION,%,107,0.992,
KIN,hr-1,107,0.992,
SMT,s,106,0.992,
KR,s-1,106,0.992,
CELLVIABILITY,,106,0.992,
NOOFROSETTES100JURKATTCELLS,,106,0.992,
IC90,mg,106,0.992,
LAD,ug.mg-1,106,0.992,
TOTALRADIOACTIVITY,%,106,0.992,
SENSITIVITY,,106,0.992,
INH,ug.mg-1,105,0.992,
MIC>85,umol.L-1,105,0.992,
ESTROGENICPOTENCY,,105,0.992,
INHIBITORYINDEX,,105,0.992,
MTD,mg.kg-1.d-1,105,0.992,
ONSET,s,105,0.992,
DELTALOGIC50,,104,0.992,
RATIOPKB,,104,0.992,
ANTIFERTILITYPOTENCY,,104,0.992,
WETWEIGHTOFTISSUE,nM g-1,104,0.992,
ED2,ug.mg-1,104,0.992,
ACTIVITY,uEq,104,0.992,
CONCENTRATION,ng g-1,104,0.992,
ACTIVITY,umol.h.L-1,104,0.992,
MIC95,umol.ml-1,104,0.992,
TCX100,,104,0.992,
LC50,ug.cm-3,104,0.992,
ACTIVITY,disintegrations/minute,104,0.992,
K,/M/min,104,0.992,
KAPP,10e-7/M,103,0.992,
LOG(RATIOKI),,103,0.992,
ED50,ug injection-1,103,0.992,
BPR,%,103,0.992,
PERMEABILITY,umol.L-1.s-1,103,0.992,
MBP,mmHg,103,0.992,
AD50,ug/kg,103,0.992,
KAPP,10^6L/mol,102,0.992,
BETA2DURATION,s,102,0.992,
IR,%,102,0.992,
P50C,mmHg,102,0.992,
ACTIVITY,uM/L,102,0.992,
INCREASEINBLOODPRESSURE,mmHg,102,0.992,
FM,,102,0.992,
PBI,,102,0.992,
PROTEIN-DNACOMPLEXFORMATION,%,102,0.992,
IS,,102,0.992,
TM,°C,102,0.992,
SERUMCA2+,mg dl-1,101,0.992,
PI50,uM pupa-1,101,0.992,
HR,,101,0.992,
TPE,,101,0.992,
ID50RATIO,,101,0.992,
PAPP,cm/s,101,0.992,
ACCUMULATION,,101,0.992,
LD10,M kg-1,101,0.992,
CCID50,umol.L-1,100,0.992,
MEC,,100,0.992,
CURESNOOFANIMALS,,100,0.992,
IP,,100,0.992,
PAWSWELLING,%,100,0.992,
NOOFSENSITIVE,,100,0.992,
SPECIFICBINDING,%ID/g,100,0.992,
KINACTKI,/mol.L-1.s-1,100,0.992,
TCID50,umol.L-1,100,0.992,
NOOFCELLS,%,100,0.992,
CHANGEINRESPONSE,%,99,0.992,
EFFICACY,umol.L-1,99,0.992,
AUCDOSE,ng.hr/ml/mg/kg,99,0.992,
INHIBITIONZONE,,99,0.992,
KINACT,hr-1,99,0.992,
ED15,,99,0.992,
ADHESION,%,99,0.992,
RE,,99,0.992,
PROTECTIVEINDEX,,99,0.992,
RELATIVEBINDINGAFFINITY,%,99,0.992,
PERMEABILITY,cm/s,99,0.992,
CLFREE,uL/min,99,0.992,
KI,%,99,0.992,
AVERAGEDOSEPERORGAN,%,98,0.992,
ED50,10'-4 ug/ml,98,0.992,
LOG(1IC50),umol.L-1,98,0.992,
TMAX,,98,0.992,
HYDROLYSIS,,98,0.992,
ANTAGONISTACTIVITY,,98,0.992,
MBEC50,umol.L-1,98,0.992,
ED25,umol.L-1,98,0.992,
AGONISM,%,98,0.992,
AMOUNTOFTNF-ALPHA,%,98,0.992,
PXC50,umol.L-1,98,0.992,
APDC,,98,0.992,
INCREASEINIC50,,98,0.992,
ACTIVITY,mol%,98,0.992,
DELTAMAP,%,98,0.992,
HAMMETTCONSTANT,,98,0.992,
CL,L/min,97,0.992,
BENZIDINEPOSITIVECELLS,%,97,0.992,
URINEVOLUME,ml 4hr-1,97,0.992,
MTD,,97,0.992,
ACTIVITY,pmol/mg,97,0.993,
LATENCY,s,97,0.993,
IP,%,97,0.993,
ED25,mg.kg-1.d-1,97,0.993,
PCMAANTAGONISM,,97,0.993,
MES,ug.mg-1,97,0.993,
K,10'-3/min,97,0.993,
MFC100,umol.L-1,96,0.993,
RATECONSTANT,M-1 min-1,96,0.993,
SEROSALMUCOSALCA,,96,0.993,
RESIDUALINSULINRELEASE,,96,0.993,
TRANSFECTIONEFFICIENCY,RLU (ug of protein)-1,96,0.993,
DRUGEXCRETION,mg,96,0.993,
MAXREVERSAL,%,96,0.993,
XI50,mole fraction,96,0.993,
TI50,,96,0.993,
ACTIVITY,uMequiv,96,0.993,
K,10'-4/s,96,0.993,
METABOLITELEVEL,,96,0.993,
LD,umol.L-1,95,0.993,
TASTE,,95,0.993,
ACTIVITY,RLU,95,0.993,
BODYWEIGHTCHANGE,%,95,0.993,
KSV,L.umol-1,95,0.993,
FOLDINDUCTION,,95,0.993,
ACTIVITY,mA,95,0.993,
3LOGKILL,,95,0.993,
DARELEASE,%,95,0.993,
DOSE,,94,0.993,
H2O2PROT,,94,0.993,
DELTASBP,mmHg,94,0.993,
CL,umol.L-1,94,0.993,
LOG1D40,,94,0.993,
RECOVERYBTOA(MEAN),%,94,0.993,
KA,s-1,94,0.993,
PLAQUEREDUCTION,%,94,0.993,
LOG(1BC),,94,0.993,
ED20,gAi/ha,94,0.993,
RIC50,,94,0.993,
EH,,93,0.993,
DIURETICACTIVITY,m equiv kg-1,93,0.993,
KEL,s-1,93,0.993,
KI,nM l-1 hr-1,93,0.993,
LOGK'W,,93,0.993,
AVERAGESURVIVAL(DAYS),,93,0.993,
LD50,g/Kg,93,0.993,
LACTONE,%,93,0.993,
MED=>50,ug.mg-1,93,0.993,
RADIATIONPROT,,93,0.993,
D,,93,0.993,
SVT,%,93,0.993,
CAC,umol.L-1,93,0.993,
RATIOLD50IC50,,93,0.993,
MAXFALLINBLOODPRESSURE,,92,0.993,
MEANAORTICBLOODPRESSURE,mmHg,92,0.993,
APD,-60mV,92,0.993,
MIC95,,92,0.993,
MEAN,,92,0.993,
INCREASEINEARTHICKNESS,1/100mm,92,0.993,
ABSAC50,umol.L-1,92,0.993,
MAXDELTATM,umol.L-1,92,0.993,
INDUCTION,,92,0.993,
BLOODFLOW,100ml g-1 min-1,92,0.993,
DIFFERENTIATION,%,92,0.993,
MGM,umol.L-1,92,0.993,
DRUGRECOVERY,,92,0.993,
NORELEASE,%,92,0.993,
BODYWEIGHT,,92,0.993,
RATIOLD50EC50,,92,0.993,
C20,umol.L-1,91,0.993,
PAPP,10'-5cm/s,91,0.993,
ANTAGONISM,,91,0.993,
EXCRETIONNA+,m equiv,91,0.993,
EXCRETIONK+,m equiv,91,0.993,
V,ml,91,0.993,
EXCRETIONCL-,m equiv,91,0.993,
PI50,,91,0.993,
ED50,ug mouse-1,91,0.993,
KR,umol.L-1,91,0.993,
BETAT12,,91,0.993,
EXCRETION,m equiv,90,0.993,
PRODUCTION,%,90,0.993,
DRUGMETABOLISM,microL/min/mg,90,0.993,
MEANURINEVOLUME,ml,90,0.993,
AVERAGECONSUMED,mg,90,0.993,
IAR,,90,0.993,
MED,mg,90,0.993,
LOGKOW,,90,0.993,
BILIARYEXCRETION,%,90,0.993,
UPTAKE,%,90,0.993,
MEANEXCRETIONOFNA+,m equiv,90,0.993,
MEANEXCRETIONOFCL-,m equiv,90,0.993,
AM,%,90,0.993,
EC50,mg,90,0.993,
MIC,ug.cm-3,90,0.993,
MEANEXCRETIONOFK+,m equiv,90,0.993,
ISA,%,90,0.993,
ACTIVITY,Kg,90,0.993,
ED50,micromol/kg/min,90,0.993,
A10,umol.L-1,90,0.993,
REC,,89,0.993,
IC50,equiv,89,0.993,
LOGS0,,89,0.993,
P[A]50,,89,0.993,
VMAX,umol.L-1.min-1.mg-1,89,0.993,
FLUORESCENCE,umol.L-1,89,0.993,
ACTIVITY,% dose (g of tissue)-1,89,0.993,
ID50,ng min-1 rat-1,88,0.993,
ED90,,88,0.993,
PDK,,88,0.993,
V0,microM/min,88,0.993,
TEMPERATURE,Cel,88,0.993,
K2,umol.L-1,88,0.993,
PK1,,88,0.993,
METABOLISM,%,88,0.993,
CCTD50,umol.L-1,88,0.993,
BWD,,88,0.993,
KINETICCONSTANT,,88,0.993,
MEANLOGD,,88,0.993,
NUCLEARCATARACT,%,88,0.993,
GLUCOSETRANSPORT,%,87,0.993,
ABSAC90,umol.L-1,87,0.993,
-DELTAG,,87,0.993,
%OFRESIDUALACTIVITY,%,87,0.993,
ANALGESICACTIVITY,,87,0.993,
OVULATINGRATS,,87,0.993,
KD,10'-2/s,87,0.993,
BK,%,87,0.993,
DELTARM,,87,0.993,
RELATIVEUTERUSWEIGHT,,87,0.993,
ACTIVITY,deltalog10[CFU].ml-1,87,0.993,
RAC,,87,0.993,
DECREASEINAP,%,87,0.993,
INHIBITORYZONE,umol.L-1,87,0.993,
ESCLOSS,%,87,0.993,
RELATIVERESISTANCE,,87,0.993,
KR,/mol.L-1.s-1,87,0.993,
JUDGMENTS,,87,0.993,
LEVEL,umol.L-1,87,0.993,
DIURETICACTIVITY,ml,87,0.993,
ACTIVITY,10'3/mm3,87,0.993,
DIAMETEROFINHIBITIONZONE,,86,0.993,
REVERTANTSPLATE,,86,0.993,
ACTIVITY,ug/mg,86,0.993,
SYSTOLICBLOODPRESSURE,mmHg,86,0.993,
THERAPEUTICRATIO,,86,0.993,
PCC50,umol.L-1,86,0.993,
METABOLISM,umol.L-1.min-1.mg-1,86,0.993,
CYTOTOXICITY,U,86,0.993,
MEANBLOODPRESSURE,mmHg,86,0.993,
DELTAAPD95,%,86,0.993,
NOOFRATSOVULATED,,86,0.993,
RESULT,,86,0.993,
RATIOPA2,,86,0.993,
CLH(APP),uL/min,86,0.993,
WEIGHTDIFFERENCE,,86,0.993,
METABOLISM,,86,0.993,
PIC50(APP),,86,0.993,
STABILITY,uL/min.mg,85,0.993,
CONCENTRATION,nM (10e6*cells)-1,85,0.993,
LOGD50,,85,0.993,
CLH,umol.min-1.mg-1,85,0.993,
LOGKB,,85,0.993,
CLFREE,,85,0.993,
PROTECTIONINDEX,,85,0.993,
CONTRACTION,%,85,0.993,
INJECTEDDOSEGTISSUE,%,85,0.993,
ANTIBACTERIALACTIVITY,,85,0.993,
DECREASEINBLOODPRESSURE,mmHg,84,0.993,
KI'',umol.L-1,84,0.993,
OVRATTOTAL,,84,0.993,
STABILITY,uL/min,84,0.993,
LLRSCORE,,84,0.993,
MD,,84,0.993,
PLASMACONTENT,nM ml-1,84,0.993,
BRAINCONTENT,nM ml-1,84,0.993,
DRF,,84,0.993,
CHANGEINWEIGHT,%,84,0.993,
MPE50,ug.mg-1,84,0.993,
IC50RELATIVE,,84,0.993,
KI',umol.L-1,84,0.993,
LOSS,%,84,0.993,
INHIBITIONRATIO,,84,0.993,
DECREASEINBLOODGLUCOSE,%,84,0.993,
LDH,MU,84,0.993,
RELATIVEPROTECTION,,84,0.993,
PA10,,84,0.993,
EII50,,84,0.993,
EC100,[ppm],84,0.993,
CHANGEINBLOODPRESSURE,mmHg,84,0.993,
S,,84,0.993,
LOGKCAT,,83,0.993,
AVERAGEWEIGHTCHANGE,%,83,0.993,
CLAST,umol.L-1,83,0.993,
RELATIVEJC-1ACCUMULATION,,83,0.993,
RMAX,,83,0.993,
VMAX,pmol/min/mg,83,0.993,
DRUGMETABOLISM,nmol/g,83,0.993,
SURVIVALRATIO,,83,0.993,
T-C,mg,82,0.993,
NOOFCOLONYFORMINGUNITS,,82,0.993,
PD50,,82,0.993,
PIC100,,82,0.993,
BPDECREASE,mmHg,82,0.993,
KIKI,M-1 min-1,82,0.993,
P(1MIC),,82,0.993,
FIBRILFORMATION,%,82,0.993,
KD,10'-1/s,82,0.993,
ID50,umol,82,0.993,
VMAX,micromol/min,82,0.993,
ALPHAKI,umol.L-1,82,0.993,
ACTIVITY,umol.L-1.s-1,82,0.993,
RP,,82,0.993,
LTC,,82,0.993,
ACTIVITY,total picomoles,82,0.993,
EH,none,82,0.993,
LEVEL,%,82,0.993,
IC50,10^-7mol/L,81,0.993,
RELATIVEEC30,umol.L-1,81,0.993,
ACTIVITY,L/mol/s,81,0.993,
EXTRACTED,%,81,0.993,
SOLUBILITY,mg,81,0.993,
MTC,,81,0.993,
ACTIVITY,pmol/hr,81,0.993,
EC50,microg/cm2,81,0.993,
LIPIDLEVEL,mg dl-1,80,0.993,
ACTIVITY,/M/cm,80,0.993,
ACTIVITY,milli optical density/minute,80,0.993,
ACTIVITY,log10FFU/ml,80,0.993,
BIODISTRIBUTION,%Dose/g,80,0.993,
CONTRACTION,,80,0.993,
LC50,ugAi/ml,80,0.993,
RELATIVEAMOUNT,%,80,0.993,
CMP,,80,0.993,
-LOG(RATIOIC50),,80,0.993,
ED99,ug.mg-1,80,0.993,
LD90,ug.mg-1,80,0.993,
ALPACTIVITY,,80,0.993,
MABP,,80,0.993,
MYCELIALGROWTH,cm,80,0.993,
OCC50,umol.L-1,80,0.993,
RU,,79,0.993,
LOGMIC,,79,0.993,
STABILTY,s,79,0.993,
ACTIVITY,pM,79,0.993,
T-C,,79,0.993,
AUCDOSE,uM.hr.Kg/mg,79,0.993,
SURVIVALDAYS,,79,0.993,
ECSRATIO,,79,0.993,
XI50,,79,0.993,
ED200,umol.L-1,79,0.993,
MEANWEIGHT,mg,79,0.993,
LOG10CCID50,,78,0.993,
LBF,%,78,0.993,
DOM,%,78,0.993,
IF,,78,0.993,
-TDELTAS,kJ.mol-1,78,0.993,
BASELINESYSTOLICBP,%,78,0.993,
RATIOGI50EC50,,78,0.993,
SI,umol.L-1,78,0.993,
CONCENTRATION,pg ml-1,78,0.993,
AA,,78,0.993,
ACTIVITY,fmol,78,0.993,
I50,[ppm],77,0.993,
INCREASEINLIFE-SPAN,%,77,0.993,
CL,ml/hr,77,0.993,
DRUGMETABOLISM,pmol/min/mg,77,0.993,
BINDINGINTENSITY,,77,0.993,
EC10,umol.L-1,77,0.993,
RUMAX,,77,0.993,
KIKM,,77,0.993,
PEAKRHGH,umol.L-1,77,0.993,
P,cm s-1,77,0.993,
AFFINITYCONSTANT,umol.L-1,77,0.993,
CI50,,76,0.993,
D50,mg.kg-1.d-1,76,0.993,
MAXDECREASEINHEARTRATE,%,76,0.993,
ORALDIURETICACTIVITY,m equiv [Na+] 5hr-1kg-1,76,0.993,
DECREASEINCR,%,76,0.994,
GS,,76,0.994,
SVT,,76,0.994,
BMAX,umol,76,0.994,
PKA4,,76,0.994,
EC,,76,0.994,
TIRATING,,76,0.994,
DIZ,mm.mg-1,76,0.994,
IC200,umol.L-1,76,0.994,
INHIBITORYRESPONSE,%,76,0.994,
FOLDRESISTANCE,,76,0.994,
RANGE,umol.L-1,76,0.994,
CT,% ID/g,76,0.994,
TG100,umol.L-1,76,0.994,
LOGKMEMB,,76,0.994,
ACTIVITY,IU,76,0.994,
ANTIBIOTICACTIVITY,,76,0.994,
IC16,umol.L-1,76,0.994,
SCMET,,75,0.994,
2-DGUPTAKESTIMULATION,,75,0.994,
CYD50,umol.L-1,75,0.994,
HSAI,,75,0.994,
REVERSALACTIVITY,%,75,0.994,
PB,umol,75,0.994,
RELATIVEAFFINITY,%,75,0.994,
MUTAGENICITY,,75,0.994,
MCC50,umol.L-1,75,0.994,
K,10^-3/min,75,0.994,
AUC,ng/g.hr,75,0.994,
DURATION,,75,0.994,
SLOPE,,75,0.994,
LOGPOTENCYRATIO,,75,0.994,
DEGRADATION,%,75,0.994,
EC15,,74,0.994,
AUCDOSE,nM.hr.kg/mg,74,0.994,
STABILITY,mm,74,0.994,
CELLPROLIFERATIONIC50,umol.L-1,74,0.994,
AFFINITY,umol.L-1,74,0.994,
DELTALOGP,,74,0.994,
CUREDTREATED,,74,0.994,
IC50,10^-9mol/L,74,0.994,
GROWTHZONE,umol.L-1,74,0.994,
MORTALITY,d,74,0.994,
%AUCEXTRA,%,74,0.994,
ZONEOFINHIBITION,,74,0.994,
ED50,%,74,0.994,
RATE,,74,0.994,
TUMORWEIGHT,mg,74,0.994,
CAVE,umol.L-1,74,0.994,
ACTIVITY,nmol/hr,74,0.994,
MGC,umol.L-1,74,0.994,
EC5,umol.L-1,74,0.994,
K,Min-1,73,0.994,
REMAININGACTIVITY,%,73,0.994,
MLD50,umol.L-1,73,0.994,
PALPHA,,73,0.994,
BIOREDUCTION,%,73,0.994,
TGIR,%,73,0.994,
MI05,umol.L-1,73,0.994,
DRUGDISCRIMINATIONEFFECT,%,73,0.994,
HILLCOEFFICIENT(N50),,73,0.994,
RBLOODPLASMA,,73,0.994,
DRUGUPTAKE,nmol/Kg,73,0.994,
NOOFRABBITSCONVULSED,,73,0.994,
LOG[MRI],,73,0.994,
ACTIVITY,pg/mg,73,0.994,
FR,,73,0.994,
FLUINTENSITY,%,72,0.994,
EXCRETIONRATE,,72,0.994,
DIURETICACTIVITY,ml kg-1,72,0.994,
COMPOUNDCONCENTRATI,umol.L-1,72,0.994,
SWEETNESSPOTENCY,0-15 scale,72,0.994,
LOG(1MED),,72,0.994,
RATIO,U,72,0.994,
ACTIVITY,RPKM,72,0.994,
INCREASEINMEANSURVIVALTIME,d,72,0.994,
TBPSSHIFT,,72,0.994,
KDISS,umol.L-1,72,0.994,
KOBS,,72,0.994,
BLOCKAGEACTIVITY,,72,0.994,
PK2,,72,0.994,
SALURETICACTIVITY,m equiv 6hr-1 kg-1,72,0.994,
LOG(TAUKA),,72,0.994,
BIODISTRIBUTION,nM (g of tissue)-1,72,0.994,
ACTIVITY,fL,72,0.994,
SERUMCONCENTRATION,,72,0.994,
ED30,umol.L-1,72,0.994,
SHIFT,,71,0.994,
DEATH,%,71,0.994,
LOG%ABS,,71,0.994,
CONCENTRATION,% kg dose g-1,71,0.994,
INFLECTIONPOINT,umol.L-1,71,0.994,
CR,mg dl-1,71,0.994,
SELECTIVITYINDEX,SI,71,0.994,
INHIBITORLEVEL,,71,0.994,
P-VALUE,,71,0.994,
MOUSEBEHAVIORACTIVITY,,71,0.994,
ND,,71,0.994,
AUCDOSE,kg.hr/L,71,0.994,
LWBW,,71,0.994,
BLOODSUGARLOWERING,%,71,0.994,
LOGPF,,71,0.994,
CELLS,%,70,0.994,
NOOFCURES,d,70,0.994,
KA',,70,0.994,
LOGCELLKILL,,70,0.994,
LOGD65,,70,0.994,
AUC,uM.hr/ml,70,0.994,
IC50,% conc,70,0.994,
BA,%,70,0.994,
ED30,uM kg-1,70,0.994,
METHEMOGLOBIN,,70,0.994,
AUCDOSE,min.kg/L,70,0.994,
UD50,ug.mg-1,70,0.994,
GHI,,70,0.994,
ED50,g/Kg,70,0.994,
BIODISTRIBUTION,% g-1,70,0.994,
C20APD95,umol.L-1,70,0.994,
PAPP,uL/hr/cm2,70,0.994,
GLYCEAMIAEVOLUTION,%,70,0.994,
RESISTANCE,%,70,0.994,
NOAEL,mg.kg-1.d-1,70,0.994,
ULCEROGENICINDEX,,70,0.994,
SURVIVORSANIMALSTESTED,,69,0.994,
KAPP,10^3/M,69,0.994,
ACTIVITY,m,69,0.994,
LATENCY,,69,0.994,
INHIBITORYPOTENCY,,69,0.994,
AOA,,69,0.994,
DELTA,%,69,0.994,
I05,umol.L-1,69,0.994,
COLLAPSETIME,s,69,0.994,
UN,mg dl-1,69,0.994,
LOGCR,,69,0.994,
KA,/uM,69,0.994,
DELTAPIC50,,69,0.994,
SS,%,69,0.994,
CHANGEINREACTIONTIME,%,69,0.994,
LOGA,,69,0.994,
DIURETICEFFECTS,,69,0.994,
LS,%,69,0.994,
ED50,umol.L-1.ml-1,69,0.994,
EC30,,69,0.994,
DELTAG,kCal,68,0.994,
LOGRELATIVEK',,68,0.994,
TEMPERATURECHANGE,Cel,68,0.994,
ACTIVITY,% ID/g,68,0.994,
CC30,umol.L-1,68,0.994,
DISPLACEMENT,,68,0.994,
POTENCY,mg.kg-1.d-1,68,0.994,
ACTIVITY,ml.kg-1,68,0.994,
CHANGETC,%,68,0.994,
PCA,,68,0.994,
MID,,68,0.994,
MBC,mg,68,0.994,
%ABSORBED,%,68,0.994,
-DELTAG,kCal mol-1,68,0.994,
PC1,,68,0.994,
CONVULSION,%,68,0.994,
TURNOVER,umol.L-1,68,0.994,
AR,,68,0.994,
MHC,mg,67,0.994,
ACTIVITY,mmol/Kg,67,0.994,
BMAX,fM mg-1,67,0.994,
ACTIVITY,nmol/L,67,0.994,
MEANPEAKAPTT,,67,0.994,
[3H]CONCENTRATION,% kg dose g-1,67,0.994,
ACTIVITY,[CFU].g-1,67,0.994,
ACTIVITY,uIU/ml,67,0.994,
TC,mg dl-1,67,0.994,
HYPOTHERMICEFFECT,,67,0.994,
DELTAVMAX,%,67,0.994,
STABILITY,ml/min,67,0.994,
OCC,,67,0.994,
SP,mmHg,67,0.994,
NOOFCHICKS,,67,0.994,
NOOFEMETICEPISODES,,67,0.994,
AVERAGECHANGEINBODYWEIGHT,%,67,0.994,
ED150,ug.mg-1,67,0.994,
MI50,umol.L-1,67,0.994,
EC50,%,66,0.994,
KI05,umol.L-1,66,0.994,
URINARYRECOVERY,%,66,0.994,
LOGPE,cm/s,66,0.994,
WEIGHTLOSS,mg,66,0.994,
LOG1KI,,66,0.994,
PFC,,66,0.994,
CD100,umol.L-1,66,0.994,
[I],umol.L-1,66,0.994,
BWLMAX,%,66,0.994,
RATIOPAPP,,66,0.994,
EC2X,umol.L-1,66,0.994,
MBEC,,66,0.994,
AUC,ug.hr/g,66,0.994,
RATIO,M-1 min-1,66,0.994,
DRUGUPTAKE,ugequiv,66,0.994,
EDEMAVARIATION,%,66,0.994,
ACTIVITY,mol/min,66,0.994,
P50D,mmHg,66,0.994,
AUCRATIO,,66,0.994,
PARASITECLEARANCE,%,66,0.994,
IRONOUTPUT,,66,0.994,
%RECOVERY,,66,0.994,
SERUMLEVEL,mg dl-1,65,0.994,
POTENCYCLK4UM,umol.L-1,65,0.994,
-LOGKA,,65,0.994,
BIOLOGICALACTIVITY,%,65,0.994,
C16,umol.L-1,65,0.994,
MAXREDUCTION,%,65,0.994,
K,10'3/M/min,65,0.994,
ID90,umol.L-1,65,0.994,
ED50,mg.ml-1,65,0.994,
CT50,umol.L-1,65,0.994,
P50EP50C,,65,0.994,
ULCERINCIDENCE,number/group,65,0.994,
SELECTIVITY,zone unit,65,0.994,
SPECIFICBINDING,%,65,0.994,
BODYWEIGHTCHANGE,mg,65,0.994,
ACTIVITY,umol.s-1,65,0.994,
SERUMCA2+,,65,0.994,
KIEQ,umol.L-1,65,0.994,
MDD,,65,0.994,
BEHAVIORALSCORE,,64,0.994,
ROTARODTOXICITY,,64,0.994,
KI,L.umol-1,64,0.994,
PAPPBTOA(MEAN),1E-6 cm/s,64,0.994,
SYSTOLICBLOODPRESSURE,,64,0.994,
P24,pg ml-1,64,0.994,
LD100,ug.mg-1,64,0.994,
TOXICITY,uM kg-1,64,0.994,
ED100,,64,0.994,
RATIOIC50,umol.L-1,64,0.994,
TRACER,%,64,0.994,
RELATIVEEC30,,64,0.994,
LOG(1SD90),,64,0.994,
ACTIVITY,10^2 mm,64,0.994,
DISCRIMINATIONRATIO,,64,0.994,
FRACTIONIONISED,,64,0.994,
LOGPE,cm s-1,64,0.994,
LD20,,64,0.994,
PC,cm s-1,64,0.994,
PAPP,10'-5 cm/s,64,0.994,
CLRENAL,L/hr,64,0.994,
CHANGEINWEIGHT,,64,0.994,
ACTIVITY,/cm3,64,0.994,
NETCELLKILL,log10,64,0.994,
DELTAPKI,,64,0.994,
STABILITY,ml/min/mg,64,0.994,
K,10^-3/s,64,0.994,
INHIBITIONZONE,cm,64,0.994,
CC,,64,0.994,
TM,,64,0.994,
RADIUSOFINHIBITIONZONE,umol.L-1,64,0.994,
MIC=<50,umol.L-1,64,0.994,
RESIDUALINSULINSECRETION,%,64,0.994,
ELOGD,,64,0.994,
AC3,umol.L-1,64,0.994,
DELTAHDL,%,64,0.994,
ACTIVITY,molar ratio,63,0.994,
AGONISTACTIVITY,,63,0.994,
IMAX,mmHg,63,0.994,
CL-CURRENTCHANGE,,63,0.994,
PLC50,,63,0.994,
RUMAX,10'2/Da,63,0.994,
SPECIFICACTIVITY,umol.L-1.min-1.mg-1,63,0.994,
LOGACTIVITY,,63,0.994,
METABOLICSTABILITY,%,63,0.994,
CT10,uM h,63,0.994,
ED85,g/ha,63,0.994,
ACTIVITYRATIO,,63,0.994,
INHIBITIONUPTAKE,%,63,0.994,
PAPP,10^6cm/s,63,0.994,
IABC,,63,0.994,
APD75,%,63,0.994,
STABILITY,pmol/min/mg,63,0.994,
KASS,l uM-1,63,0.994,
NOOFCELLS,,63,0.994,
RELATIVEVELOCITY,,63,0.994,
-LOGKD,,63,0.994,
ACTIVITY,10'-3/M/s,63,0.994,
LOG(1LD50),,62,0.994,
LATENCYTIME,s,62,0.994,
ULCEROGENICACTIVITY,%,62,0.994,
ACTIVITY,m equiv kg-1,62,0.994,
DELTAMAP,,62,0.994,
CPA,%,62,0.994,
RELATIVEVELOCITY,%,62,0.994,
UTEROTROPHICEFFECT,,62,0.994,
PERMEABILITY,10'-5 cm/s,62,0.994,
PHA,,62,0.994,
HYDROLYSISRATE,,62,0.994,
K,10^5/M/min,62,0.994,
ACTIVITY,pmol/g,62,0.994,
MAXNON-TOXICDOSE,umol.L-1,62,0.994,
GR50,kg/ha,62,0.994,
AUC,%,62,0.994,
K,10'5/M.s,62,0.994,
ACTIVITY,10'9/L,62,0.994,
LOG(IA),,62,0.994,
CONCENTRATION,mg.ml-1,62,0.994,
VMAX,s-1,62,0.994,
EC5X,umol.L-1,62,0.994,
ED50,mg.mouse-1,62,0.994,
INHIBITIONOFCONTROL,%,62,0.994,
CAMPACCUMULATION,%,62,0.994,
ED99,umol.L-1,62,0.994,
ACTIVITY,10^3 /uL,62,0.994,
A05,umol.L-1,62,0.994,
LOGRAI,,62,0.994,
PA50,,62,0.994,
MFC999,,62,0.994,
PITURNOVER,,62,0.994,
KA,10^6/M,61,0.994,
SIGNIFICANCE,,61,0.994,
LOWERING,,61,0.994,
INACTIVATION,%,61,0.994,
ACTIVITY,10^-7/M,61,0.994,
ORGANDISTRIBUTION,%,61,0.994,
LOGED50,uM kg-1,61,0.994,
LD50,microgAi/g,61,0.994,
DEADCELLS,%,61,0.994,
ISA,,61,0.994,
POTENCYCLK2UM,umol.L-1,61,0.994,
ED20,,61,0.994,
STABILITY,umol,61,0.994,
PAPP,umol.L-1.s-1,61,0.994,
E12,,61,0.994,
ALPHAE,,61,0.994,
CLH,uL/mg/min,61,0.994,
KDKI,umol.L-1,61,0.994,
EFFECT,mg 100g-1,61,0.994,
STABILITY,uL/min/kg,61,0.994,
DPDT,mmHg s-1,61,0.994,
DELTAMAP,mmHg,61,0.994,
ED95,ug.mg-1,61,0.994,
%REMAINING,%,61,0.994,
ACTIVITY,10'7mol/J,60,0.994,
POTENCYDYRK1AUM,umol.L-1,60,0.994,
ABSORBANCE,mm,60,0.994,
ACTIVITY,mg/mg/day,60,0.994,
SF,,60,0.994,
SENSORYEVALUATION,,60,0.994,
CHEMOTHERAPEUTICINDEX,,60,0.994,
PCASHIFT,,60,0.994,
MEDIANDAYOFDEATH,,60,0.994,
MGMID,umol.L-1,60,0.994,
BMAX,fM (mg of protein)-1,60,0.994,
ED50,nM mouse-1,60,0.994,
IFN,ml,60,0.994,
EFFECTIVEDOSE,ug.mg-1,60,0.994,
CHANGEINHEARTRATE,beats min-1,60,0.994,
RC50,umol.L-1,60,0.994,
%MAXIMUMRESPONSE,%,60,0.994,
DAR,,60,0.994,
-LOGED50,,60,0.994,
VMAX,nM min-1,60,0.994,
DRUGRELEASE,,60,0.994,
WEIGHT,%,60,0.994,
ACTIVITY,10'-3cpm,60,0.995,
ANTICOCCIDIALACTIVITY,%,60,0.995,
T999%,s,60,0.995,
IC50,10^-8mol/L,60,0.995,
RATIOATPASEACTIVITY,,60,0.995,
NOOFANIMALSPROTECTED,,60,0.995,
ACTIVITY,ugequiv/ml,60,0.995,
PID50,,60,0.995,
HYPO,,60,0.995,
ED30,,59,0.995,
AVERAGEWEIGHT,,59,0.995,
DOSERATIO,,59,0.995,
RHT,,59,0.995,
CHANGEOFTUMORAREA,%,59,0.995,
HALFDURATION,s,59,0.995,
KOFF,min^-1,59,0.995,
TOTALCHOLESTEROL,mg dl-1,59,0.995,
RELATIVEHYDROLYSIS,,59,0.995,
RESISTANCEFACTOR,,59,0.995,
KON,nM^-1 min^-1,59,0.995,
CD,,59,0.995,
ERYTHROIDINDUCTION,%,59,0.995,
KI,/mol.L-1.s-1,59,0.995,
CI75,,59,0.995,
RELATIVEUTERINEWEIGHT,,59,0.995,
AESCORE,%,59,0.995,
OTHER,,59,0.995,
KIMICROM,mm,58,0.995,
AWC,mg,58,0.995,
LEVEL,pM g-1,58,0.995,
ACTIVITY,L.mol-1,58,0.995,
CMAX,nmol/g,58,0.995,
GLYCAEMIAEVOLUTION,%,58,0.995,
NEUROPROTECTION,%,58,0.995,
INHIBITIONRATIO,%,58,0.995,
LC95,umol.L-1,58,0.995,
ACT,%,58,0.995,
DELTAPEC50,,58,0.995,
MIC70,umol.L-1,58,0.995,
AUC,uM.hr/mg.kg,58,0.995,
REDUCTIONFACTOR,,58,0.995,
TPCONTROL,%,58,0.995,
RELATIVESALIDIURETICACTIVITY,,58,0.995,
IE50,uM/L,58,0.995,
DPDT20,ug.mg-1,58,0.995,
DRUGUPTAKE,%ID/ml,58,0.995,
POTENCYDYRK1BUM,umol.L-1,58,0.995,
ECMAX,,58,0.995,
PA2,umol.L-1,58,0.995,
ED50,g/ha,58,0.995,
MED,uM kg-1,58,0.995,
STABILTY,ml/min.kg,58,0.995,
INCREASEINDPDTMAX,%,58,0.995,
UR,%,58,0.995,
BODYWEIGHTLOSS,%,58,0.995,
POLYAMINELEVEL,,57,0.995,
ANTI-PENTEFFECT,,57,0.995,
TOTALRADIOACTIVITY,ug equiv g-1,57,0.995,
ED25,uM kg-1,57,0.995,
MAXPI,%,57,0.995,
CL,L/Kg,57,0.995,
MEANUTERINEWEIGHT,mg,57,0.995,
UTERINEACTIVITY,%,57,0.995,
ACTIVITY,mmHg/s,57,0.995,
MAXINCREASE,%,57,0.995,
RPP,%,57,0.995,
LD0,ug.mg-1,57,0.995,
AUCCYTOTOXICITY,,57,0.995,
VZF,l,57,0.995,
ANTIOVULATORYACTIVITY,%,57,0.995,
SURVIVINGFRACTION,,57,0.995,
ED50,microg/cm2,57,0.995,
EMAX,dyn/mg,57,0.995,
CT,% dose/g,57,0.995,
D50,umol.L-1,57,0.995,
PRA2,,56,0.995,
PTCD50,,56,0.995,
LIPID-SOLUBLERADIOACTIVITY,,56,0.995,
CLZF,L/hr/kg,56,0.995,
THERAPEUTICINDEX99,,56,0.995,
KCATKM,umol.L-1.s-1,56,0.995,
MDD50,ug.mg-1,56,0.995,
GROWTHOFCELLS,,56,0.995,
ED100,mg,56,0.995,
ACTIVITY,10'6CFU,56,0.995,
%INHIBITIONOFCONTROLVALUES(MEANN=2),%,56,0.995,
RELATIVESTABILITY,%,56,0.995,
STIMULATION,,56,0.995,
PRA1,,56,0.995,
MODIFICATION,%,56,0.995,
ITP,%,56,0.995,
VASORELAXANTEFFECT,,56,0.995,
TC,s,56,0.995,
UTERINEWEIGHT,,56,0.995,
ACTIVITY,uL,56,0.995,
DEUTERIUMRETENTION,%,56,0.995,
ACTIVITY,umolequiv/g,56,0.995,
IZ,mm.mg-1,56,0.995,
BMAX,fmol/mg,56,0.995,
INHIBITORYCONCENTRATION,umol.L-1,56,0.995,
ED50,ug ear-1,55,0.995,
DRUGMETABOLISM,ng/g,55,0.995,
ACTIVITY,uM kg-1,55,0.995,
PERMEABILITY,10'-4 cm/s,55,0.995,
GC50,,55,0.995,
LOGAP,,55,0.995,
LOG1EDMES(25),,55,0.995,
EDMES(25),ug.mg-1,55,0.995,
STYSEIZURE,ug.mg-1,55,0.995,
ANTIDIURETICACTIVITY,mg,55,0.995,
K2,,55,0.995,
VIRUCIDAL,umol.L-1,55,0.995,
ACTIVITY,umol.g-1,55,0.995,
CLEARANCE,ul min-1,55,0.995,
ACTIVITY,pA/pF,55,0.995,
CLEARANCE,L.h-1.kg-1,55,0.995,
NOFORMATION,%,55,0.995,
AUCDOSE,ug.h-1.mL-1,55,0.995,
D50,,55,0.995,
KBAPP,,55,0.995,
-LOG(INH100-INH),,55,0.995,
PO2,%,55,0.995,
RECOVERY,,55,0.995,
SUPRESSION,%,55,0.995,
REACTORSTESTGROUP,,55,0.995,
KINACT,/M/min,55,0.995,
TAC,mmol/L,55,0.995,
CI90,,55,0.995,
ANTIVIRALACTIVITY,umol.L-1,55,0.995,
ACTIVITY,kcal.mol-1,55,0.995,
ORGANWEIGHT,mg,55,0.995,
REACTIONTIME,s,55,0.995,
METABOLISM,pM min-1 mg-1,55,0.995,
LOG10LC50,,55,0.995,
ID75,uM kg-1,55,0.995,
REMOVALOFMICROFILARIAE,%,55,0.995,
SALURETICSCORE,,55,0.995,
K,10'3/s,55,0.995,
SERUMTOTALTRIGLYCERIDES,mg dl-1,55,0.995,
LOG(1D40),,55,0.995,
NOHA,%,55,0.995,
INITIALACTIVITY,%,54,0.995,
NHILL,,54,0.995,
NOOFLUNGCOLONIES,,54,0.995,
TOTALDOSE,ug.mg-1,54,0.995,
POLYAMINECONTENT,nM g-1,54,0.995,
ZIMAXKZI,mm.L.umol-1,54,0.995,
NOOFFALLS,,54,0.995,
ED300,ug.mg-1,54,0.995,
RELATIVEID50,,54,0.995,
PKM,,54,0.995,
DRUGUPTAKE,pmol/mg,54,0.995,
INJECTIONDOSEG,%,54,0.995,
BINDINGENERGY,kCal M-1,54,0.995,
ACTIVITY,mmol/g,54,0.995,
LOG(1ED30),,54,0.995,
MAXIMALEFFECT,%,54,0.995,
AUC,microM.hr/mg/kg,54,0.995,
RELATIVEINHIBITION,%,54,0.995,
MEDIANSURVIVALDAY,,54,0.995,
GROWTHINHIBITION,mm,54,0.995,
RECEPTOROCCUPANCY,%,54,0.995,
LOGLD50,,54,0.995,
DRUGUPTAKE,[ppm],54,0.995,
PROTECTEDMICE,%,54,0.995,
LENGTH,umol.L-1,54,0.995,
LOG(10'6IC50),,54,0.995,
CONCENTRATION,ng (g of tissue)-1,54,0.995,
CC25,,54,0.995,
PAPP,10^-8cm/s,54,0.995,
BIODISTRIBUTION,dose/organ %,54,0.995,
ROTATIONNUMBER,,54,0.995,
CD50,nM mouse-1,54,0.995,
RELMAXFI,,54,0.995,
AUBC,log10[CFU].ml-1.h-1,54,0.995,
K,10^-4/s,54,0.995,
KA,L/mol,54,0.995,
METHEMOGLOBIN,%,53,0.995,
VMAX(APP),s-1,53,0.995,
DELTAHR50,beats min-1,53,0.995,
RELATIVEAGONISTICACTIVITY,%,53,0.995,
BINDINGAFFINITY,%,53,0.995,
DELTAHR50,%,53,0.995,
PKP,,53,0.995,
CLINEDSCREENTEST,,53,0.995,
LOGFC,,53,0.995,
TURNS,,53,0.995,
MAXINCREASE,,53,0.995,
BEHAVIORALEFFECT,,53,0.995,
DOPAACCUMULATION,,53,0.995,
ANTI-FIGHTINGBEHAVIOUR,,53,0.995,
K,10'6/M/min,53,0.995,
NORMALIZEDABUNDANCESFORCOMPOUND,,53,0.995,
NORMALIZEDABUNDANCESFORDMSO,,53,0.995,
MLD,umol.L-1,53,0.995,
MFI,,53,0.995,
ID50,umol.L-1.ml-1,53,0.995,
ED90,gAi,53,0.995,
MED=>50,,53,0.995,
BLOODGLUCOSE,mg dl-1,53,0.995,
STABILITY,umol.min-1.mg-1,53,0.995,
CSINDEX,,53,0.995,
PUNCHWEIGHTMPOACTIVITY,,53,0.995,
MAXIMALACTIVATION,%,53,0.995,
DRUGDEGRADATION,mol%,53,0.995,
LD10,,53,0.995,
PM,,53,0.995,
LIFESPAN,d,53,0.995,
BINDING,,53,0.995,
VMAXKM,uL/min,52,0.995,
KA,10'3/M,52,0.995,
STOOLOUTPUT,g (350g of rat weight)-1,52,0.995,
IC90,[ppm],52,0.995,
SALDIURETICACTIVITY,m equiv 6hr-1 kg-1,52,0.995,
VMAX,umol.L-1,52,0.995,
SUVMAX,,52,0.995,
DELTAP,%,52,0.995,
GM-MIC,umol.L-1,52,0.995,
-LOGKDISS,,52,0.995,
K,10'-5/M,52,0.995,
SER,,52,0.995,
MAXAVERAGE,,52,0.995,
KINETICSOLUBILITY,Ug/ml,52,0.995,
FRACTIONEXPERIENCINGSEIZURES,,52,0.995,
DISTRIBUTIONCOEFFICIENT,,52,0.995,
DELTAPH,,52,0.995,
IC90,umol.L-1.well-1,52,0.995,
ESTROGENICEFFECT,%,52,0.995,
PROTECTIVEEFFECT,%,52,0.995,
VMAX,pM min-1 mg-1,52,0.995,
N,,52,0.995,
MBC=>999,umol.L-1,52,0.995,
INHIBITIONPOTENCY,,52,0.995,
KB,10^4/M,52,0.995,
ACTIVITY,degree,52,0.995,
EYETOXICITY,,52,0.995,
ACTIVITY,million/mm3,52,0.995,
INHIBITORYDIAMETER,,52,0.995,
RHODAMINE-123ACCUMULATION,arbitrary units,52,0.995,
IC50,umol.L-1.well-1,52,0.995,
TRANSACTIVATION,%,52,0.995,
EC50,nmol/cm2,52,0.995,
INCORPORATION,c.p.m.,52,0.995,
ZONEDIAMETER,umol.L-1,52,0.995,
CAMPACTIVITYINDEX,,51,0.995,
T>MIC,s,51,0.995,
PIC90,,51,0.995,
WEIGHTLOSS,%,51,0.995,
LC50,mg,51,0.995,
ANEUPLOIDYACTIVTY,,51,0.995,
RELATIVEINOTROPICPOTENCY,,51,0.995,
ASCITESVOLUME,ml mouse-1,51,0.995,
TC,d,51,0.995,
PACKEDCELLVOLUME,%,51,0.995,
PAPP,10'-4 cm/s,51,0.995,
%INHIBITIONOFCONTROLAGONISTRESPONSE(MEANN=2),%,51,0.995,
ZONEOFSTIMULATION,umol.L-1,51,0.995,
ED50,pM mouse-1,51,0.995,
ANTIHYPERTENSIVESCORE,,51,0.995,
INCREASEINCBF,ml min-1,51,0.995,
IC90MUTANTIC90WT,,51,0.995,
MOT,s,51,0.995,
MAXACHIEVABLEBIOAVAILABILITY,%,51,0.995,
COMPETITIONFACTOR,,51,0.995,
LOGESA,,51,0.995,
DEATHS,,51,0.995,
UI,mm,51,0.995,
CHALLENGETIME,s,51,0.995,
%CONTROLSPECIFICBINDING(MEANN=2),%,51,0.995,
DRUGUPTAKE,cpm,51,0.995,
VMAX,umol.L-1.min-1,51,0.995,
RESPONDING,%,51,0.995,
CLH(APP),,51,0.995,
%OFCONTROLAGONISTRESPONSE(MEANN=2),%,51,0.995,
ACCEPTORACTIVITY,,51,0.995,
XI50,umol.L-1,51,0.995,
ACTIVITYOFCONTROL,%,51,0.995,
KIS,,51,0.995,
KIH,umol.L-1,51,0.995,
ACTIVITY,kCounts,51,0.995,
EC1000,umol.L-1,51,0.995,
FBPMEANSCORE,,50,0.995,
TOTALEXCRETION,%,50,0.995,
GDPED50,ug.mg-1,50,0.995,
PAPP,10^7cm/s,50,0.995,
BLOODPRESSURE,%,50,0.995,
MAXDELTAAPD95,%,50,0.995,
BP,%,50,0.995,
LOGCL,,50,0.995,
FTMEANSCORE,,50,0.995,
MAX,mmHg,50,0.995,
MEQUIVOFNA+KG,0-5h,50,0.995,
ABSAC30,umol.L-1,50,0.995,
KA,10'-4L/mol,50,0.995,
KAPP,/mol.L-1.s-1,50,0.995,
SYSTEMICEFFECT,%,50,0.995,
REVERSIONACTIVITY,%,50,0.995,
CL,uL/ml/kg,50,0.995,
RATEOFO2CONSUMPTION,nM min-1,50,0.995,
LOGK1,,50,0.995,
GTFOLDSTIMULATION,,50,0.995,
S05,umol.L-1,50,0.995,
EFFICACYRATIO,,50,0.995,
CP(F),%,50,0.995,
K,10'4/M.s,50,0.995,
BDW,mg,50,0.995,
INCREASEINCONCENTRATION,umol.L-1,50,0.995,
INITIALBLOODPRESSURE,mmHg,50,0.995,
UPTAKE,nM (mg of protein)-1,50,0.995,
MODULATIONFACTOR,,50,0.995,
SURVIVALRATE,number of mice,50,0.995,
TISSUEDISTRIBUTION,ug g-1,50,0.995,
MPC,,50,0.995,
C20,ug.mg-1,50,0.995,
LED,ug.mg-1,50,0.995,
MAXTC,,50,0.995,
TLAG,s,50,0.995,
LOG1RATIO,,50,0.995,
AVGIC90,umol.L-1,50,0.995,
BETA-LACTAMASEINDUCTION,,50,0.995,
DAYS,,50,0.995,
ACTIVITY,nmol/mg.min,50,0.995,
LOCOMOTORACTIVITY,ug.mg-1,50,0.995,
RT50,s,49,0.995,
ACTIVITY,um/hr,49,0.995,
KSV,10'4L/mol,49,0.995,
BMAX,%,49,0.995,
ADI,,49,0.995,
KSV,10^4L/mol,49,0.995,
DELTATAO,,49,0.995,
MEDIANLIFESPAN,d,49,0.995,
PEC100,,49,0.995,
PTI,,49,0.995,
ID50,uM hr-1 kg-1,49,0.995,
MEANBODYWEIGHT,g mouse-1,49,0.995,
DOSE,mg,49,0.995,
-LOGC,,49,0.995,
ARTERIALPRESSURE,mmHg,49,0.995,
GTPSHIFT,,49,0.995,
ICMAX,umol.L-1,49,0.995,
ANTIVIRALEFFECT,,49,0.995,
ACCUMULATEDCOUNTS,,49,0.995,
APTT,IU mg-1,49,0.995,
INHIBITORYDIAMETER,umol.L-1,49,0.995,
KSI,umol.L-1,49,0.995,
CONTROLUPTAKE,%,49,0.995,
ED2,,49,0.995,
TURNOVER,,49,0.995,
SKINTESTSINTENSITY,,48,0.995,
KSV,10'3/M,48,0.995,
RH,%,48,0.995,
AUCDOSE,ng/hr/ml,48,0.995,
LOGPM,,48,0.995,
CONCENTRATION,uM g-1,48,0.995,
REVERSAL,,48,0.995,
POTENTIATION,,48,0.995,
BASELINE,%,48,0.995,
BRONCHOSELECTIVITY,,48,0.995,
ED50,uM l-1,48,0.995,
MTD50,ug.mg-1,48,0.995,
FI5,umol.L-1,48,0.995,
PLADM,,48,0.995,
BINDINGCONSTANT,L.umol-1,48,0.995,
MABPCHANGE,mmHg,48,0.995,
TOTALACTIVITY,umol.L-1.min-1.,48,0.995,
ECI,%,48,0.995,
EFFICACYINDEX,,48,0.995,
BEHAVIORSCORE,,48,0.995,
ED40,,48,0.995,
DRUGCONCENTRATION,umol.L-1,48,0.995,
MNTD,ug.mg-1,48,0.995,
PD50,umol.L-1,48,0.995,
SPECIFICACTIVITY,nM min-1,48,0.995,
IRRITATION,arbitrary units,48,0.995,
INCREASEINFOOTPADTHICKNESS,umol.L-1,48,0.995,
DIAMETER,umol.L-1,48,0.995,
CLH,min/ml/kg,48,0.995,
DRUGRECOVERY,%ID,48,0.995,
CD50,,48,0.995,
RADIOACTIVITY,c.p.m.,48,0.995,
ACTIVITY,ng/g,48,0.995,
SURVIVALRANGE,,48,0.995,
CYTOPROTECTIVEEFFECT,,48,0.995,
URINEVOLUME,ml min-1,48,0.995,
ACTIVITY,fmol/min,48,0.995,
LOG10FFU,,48,0.995,
EC75,umol.L-1,48,0.995,
NOPROTECTEDTESTED,,48,0.995,
TMSHIFT,Cel,48,0.995,
FOLDSELECTIVITY,fold selectivity,48,0.995,
PWT,mg,48,0.995,
MID,uL/L,48,0.995,
GLUCOSERISE,mg dl-1,48,0.995,
PLADY,,48,0.995,
IA50,%,48,0.995,
PMAX,umol.L-1,48,0.995,
ED25,,48,0.995,
PABC,,48,0.995,
OPTIMALCONCENTRATION,umol.L-1,48,0.995,
PGPABAANALOGUERATIO,,47,0.995,
MEANLATENCY,s,47,0.995,
ALPHAX10E,,47,0.995,
ESTROGENICEFFECT,,47,0.995,
LMA,,47,0.995,
RECTALTEMPERATURE,Cel,47,0.995,
SURVIVALRATE,,47,0.995,
ACTIVITY,mmolequiv/L,47,0.995,
ACTIVITY,/mm3,47,0.995,
CP,%,47,0.995,
CAMP,%,47,0.995,
VCF,l,47,0.995,
SOLUBILITY,10^-6 cm/s,47,0.995,
ACTIVITY,IU mg-1,47,0.995,
IC50,10^-5 mol/L,47,0.995,
REACTIVATION,%,47,0.995,
PERMEABILITY,cm s-1,47,0.995,
BODYWEIGHT,%,47,0.995,
GROWTH,,47,0.995,
CBFRATIO,,47,0.995,
COMPOUNDREMAINING,%,47,0.995,
ID50,nM ml-1,47,0.995,
GROWTHDELAY,d,47,0.995,
CL,L/Kg.hr,47,0.995,
RELATIVEKI,,47,0.995,
[35S]TBPSSHIFT,,47,0.995,
LOGPN,,47,0.995,
LOGKO,,47,0.995,
IC15,umol.L-1,47,0.995,
FBFRATIO,,47,0.995,
CONTRAGESTATIONALACTIVITY,ug.mg-1,47,0.995,
DRUGMETABOLISM,pmol/mg/hr,47,0.995,
RESPONSERATE,,47,0.995,
POSITIVECELLS,%,47,0.995,
VARIATIONCONTROL,%,46,0.995,
DURATIONOFACTION,,46,0.995,
DOSEEXCRETED,%,46,0.995,
KI,ug nM-1,46,0.995,
PROTECTEDTESTED,,46,0.995,
LOGTGI,,46,0.995,
PFUML,,46,0.995,
KINACT,10^-3/s,46,0.995,
ACTIVITY,10'6/mm3,46,0.995,
LOGILSMAX,,46,0.995,
LOGSOSIP,,46,0.995,
HC20,umol.L-1,46,0.995,
C175,umol.L-1,46,0.995,
VIGOURINDEX,,46,0.995,
GINDEX,,46,0.995,
DELTAAPD90,,46,0.995,
CYTOTOXICACTIVITY,,46,0.995,
LM,uL/min/mg protein,46,0.995,
ACTIVITY,nM/mg,46,0.995,
RELATIVEUPTAKE,,46,0.995,
LETHALDOSE,ug.mg-1,46,0.995,
RD50,ug.mg-1,46,0.995,
CELLNUMBER,,46,0.995,
LOG1I50,1/M,46,0.995,
AVERAGELESIONSCORE,,46,0.995,
KT,,46,0.995,
REP,%,46,0.995,
ATAXIA,%,46,0.995,
AFC50,umol.L-1,46,0.996,
PERMEABILITY,%/hr,46,0.996,
ACTIVETOTALCULTURES,%,46,0.996,
MED20,ug.mg-1,46,0.996,
EC20,%,46,0.996,
BLOODSUGARLOWERING,,46,0.996,
ACTIVITY,10'-3mg/ml,46,0.996,
RELATIVEET-AIC50,,46,0.996,
LOGM50,,46,0.996,
FOLD-INDUCTION,,46,0.996,
CFC20,umol.L-1,46,0.996,
RELATIVEKD,,45,0.996,
TUBULINBINDING,%,45,0.996,
PAPP,10^-7 cm/s,45,0.996,
CHANGEINBODYTEMPERATURE,Cel,45,0.996,
FOCIDISH,,45,0.996,
ALPHA,,45,0.996,
DELTAMABP,mmHg,45,0.996,
ACUTEELECTROSHOCKACTIVITY,,45,0.996,
KA,10'-5/M,45,0.996,
ACTIVITY,cm/s,45,0.996,
APPARENTENZYMEACTIVITY,,45,0.996,
LOGK(LUNG),,45,0.996,
AUEC,A% min-1,45,0.996,
K1,s-1,45,0.996,
NOOFANIMALSWITHLIVERNECROSIS,,45,0.996,
PEC170,,45,0.996,
LEVEL,mg dl-1,45,0.996,
RELATIVEF%,,45,0.996,
DRUGMETABOLISM,micromol/min,45,0.996,
HEPATICEXTRACTIONRATIO,,45,0.996,
BLOODLEVEL,umol.L-1,45,0.996,
MDRRATIO,,45,0.996,
DELTAG,kCal mol-1,45,0.996,
TOXICDOSE,ug.mg-1,45,0.996,
TT,umol.L-1,45,0.996,
ACTIVITY,ng dl-1,45,0.996,
POSSIBLERESPONSE,%,45,0.996,
LOG(1CON),,45,0.996,
LVFRP,%,45,0.996,
KAKI,uM-1 min-1,45,0.996,
RACAPP,,45,0.996,
DRUGUPTAKE,ng/ml/g,45,0.996,
ACTIVITY,nM/mg*min,45,0.996,
OD(540NM),,45,0.996,
NC,,45,0.996,
REVERSALTYPE,,44,0.996,
CPP,mmHg,44,0.996,
FRACTIONCURED,,44,0.996,
TWI,%,44,0.996,
INHIBITIONCONSTANT,,44,0.996,
LVP,mmHg,44,0.996,
ED80,ug.mg-1,44,0.996,
CHANGEINBLOODPRESSURE,delta mmHg,44,0.996,
VIRUSYIELD,log pfu ml-1,44,0.996,
GR,%,44,0.996,
KISS,umol.L-1,44,0.996,
GSH-PXACTIVITY,,44,0.996,
KIKI,/mol.L-1.s-1,44,0.996,
ANTITUMORACTIVITY,%,44,0.996,
ACTIVITY,10'-6M,44,0.996,
CELLSKILLED,%,44,0.996,
C,umol.L-1,44,0.996,
ALPHAMAX,%,44,0.996,
ADMINISTEREDDOSE,%,44,0.996,
LOG1CLD50,,44,0.996,
ECMAX,%,44,0.996,
IC20,,44,0.996,
CHANGEINRESPONSERATE,%,44,0.996,
LOGK(BLOOD),,44,0.996,
AVERAGEWEIGHTCHANGE,,44,0.996,
DECREASEINMABP,%,44,0.996,
IT50,s,44,0.996,
PA2PKB,,44,0.996,
DRUGDEGRADATION,h-1,44,0.996,
MEANBLOODPRESSURE,%,44,0.996,
IMMOBILITYTIME,s,44,0.996,
NOOFMICESURVIVED,,44,0.996,
LEVEL,U l-1,44,0.996,
ACTIVITY,ug/L,44,0.996,
CL,ug/min,44,0.996,
DELTATM,c,44,0.996,
DECREASEINQAINTERVAL,,44,0.996,
LIVERWEIGHT,mg (g of body weight)-1,44,0.996,
REA,,43,0.996,
ED50,mg ear-1,43,0.996,
RELATIVEUTERUSWEIGHT,mg,43,0.996,
RD500,ug.mg-1,43,0.996,
ILS30,,43,0.996,
SLEEPINGTIME,,43,0.996,
PD,umol.L-1,43,0.996,
UNCHANGED,%,43,0.996,
DELTAS,kJ.mol-1,43,0.996,
CP,ng/g,43,0.996,
R,,43,0.996,
ACTIVEDOSE,ug.mg-1,43,0.996,
INFLUX,nM mg-1,43,0.996,
LOG1CED90,,43,0.996,
NETLOGCELLKILL,,43,0.996,
CLRENAL,ml/min,43,0.996,
PAPP,10^-5cm/s,43,0.996,
DRUGMETABOLISM,umol.mg-1.hr-1,43,0.996,
K1,umol.L-1,43,0.996,
ACTIVITY,pg/g,43,0.996,
DR10,ug.mg-1,43,0.996,
KIL,umol.L-1,43,0.996,
RECOVERYTIME,s,43,0.996,
KA,h-1,43,0.996,
TP,%,43,0.996,
MED,mM kg-1,43,0.996,
COMPETITION,%,43,0.996,
PEC90,,43,0.996,
RSA,%,43,0.996,
NOOFENTRIES,,43,0.996,
DIURETICACTIVITY,ml kg-1 6hr-1,43,0.996,
INHIBITION,ug.mg-1,43,0.996,
POTENTIAL,,43,0.996,
RATIO,10^-3/microM/s,43,0.996,
EPMR,,43,0.996,
MAXINHIBITION,,43,0.996,
SP,%,43,0.996,
LD5,umol.L-1,43,0.996,
ACTIVITY,micromol/m2/s,43,0.996,
MED,mg.kg-1.d-1,43,0.996,
INHIBITIONOVERTIME,%,43,0.996,
LT50,[ppm],43,0.996,
ACTIVITY,10'3 /uL,43,0.996,
DEOXYRIBOSEDEGRADATION,uM of MDA mM-1,43,0.996,
GR80,gAi/ha,43,0.996,
AUCLAST,hr.ng/g,43,0.996,
KACT,umol.L-1,43,0.996,
RL,%,43,0.996,
COMPOUNDRECOVERY,10^-9M,42,0.996,
ANTIHYPERTENSIVEACTIVITY,,42,0.996,
LETHALITY,dead/total,42,0.996,
MIC,ug.disk-1,42,0.996,
APD60,,42,0.996,
SEPARATION,,42,0.996,
MAC,,42,0.996,
ID40,ug.mg-1,42,0.996,
TREMOROLYTICDOSE,uM kg-1,42,0.996,
DECREASEINSBP,mmHg,42,0.996,
PARTITIONRATIO,,42,0.996,
P(EI),,42,0.996,
LD90,[ppm],42,0.996,
EC80,[ppm],42,0.996,
CAPACITY,,42,0.996,
NOOFCURED,,42,0.996,
NA+EXCRETION,,42,0.996,
ED35,ug.mg-1,42,0.996,
K+EXCRETION,,42,0.996,
NOOFSHOCKS,,42,0.996,
RISEHR,,42,0.996,
VDU,ml,42,0.996,
KCATKM,10e4 M-1 s-1,42,0.996,
CO,g dl-1,42,0.996,
NOOFDEADMICE,,42,0.996,
UPTAKERATIO,,42,0.996,
MED>50,ug.mg-1,42,0.996,
K,/M,42,0.996,
RADIOACTIVITY,nM equiv (mg of tissue)-1,42,0.996,
BMAX,pmol/mg,42,0.996,
CSATCO,,42,0.996,
CELLPROTEIN,ug dish-1,42,0.996,
LOSSOFRIGHTINGREFLEX,,42,0.996,
RANGE,d,42,0.996,
PCY,,42,0.996,
INHIBITIONRATE,%,42,0.996,
CSAT,g dl-1,42,0.996,
DISTRIBUTION,% dose g-1,42,0.996,
DIURETICACTIVITY,m equiv,42,0.996,
EMAX,pM,42,0.996,
URINARYVOLUME,,42,0.996,
INHIBITION,delta A min-1,42,0.996,
MED,M kg-1,42,0.996,
AUC,ng.hr/ml/mg/kg,42,0.996,
MAXCHANGEINBLOODPRESSURE,mmHg,42,0.996,
NBTPOSITIVECELLS,%,42,0.996,
DAQ,10'-6cm2/s,42,0.996,
PK50,,41,0.996,
SMAX,uM min-1 kg-1,41,0.996,
VMAX,nmol.L-1.min-1.mg-1,41,0.996,
LOGC,,41,0.996,
CELLDEATH,%,41,0.996,
RELATIVERATE,,41,0.996,
CL,ml.min/kg,41,0.996,
DNACROSSLINKING,,41,0.996,
AC200,umol.L-1,41,0.996,
AUCLAST,,41,0.996,
-LOGIC25,,41,0.996,
ANTAGONISTICACTIVITY,,41,0.996,
ACTIVITY,U mg-1,41,0.996,
SURVIVALRATE,%,41,0.996,
WBC,%,41,0.996,
PERMEABILITY,10^-7 cm/s,41,0.996,
LOGED50,,41,0.996,
CAR,,41,0.996,
RELATIVERATEOFHYDROLYSIS,%,41,0.996,
ED125,uM kg-1,41,0.996,
MIGRATIONINDEX,,41,0.996,
KCAT(APP),s-1,41,0.996,
INDEX,%,41,0.996,
FMUT,,41,0.996,
CONCENTRATION,ug/g tissue,41,0.996,
MNTD90,umol.L-1,41,0.996,
PIGMENTBINDING,%,41,0.996,
KREACT,s-1,40,0.996,
ID90,ug.mg-1,40,0.996,
LD20,ug.mg-1,40,0.996,
CHANGEINBP,,40,0.996,
ARTHRITICSCORE,,40,0.996,
"KPOTA,B",,40,0.996,
DD,uM of MDA mM-1,40,0.996,
LOG(1MIC>90),,40,0.996,
RPF,pM nM-1,40,0.996,
CPM,,40,0.996,
MP,%,40,0.996,
MIC=<80,umol.L-1,40,0.996,
CHANGEINBP,%,40,0.996,
EC90,pM,40,0.996,
MAXINHIBITORYEFFECT,%,40,0.996,
LC50,ug.mg-1,40,0.996,
ACTIVITY,Bq,40,0.996,
INVIVODURATION,Minutes,40,0.996,
INHIBITORYACTIVITY,umol.L-1,40,0.996,
ED50,umol/cm2,40,0.996,
AZTFORMATION,,40,0.996,
QUANTITY,mg,40,0.996,
RU,pg/mm2,40,0.996,
K,1/s,40,0.996,
QH,,40,0.996,
DELTAERPC,%,40,0.996,
LUCIFERASEACTIVITY,RLU 10s-1,40,0.996,
LD50,g/ha,40,0.996,
SERUMCHOLESTEROL,mg dl-1,40,0.996,
TC25,umol.L-1,40,0.996,
REACTIVITY,,40,0.996,
LOG1ID75(UML-1),,40,0.996,
CYTOKINEINDUCTION,,40,0.996,
LOGK-IAMEX,,40,0.996,
BODYWEIGHTREDUCTION,%,40,0.996,
ED999,ug.mg-1,40,0.996,
ACTIVITY,U/min,40,0.996,
TMAX,umol.L-1,40,0.996,
RECOVERYTIME,%,40,0.996,
ASF,[ppm],40,0.996,
POSITIVECONTROL,%,40,0.996,
IC50,g/ha,40,0.996,
ASPIRINFORMED,%,40,0.996,
MESED50,ug.mg-1,40,0.996,
PKAB2,,40,0.996,
DRUGUPTAKE,nmol/mg.min,40,0.996,
KN,M-1 min-1,40,0.996,
FOLDACTIVATION,%,40,0.996,
EC12,umol.L-1,40,0.996,
ZONEDIAMETER,,40,0.996,
MEANNOOFREVERTANTS,,40,0.996,
ACTIVITY,umol.L-1.min-1.mg-1,40,0.996,
MTC50,umol.L-1,40,0.996,
KA,10^4/M,40,0.996,
TISSUECONCENTRATION,% injected dose g-1,40,0.996,
EC25,,40,0.996,
GR,,40,0.996,
INFECTEDMOSQUITOES,%,39,0.996,
I90,,39,0.996,
BWC,%,39,0.996,
DEAD,,39,0.996,
DECREASEINCR,,39,0.996,
ACTIVITY,Hz,39,0.996,
KCATKM,mM-1 min-1,39,0.996,
AVERAGEDOSE,ug.mg-1,39,0.996,
CLINT,uL/min/1E6 cells,39,0.996,
RATEOFPHOSPHORYLATION,,39,0.996,
ACTIVATION,,39,0.996,
RATIOAUC,%,39,0.996,
SUPPRESSION,,39,0.996,
ANALGESIADURATION,,39,0.996,
BCMSERUMCA,mg 100ml-1,39,0.996,
RSA,,39,0.996,
EC170,umol.L-1,39,0.996,
KI,s-1,39,0.996,
ACTIVITY,ug (mg of protein)-1,39,0.996,
CHANGEINBODYWEIGHT,g mouse-1,39,0.996,
E,,39,0.996,
ACTIVITY,nM (mg of protein)-1,39,0.996,
NA,m equiv 6hr-1 kg-1 (body weight)-1,39,0.996,
CLEAVAGE,umol.L-1,39,0.996,
LOGKP,cm/s,39,0.996,
TBMIC,umol.L-1,39,0.996,
VMAX,microM/min/mg,39,0.996,
KQ,10'12/M/s,39,0.996,
MAP,,39,0.996,
MEANARTERIALBLOODPRESSURE,,39,0.996,
KP,10^-6 cm/s,39,0.996,
TOPICALPOTENCY,,39,0.996,
DELTAPCA50,,39,0.996,
D150,ug.mg-1,39,0.996,
FLEA,[ppm],39,0.996,
KP,ucm.s-1,39,0.996,
ORALDIURETICACTIVITY,u equiv of [Na+] kg-1 hr-1,39,0.996,
VMAX,nM/mg*min,39,0.996,
DELTA(V12),mV,39,0.996,
MIC,umol.L-1.ml-1,39,0.996,
ISAAR,%,39,0.996,
K,10^-2/uM/min,39,0.996,
TOXICLEVEL,umol.L-1,39,0.996,
EC>90,umol.L-1,39,0.996,
V,ml 6hr-1 (kg of body weight)-1,39,0.996,
LESIONLENGTH,mm mice-1,39,0.996,
MAXTEMPERATUREDECREASE,,39,0.996,
FI,,39,0.996,
P24CONCENTRATION,umol.L-1,39,0.996,
RELATIVESUSCEPTIBILITY,,39,0.996,
I90,[ppm],38,0.996,
WEIGHT,,38,0.996,
NOOFANIMALSSURVIVED,,38,0.996,
PMIC,,38,0.996,
HISTONEMODIFICATION,,38,0.996,
LOGPR,,38,0.996,
LIPOPHILICITY,=,38,0.996,
CT,pmol/g,38,0.996,
XFOLD,,38,0.996,
ACTIVITY,nmol.L-1.min-1.mg-1,38,0.996,
AUCDOSE,hr.kg.ng/ml/mg,38,0.996,
TIME,nanoseconds,38,0.996,
LD0,mg,38,0.996,
PDHACTIVEPDHTOTAL,%,38,0.996,
MLC,%,38,0.996,
BINDING,(ng of DNA) dish-1,38,0.996,
AUCT,,38,0.996,
DOSE,mg.kg-1.d-1,38,0.996,
ED50,mg/day,38,0.996,
DOSEGOFTISSUE,%,38,0.996,
CIC,umol.L-1,38,0.996,
VERTEBRALBLOODFLOW,,38,0.996,
F(CAVE),umol.L-1,38,0.996,
PL,%,38,0.996,
CLH,ml/hr,38,0.996,
ACTIVITY,No unit,38,0.996,
ACTIVITY,/g,38,0.996,
ACUTETOXICITY,,38,0.996,
STABILITY,d,38,0.996,
CHANGEINHEARTRATE,,38,0.996,
BMF,,38,0.996,
TOX50,umol.L-1,38,0.996,
KAPS,l M-1,38,0.996,
BINDINGRATIO,,38,0.996,
ACTIVITY,kilobase,38,0.996,
IC80,,38,0.996,
AFFINITYRATIO,,38,0.996,
APOPTOTICACTIVITY,%,38,0.996,
RIA,,38,0.996,
IC50,mMequiv,38,0.996,
ACTIVITY,log10PFU/ml,38,0.996,
PKAPP,,38,0.996,
DNABINDING,Cel,38,0.996,
IC75,umol.L-1,38,0.996,
XFOLD,umol.L-1,38,0.996,
NOOFANIMALSEXHIBITINGTOXICITYNUMBEROFANIMALSTESTED,,37,0.996,
BSI,,37,0.996,
GMMIC,umol.L-1,37,0.996,
HYPERGLYCEMICACTIVITY,,37,0.996,
CHANGEINTM,,37,0.996,
AUC,ng.hr/Kg,37,0.996,
LOG1GI50,,37,0.996,
PRESYNAPTICANTAGONISM,,37,0.996,
BWC,mg,37,0.996,
30DAYSURVIVALTOTAL,,37,0.996,
KDISS,10'-4/s,37,0.996,
DELTABG,,37,0.996,
MAXDELTAHR,beats min-1,37,0.996,
INIHIBITION,%,37,0.996,
ACTIVITY,PSL/mm2,37,0.996,
AUCDOSE,nmol.hr/L,37,0.996,
DRUGUPTAKE(FREE),,37,0.996,
AD50,uM kg-1,37,0.996,
LOAEL,umol.L-1,37,0.996,
HMAX,,37,0.996,
TENSION,%,37,0.996,
DELTAHR,beats min-1,37,0.996,
NOOFMOUSEPROTECTED,,37,0.996,
DOSE-MODIFYINGFACTOR,,37,0.996,
VMAX,deltaOD/min,37,0.996,
MAXDELTAMAP,mmHg,37,0.996,
INH,mm,37,0.996,
DNACLEAVAGE,umol.L-1,37,0.996,
GLUCOSELEVEL,mg dl-1,37,0.996,
FAFG,,37,0.996,
MUKAPPARATIO,,37,0.996,
G30,,37,0.996,
CP(T),umol.L-1,37,0.996,
C20,uM l-1,37,0.996,
PAPP,%,37,0.996,
MTD,mg kg-1 5day-1,37,0.996,
POSTSYNAPTICANTAGONIST,,37,0.996,
A1SELECTIVITY,,37,0.996,
NSB,,37,0.996,
TESTCONTROLSURVIVAL,,37,0.996,
ALPHAMAX,umol.L-1,37,0.996,
MED,mg kg-1 5day-1,37,0.996,
STABILITY,% ID/g,37,0.996,
VASOCONSTRICTIONEFFECT,,37,0.996,
LOG(10'3IC50),,37,0.996,
CT10RATIO,,37,0.996,
HABC,,37,0.996,
BPCHANGE,%,37,0.996,
K,10^-2/min,37,0.996,
LOG1LD50,,36,0.996,
VMAX,pmol/mg/min,36,0.996,
VMAX,mAU/min,36,0.996,
DECREASEINAP,,36,0.996,
ACTIVITY,umol/hr,36,0.996,
DELTAKAPPA,,36,0.996,
SURVIVALINCREASE,,36,0.996,
%NO2-,M/M,36,0.996,
-LOG(1EC50),,36,0.996,
INITIALRATES,,36,0.996,
FORMATIONOFNO2-,umol.L-1,36,0.996,
ED95,p.p.m. in feed,36,0.996,
OPTIMALDOSE,mg,36,0.996,
MSD,,36,0.996,
DELTACPMX10E-3,,36,0.996,
KI,10^2 uM,36,0.996,
ACTIVITY,/mmol/min,36,0.996,
ACTIVITY,Counts,36,0.996,
AMAX,pmoles,36,0.996,
EXPINHIBCONSTANT,,36,0.996,
FPIC50,,36,0.996,
SD,s,36,0.996,
TI,umol.L-1,36,0.996,
KD1,umol.L-1,36,0.996,
INCORPORATIONRATE,c.p.m. hr-1,36,0.996,
SI,beats min-1,36,0.996,
PC,nm s-1,36,0.996,
PRESSURE,mmHg,36,0.996,
CMR,,36,0.996,
AUCDOSE,ug.hr/mL/mg/kg,36,0.996,
K,umol.L-1.min-1,36,0.996,
IG,%,36,0.996,
RATECONSTANT,s-1,36,0.996,
RVR,,36,0.996,
LOGM,,36,0.996,
RBARATIO,,36,0.996,
NNOSACTIVITY,%,36,0.996,
INHIBITION,pM of cAMP min-1 mg-1,36,0.996,
VD,ml,36,0.996,
THYMIDINESHIFT,,36,0.996,
ACTIVITY,g%,36,0.996,
LD50,mg.kg-1.d-1,36,0.996,
MIC50MIC90,,36,0.996,
ID50,mg/day,36,0.996,
DEGRADATIONRATECONSTANT,hr-1,36,0.996,
MAXIMALNON-TOXICDOSE50,umol.L-1,36,0.996,
ACTIVITY,10'-5/ml,36,0.996,
CROSSLINKING,%,36,0.996,
TUBULINPOLYMERIZATIONRATIO,,36,0.996,
SENSITIZEDANIMALS,,36,0.996,
LOG1ED50,,36,0.996,
CHANGEOFBODYWEIGHT,%,36,0.996,
RELATIVEINHIBITORYPOTENCY,,36,0.996,
LOG1ACTIVITY,,36,0.996,
ACTIVITY,nmol/g tissue,36,0.996,
PEC05,,36,0.996,
%INHIBITIONOFCONTROLVALUES,%,36,0.996,
INTRINSICTOXICITY,,36,0.996,
KOFF,1-s,36,0.996,
KA,10^3/M,36,0.996,
PLASMAGHRELEASE,umol.L-1,36,0.996,
MBIC50,,36,0.996,
POLYAMINE,pM g-1,36,0.996,
36CL-UPTAKE,,36,0.996,
AUCDOSE,nM.hr/mg/kg,36,0.996,
REVERSALABILITY,,36,0.996,
DRUGDEGRADATION,umol.L-1,36,0.996,
CL,nmol/mg.min,36,0.996,
BNA,%,36,0.996,
RATE,%,36,0.996,
CELLULARREVERSION,%,35,0.996,
PKHB,,35,0.996,
AVERAGETURNS,,35,0.996,
LC50,microg/cm2,35,0.996,
LOGTCID50,,35,0.996,
KSV,10^4/M,35,0.996,
VMAXKM,microL/min/mg,35,0.996,
KCATKM,mM-1 s-1,35,0.996,
SOLUBILITY,ml,35,0.996,
AFI,,35,0.996,
ERP,%,35,0.996,
LOSSOFRIGHTINGREFLEX,%,35,0.996,
PLASMAGLUCOSE,mg dl-1,35,0.996,
RETENTIONINDEX,,35,0.996,
MCPHAILINDEX,,35,0.996,
TMPDECREASE,degrees F,35,0.996,
AUC,ng.hr.kg/mg/ml,35,0.996,
FT>MIC,s,35,0.996,
LD50,microg/cm2,35,0.996,
MF,%,35,0.996,
KA,10^4L/mol,35,0.996,
WEIGHTGAIN,%,35,0.996,
FSCRECOVERY,%,35,0.996,
AVERAGETUMORVOLUME,mm**3,35,0.996,
ED50,M kg-1,35,0.996,
AUC,s,35,0.996,
ED50,mg 4kg-1,35,0.996,
CLH,10^-6uL/min,35,0.996,
DRUGUPTAKE,fmol,35,0.996,
CHOLESTEROL,mg 100ml-1,35,0.996,
CHANGEFROMCONTROL(LVDPDT),%,35,0.996,
ACTIVITY,beats min-1,35,0.996,
MOTORACTIVITY,,35,0.996,
AGONISTACTIVITY,%,35,0.996,
ACTIVITY,mg.ml-1,35,0.996,
LOG1ED40,,35,0.996,
PERMEABILITY,umol.L-1,35,0.996,
DECREASEINIC50,,35,0.996,
PALPHAKA,,35,0.996,
MD,ug.mg-1,35,0.996,
LED,mgP kg-1,35,0.996,
ABSAC039UM,umol.L-1,35,0.996,
MPC4,umol.L-1,35,0.996,
TUMORRESPONSE,%,35,0.996,
IA50,equiv,35,0.996,
K2KI,/mol.L-1.s-1,35,0.996,
VOLUME,l hr-1,35,0.996,
EXHIBITINGTURNING,%,35,0.996,
PROTECTED,,35,0.996,
ACTIVITY,RFU min-1,35,0.996,
MTD50,umol.L-1,35,0.996,
TDELTAS,kJ.mol-1,35,0.996,
MIC,U.ml-1,35,0.996,
SBP,mmHg,35,0.996,
MEANSURVIVALTIME,,35,0.996,
MTD,umol.mg-1,35,0.996,
SEIZURESCORE,,35,0.996,
INTRINSICACTIVITY,umol.L-1,35,0.996,
MINIMALDOSE,umol.L-1,35,0.996,
ACTIVITY,/nmol,35,0.996,
IT100,s,35,0.996,
CL,ml/mg/kg,34,0.996,
SERUMLEVEL,,34,0.996,
ACTIVITY,10^3/mm3,34,0.996,
LOGKAT,,34,0.996,
KD2,umol.L-1,34,0.996,
SELECTIVITYRATIOS31,,34,0.996,
KILOW,umol.L-1,34,0.996,
DPDTMAX,,34,0.996,
CONTROLCURRENT,%,34,0.996,
KD',umol.L-1,34,0.996,
%OFSELECTIVITY,%,34,0.996,
K,10'7/M/min,34,0.996,
STABILTY,ml/min.Kg,34,0.996,
AE,%,34,0.996,
CELLCYCLEANALYSIS,,34,0.996,
RANGEOFSURVIVALDAYS,,34,0.996,
AUCT,ng/g.hr,34,0.996,
DEATH,,34,0.996,
DELTAGSOLV,kCal mol-1,34,0.996,
S50,umol.L-1,34,0.996,
AGONISTICACTIVITY,,34,0.996,
KH,umol.L-1,34,0.996,
DELTAFMAX,%,34,0.996,
TN,umol.L-1.min-1.,34,0.996,
PIMETABOLISM,%,34,0.996,
NOOFRETCHES,,34,0.996,
SHLEVEL,uM g-1,34,0.996,
TMED50,ug.mg-1,34,0.996,
ACTIVITYA,uM kg-1,34,0.996,
LT50,s,34,0.996,
CTS,,34,0.996,
K,10'4L/mol,34,0.996,
CELLSINMETAPHASE,%,34,0.996,
CURRENTS,%,34,0.996,
KCAT,1/sec,34,0.996,
INCIDENCE,,34,0.996,
ACTIVITY,10'5U/mL,34,0.996,
ER,,34,0.996,
JUMPLATENCYTIME,s,34,0.996,
ACTIVITY,10'7No_unit,34,0.996,
BA,,34,0.996,
RF50,,34,0.996,
BAPP,,34,0.996,
ACTIVITY,cm3,34,0.996,
LAMBDAZ,s,34,0.996,
ED90,[ppm],34,0.996,
EA,kJ.mol-1,34,0.996,
LOSSOFCELLS,%,34,0.996,
SURVIVALMEDIAN,,34,0.996,
CYTOTOXICCONCENTRATION,umol.L-1,34,0.996,
KB,10^6/M,34,0.996,
TAR,,34,0.996,
MFC,mg,34,0.996,
ROLIPRAMACTIVITY,%,34,0.996,
CARDIOSELECTIVITY,,34,0.996,
PARENTCOMPOUND,%,34,0.996,
CACO-2PAPP,cm s-1,34,0.996,
UPTAKEATC50,,34,0.996,
C24,umol.L-1,34,0.996,
SYNERGY,fold,34,0.996,
PEFF,cm/s,34,0.996,
CHANGEOFCO,%,33,0.996,
RBF,,33,0.996,
KASS,l mol-1,33,0.996,
ACCUMULATIONCOEFFICIENT,,33,0.996,
CHANGEINSYSTOLICPRESSURE,mmHg,33,0.996,
MUD,ug.mg-1,33,0.996,
CHANGEOFCF,%,33,0.996,
CHANGEOFHR,%,33,0.996,
CHANGEOFDBP,%,33,0.996,
DPDT,max,33,0.996,
BPDECREASE,%,33,0.996,
CHANGEOFSBP,%,33,0.996,
ENZYMELEVEL,U l-1,33,0.996,
HVACONTROL,%,33,0.996,
TOTALSCORE,,33,0.996,
LCE,%,33,0.996,
RELATIVEINHIBITIONINDEX,,33,0.996,
RATIO,/uM,33,0.996,
ACTIVITYINANIMALS,%,33,0.996,
VMAX,U.mg-1,33,0.996,
KI50,umol.L-1,33,0.997,
CLEARANCE,,33,0.997,
SPECIFICINDEX,,33,0.997,
CYTOTOXICIY,,33,0.997,
IW,,33,0.997,
KQ,L.umol-1.s-1,33,0.997,
NOOFMONKEYS,,33,0.997,
SC50,,33,0.997,
KIKI,,33,0.997,
TG,mg dl-1,33,0.997,
PDD50,umol.L-1,33,0.997,
SALURETICPOTENCY,u equiv min-1,33,0.997,
CGMPCONTENT,pmol/mg protein,33,0.997,
CL,hr.Kg/L,33,0.997,
MI100,ug.mg-1,33,0.997,
KAPP,10^-6/M,33,0.997,
PHOSPHOLIPIDOSISAS%OFPOSITIVECONTROL,%,33,0.997,
EDEMA,,33,0.997,
PM,10^-5 cm/min,33,0.997,
RATIO,1/uM*sec,33,0.997,
IM,,33,0.997,
ACTIVITY,uV,33,0.997,
AUC,nmol.hr/g,33,0.997,
SELECTIVITYCOEFFICIENT,,33,0.997,
INOTROPICEFFECT,,33,0.997,
CYTOKINETICRESPONSE,,33,0.997,
DNACLEAVAGE,,33,0.997,
POLYAMINELEVEL,umol.L-1,33,0.997,
EC37,umol.L-1,33,0.997,
KD,10^-1/s,33,0.997,
SRR,,33,0.997,
TMSHIFT,°C,33,0.997,
STEREOTYPYSCORE,,33,0.997,
-LOG1KB,,33,0.997,
ACTIVITY,umol.mg-1.min-1,33,0.997,
SYMPTOMS,,33,0.997,
NOPOSITIVECASESTESTED,,33,0.997,
FUNCTIONALPROFILE,,33,0.997,
MAXIMUMTESTCONCENTRATIONTHATDIDNOTEXHIBITCYTOTOXICITY,umol.L-1,33,0.997,
AC50,%,33,0.997,
PLASMAINSULIN,ml,33,0.997,
CMAXDOSE,nM.kg/mg,33,0.997,
K,/nM/min,33,0.997,
EDAREC,ug.mg-1,33,0.997,
ED80,ug/kg,33,0.997,
TREATEDCELLS,,32,0.997,
REPRESSION,%,32,0.997,
PERMEABILITY,cm hr-1,32,0.997,
RLU,%,32,0.997,
REVERSETRANSCRIPTASEACTIVITY,,32,0.997,
ACTIVITY,nmol/umol,32,0.997,
UI,%,32,0.997,
CP,ng.Eq/ml,32,0.997,
TCID50,ml-1,32,0.997,
PLASMALIPIDS,mg dl-1,32,0.997,
RELATIVERATEOFHYDROLYSIS,,32,0.997,
SURVIVORSTREATED,,32,0.997,
ACTIVITY,pmol/L,32,0.997,
ACTIVITY,10^-10.mol/mg/min,32,0.997,
ACTIVITY,pmol/ml,32,0.997,
VDSSF,L.kg-1,32,0.997,
TAC,U,32,0.997,
ACTIVITY,mAU,32,0.997,
RATIO,10'3/M/min,32,0.997,
PIC50(CALC),,32,0.997,
AUCN,mM hr dose-1,32,0.997,
RC10,umol.L-1,32,0.997,
ACTIVITYSCALE,,32,0.997,
ACTIVITY,umol/L/min,32,0.997,
ACTIVITY,/day,32,0.997,
TEMPERATURE,,32,0.997,
ACTIVEDOSERANGE,ug.mg-1,32,0.997,
CIC95,,32,0.997,
CI,ml min-1 kg-1,32,0.997,
ACTIVATIONTIME,%,32,0.997,
CL,umol.min-1.mg-1,32,0.997,
SRR,%,32,0.997,
CELLVIABILITY,umol.L-1,32,0.997,
PGC50,,32,0.997,
SPF,,32,0.997,
1IC50,,32,0.997,
RECOVERY,mg,32,0.997,
KHOX,,32,0.997,
RBA2,,32,0.997,
OD,mm,32,0.997,
NOOFCIRCLINGS,,32,0.997,
K3,s-1,32,0.997,
NOOFPLATELETS,%,32,0.997,
NOOFPOSITIVEANIMALS,,32,0.997,
LOG10TCID50,,32,0.997,
DPDT,%,32,0.997,
LICKINGLATENCY,,32,0.997,
LOGBF,,32,0.997,
KILLATC50,%,32,0.997,
KDAPP,umol.L-1,32,0.997,
ORALDIURETICACTIVITY,u equiv of [Na+]  kg-1,32,0.997,
KA,10^7/M,32,0.997,
ED50,molar ratio,32,0.997,
MAXDROP,%,32,0.997,
LOG1IC50,umol.L-1,32,0.997,
RBA1,,32,0.997,
DD,umol.L-1,32,0.997,
IONOTROPICACTIVITY,mg,32,0.997,
DRUGRECOVERY,ngequiv/g,32,0.997,
MLD,,32,0.997,
KCAT,10'6/s,32,0.997,
PLASMAGH,umol.L-1,32,0.997,
RLUWELL,,32,0.997,
%,,32,0.997,
EC10X,umol.L-1,32,0.997,
CYTOSTATICACTIVITY,%,32,0.997,
MITOTICINDEX,umol.L-1,32,0.997,
VISCOSITY,,32,0.997,
HDL-C,mg dl-1,32,0.997,
MRF,,32,0.997,
MRT,,32,0.997,
EC001,uM/A unit/min,32,0.997,
KINX10E3,hr-1,32,0.997,
DARESPONSE,%,32,0.997,
DRYWEIGHT,%,32,0.997,
ANALGESICACTIVITY,%,31,0.997,
SSC,,31,0.997,
DISSOCIATIONCONSTANT,,31,0.997,
ACTIVITY,uM g-1,31,0.997,
IC50,10^3nM,31,0.997,
PGI50,umol.L-1,31,0.997,
LC20,umol.L-1,31,0.997,
SPONTACTIVITY,Counts 10min-1,31,0.997,
CREL,,31,0.997,
RBF,ml min-1,31,0.997,
FLUORESCENCEACTIVITYRATIO,,31,0.997,
LOG1S,,31,0.997,
CUREDANIMALS,,31,0.997,
MPE,,31,0.997,
PMIC,umol.L-1,31,0.997,
NGRATIO,,31,0.997,
CHANGEFROMCONTROL,%,31,0.997,
EC025,,31,0.997,
CA2+TRANSPORT,,31,0.997,
KCAT,10^5/s,31,0.997,
PEC15,,31,0.997,
LOG1MIC(MML-1),,31,0.997,
FCMIN,umol.L-1,31,0.997,
AUCDOSE,ug.hr.ml-1,31,0.997,
VD,ml/cm3,31,0.997,
TIMEABOVEIC50,s,31,0.997,
DHP-ISUSCEPTIBILITY,,31,0.997,
TAILVEINTOXICITY,,31,0.997,
TAILFLICKLATENCY,s,31,0.997,
FL-1,,31,0.997,
CL-,m equiv 6hr-1 kg-1 (body weight)-1,31,0.997,
POTENTIATION,nM mg-1,31,0.997,
MLC,,31,0.997,
K,%,31,0.997,
KAPP,s-1,31,0.997,
MAXPOSSIBLEEFFECT,%,31,0.997,
ACCUMULATION,nM (mg of protein)-1,31,0.997,
EFTPC,umol.L-1,31,0.997,
VOLUME,,31,0.997,
KEL,hr-1,31,0.997,
PA2-PA10,,31,0.997,
UVAPF,,31,0.997,
UTERINEWETWEIGHT,,31,0.997,
DELTAG,%,31,0.997,
VMAX,nmol/mg.min,31,0.997,
URINARYOUTPUT,ml,31,0.997,
FSC,,31,0.997,
VT50,s,31,0.997,
DELTAFC,%,31,0.997,
K12,umol.L-1,31,0.997,
MIC+MIC-,,31,0.997,
RELATIVEPT,,31,0.997,
KH,s-1,31,0.997,
NOOFNONPREGNANTTREATED,,31,0.997,
-LOGACTIVITY,,31,0.997,
MIC50,%,31,0.997,
PERMEABILITY,pmol/s,31,0.997,
C50,,31,0.997,
SURVIVORSATDAY9,,31,0.997,
FVDSS,L/Kg,31,0.997,
KCATKM,umol.L-1.h-1,31,0.997,
HYPOTHERMICEFFECT,Cel,31,0.997,
MAXHYPOTENSION,%,31,0.997,
BINDINGSTOICHIOMETRY,,31,0.997,
LOCOMOTORACTIVITY,uM kg-1,31,0.997,
G30,%,31,0.997,
TREATMENTPERIOD,,31,0.997,
SURVIVAL,s,31,0.997,
BINDINGSITEPREFERENCE,,31,0.997,
METABOLICSTABILITY,,31,0.997,
K,m equiv 6hr-1 kg-1 (body weight)-1,31,0.997,
ESTROGENICEFFECT,umol.L-1,31,0.997,
MAXCOLLATERALINDEX,,31,0.997,
-LOGIC50,,31,0.997,
LD90,J cm**-2,31,0.997,
COLLATERALINDEX,,31,0.997,
DELTAERP,%,31,0.997,
ACTIVITY,IU ml-1,30,0.997,
ACTIVITY,ug/min,30,0.997,
MAXDELTAFRP,%,30,0.997,
-LOGK,,30,0.997,
ASSEMBLY,%,30,0.997,
ED30,mg,30,0.997,
NOOFCOUNTS,uM kg-1,30,0.997,
BPINCREASE,mmHg,30,0.997,
KF,,30,0.997,
TC1,,30,0.997,
ED85,ug.mg-1,30,0.997,
RELATIVETOXICITY,,30,0.997,
K,10'5/Ms,30,0.997,
RESIDUALACTIVITY,,30,0.997,
RESIDUALSECRETION,%,30,0.997,
NOOFCULTURESACTIVETOTAL,,30,0.997,
BRAINLEVEL,nM g-1,30,0.997,
DRUGEXCRETION,umol/min/kg,30,0.997,
ACTIVITY,c.p.m. min-1 mg-1,30,0.997,
HDL-C,,30,0.997,
ACTIVITY,u equiv min-1,30,0.997,
-LOGKB,%,30,0.997,
TD50,mmol/Kg,30,0.997,
LOGSWEETBITTER,,30,0.997,
PERMEABILITY,10'-9meter/s,30,0.997,
MAXCFRESPONSE,%,30,0.997,
TV,,30,0.997,
DEC,%,30,0.997,
T-CELLINHIBITION,,30,0.997,
GI80,umol.L-1,30,0.997,
MAXSTIMULATION,,30,0.997,
LOGCFU,,30,0.997,
PAPPATOBPLUSINHIBITOR(MEAN),10E-6 cm/s,30,0.997,
PAPPATOB(MEAN),10E-6 cm/s,30,0.997,
KASS,L.umol-1,30,0.997,
PAPPBTOA(MEAN),10E-6 cm/s,30,0.997,
GM,,30,0.997,
APTT,,30,0.997,
ID(PERGOFORGAN),%,30,0.997,
MAXDECREASE,%,30,0.997,
MAXDECREASE,,30,0.997,
PAPPBTOAPLUSINHIBITOR(MEAN),10E-6 cm/s,30,0.997,
LEASTDOSE,ug.mg-1,30,0.997,
ACTIVITY,uL.ml-1,30,0.997,
ACTIVITY,cps,30,0.997,
CARDIACFORCE,,30,0.997,
LC95,mgAi/L,30,0.997,
DIFFERENTIAL,,30,0.997,
EFFLUXRATIOPLUSINHIBITOR,,30,0.997,
KSV,,30,0.997,
MEANDAYOFDEATH,,30,0.997,
SKINREACTION,,30,0.997,
FICI80,,30,0.997,
PHORBOLDISPLACEMENT,umol.L-1,30,0.997,
IMMOBILITY,%,30,0.997,
SPEEDOFINDUCTION,,30,0.997,
PTZPROTECTION,%,30,0.997,
PIC50,umol.L-1,30,0.997,
2APTT,,30,0.997,
PHOTOTOXICEFFECT,,30,0.997,
DOSE,rd mCi-1,30,0.997,
INFI,,30,0.997,
ELECTROLYTEEXCRETION,uM sample-1,30,0.997,
AVERAGEPEAKCONCN,umol.L-1,30,0.997,
BASALINHIBITION,%,30,0.997,
NON-HDL-C,,30,0.997,
MEANNOOFSHOCKS,,30,0.997,
RECOVERYTIME,,30,0.997,
CHANGEINTM,Cel,30,0.997,
RECOVERYBTOAPLUSINHIBITOR(MEAN),%,30,0.997,
TUMORSIZE,,30,0.997,
KE,s-1,30,0.997,
LOG(M50),,30,0.997,
VAR,,30,0.997,
EFFECT,mg dl-1,30,0.997,
VMAX,abs/min,30,0.997,
LAD,umol.L-1,30,0.997,
MSIC,umol.L-1,30,0.997,
EFFLUXRATIO,,30,0.997,
CELLCYCLE,umol.L-1,30,0.997,
DLSCONCENTRATION,umol.L-1,30,0.997,
CC75,umol.L-1,30,0.997,
IRONEXCRETION,ug.mg-1,30,0.997,
LC50,microg/mL2,30,0.997,
VERP,ms,30,0.997,
A2SELECTIVITY,,30,0.997,
ACTIVITY,10'1AU.min,30,0.997,
RECOVERYATOBPLUSINHIBITOR(MEAN),%,30,0.997,
RELATIVECHANGE,%,29,0.997,
MBP,ug.mg-1,29,0.997,
DRUGDEGRADATION,umol.min-1,29,0.997,
ANTIMALARIALACTIVITY,,29,0.997,
-LOGK05,,29,0.997,
MEANENHANCEMENTOFBINDING,,29,0.997,
STABILITY,nmol/min/kg,29,0.997,
PC3,umol.L-1,29,0.997,
IMAX,umol.L-1,29,0.997,
FEEDEFFICIENCY,,29,0.997,
FEEDCONSUMPTION,g day-1,29,0.997,
CONCENTRATIONINSERUM,umol.L-1,29,0.997,
LOGKI,D4,29,0.997,
ACTIVITY,pmol/mg/min,29,0.997,
RELATIVEBINDING,%,29,0.997,
COMPOUNDRECOVERY,ng/g,29,0.997,
KA,10'3/M/min,29,0.997,
NETLOGKILL,,29,0.997,
DELTAH,,29,0.997,
ANTIBODYSTIMULATION,,29,0.997,
PGE2LEVEL,umol.L-1,29,0.997,
RATECONSTANT,,29,0.997,
CONTRACTILITY,%,29,0.997,
IC50,10^-5 uM,29,0.997,
ACTIVITY,%ID,29,0.997,
CL,ml/kg.min,29,0.997,
MAXIMALEFFICACY,%,29,0.997,
TOXICITYZONE,umol.L-1,29,0.997,
PEFF,10'-7 cm/s,29,0.997,
ACTIVITY,mgequiv/mmol,29,0.997,
LD,ug.mg-1,29,0.997,
NOOFERRORS,,29,0.997,
INCREASEINCONCENTRATION,pmol/mg prot.,29,0.997,
RIA,%,29,0.997,
SUBMIC,umol.L-1,29,0.997,
CP,pmol/ml,29,0.997,
KINACT,10^-4/s,29,0.997,
LETHALITY,,29,0.997,
BODYWEIGHTGAIN,g day-1,29,0.997,
MAXDOSE,ug.mg-1,29,0.997,
DELTAMV,,29,0.997,
RV,%,29,0.997,
ACTIVITY,kDa,29,0.997,
DISTRIBUTION,,29,0.997,
ENHANCEMENT,,29,0.997,
NCC,%,29,0.997,
VZ,l,29,0.997,
MI,,29,0.997,
TOTALCHOLESTEROL,mg 100ml-1,29,0.997,
NRN,,29,0.997,
EDRATIO,,29,0.997,
BPR,ml/g,29,0.997,
PKIRATIO,,29,0.997,
CLH,umol.ml-1,29,0.997,
CMIN,,29,0.997,
BFU,,29,0.997,
MAXCONTRACTION,%,29,0.997,
VIABLECELLS,*10e-5,29,0.997,
GLUCOSENORMALISATION,,29,0.997,
RHR,,29,0.997,
NT,ug.mg-1,29,0.997,
TOP1CLEAVAGEACTIVITY,,29,0.997,
KA,10^-6/M,29,0.997,
CELLGROWTH,,29,0.997,
REVERSIBLE,%,29,0.997,
TCMIN,%,29,0.997,
CLIP,,29,0.997,
AUCN,uM hr dose-1,28,0.997,
MEANLOGCONCENTRATIONRATIO,,28,0.997,
DRUGMETABOLISM,mmol/L,28,0.997,
FSC,%,28,0.997,
TDI,s-1,28,0.997,
K,10^6/M/min,28,0.997,
ACTIVITY,nanoampere,28,0.997,
LOGT12,,28,0.997,
PKRED,,28,0.997,
ADJUSTEDKI,umol.L-1,28,0.997,
K2,M-1 min-1,28,0.997,
NOOFDEATHS,,28,0.997,
FICI,umol.L-1,28,0.997,
CLH,uL.ml-1,28,0.997,
SALDIURETICACTIVITY,,28,0.997,
N50E,,28,0.997,
EP,mV,28,0.997,
DRUGMETABOLISM,uM/L,28,0.997,
TDELTAS,J/mol,28,0.997,
DELTAG,J/mol,28,0.997,
ACTIVEDOSERANGE,mg.kg-1.d-1,28,0.997,
AGGREGATES,%,28,0.997,
RATIO,Io/Eo,28,0.997,
NOOFTUMOURS,,28,0.997,
2XPT,umol.L-1,28,0.997,
NOOFRATS,,28,0.997,
TUMORSWITHCR,%,28,0.997,
ACTVITY,mmHg,28,0.997,
IC30,,28,0.997,
ATAXIA,ug.mg-1,28,0.997,
CLF,mL/min,28,0.997,
EFFECT,d,28,0.997,
DELTAH,J/mol,28,0.997,
RFU,%,28,0.997,
EDEMARATIO,,28,0.997,
CTLACTIVITY,,28,0.997,
CONTENT,ug (g of tissue)-1,28,0.997,
RI,%,28,0.997,
MYDRIASIS,%,28,0.997,
TUMOR-FREE,survivors/total,28,0.997,
ARRHYTHMIASTIMES,,28,0.997,
SOLUBILITY,10'-3mol/dm3,28,0.997,
CMAX,s,28,0.997,
GRIPSCORE,,28,0.997,
SYNERGY,,28,0.997,
ED5,ug.mg-1,28,0.997,
MET,,28,0.997,
ANTIVIRALINDEX,,28,0.997,
OPTICALDENSITY,,28,0.997,
WORMREDUCTION,%,28,0.997,
OPTIMALDOSAGE,mg kg-1 dose-1 day-1,28,0.997,
A-SELECTIVITY,,28,0.997,
ISC,%,28,0.997,
PED50,uM kg-1,28,0.997,
VCRACCUMULATION,,28,0.997,
BLOCKADE,%,28,0.997,
CPE50,umol.L-1,28,0.997,
LC100,[ppm],28,0.997,
KI,10'3/M/min,28,0.997,
MAXEFFECT,mmHg,28,0.997,
APD50,ms,28,0.997,
ANTI-UTEROTROPHICEFFECT,,28,0.997,
HEARTRATE,s-1,28,0.997,
EC50,mol%,28,0.997,
TN,M min-1 M-1,28,0.997,
CLF,ml/min,28,0.997,
ACTIVITY,10^6 /uL,28,0.997,
TC,survivors/total,28,0.997,
BLOODLEVEL,Counts min-1 0.2ml-1,28,0.997,
INVERSERELATIVEPOTENCY,,28,0.997,
RELATIVEINHIBITION,,28,0.997,
LC50,umol/dm3,28,0.997,
CURE,,28,0.997,
CATSCORE,,28,0.997,
OCC50,ug.mg-1,28,0.997,
ORGANWEIGHTRATIO,,28,0.997,
CURERATE,%,28,0.997,
LC50,ng/cm2,28,0.997,
DELTAP50,,28,0.997,
LOWESTEFFECTIVEDOSE,ug.mg-1,28,0.997,
ACTIVITY,nM (10e6*cells)-1,27,0.997,
ACTIVITY,USP-U/mg,27,0.997,
MED50,,27,0.997,
DELTAIC,%,27,0.997,
PKI1-PKI2,,27,0.997,
ACTIVITY,mg%,27,0.997,
MCT,s,27,0.997,
ACTIVITY,nmol/hr/mL,27,0.997,
ASCRIT,,27,0.997,
DELTAG,kCal M-1,27,0.997,
AUCDOSE,pmol.hr/ml,27,0.997,
ID16,umol.L-1,27,0.997,
MAXDELTA,%,27,0.997,
WEIGHTGAIN,,27,0.997,
ID84,umol.L-1,27,0.997,
LD90,,27,0.997,
ED50,mmol/L,27,0.997,
FRPC20,umol.L-1,27,0.997,
BMAX,umol.L-1,27,0.997,
WEIGHTLOSS,,27,0.997,
PLASMALEVEL,mg.ml-1,27,0.997,
GTP-GAMMASINDEX,,27,0.997,
AUCDOSE,ng.hr/ml.mg,27,0.997,
ACTIVITY,micrometer/day,27,0.997,
ACTIVITY,microM/min/mg,27,0.997,
DD,,27,0.997,
MABP,delta mmHg,27,0.997,
LOG1EC50,umol.L-1,27,0.997,
2PT,,27,0.997,
SALINECONTROL,%,27,0.997,
SOLUBILITY,[ppm],27,0.997,
PARASITAEMIA,,27,0.997,
SSAT,%,27,0.997,
TOTALTURNINGS,,27,0.997,
SPECIFICACTIVITY,nmol.L-1.min-1.mg-1,27,0.997,
PM,nm/s,27,0.997,
AUC,ug.hr/kg,27,0.997,
DELTABP,%,27,0.997,
TT,,27,0.997,
TOXICITYSURVIVORS,,27,0.997,
VD,,27,0.997,
T-CC,%,27,0.997,
PNF,,27,0.997,
AUCDOSE,pmol.hr/g,27,0.997,
ID(PERGOFTISSUE),%,27,0.997,
SURVIVALAFTER10DAYS,,27,0.997,
CARDIOTOXICITY,,27,0.997,
T>IC50,s,27,0.997,
IC50,uL,27,0.997,
LONG-TERMSURVIVORS,,27,0.997,
KB,10'3/M,27,0.997,
CHANGE,mmHg,27,0.997,
AMOUNTOFCROSS-LINKEDPROTEIN,(ug of cross-linked protein) (mg of protein)-1,27,0.997,
KASS,10e6 l M-1,27,0.997,
ACTIVITY,um2,27,0.997,
KB,10'-4L/mol,27,0.997,
TG100,,27,0.997,
VMAX,M s-1,27,0.997,
NOOFPOSRXNS,,27,0.997,
DRUGMETABOLISM,mg,27,0.997,
LOGKOBS,,27,0.997,
ADOMETDC,%,27,0.997,
LOGK2,,27,0.997,
ODC,%,27,0.997,
KINACTKI,M-1 min-1,27,0.997,
MONOAMINELEVEL,pg mg-1,27,0.997,
ACTIVITY,pM (10e6*cells)-1,27,0.997,
VOLUMEOFASCRITFLUID,,27,0.997,
MITOTICINDEX,,27,0.997,
KSV,/M,27,0.997,
OCC90,umol.L-1,27,0.997,
REVERSIBILITYRATIO,,27,0.997,
MUSCARINICAGONISTINDEX,,27,0.997,
AVERAGESURVIVALDAYS,,27,0.997,
AUCT,ng.hr/g,27,0.997,
PLASMASELECTIVITY,,27,0.997,
PNMED,,27,0.997,
NOEC,umol.L-1,27,0.997,
RATEOFHYDROLYSIS,nmol.L-1.min-1.mg-1,27,0.997,
KQ,10'13L/mol/s,27,0.997,
CLH,microM/min,27,0.997,
PCF,,27,0.997,
KCAT,10'3/s,27,0.997,
ANALGESICEFFICACY,%,27,0.997,
MYOBLASTSWITHPARASITES,%,27,0.997,
MPORELEASE,umol.L-1,27,0.997,
NA,,27,0.997,
NOOFANIMALSRESPONDINGANIMALSRECEIVINGDRUG,,27,0.997,
NA+EXCRETION,m equiv kg-1,27,0.997,
VF,%,27,0.997,
ACTIVITY,pmol/min/mg,26,0.997,
LDLCHOLESTEROL,mg 100ml-1,26,0.997,
LACTONEPRODUCTION,,26,0.997,
ACTIVITY,V/s,26,0.997,
BIC,umol.L-1,26,0.997,
EC125,umol.L-1,26,0.997,
MTD,mM kg-1,26,0.997,
K,10'-7/s,26,0.997,
RHA,%,26,0.997,
RESIDUALCONTRACTILEACTIVITY,%,26,0.997,
ALPHA-CHOLESTEROL,%,26,0.997,
ACTIVITY,g/m,26,0.997,
ALPHA-ADRENOLYTICACTIVITY,,26,0.997,
CHANGEINCHOLESTEROL,%,26,0.997,
SURVIVINGFACTOR,%,26,0.997,
ID50,L.mol-1,26,0.997,
LIVERWEIGHT,mg,26,0.997,
TOTALCELLS,ml,26,0.997,
ALLOSTEICENHANER(AE),,26,0.997,
RATIO,/min/microM,26,0.997,
NATRIURETICACTIVITY,uM g-1,26,0.997,
ETOPICBEATS,%,26,0.997,
KSV,10'5L/mol,26,0.997,
BMAX,pM (mg of protein)-1,26,0.997,
HD100,umol.L-1,26,0.997,
CAMPPRODUCTION,pM min-1 well-1,26,0.997,
EC68,umol.L-1,26,0.997,
RESIDUALPEPTIDE,%,26,0.997,
ED75,ug.mg-1,26,0.997,
DNARELAXATION,,26,0.997,
UNALTEREDCOMPOUND,%,26,0.997,
FOODINTAKE,g mouse-1 day-1,26,0.997,
ANTIBIOTICRESISTANCE,,26,0.997,
CLH,microL/min/g,26,0.997,
KAFF,,26,0.997,
KD,10'-4/s,26,0.997,
KA,10'8/M/s,26,0.997,
OCCUPANCY,%,26,0.997,
PAI50,,26,0.997,
DIURETICACTIVITY,ml g-1,26,0.997,
CLH,mL.min/g,26,0.997,
POTENCY,IU mg-1,26,0.997,
DAP,%,26,0.997,
KALIURETICACTIVITY,uM g-1,26,0.997,
PERMEABILITY,10^6cm/s,26,0.997,
PAPP,10'-6/cm,26,0.997,
DAYOFFIRSTPOSITVEREACTION,,26,0.997,
KAPP,/M,26,0.997,
PHORBOLDISPLACEMENT,,26,0.997,
DELTAS,J/mol.K,26,0.997,
PC100,umol.L-1,26,0.997,
CORONARYFLOW,,26,0.997,
POTENCYCLK3UM,umol.L-1,26,0.997,
PLAQUEACCUM,,26,0.997,
PLEURALFLUID,ml,26,0.997,
KIF,umol.L-1,26,0.997,
POTENCY,uM kg-1,26,0.997,
CO,umol.L-1,26,0.997,
KB,ug.mg-1,26,0.997,
EC60,umol.L-1,26,0.997,
LOWESTEFFECTIVECONCENTRATION,[ppm],26,0.997,
CA2+ANTAGONISM,,26,0.997,
ACTIVITY,mg/day,26,0.997,
SINUSBEATS,%,26,0.997,
KM,/mol.L-1.s-1,26,0.997,
ACTIVITY,mole fraction,26,0.997,
QH,ml/min.kg,26,0.997,
AEACTIVITY,%,26,0.997,
STABILITY,months,26,0.997,
STABILITY,ml/min/g,26,0.997,
VMAX,umol,26,0.997,
TOXTOTAL,,26,0.997,
PTD50,ug.mg-1,26,0.997,
TOXICDOSE,umol.L-1,26,0.997,
SPEEDOFPERFORMANCE,,26,0.997,
LOG(PB),,26,0.997,
KINACTKI,,26,0.997,
SPST,%,26,0.997,
ACTIVITY,um/min,26,0.997,
SERUMMG2+LEVEL,,26,0.997,
MINLYTICCONCENTRATION,umol.L-1,26,0.997,
STAININGPOTENTIAL,,26,0.997,
FABS,,26,0.997,
SELECTIVITY,Ratio,26,0.997,
VMAX,milli optical density/minute,26,0.997,
NOEFFECTDOSE,ug.mg-1,26,0.997,
IMPROVEMENT,,26,0.997,
RATE,mg of protein,26,0.997,
RATECONSTANT(K),Ie3 M-1 s-1,26,0.997,
ACTIVITY,ug/kg,26,0.997,
HYPO,ug.mg-1,26,0.997,
TRANSCRIPTIONALACTIVATION,,26,0.997,
ACTIVITY,nM/min,26,0.997,
LD50,mg kg-1 i.p.,26,0.997,
AUCLAST,%,26,0.997,
GTRATE,nM min-1 (mg of protein)-1,26,0.997,
MNTD50,umol.L-1,26,0.997,
V,%,26,0.997,
HDLCHOLESTEROL,mg 100ml-1,26,0.997,
HEARTRATE,delta beats min-1,26,0.997,
CATALEPSY,%,26,0.997,
V,,26,0.997,
LD100,,26,0.997,
MA,%,26,0.997,
MIC75,umol.L-1,26,0.997,
ANTITUMORACTIVITY,,26,0.997,
AP50,umol.L-1,26,0.997,
VENTRICULARRATE,beats min-1,26,0.997,
LOGBETA3,,26,0.997,
RATIO,equiv,26,0.997,
RADIOLABELRECOVERY,ngequiv/ml,26,0.997,
ICD,,26,0.997,
ID80,ug.mg-1,26,0.997,
LOG(1ED80),,26,0.997,
RADIOACTIVITY,,26,0.997,
DRUGMETABOLISM,ug/kg,26,0.997,
TRIGLYCERIDES,mg 100ml-1,26,0.997,
TRIGLYCERIDES,umol.L-1,26,0.997,
CCCT,umol.L-1,26,0.997,
BODYTEMPCHANGE,Cel,26,0.997,
ACTIVITY,uM (g of spores)-1,26,0.997,
ED30,ug/kg,25,0.997,
ED99,,25,0.997,
RELATIVEBIOAVAILABILITY,,25,0.997,
GI99,umol.L-1,25,0.997,
RELATIVEENZYMEACTIVITY,,25,0.997,
ED20,uM kg-1,25,0.997,
PTZSEIZURE,ug.mg-1,25,0.997,
C90,umol.L-1,25,0.997,
POTENCY,nM kg-1,25,0.997,
EC150,,25,0.997,
LC90,mgAi/L,25,0.997,
DELTABLOODPRESSURE,umol.L-1,25,0.997,
KCAT,%,25,0.997,
INHIBITION(%OFCONTROL),%,25,0.997,
ACTIVATION(%OFCONTROL),%,25,0.997,
E2RESPONSE,%,25,0.997,
RATIO,mg dl-1,25,0.997,
HSF,ml,25,0.997,
COUNTH,,25,0.997,
KAFF,L.umol-1,25,0.997,
MINORALDOSE,ug.mg-1,25,0.997,
SURVIVAL,months,25,0.997,
%RECOVERY,%,25,0.997,
ED10,umol.L-1,25,0.997,
SD50,mg.kg-1.d-1,25,0.997,
IC50,/uM,25,0.997,
FOLDSELECTIVE,,25,0.997,
MEANGRAPHMIDPOINT,,25,0.997,
BIODISTRIBUTION,ug equiv/g,25,0.997,
TOTALTUMORS,,25,0.997,
UPTAKEBINDINGRATIO,,25,0.997,
BINDINGSELECTIVITY,,25,0.997,
KA,10'8/M,25,0.997,
RELATIVETUMORGROWTH,,25,0.997,
INJECTED(DOSEG),%,25,0.997,
PAPP,nm s-1,25,0.997,
MET,umol.min-1.mg-1,25,0.997,
RELATIVEMAXIMUM,,25,0.997,
BINDINGACTIVITY,c.p.m.,25,0.997,
BIOLOGICALEVALUATION,,25,0.997,
KOH,/mol.L-1.s-1,25,0.997,
KASS,/mol.L-1.s-1,25,0.997,
MDL50,umol.L-1,25,0.997,
LOGK-1,,25,0.997,
TUMORMASS,mg,25,0.997,
K,10'-2/hr,25,0.997,
CD50,mg.kg-1.d-1,25,0.997,
TUMORNUMBER,,25,0.997,
KNBP,s-1,25,0.997,
CD90,mg.kg-1.d-1,25,0.997,
PKAA2,,25,0.997,
GSH,%,25,0.997,
CARDIOTOXICITY,umol.L-1,25,0.997,
VELOCITY,%,25,0.997,
GR50,[ppm],25,0.997,
ACTIVITY,10'6PFU/ml,25,0.997,
MEANLIFEEXTENSION,,25,0.997,
CALCIUMRELEASE,,25,0.997,
CMC,mmol/L,25,0.997,
DRUGUPTAKE(FREE),%,25,0.997,
PEFF,10'-5cm/s,25,0.997,
CS50,umol.L-1,25,0.997,
EXCESSZONERADIUS,umol.L-1,25,0.997,
TINH,s,25,0.997,
IC50,10^-4microM,25,0.997,
CPSS,umol.L-1,25,0.997,
ILEALACTIVITY,umol.L-1,25,0.997,
VMAX,nM/min,25,0.997,
ERYTHEMA,,25,0.997,
DRUGRESPONSE,%,25,0.997,
KQ,L.umol-1,25,0.997,
ACTIVITY,/mm2,25,0.997,
PAFC50,,25,0.997,
CHANGEINWBC,%,25,0.997,
EPILEPTOGENICITY,,25,0.997,
ACTIVITY,log10IU/ml,25,0.997,
CTE,umol.L-1,25,0.997,
TCUNTREATED,,25,0.997,
LOG1S0,,25,0.997,
RATERESPONSE,s-1,25,0.997,
KCAT,10^-3/s,25,0.997,
ACTIVITY,pg/L,24,0.997,
LEVEL,pM min-1,24,0.997,
IDGTISSUE,%,24,0.997,
HC5,umol.L-1,24,0.997,
HC30,umol.L-1,24,0.997,
SELECTIVITYRATIOS32,,24,0.997,
BWL,%,24,0.997,
VDRAFFINITY,%,24,0.997,
ACTIVITY,Miller_unit,24,0.997,
AE,a.u.,24,0.997,
ACTIVITY,cells ml-1,24,0.997,
FAUCLAST,hr.ng/ml,24,0.997,
TISSUEDISTRIBUTION,%,24,0.997,
MBEC90,umol.L-1,24,0.997,
KAPP,10^-7/M,24,0.997,
INTRINSICACTIVITY,umol,24,0.997,
ACTIVITY,c.p.m.,24,0.997,
LD50,M kg-1,24,0.997,
VMAX,10'-3uM/min,24,0.997,
SUPPRESSIONRATIO,%,24,0.997,
AUCDOSE,micromol.hr/L,24,0.997,
URINARYGLUCOSEEXCRETION,,24,0.997,
RM,%,24,0.997,
EC50IGC,umol.L-1,24,0.997,
NUMBER,millions,24,0.997,
AUC,%ID/g/hr,24,0.997,
LOGTA98,,24,0.997,
MEAN%GROWTH(N=2)FOR01ΜMPROBECONCENTRATION,%,24,0.997,
MEAN%GROWTH(N=2)FOR1000ΜMPROBECONCENTRATION,%,24,0.997,
MEAN%GROWTH(N=2)FOR001ΜMPROBECONCENTRATION,%,24,0.997,
MEANNOCOLONIES,10e4*cells,24,0.997,
P50,Torr,24,0.997,
MEAN%GROWTH(N=2)FOR100ΜMPROBECONCENTRATION,%,24,0.997,
NOOFSENSITIVEANIMALS,,24,0.997,
ACTVITY,ngAoxigen/min/mg of RLM,24,0.997,
TRANSPORTINHIBITION,%,24,0.997,
MEAN%GROWTH(N=2)FOR10ΜMPROBECONCENTRATION,%,24,0.997,
DECREASEINSYSTOLICBLOODPRESSURE,,24,0.997,
AIDHACTIVITY,nM min-1,24,0.997,
NOTOXICITYTESTED,,24,0.997,
KOBS1,L.umol-1,24,0.997,
%NUCLEOTIDEPRESENT,%,24,0.997,
TRITIUMRELEASE,%,24,0.997,
AGGREGATIONRESPONSE,,24,0.997,
PTD50,mg,24,0.997,
NOOFAXONALPOINTS,,24,0.997,
KOH,M-1 min-1,24,0.997,
TIME,hr/ha,24,0.997,
AUCTDOSE,hr.ng/ml.mg,24,0.997,
PRECURSORINHIBITION,%,24,0.997,
K'A,,24,0.997,
SCHIZONTSIZE,,24,0.997,
KINACT,10'-4/s,24,0.997,
DRUGTRANSPORT,pmol/cm2/hr,24,0.997,
ERP,ms,24,0.997,
NOOFMICERECEOVERED,,24,0.997,
VMAX,uM s-1,24,0.997,
P50,%,24,0.997,
FI,%,24,0.997,
-LOG(1MKC),,24,0.997,
SUBSTRATESPECIFICITY,umol.L-1.min-1.mg-1,24,0.997,
FORMATIONOFERYTHEMA,,24,0.997,
CHANGESYSTOLICBP,%,24,0.997,
CMAXDOSE,kg/L,24,0.997,
NEWTUMORS,,24,0.997,
TC41,,24,0.997,
ACTIVITY,pA,24,0.997,
FREQUENCY,,24,0.997,
ENZYMEINHIBITION,%,24,0.997,
KSV,10'-4L/mol,24,0.997,
-LOGID50,,24,0.997,
CARDIACDEPRESSION,%,24,0.997,
ACTIVITY,mol/L.sec,24,0.997,
CMAXDOSE,uM.kg/mg,24,0.997,
MEANSCORE,,24,0.997,
KD,/uM,24,0.997,
OTHERS,%,24,0.997,
APE,,24,0.997,
DELTACURATEDELTACINSULIN,,24,0.997,
ACTIVITY,EU/ml,24,0.997,
SUBSTRATEACTIVITY,c.p.m.,24,0.997,
PKACT,,24,0.997,
CUMULATIVEDOSE,,24,0.997,
DELTATC,,24,0.997,
TC-CQ,,24,0.997,
ONCOSTATICINDEX,,24,0.997,
CMAX,ng g-1,24,0.997,
MG-MID,umol.L-1,24,0.997,
PC60,uM kg-1,24,0.997,
DELYSE,%,24,0.997,
FEMORALBLOODFLOW,,24,0.997,
REDUCTIONINRBS,%,24,0.997,
ACTIVITY,10'12/L,24,0.997,
ACTIVITY,10^4/M/cm,24,0.997,
BEATSMIN,,24,0.997,
FM,%,24,0.997,
INH,mg,24,0.997,
-LOG(1MED),,24,0.997,
SWEETNESSPOTENCY,,24,0.997,
LYSISDIAMETER,mm,24,0.997,
VSSF,l,24,0.997,
MINEFFECTIVEDOSE,ug.mg-1,24,0.997,
ANTIINFLAMMATORYACTIVITY,%,24,0.997,
ASTROCYTEREVERSAL,%,24,0.997,
PED40,,24,0.997,
RATIO,/min/M,24,0.997,
CAGELEAVING,,24,0.997,
EDEMA,ml,24,0.997,
RELMAX,,24,0.997,
RATIO,/min.mg,24,0.997,
DRUGUPTAKE,pmol/L,24,0.997,
NADPHOXIDATION,nM min-1 (mg of protein)-1,24,0.997,
REFIONCOSTATICINDEX,,24,0.997,
RELAXATION,,24,0.997,
CA2+CURRENT,mV,24,0.997,
%TURNOVER,%,24,0.997,
RATIO,l s-1 M-1,24,0.997,
Q50,umol.L-1,23,0.997,
DELTAH,cal/mol,23,0.997,
FPT,,23,0.997,
KI,10'5/M/min,23,0.997,
DOPAMINERELEASE,%,23,0.997,
KDISS,,23,0.997,
FBP,,23,0.997,
ACUTETOXICITY,%,23,0.997,
PKB,umol.L-1,23,0.997,
TUMORVOLUME,,23,0.997,
INTRINSICSOLUBILITY,,23,0.997,
GATEDCURRENT,,23,0.997,
ED80,uM/g,23,0.997,
K',s-1,23,0.997,
INTINSICACTIVITY,,23,0.997,
OPTIMALDOSE,mg.kg-1.d-1,23,0.997,
DELTAS,cal/mol.K,23,0.997,
LOG,,23,0.997,
DELTAHR,,23,0.997,
MIC>98,,23,0.997,
NOOFTRANSFERS,,23,0.997,
ED,,23,0.997,
INCREASEINVOLUME,ml min-1,23,0.997,
ST,s,23,0.997,
FAPP,%,23,0.998,
INSULINRELEASE,,23,0.998,
CHANGEMAP,%,23,0.998,
ACTIVITY,uM/g,23,0.998,
"PEC05,DISS",,23,0.998,
KON,10e3* M-1 s-1,23,0.998,
LOGEC50,umol.L-1,23,0.998,
KOH-,/mol.L-1.s-1,23,0.998,
MCC50,,23,0.998,
AI,,23,0.998,
CHANGEOFBODYTEMPERATURE,Cel,23,0.998,
ABSAC054UM,umol.L-1,23,0.998,
KON,M-1-s-1,23,0.998,
CLT50,umol.L-1,23,0.998,
PC2A,umol.L-1,23,0.998,
SD90,ug.mg-1,23,0.998,
ACTIVITY,10^12/L,23,0.998,
PMA,%,23,0.998,
MEANHEMAGGLUTINATIONTITERS,,23,0.998,
ACTIVITY,ugequiv,23,0.998,
ED90,uM kg-1,23,0.998,
PD50,mg.kg-1.d-1,23,0.998,
"MEDIANSURVIVALTIME,DAYS",,23,0.998,
KI,Ratio,23,0.998,
EC,ug.mg-1,23,0.998,
NOOFCROSSES,,23,0.998,
ANTILIPIDPEROXIDATION,%,23,0.998,
RD500,,23,0.998,
MED25,ug.mg-1,23,0.998,
PGI,,23,0.998,
TOX,,23,0.998,
DHP-ISTABILITY,,23,0.998,
CASPASEINDUCTION,,23,0.998,
AC10,umol.L-1,23,0.998,
"EMAX,DISS",%,23,0.998,
AZTFORMATION,%,23,0.998,
LC50,umol.g-1,23,0.998,
CP(F),,23,0.998,
AUC,ug hr uM-1,23,0.998,
LOG10ED50,,23,0.998,
CL,min/ml/kg,23,0.998,
DRUGMETABOLISM,%ID,23,0.998,
IC,,23,0.998,
PD2,umol.L-1,23,0.998,
ACTIVITY,nM min-1 (mg of protein)-1,23,0.998,
SCAVENGINGACTIVITY,%,23,0.998,
MTD50,,23,0.998,
BLOODLEVEL,umol.L-1.ml-1,23,0.998,
ED200,ug.mg-1,23,0.998,
HSFRELEASE,umol.L-1,23,0.998,
ACTIVITY,nmol.hr/g,23,0.998,
ED90,mg kg-1 5day-1,23,0.998,
KCATKM,/min/mM,23,0.998,
PLASMA-E2CONCENTRATION,pg ml-1,23,0.998,
PAPP,10e-6 cm s-1,23,0.998,
INH,10'4L/mol/s,23,0.998,
CELLSURVIVED,d,23,0.998,
DOSEINTERVAL,s,23,0.998,
EMAX,meter/s,23,0.998,
K,10^4/M,23,0.998,
ED50,mg kg-1 5day-1,23,0.998,
FCMAXMIC,,23,0.998,
CGI,umol.L-1,23,0.998,
PLASMACONCENTRATION,,23,0.998,
INFLUXKI,umol.L-1,23,0.998,
KA,10'9/M,23,0.998,
ED50,uM/L,22,0.998,
MEDIANTC,d,22,0.998,
MINIMALBACTERIOSTATICCONCENTRATION,,22,0.998,
K,10^-4/min,22,0.998,
LOGPOTENCY,,22,0.998,
MAXIOPREDUCTION,mmHg,22,0.998,
SOLUBILITY,mg-1.g-1,22,0.998,
X1(50),,22,0.998,
REMAINING,,22,0.998,
K,uM-1,22,0.998,
CTLACTIVITY,umol.L-1,22,0.998,
LOG1D125(L1210)(MMKG-1),,22,0.998,
ACTIVITY,kC/sec,22,0.998,
EEMAX,%,22,0.998,
K0,L.umol-1,22,0.998,
LED100,ug.mg-1,22,0.998,
ABSORPTION,,22,0.998,
KR,,22,0.998,
INTESTINALTOXICITY,,22,0.998,
ACCUMULATIONCOUNTS,,22,0.998,
RBA,mg,22,0.998,
INCREASEINPLASMAAMYLASE,IU ml-1,22,0.998,
LD90,ug/kg,22,0.998,
CYTOCIDALACTIVITY,%,22,0.998,
MUTAGENICITY,%,22,0.998,
MAXINTENSITY,turns min-1,22,0.998,
ULCERSCORE,,22,0.998,
TGICORRELATIONCOEFFICIENT,,22,0.998,
LOG(1LC50),,22,0.998,
PEC200,,22,0.998,
CT10,uM hr-1,22,0.998,
LOGAPA,,22,0.998,
CELLNUMBER,%,22,0.998,
THYMIDINEUPTAKE,c.p.m. (mg of protein)-1,22,0.998,
T>MIC,%,22,0.998,
MEANVESICLESCORE,,22,0.998,
ACTIVITY,M g-1,22,0.998,
BIODISTRIBUTION,ug of B g-1,22,0.998,
DC50,pM,22,0.998,
MEANTIMETOSEIZURE,s,22,0.998,
ANESTHESIADURATION,s,22,0.998,
KEFF,M-1 min-1,22,0.998,
K,10^-6/s,22,0.998,
CVDOSE,ug.mg-1,22,0.998,
MTD,mg,22,0.998,
TDECREASE,Cel,22,0.998,
LOGSI,,22,0.998,
LIFESPAN,,22,0.998,
AGONIST,%,22,0.998,
AUC,AU.min,22,0.998,
RECOVERYTIME,ug.mg-1,22,0.998,
IC2X,umol.L-1,22,0.998,
VERP,,22,0.998,
MEANACTIVITYCOUNTS,,22,0.998,
NORESPANIMALSTOTAL,/ 7,22,0.998,
LC50,g/m2,22,0.998,
RATEOFDECOMPOSITION,(nM of drug) min-1 ml-1,22,0.998,
INCIDENCE,N,22,0.998,
OBSERVEDLOGAPA,,22,0.998,
HIA,%,22,0.998,
VREL,,22,0.998,
GASTRICTOXICITY,,22,0.998,
EXCRETION,ml,22,0.998,
DECREASEINQAINTERVAL,ms,22,0.998,
KDMPC,L.umol-1,22,0.998,
PHYSICALDEPENDENCECAPACITY,,22,0.998,
NOEFFECTDOSE,mg,22,0.998,
PERMEABILITYCOEFFICIENT,cm s-1,22,0.998,
PR,,22,0.998,
LOG1CONC(MMMIN-1L-1),,22,0.998,
ED75,uM kg-1,22,0.998,
ACTIVITY,umol.L-1.min-1,22,0.998,
IC50,meq,22,0.998,
TR,s,22,0.998,
KERATIO,,22,0.998,
EC50,g/m2,22,0.998,
PDEINHIBITION,,22,0.998,
IG50,,22,0.998,
GI20,umol.L-1,22,0.998,
MEDIANTC,,22,0.998,
PLATELETAGGREGATION,umol.L-1,22,0.998,
LD50,uM/L,22,0.998,
BEI,%,22,0.998,
COVALENTBINDING,,22,0.998,
AI50,,22,0.998,
EP,V,22,0.998,
AMOUNT,ml,22,0.998,
SI,%,22,0.998,
C30,umol.L-1,22,0.998,
BWLOSS,%,22,0.998,
OPTIMALDOSE,,22,0.998,
PMAX,%,22,0.998,
PERMEABILITY,uL/hr/cm2,22,0.998,
K1,/mol.L-1.s-1,22,0.998,
DNA,mg,22,0.998,
VMAXKM,s-1,22,0.998,
ED100,umol.L-1,22,0.998,
KA,/M,22,0.998,
KINACT,10'3/s,22,0.998,
TFS,%,22,0.998,
ACTIVITY,10'3No_unit,22,0.998,
CT10,mM hr,21,0.998,
KDISS,/mol.L-1.s-1,21,0.998,
CELLCYCLE,,21,0.998,
POT,umol.L-1,21,0.998,
KCALC,/mol.L-1.s-1,21,0.998,
CD90,ug.mg-1,21,0.998,
CT,nmol/Kg,21,0.998,
PREJUNCTIONALANTAGONISTPOTENCY,,21,0.998,
METABOLISM,pM min-1,21,0.998,
WEIGHT,mg dl-1,21,0.998,
EGGS,%,21,0.998,
ACTIVITY,um3/um2,21,0.998,
CMAXSS,umol.L-1,21,0.998,
INITIALAVERAGETUMORWEIGHT,mg,21,0.998,
CC50,10^2 uM,21,0.998,
IC60,umol.L-1,21,0.998,
POSTJUNCTIONALANTAGONISTPOTENCY,,21,0.998,
ACTIVITY,/cm2,21,0.998,
AUC,ugequiv/l.hr,21,0.998,
METABOLICSTABILITY,mg.ml-1,21,0.998,
LOGDELTA(1T2),,21,0.998,
GI25,umol.L-1,21,0.998,
GAIN,%,21,0.998,
KA,10'8/M/min,21,0.998,
RTW,%,21,0.998,
PAWWEIGHTINCREASE,%,21,0.998,
DRUGABSORPTION,,21,0.998,
MSTINCREASE,,21,0.998,
LOGC50,,21,0.998,
SERUMLIPOPROTEINCHOLESTEROL,,21,0.998,
LOGPI,,21,0.998,
RATIO,10^3/M/s,21,0.998,
IC100,,21,0.998,
ED25,mg,21,0.998,
K,10^3/M/s,21,0.998,
-LOGIC50,umol.L-1,21,0.998,
RTW,,21,0.998,
LED,,21,0.998,
DEATHSTOTAL,,21,0.998,
NA,u equiv kg-1,21,0.998,
POTENCYINDEX,,21,0.998,
SYMPTOMINITIATION,%,21,0.998,
LOGK'IAM,,21,0.998,
MIC,%,21,0.998,
CHANGEINENTRYLATENCY,s,21,0.998,
CI,umol.L-1,21,0.998,
MODIFICATIONOFHEMOGLOBIN,%,21,0.998,
TOTALLYSIS,umol.L-1,21,0.998,
NOEFFECTIVE,,21,0.998,
ANIMALDEATH,%,21,0.998,
LHLEVEL,umol.L-1,21,0.998,
PICOEQUIVALENTSOFAMINE10E6CELLS,,21,0.998,
WETWEIGHT,mg,21,0.998,
K,L.mol-1,21,0.998,
ATAXIA,,21,0.998,
AIRECOVERYTIME,s,21,0.998,
RANGEOFDEATH,d,21,0.998,
EFFECTIVECONCENTRATION,umol.L-1,21,0.998,
AVERAGE,%,21,0.998,
K,/min/microM,21,0.998,
LOGCC50,,21,0.998,
INH,Miller_unit,21,0.998,
LOGTA100,,21,0.998,
MEDIANSURVIVALTIME,d,21,0.998,
SUPRESSION,,21,0.998,
RATE,pM,21,0.998,
LOG1ID50,,21,0.998,
EDDELTA5,nM kg-1,21,0.998,
LOGMBC,,21,0.998,
VMAX,umol.L-1.min-1.,21,0.998,
MEANNUMBEROFPARASITES,,21,0.998,
DIZ,mm3,21,0.998,
TOXICITY,ug.mg-1,21,0.998,
INCIDENCEOFRBCDECREASE,,21,0.998,
BT,,21,0.998,
APOPTOSIS,,21,0.998,
TG,%,21,0.998,
ACTIVITY,10'6dpm,21,0.998,
CONCENTRATION,ug.mg-1,21,0.998,
KE,L.umol-1,21,0.998,
KA,10'4L/mol,21,0.998,
DECREASEINMABP,mmHg,21,0.998,
MEANSURVIVALDAYS,,21,0.998,
V0,s-1,21,0.998,
NOOFESCAPEFAILURES,,21,0.998,
HTD,ug.mg-1,21,0.998,
THROMBUSWEIGHT,mg,21,0.998,
PC25,,21,0.998,
EDDELTA20,nM kg-1,21,0.998,
GII50,,21,0.998,
TGD,d,21,0.998,
MPE50,,21,0.998,
CV,%,21,0.998,
EC99,,21,0.998,
PREJUNCTIONALAGONISTPOTENCY,,21,0.998,
REFLEX,ug.mg-1,21,0.998,
TOTALTURNS,,21,0.998,
POSTJUNCTIONALAGONISTPOTENCY,,21,0.998,
ACTIVITY,10'4Meq,21,0.998,
PASSIVITY,ug.mg-1,21,0.998,
PC60,,21,0.998,
CONTROL,ug.mg-1,21,0.998,
C20FRP,umol.L-1,21,0.998,
KOFF,,21,0.998,
ED100,mg.kg-1.d-1,21,0.998,
ACTIVITY,turns hr-1,21,0.998,
PLATELETAGGREGATION,%,21,0.998,
TREATED,,21,0.998,
VC,l,21,0.998,
LOG1D125(MMKG-1),,21,0.998,
KD,10^2 uM,21,0.998,
DTOX,,21,0.998,
DISTRIBUTION,umol.mg-1,21,0.998,
NEA,,21,0.998,
EDEMAINHIBITION,%,21,0.998,
TESTESWEIGHT,mg,21,0.998,
FINALAVERAGETUMORWEIGHT,mg,21,0.998,
K,u equiv kg-1,21,0.998,
CHANGEHDL-C,%,21,0.998,
RELAPSES,,21,0.998,
IDBRAIN,%,21,0.998,
ABSOLUTETURNANGULAR3MIN,,21,0.998,
LOGK3,,21,0.998,
SURVIVORINCREASE,,21,0.998,
LIPIDPEROXIDATION,%,20,0.998,
DRUGMETABOLISM,pmol/mg.hr,20,0.998,
DISTRIBUTION,fM mg-1,20,0.998,
DTAGG,K,20,0.998,
LOGAC50,umol.L-1,20,0.998,
FLOWRATE,ml min-1 100g-1,20,0.998,
CL,/mol.L-1.s-1,20,0.998,
DRUGMETABOLISM,% ID/g,20,0.998,
K2',s-1,20,0.998,
AVERAGENOOFMETASTASIS,%,20,0.998,
AUCTDOSE,ng/mL.hr,20,0.998,
CPMAX,umol.L-1,20,0.998,
AVERAGEONSET,s,20,0.998,
TIMECONSTANTT1,ms,20,0.998,
K,10'6L/mol,20,0.998,
HD50,,20,0.998,
SPLEENWEIGHT,mg,20,0.998,
ACTIVITY,10'-2/hr,20,0.998,
CQ,umol.L-1,20,0.998,
MTD,uM/g,20,0.998,
LOGII50,,20,0.998,
2DGUPTAKE,umol.L-1,20,0.998,
NSR,,20,0.998,
TBPSIC50,umol.L-1,20,0.998,
-TDELTAS,,20,0.998,
CHANGEINCAMP,%,20,0.998,
AVERAGE,,20,0.998,
KIC,,20,0.998,
-LNK,,20,0.998,
MDL50,,20,0.998,
CARDIACFREQUENCY,beats min-1,20,0.998,
FPGCORRECTION,%,20,0.998,
APD90,ms,20,0.998,
MAPD90,ms,20,0.998,
SERUMCHOLESTEROL,%,20,0.998,
SURVIVORSATDAY8,%,20,0.998,
NOOFMICEEFFECTEDNOOFTREATED,,20,0.998,
PHOTO-CROSS-LINKINGOFDNA,,20,0.998,
LOGKDELTA,,20,0.998,
SURVIVORSALIVETOTAL,,20,0.998,
DRUGUPTAKE,pmol/g,20,0.998,
INCREASEDLIFESPAN,%,20,0.998,
PAPP,10'-8cm/s,20,0.998,
KI,10'4/M/min,20,0.998,
CLH,ml/mg/kg,20,0.998,
CI,l hr-1 kg-1,20,0.998,
INCREASEINRFU,%,20,0.998,
CONCENTRATIONRATIO,,20,0.998,
VMAX,pmol/hr,20,0.998,
VMAX(APP),umol.min-1,20,0.998,
ACTIVITY,umolequiv/L,20,0.998,
ACTIVITY,mmol.ml-1,20,0.998,
CL,uL/ml.millig,20,0.998,
ED15,mg,20,0.998,
C8H,umol.L-1,20,0.998,
KB,10^22/M,20,0.998,
PW,,20,0.998,
CA2+TRANSPORTSM,,20,0.998,
TURNSFIRSTHOUR,,20,0.998,
ACTIVITY,day of onset,20,0.998,
VC,ml,20,0.998,
-LOGEC20,,20,0.998,
MINEFFECTIVEDOSE,,20,0.998,
COMPLEXFORMATION,,20,0.998,
ED(1MV),ug.mg-1,20,0.998,
MEANHR,beats min-1,20,0.998,
P[BH+50],,20,0.998,
QTCINTERVAL,ms,20,0.998,
MBC90,,20,0.998,
VMAX,cm-1,20,0.998,
DEGREEOFRESISTANCE,,20,0.998,
RETENTIONTIME,,20,0.998,
ACTIVITY,K/uL,20,0.998,
SELECTIVITY,A1/A2A,20,0.998,
AUC,mg hr-1 kg-1,20,0.998,
RESPIRATORYFREQUENCY,r.p.m.,20,0.998,
LOGY,,20,0.998,
ACTIVITY,nM mg-1,20,0.998,
DELTALATENCYTIME,s,20,0.998,
ACTIVITY,ng/hr,20,0.998,
TOTALCOUNTS,,20,0.998,
DP,%,20,0.998,
ID95,umol.L-1,20,0.998,
KP,10'-6 cm/s,20,0.998,
PIHYDROLYSIS,%,20,0.998,
KA,10'7/M/min,20,0.998,
HIGHESTACTIVEDOSE,ug.mg-1,20,0.998,
KI,/M/min,20,0.998,
DIAMETER,mm,20,0.998,
WATERCONSUMPTION,ml,20,0.998,
BHIA50,,20,0.998,
STABILTY,microL/min/mg,20,0.998,
CHANGENONHDL-C,%,20,0.998,
RESIDUALBINDING,%,20,0.998,
ED3,ug.mg-1,20,0.998,
ID99,umol.L-1,20,0.998,
AUCMETAUCP,%,20,0.998,
KQ,10^12/M/s,20,0.998,
ACTUALDURACTION,s,20,0.998,
KB,10'4L/mol,20,0.998,
IC50,kJ m**-2,20,0.998,
RATEOFFORMATION,pM min-1 (mg of protein)-1,20,0.998,
DEADTOTAL,,20,0.998,
INTRINSICEFFICACY,,20,0.998,
URINEVOLUME,ml kg-1,20,0.998,
EPIDERMALTHICKNESS,,20,0.998,
ACTIVITY,g/m2,20,0.998,
COMPLEXFORMATION,deltaA.10^4nmol-1,20,0.998,
DRUGUPTAKE,umol.g-1,20,0.998,
ANALGESICEFFECT,%,20,0.998,
RECOVEREDRADIOACTIVITY,%,20,0.998,
ACTIVITY,pg ml-1,20,0.998,
CLH,uL/ml.millig,20,0.998,
SERUMHDL-CHOLESTEROL,%,20,0.998,
HEMODYNAMICCHANGE,%,20,0.998,
RCI,,20,0.998,
SERUMLDL-CHOLESTEROL,%,20,0.998,
TOXICLEVEL,ug.mg-1,20,0.998,
K50,umol.L-1,20,0.998,
CLH,ug/min/mg,20,0.998,
ACTIVITY,pmol/mg/hr,20,0.998,
MORTALITYINHIBITION,%,20,0.998,
K,10^6/M,20,0.998,
KP,s-1,20,0.998,
TIMECONSTANTT2,ms,20,0.998,
MEANLAF,ml min-1,20,0.998,
URINARYNA+,m equiv,20,0.998,
BRAINCONCENTRATION,ng g-1,20,0.998,
KD,/mol.L-1.s-1,20,0.998,
REMOVAL,%,20,0.998,
CTF,%,20,0.998,
ACTIVITY,nM ml-1,20,0.998,
K2'',s-1,20,0.998,
BMAX,,20,0.998,
I50,molar excess,20,0.998,
SERUMCONCENTRATION,s,20,0.998,
MEANRBF,ml min-1,20,0.998,
LOGED50,mM kg-1,19,0.998,
KIHIGH,umol.L-1,19,0.998,
MAXEFFECT,,19,0.998,
NUMBER,%,19,0.998,
DRUGMETABOLISM,pmol/hr,19,0.998,
EC50,mol/g,19,0.998,
MNTC,umol.L-1,19,0.998,
ED50,nM min-1 kg-1,19,0.998,
URINEOSMOLALITY,mOsmol kg-1,19,0.998,
PERMEABILITY,10'-8cm/s,19,0.998,
LD50,10'-3M,19,0.998,
CT2,umol.L-1,19,0.998,
LOGCDQR,,19,0.998,
ED25,ug.cm-3,19,0.998,
DRUGMETABOLISM,s-1,19,0.998,
ANALGESICEFFICACY,,19,0.998,
CLT,ml min-1,19,0.998,
LOGCDGH,,19,0.998,
HVALEVEL,%,19,0.998,
LC999,umol.L-1,19,0.998,
CT1,,19,0.998,
MID,mg,19,0.998,
HORIZONTALACTIVITY,Counts min-1,19,0.998,
CHANGEINBODYWEIGHT,%,19,0.998,
LOGPE,10^-3cm/min,19,0.998,
ABBC,log10[CFU].ml-1.h-1,19,0.998,
TIME,%,19,0.998,
EA,,19,0.998,
LOGKOA,,19,0.998,
DISEASECONTROL,,19,0.998,
CC,umol.L-1,19,0.998,
ED0,gAi/ha,19,0.998,
K-1,s-1,19,0.998,
VIABILITY,,19,0.998,
KINETIC,,19,0.998,
C100,umol.L-1,19,0.998,
MAXAGGREGATIONRESPONSE,,19,0.998,
PT,,19,0.998,
[EOP']INFINITY[EOH]INFINITY,,19,0.998,
MAXHEMORRHAGE,,19,0.998,
CYTOTOXICENDPOINT,umol.L-1,19,0.998,
NOOFMETASTASES,,19,0.998,
MTD,ug/kg,19,0.998,
PROLONGATION,%,19,0.998,
K,10'3/M,19,0.998,
AUC,mmHg hr-1,19,0.998,
VDSS,L/hr/kg,19,0.998,
K+NA+RATIO,,19,0.998,
IC50IC50,,19,0.998,
K+IONCONTENT,,19,0.998,
APPROXLETHALDOSE,,19,0.998,
HI,%,19,0.998,
MAX,(fM of GTP-gammaS bound) (mg of protein)-1,19,0.998,
SURVIVORSATDAY15,%,19,0.998,
KINACT,10^5nM,19,0.998,
TESTEDCONTROL,,19,0.998,
AVERAGEINHIBITION,,19,0.998,
RELATIVESTABILITY,,19,0.998,
LED100,,19,0.998,
ERP3,,19,0.998,
ACTIVITY,U/g,19,0.998,
TREATEDCELLS,%,19,0.998,
PFU,,19,0.998,
DECREASEINRFU,%,19,0.998,
PKC,umol.L-1,19,0.998,
BINDINGCOMPETITION,mean counts,19,0.998,
FOC,,19,0.998,
ACTIVITY,N,19,0.998,
PG,%,19,0.998,
TVI,%,19,0.998,
SMAX,ul min-1 kg-1,19,0.998,
ILS30,ug.mg-1,19,0.998,
ILSMAX,ug.mg-1,19,0.998,
EFFECTIVEMOLARITY,umol.L-1,19,0.998,
TUMORUPTAKE,umol.L-1,19,0.998,
ACTIVITY,log10ng/ml,19,0.998,
ACTIVITY,mU/mg,19,0.998,
BASAL,(fM of GTP-gammaS bound) (mg of protein)-1,19,0.998,
AUMC,hr.hr.ng/ml,19,0.998,
MEC,ug.mg-1,19,0.998,
KDS,umol.L-1,19,0.998,
KE,hr-1,19,0.998,
PKINC,,19,0.998,
CORR,%,19,0.998,
ACTIVITY,g/cm2,19,0.998,
ACTIVITY,ml min-1,19,0.998,
INCREASEINMEANSURVIVALTIME,,19,0.998,
INHIBITIONACTIVITY,umol.L-1,19,0.998,
CHANGEINSYSTOLICBP,%,19,0.998,
ERP1,,19,0.998,
ANTAGONISTEFFECT,,19,0.998,
KM,s-1,19,0.998,
NA+IONCONTENT,,19,0.998,
CATIONINFLUX,,19,0.998,
CHANGEINWEIGHT,mg,19,0.998,
ACTIVECONCENTRATIONI,umol.L-1,19,0.998,
PERMEABILITY,10'-6/cm,19,0.998,
PERMEABILITY,10'-5cm/s,19,0.998,
CMAXDOSE,nM/mg/kg,19,0.998,
RELATIVEPROTECTION,%,19,0.998,
CMAX[GH],umol.L-1,19,0.998,
DECREASE,Cel,19,0.998,
SELECTIVITYFACTOR,,19,0.998,
RFU,a.u.,19,0.998,
AVERAGESEIZURESCORE,,19,0.998,
IMPROVEMENT,%,19,0.998,
ACTIVITY,millimeter/min,19,0.998,
SKINUPTAKE,umol.L-1,19,0.998,
INCIDENCE,%,19,0.998,
1KOBSD-KA,s,19,0.998,
CONCENTRATION,ug (g of wet tissue)-1,19,0.998,
COMBINATIONINDEX,,19,0.998,
PLASMAGLUCOSE,mg 100ml-1,18,0.998,
ED50,ug.cm-3,18,0.998,
BLOCKADE,,18,0.998,
STABILITY,weeks,18,0.998,
MINANTIVIRALCONCENTRATION,umol.L-1,18,0.998,
KA,10'5L/mol,18,0.998,
PLASMALEVELS,umol.L-1,18,0.998,
RESPONSE,mmHg,18,0.998,
ED10,gAi/ha,18,0.998,
AUC,min.g.nM/mg,18,0.998,
G2M,%,18,0.998,
CONTROLS,%,18,0.998,
MFED,ug.mg-1,18,0.998,
STOMACH,%,18,0.998,
PERMEABILITY,ng/cm2/min,18,0.998,
CONTROLRESPONSE,%,18,0.998,
CONVERSIONDOSE,ug.mg-1,18,0.998,
MAXLOWERING,%,18,0.998,
ACTIVITY,U (mg of protein)-1,18,0.998,
INSULINSECRETION,,18,0.998,
BMAX,umol.mg-1,18,0.998,
GLUCOSECORRECTION,%,18,0.998,
INITIALRATE,deltaA.10^4nmol-1.min-1,18,0.998,
ED100,ug.cm-3,18,0.998,
STABILITY,cpm,18,0.998,
CMAXUNBOUND,umol.L-1,18,0.998,
V0,RFU/s,18,0.998,
INITIALRATERATIO,,18,0.998,
RELATIVEODNUPTAKE,,18,0.998,
RELATIVEMOLARPOTENCY,,18,0.998,
INTACT,%,18,0.998,
MAXDELTAVMAX,,18,0.998,
BRAINLEVEL,pM g-1,18,0.998,
BINDINGACTIVITY,,18,0.998,
BINDING,pM 30min-1 (mg of DNA)-1,18,0.998,
GHMAX,umol.L-1,18,0.998,
OPTIMALDOSE,mg uM kg-1,18,0.998,
ACTIVITY,ng/uL,18,0.998,
STABILITY,ml/min.Kg,18,0.998,
IONIZATION,%,18,0.998,
LD100,%,18,0.998,
ACTIVITY,nm/s,18,0.998,
UTERINEACTIVITY,mg,18,0.998,
GI50RATIO,umol.L-1,18,0.998,
PERMEABILITY,10^-5 cm/min,18,0.998,
ANTIEMETICACTIVITY,%,18,0.998,
LD10,mg m**-2,18,0.998,
IRONEXCRETION,%,18,0.998,
MI20,nmol/L,18,0.998,
AUC,ug.hr/mL/mg/kg,18,0.998,
STABILITY,pmol/mg/hr,18,0.998,
ANTIMALARIALACTIVITY,%,18,0.998,
GSHLEVEL(MG),%,18,0.998,
CE37,umol.L-1,18,0.998,
AUC,ug/hr.kg,18,0.998,
PED50,mg,18,0.998,
UNCUTDNA,%,18,0.998,
PK1D,,18,0.998,
CELLNO,,18,0.998,
MBC9999,umol.L-1,18,0.998,
POLYAMINEPOOLS,%,18,0.998,
ACTIVITY,fold,18,0.998,
ONSETOFACTION,s,18,0.998,
DELTAVMAX,,18,0.998,
PARTIALREMISSION,%,18,0.998,
GOF,,18,0.998,
LOG1LD50(MMKG-1),,18,0.998,
ACTIVITY,delta mmHg,18,0.998,
EC80,%,18,0.998,
GR50,g/ha,18,0.998,
VDF,L,18,0.998,
ACTIVITY,delta mV,18,0.998,
ACTIVITY,pM of drug (10e6*cells)-1,18,0.998,
MRP,,18,0.998,
MACROPHAGECYTOTOXICITY,%,18,0.998,
METABOLICTURNOVER,%,18,0.998,
IC85,umol.L-1,18,0.998,
ACTIVITY,HAU/ml,18,0.998,
PERMEABILITY,mN/meter,18,0.998,
MIC,%v/v,18,0.998,
PERMEABILITY,um.s-1,18,0.998,
ED50,2mg kg-1,18,0.998,
URINARYEXCRETION,ml kg-1,18,0.998,
EC20,,18,0.998,
GID75,mg m**-2,18,0.998,
FOLDREDUCTION,,18,0.998,
DIFFERENTIALAFFINITY,,18,0.998,
IE,%,18,0.998,
TM,K,18,0.998,
ACTIVITY,pixel,18,0.998,
LC50RATIO,umol.L-1,18,0.998,
EC50,uM kg-1,18,0.998,
INH,[ppm],18,0.998,
CP,ug/L,18,0.998,
EFFICACY,pM,18,0.998,
FOLDACTIVITY,,18,0.998,
EFFICACY,ug.mg-1,18,0.998,
MORTALITY,day of death,18,0.998,
SURVIVALTREATED,,18,0.998,
PMED,,18,0.998,
AUC,ugequiv.hr/g,18,0.998,
PK1A,,18,0.998,
DURATIONOFBLOCK,s,18,0.998,
MUSCARINICRECEPTORAFFINITY,,18,0.998,
RATIO,[Na+]/[K+],18,0.998,
RATIO,Ratio,18,0.998,
SLOWBINDING,,18,0.998,
MYDRIASIS,,18,0.998,
DECREASEINMAP,%,18,0.998,
CUREDINFECTED,,18,0.998,
DT,s,18,0.998,
VMAX,V s-1,18,0.998,
AUC,nM hr ml,18,0.998,
LOGPC18,,18,0.998,
VMAX,mM s-1,18,0.998,
DPDT,umol.L-1,18,0.998,
SERUMCORTICOSTERONE,umol.L-1,18,0.998,
AFFINITYCONSTANT,,18,0.998,
DRUGLEVEL,umol.L-1,18,0.998,
INACTIVATION,,18,0.998,
FBF,,18,0.998,
KIUC,,18,0.998,
NOOFLUNGMETASTASIS,,18,0.998,
LOCOMOTORACTIVITY,Counts,18,0.998,
PK1B,,18,0.998,
MTS,d,18,0.998,
CLH(APP),uL/min/mL,18,0.998,
RATIO,s-1,18,0.998,
ANTICONVULSANTDOSE,ug.mg-1,18,0.998,
ABRATIO,,18,0.998,
KD,l M-1,18,0.998,
DRUGUPTAKE,pmol/min/mg,18,0.998,
ACTIVITY,/millimeter,18,0.998,
NATURE,,18,0.998,
KQ,10^12L/mol/s,18,0.998,
NA+EXCRETION,ml kg-1,18,0.998,
CHANGEINCONFLICT,%,18,0.998,
HEMOLYTICACTIVITY,%,18,0.998,
MEANSURVIVALINDAYS,,18,0.998,
MEC2,umol.L-1,18,0.998,
CELLSIZE,,18,0.998,
PHAGOCYTOSIS,,18,0.998,
DISSOCIATIONRATIO,,18,0.998,
CELOGK',,18,0.998,
KAPP,min-1,18,0.998,
RATIOCMAX,,18,0.998,
EC100,,18,0.998,
AUCDOSE,hr.ng/ml,18,0.998,
VMAX,(nM of H202) min-1 (ug of protein)-1,18,0.998,
CL,nl/min,18,0.998,
VMAX,10^-8mol/s,18,0.998,
PVALUE,,18,0.998,
TIMECONSTANT,s,18,0.998,
ALD50,g/Kg,18,0.998,
CHOLESTEROL,umol.L-1.ml-1,18,0.998,
TT,k,18,0.998,
SF50,umol.L-1,18,0.998,
IC50,10^-6 mol/L,18,0.998,
HISTAMINELEVEL,,18,0.998,
KON,s-1,18,0.998,
CT5,umol.L-1,18,0.998,
CT3,,18,0.998,
ERPOBSERVATIONS,,18,0.998,
MEANNOOFLUNGCOLONIES,,18,0.998,
RATEOFDECREASE,%,18,0.998,
TD90,umol.L-1,18,0.998,
DRUGMETABOLISM,uM/min.mg,18,0.998,
DRUGMETABOLISM,pmol/min/ug,18,0.998,
COLONYFORMATION,%,18,0.998,
AUCLAST,ng.hr/g,18,0.998,
AGGREGATION,ug.mg-1,18,0.998,
EX-VIVOSCREENING,,18,0.998,
KOBS,h-1,18,0.998,
TRIGLYCERIDES,umol.L-1.ml-1,18,0.998,
EXTREMESTREATED,,18,0.998,
CHEMOTACTICINDEX,,18,0.998,
RATE,umol.L-1,18,0.998,
DMAX,,18,0.998,
THYMOLYSIS,,18,0.998,
TGI50,ug.mg-1,18,0.998,
1IC50,/uM,18,0.998,
TGIRATIO,umol.L-1,18,0.998,
RATEOFOXIDATION,,18,0.998,
FAUCDOSE,uM.min,18,0.998,
ACTIVITYB,uM kg-1,18,0.998,
INCC50,umol.L-1,18,0.998,
[GSH],nM (10e6*cells)-1,18,0.998,
KINACT,h-1,18,0.998,
ACCCOUNTS,,18,0.998,
AUCMETABOLITEAUCRADIOLABEL,%,18,0.998,
SELECTIVETOXICITY,,18,0.998,
NETDRYWEIGHT,mg,18,0.998,
TRANSPORTRATE,M hr-1,18,0.998,
PRODRUGREDUCTION,%,18,0.998,
2*APTT,umol.L-1,18,0.998,
K,10^7/M/min,18,0.998,
KIN,s-1,18,0.998,
NOOFCOUNTS,,18,0.998,
IC50,10'-5g/L,18,0.998,
MEANDAYAPPEARANCEOFLESIONS,,18,0.998,
CLRENAL,mL/min,17,0.998,
OPTIMALDOSE,mg kg-1 injection-1,17,0.998,
K,10'9/M/s,17,0.998,
NOOFANIMALSPROTECTEDNOANIMALSTESTED,,17,0.998,
EFFLUXCL,ml/min.Kg,17,0.998,
DELTAF75,umol.L-1,17,0.998,
RATSBLOCKED,%,17,0.998,
EC50,ug/kg,17,0.998,
KI,10'6/M/min,17,0.998,
MEC15,umol.L-1,17,0.998,
EC50,umol.mg-1,17,0.998,
RELATIVELIPOPHILICITY,,17,0.998,
ED50,10'-12 ug/ml,17,0.998,
NR,,17,0.998,
ED50,(mg/kg)/day,17,0.998,
DNACLEAVAGEACTIVITY,,17,0.998,
ACTIVITY,(fM of O6-MeG removed) (mg of protein)-1,17,0.998,
DRUGRESPONDING,%,17,0.998,
30DAYSSURVIVORS,,17,0.998,
LIVERCHOLESTEROL,mg g-1,17,0.998,
PIGMENTINDUCTION,,17,0.998,
P2UPTAKE,,17,0.998,
DNA,%,17,0.998,
C,nM g-1,17,0.998,
MEANRESPONSEMIN,,17,0.998,
VMAXKMAX100,,17,0.998,
RELATIVEDAUNOMYCINACCUMULATION,,17,0.998,
EMAX,ug.mg-1,17,0.998,
VMAX,umol.s-1,17,0.998,
ACTIVITY,g/Kg,17,0.998,
MEANIC70,umol.L-1,17,0.998,
KOX,,17,0.998,
CONCENTRATION,g dl-1,17,0.998,
KD50,ug.mg-1,17,0.998,
ED50,mg/kg.day,17,0.998,
MEANLOGGI50,umol.L-1,17,0.998,
LDLOXIDATION,%,17,0.998,
LD99,,17,0.998,
CLEARANCE,ml hr-1,17,0.998,
LOAD,%,17,0.998,
KMH,umol.L-1,17,0.998,
NOOFDEATHSMICEINJECTED,,17,0.998,
ED50,uL,17,0.998,
REMAINS,%,17,0.998,
K,10'2/min,17,0.998,
Q12,umol.L-1,17,0.998,
CMAXDOSE,ug/mL/mg/kg,17,0.998,
KINACT,10'6nM,17,0.998,
UPTAKE,nM g-1,17,0.998,
CMC,,17,0.998,
DRUGUPTAKE,%ID/cm3,17,0.998,
KA,10'6L/mol,17,0.998,
CLH,ug/ml/min,17,0.998,
LC90,mg,17,0.998,
EFFICIENCY,,17,0.998,
MLC50,umol.L-1,17,0.998,
RATIO,uL/min,17,0.998,
DELTAS,cal/mol/deg,17,0.998,
THROMBOXANEB2(TXB2),pg 0.1ml-1 500x10^3,17,0.998,
INFLUXCL,ml/min.Kg,17,0.998,
PERMEABILITY,nM hr-1 cm**-2,17,0.998,
GASTRICEMPTYING,%,17,0.998,
AGONISM,IU mg-1,17,0.998,
TFS,,17,0.998,
FS-SIF,mg.ml-1,17,0.998,
TCLOWERING,%,17,0.998,
STERILIZED,%,17,0.998,
ID50,ug min-1 kg-1,17,0.998,
G-PROTEINACTIVATION,,17,0.998,
DEATHSTOTAL,%,17,0.998,
TIMECONSTANTT3,ms,17,0.998,
AUC,ug hr-1 g-1,17,0.998,
ACTIVITYREMAINING,%,17,0.998,
GSHLEVEL,,17,0.998,
TC25,,17,0.998,
ACTIVITY,ug/dl,17,0.998,
GABACURRENT,%,17,0.998,
ACTIVITY,mg/cm3,17,0.998,
IC50,umol.mg-1,17,0.998,
PCD,,17,0.998,
KCATKM,10'8/M/s,17,0.998,
ANTIOVULATORYACTIVITY,,17,0.998,
MAXTC,%,17,0.998,
ANTIPAPILLOMAACTIVITY,%,17,0.998,
SYNERGYEC50,umol.L-1,17,0.998,
LTS,%,17,0.998,
AQ,,17,0.998,
MABP,%,17,0.998,
ACTIVITY,nM/min/mg,17,0.998,
DAY22-TC,%,17,0.998,
CYTOTOXICITY,umol.L-1.ml-1,17,0.998,
DAY9-RTV,%,17,0.998,
PARASITES,%,17,0.998,
DECREASEINBMAX,,17,0.998,
TOXDSURV,,17,0.998,
SYNERGY,umol.L-1,17,0.998,
CP,% ID/g,17,0.998,
GDPED50,,17,0.998,
FRACTIONOFACCUMULATED86RBREMAINING,,17,0.998,
I,umol.L-1,17,0.998,
"LOGPE,MAX",,17,0.998,
CRRELEASE,%,17,0.998,
SWIMMINGACTIVITY,,17,0.998,
WORMMOVEMENTINHIBITION,%,17,0.998,
TOXICITY,s,17,0.998,
TIME,microsec,17,0.998,
HYPNOSISDURATION,s,17,0.998,
ACTIVITY,um3,17,0.998,
LOGPO,,17,0.998,
HYDROPHOBICITYINDEX,,17,0.998,
PERMEABILITY,10^-5 cm/s,17,0.998,
TOXICITYDAYSURVIVORS,,17,0.998,
GR20,[ppm],17,0.998,
MDR,,17,0.998,
GI50EC50,,17,0.998,
APD95,ms,17,0.998,
AMOUNTOFACOTINEUSED,,16,0.998,
CTSINCREASE,,16,0.998,
TISSUEBLOODRATIO,,16,0.998,
KR,10^-3/min,16,0.998,
HEARTWEIGHT,mg,16,0.998,
PEAKDELTAHR,beats min-1,16,0.998,
PEAKDELTAMAP,mmHg,16,0.998,
ANALGESIC,%,16,0.998,
K,10'8/M,16,0.998,
CHANGEINIC50,fold,16,0.998,
HEMATOTOXICITY,%,16,0.998,
AVERAGESCORE,,16,0.998,
BINDINGINHIBITION,%,16,0.998,
PROBABILITY,,16,0.998,
TOXICDOSE,,16,0.998,
SELECTIVITY,%,16,0.998,
FC50,umol.L-1,16,0.998,
FLUORESCENCE,mm,16,0.998,
SPECIFICACTIVITY,Ci mM-1,16,0.998,
ACTIVITY,mU/L,16,0.998,
AMOUNTEXCRETED,,16,0.998,
SERUMMETABOLITE,mg dl-1,16,0.998,
ACTIVITY,/mmol,16,0.998,
VIABILITY,umol.L-1,16,0.998,
AMOUNTDELIVERED,pg ml-1,16,0.998,
KIAH,umol.L-1,16,0.998,
MEDIANSURVIVAL,d,16,0.998,
CELLPROTEININUNTREATEDCONTROL,%,16,0.998,
PEC99,,16,0.998,
IC50[E],,16,0.998,
LC10,umol.L-1,16,0.998,
RESISTANCEREVERSAL,,16,0.998,
CELLNODISH,,16,0.998,
CELLKILL,%,16,0.998,
VIRUSRATING,VR,16,0.998,
AB50,,16,0.998,
TIMETOMAXINHIBITION,s,16,0.998,
CC50EC50,,16,0.998,
K,10'-4/nM/min,16,0.998,
LC50,uL/L,16,0.998,
DIFFERENCE,%,16,0.998,
E,mV,16,0.998,
K,10'5L/mol,16,0.998,
MTTREDUCTION,%,16,0.998,
IC50,pmol/L,16,0.998,
KB,uM kg-1,16,0.998,
TRANSPORTRATE,nmol.L-1.min-1.mg-1,16,0.998,
TUMORGROWTH,10e3mm,16,0.998,
MED,%,16,0.998,
KE,/M,16,0.998,
KD,10^3nM,16,0.998,
EFFECTONPOLYAMINEPOOLS,,16,0.998,
HD10,umol.L-1,16,0.998,
IMBALANCE,,16,0.998,
DELTAGM,,16,0.998,
SERUMTRIGLYCERIDE,mg dl-1,16,0.998,
INHIBITIONOFDAMAGE,%,16,0.998,
KD,1/s,16,0.998,
INFLAMED,mmHg,16,0.998,
SC200,,16,0.998,
RS,uM min-1 kg-1,16,0.998,
SPREADING,%,16,0.998,
CONCPLASMA,umol.L-1,16,0.998,
ERMAX,umol.L-1,16,0.998,
ED80,,16,0.998,
MET,%,16,0.998,
ED90,(mg/kg)/day,16,0.998,
ACTIVITY,mMequiv/mg,16,0.998,
DECREASEINTHEQAINTERVAL,ms,16,0.998,
B,ug (g of abscess)-1,16,0.998,
TOXICLEVEL,,16,0.998,
AUC,nmol.min.g-1,16,0.998,
FCMAX,,16,0.998,
ACTIVITY,log10/ml,16,0.998,
EEREF,,16,0.998,
AUC,nmol/g.hr,16,0.998,
ACTIVITY,equiv/uM,16,0.998,
ACTIVITY,min-1,16,0.998,
RESPONSE,s,16,0.998,
PAPP,10'-6nanometer/s,16,0.998,
AUC,uM h kg/mg,16,0.998,
ILB,,16,0.998,
ACTIVITY,log10PFU,16,0.998,
MDD50,,16,0.998,
2XAPTT,,16,0.998,
ACTIVITY,mmHg/min,16,0.998,
SPECIFICDISPLACEMENT,%,16,0.998,
INACTIVATIONTIME,s,16,0.998,
EDMIN,,16,0.998,
CT,mg,16,0.998,
COLONYCOUNT,,16,0.998,
TP,s,16,0.998,
AUC,ug.mg-1,16,0.998,
PK3,,16,0.998,
FLUORESCENCEINTENSITY,a.u.,16,0.998,
HC10,,16,0.998,
ED50,L.mol-1,16,0.998,
RATEOFHYDROLYSIS,,16,0.998,
LC95,uL/L,16,0.998,
ACTIVITY,ng (g of tissue)-1,16,0.998,
SUPPRESSIVEDOSE,ug.mg-1,16,0.998,
ACTIVITY,nanoseconds,16,0.998,
RELATIVEINTRINSICACTIVITY,,16,0.998,
ACTIVITY,FU/min,16,0.998,
RELATIVEVALUE,,16,0.998,
ED300,uM kg-1,16,0.998,
TOTALBINDING,%,16,0.998,
ORGANWEIGHT,,16,0.998,
BUN,mg dl-1,16,0.998,
KA,1/M.sec,16,0.998,
LOGKL,,16,0.998,
MHC,,16,0.998,
REDUCTIONINVIRUSTITER,%,16,0.998,
STRETCHES,,16,0.998,
SURVIVALMEDIAN,d,16,0.998,
RELATIVEESTERASESUSCEPTIBILITY,,16,0.998,
UPTAKE,,16,0.998,
LD10,umol.L-1,16,0.998,
ED20,nM kg-1,16,0.998,
A,ug (g of abscess)-1,16,0.998,
ED2SEC,ug.mg-1,16,0.998,
MAXIMALRELAXATION,%,16,0.998,
IZ,U,16,0.998,
A50,umol,16,0.998,
CARBOHYDRATE,mg,16,0.998,
CONTROLVALUE,g dl-1,16,0.998,
SURVIVORSATDAY30,,16,0.998,
APOPTOTICACTIVITY,,16,0.998,
REMAININGRATIO,%,16,0.998,
ULCERATIVEINDEX,,16,0.998,
PLASMACHOLESTEROL,mg dl-1,16,0.998,
APOPTOSISINDEX,,16,0.998,
CP,ug.mg-1,16,0.998,
SURVIVORSTOTAL,,16,0.998,
REMAININGRATE,%,16,0.998,
MAT,s,16,0.998,
MLS,d,16,0.998,
LC90,,16,0.998,
ORIGINALAMPLITUDE,%,16,0.998,
DEPENDENCY,,16,0.998,
EC50REL,umol.L-1,16,0.998,
UNBOUND,%,16,0.998,
A0,,16,0.998,
ACTIVITY,10'6 /uL,16,0.998,
MAXCAMP,%,16,0.998,
LC60,mgAi/L,16,0.998,
CMAX,μg/mL,16,0.998,
CHOLESTEROLLEVEL,mg dl-1,16,0.998,
CLH,l/min/mg,16,0.998,
RADIOACTIVECONSTITUENTS,%,16,0.998,
PRESSORACTIVITY,mg,16,0.998,
KINACT,10^-5/s,16,0.998,
ACUTETOLERABILITY,,16,0.998,
CLEAVAGERATE,nmol.L-1.min-1.mg-1,16,0.998,
AD,umol.L-1.ml-1,16,0.998,
TI,%,16,0.998,
K,se-1,16,0.998,
K,s/counts.M,16,0.998,
[CA2+]VARIATION,,16,0.998,
VMAX,pM min-1,16,0.998,
LOGKH,,16,0.998,
CL,ug/min/mg,16,0.998,
ACTIVITY(MG),%,16,0.998,
ACT,,16,0.998,
CT-LUCITAR,T/C,16,0.998,
TENSILESTRENGTH,g cm**-2,16,0.998,
CHOLESTEROLCONCENTRATION,mg dl-1,16,0.998,
ACTIVITY,ug/100mg of tissue,16,0.998,
INSULINRELEASE,ng/islet/h,16,0.998,
NORMAL,mmHg,16,0.998,
DRUGMETABOLISM,%/min/pmol,16,0.998,
RATECONSTANT,k hr-1,16,0.998,
DRUGMETABOLISM,uL/min,16,0.998,
CA2+REDUCTION,,16,0.998,
NON-HDL-C,%,16,0.998,
INCIDENCECOUNT,,16,0.998,
A2,umol.L-1,16,0.998,
CP,umol,16,0.998,
NODEATHSTREATED,,16,0.998,
NOOFCANINE,,16,0.998,
VMAXKM,ml/min,16,0.998,
KOBS,umol.L-1,16,0.998,
VMAX,optical density/minute,16,0.998,
FAUC,,16,0.998,
HT50,%,16,0.998,
KOBS1,uM-1 s-1,16,0.998,
POTENTIATION,uM kg-1,16,0.998,
HR,mmHg,16,0.998,
CLH,mg/min/mL,16,0.998,
VMAX,nM s-1,16,0.998,
KCAT,10'-3/min,16,0.998,
NOTOTAL,,16,0.998,
DRUGMETABOLISM,uM/Gy,16,0.998,
METABOLITELEVELS,mg,15,0.998,
ACTIVITY,RLU/mg,15,0.998,
PREVENTIVEINDEX,,15,0.998,
NOOFSUNCUSVOMITED,,15,0.998,
METABOLITELEVELS,,15,0.998,
FRESHWEIGHT,ng g-1,15,0.998,
LD95,ug.mg-1,15,0.998,
AMOUNTBOUND,M g-1,15,0.998,
STABILITY,yr,15,0.998,
BLOODGLUCOSELEVEL,,15,0.998,
ID50,umol/kg/hr,15,0.998,
TC12,,15,0.998,
KINACT,min-1,15,0.998,
ID50,umol/cm2,15,0.998,
ACCUMULATEDCOUNTS30MIN,,15,0.998,
WEIGHTCHANGE,g mouse-1 on day 8,15,0.998,
ACTIVITY,mS/cm,15,0.998,
ED80,uM kg-1,15,0.998,
AUMCT,hr.hr.ng/ml,15,0.998,
I50,ppb,15,0.998,
3H-TDRINCORPOLATION,c.p.m.,15,0.998,
AUCT,ng.min/g,15,0.998,
ACTIVITY,mMequiv,15,0.998,
LOG1B+100,,15,0.998,
ANALGESIADURATION,s,15,0.998,
AUCDOSE,ng/mL.hr/(mg/kg),15,0.998,
CHANGEINRATBLOODSUGAR,%,15,0.998,
LOGCONCENTRATION,,15,0.998,
GASTRICCONCENTRATION,ug g-1,15,0.998,
BODYWEIGHTCHANGE,BWC,15,0.998,
INHIBITORYEFFECT,,15,0.998,
DELTAOD,s-1,15,0.998,
LOG1B+1,,15,0.998,
TOTALNUMBEROFENTRIES,,15,0.998,
P,umol.L-1,15,0.998,
TI,Ratio,15,0.998,
TC(RATIOOFTREATEDTOCONTROL),%,15,0.998,
KQ,10^13L/mol.s,15,0.998,
CLFREE,%,15,0.998,
MTXEQUIVALENT,ug.mg-1,15,0.998,
ACTIVITY,FU,15,0.998,
VZ,,15,0.998,
TRIGLYCERIDECORRECTION,%,15,0.998,
TCSURVIVALDAYS,,15,0.998,
ED40,nM kg-1,15,0.998,
-LOGI50,,15,0.998,
RTP,%,15,0.998,
TUMORVOLUME,cm*3,15,0.998,
MTT,s,15,0.998,
CMAX,ng.hr/ml,15,0.998,
B50,umol.L-1,15,0.998,
ANIMALSCURED,%,15,0.998,
ACTIVITY,uM of MDA (mM of deoxyribose)-1,15,0.998,
SUCCEEDEDTESTED,s,15,0.998,
ACTIVITY,mJ/m2,15,0.998,
HEMISPHERESREDUCTION,,15,0.998,
STABILITY,%/hr,15,0.998,
DOSE,mg.ml-1,15,0.998,
DELTAS,kcal.mol-1,15,0.998,
C10,mM hr,15,0.998,
ED300,umol.L-1,15,0.998,
VMKM,,15,0.998,
CROPYIELD,kg/ha,15,0.998,
HYPOGLYCEMICACTIVITY,ug.mg-1,15,0.998,
NOOFLIVINGCELLS,,15,0.998,
SURVIVAL,weeks,15,0.998,
OPTIMALDOSE,mg uM kg day-1,15,0.998,
EXTENTOFSKINLESIONS,cm**2,15,0.998,
INSULIN-SENSITIZINGACTIVITY,%,15,0.998,
FOODINTAKE,mg,15,0.998,
WLCPRA,,15,0.998,
AE,%ID,15,0.998,
MBIC80,umol.L-1,15,0.998,
NOOFENTRIES,%,15,0.998,
CL,ml/kg.hr,15,0.998,
CURES,survivors/total,15,0.998,
VMAX,RFU/min,15,0.998,
RELATIVEDIFFERENTIATINGACTIVITY,,15,0.998,
NBTPOSITIVITY,%,15,0.998,
ACTIVITY,uA.cm^-2,15,0.998,
DELTAHDL-C,%,15,0.998,
GTP-GAMMA35SBOUND,%,15,0.998,
NOOFCELLS,ml,15,0.998,
RVRED15,ug.mg-1,15,0.998,
E50,umol.L-1,15,0.998,
KOBS1,1/M 1/s,15,0.998,
TONICSEIZURES,%,15,0.998,
AERP,,15,0.998,
MAC,mg.kg-1.d-1,15,0.998,
AVERAGETUMORVOLUME,,15,0.998,
AVERAGESURVIVALTIME,d,15,0.998,
S,Dilution factor,15,0.998,
NM,,15,0.998,
RBI,,15,0.998,
RATECONSTANT,/mol.L-1.s-1,15,0.998,
DECREASEINFIGHTING,%,15,0.998,
PAH50,,15,0.998,
ED70,ug.mg-1,15,0.998,
LAGTIME,s,15,0.998,
PAD,,15,0.998,
HXSHIFT,,15,0.998,
VDF,l,15,0.998,
VCT,,15,0.998,
DRUGUPTAKE,ug/L,15,0.998,
MINERALAPPOSITIONRATE,mm day-1,15,0.998,
COMMUNICATINGCELLS,,15,0.998,
RATIOCC50IC50,10'4No_unit,15,0.998,
MAXAGONISTRESPONSE,%,15,0.998,
CR,,15,0.998,
KCATKM,L/mmol/s,15,0.998,
DRUGMETABOLISM,ml/min.kg,15,0.998,
EFFECTIVENESS,%,15,0.998,
SPENTTIME,s,15,0.998,
IC50,M ml-1,15,0.998,
CHI,%,15,0.998,
KAPP,10'-5/M,15,0.998,
EFFICACY,picometer,15,0.998,
REDUCTIONINMOVEMENT,%,15,0.998,
-LOGCONCENTRATION,umol.L-1,15,0.998,
CLOGD74,,15,0.998,
KA,10'2/M,15,0.998,
LOG2,,15,0.998,
ACTIVITY,g/ml,15,0.998,
KCAT,10'-4/s,15,0.998,
CLH,mg/min/microL,15,0.998,
MOT,,15,0.998,
ACTIVITY,/10'2cm3,15,0.998,
P50DP50C,,15,0.998,
PEC50DISS,,15,0.998,
DRUGRECOVERY,umol,15,0.998,
KA,10^3/M/s,15,0.998,
AP,,15,0.998,
CHOLESTEROL,mg,15,0.998,
FIC90,umol.L-1,15,0.998,
LOG1B5,,15,0.998,
ACTIVITY,mmolequiv,15,0.998,
REMAININGCOMPOUND,%,15,0.998,
RMAX,RU,15,0.998,
CLFREE,10^3uL/min/mg,15,0.998,
AUCLAST,min.ng/g,15,0.998,
T50,umol.L-1,15,0.998,
ACTIVITY,ug.disk-1,15,0.998,
MPE,mmHg,15,0.998,
INH,10'-3M,15,0.998,
RMP,mV,15,0.998,
ALKYLATION,%,15,0.998,
CELLPROLIFERATION,%,15,0.998,
LOG1TH+200,,15,0.998,
ANTIDIURETICACTIVITY,,15,0.998,
ROOTGALLINGINDEX,%,15,0.998,
DECREASERVR,%,15,0.998,
T12,%,15,0.998,
K,1/Maa,15,0.998,
WEIGHTCHANGES,mg,15,0.998,
AVERAGECHANGEINWEIGHT,%,15,0.998,
ACTIVITY,um,15,0.998,
FE,,15,0.998,
CF,%,15,0.998,
CLRENAL,ml/hr,15,0.998,
CMI,umol.L-1,14,0.998,
ED33,ug.mg-1,14,0.998,
LD0,,14,0.998,
ED15,uM kg-1,14,0.998,
C20APD95,,14,0.998,
C13,umol.L-1,14,0.998,
B(DPB),%,14,0.998,
TOXICITYRELATEDDEATH,,14,0.998,
ACTIVITY,10^6/mm3,14,0.998,
TUMORWEIGHT,%,14,0.998,
LD50,10'-6M,14,0.998,
DELTATM,s,14,0.998,
RELATIVELEVEL,,14,0.998,
LETHALDOSE,[ppm],14,0.998,
EDMIN,uM kg-1,14,0.998,
MIDLOGLC50,umol.L-1,14,0.998,
CMAX,hr.fmol,14,0.998,
SPMAX,%,14,0.998,
PARASITESNOPER100MYOBLASTS,,14,0.998,
EC50,10'8pM,14,0.998,
SUBCUTSCORE,,14,0.998,
ACTIVITY,ml/min.Kg,14,0.998,
AUCC,,14,0.998,
MAXDECREASEINBLOODPRESSURE,mmHg,14,0.998,
PEI,%,14,0.998,
MIC98,umol.L-1,14,0.998,
LD20,umol.L-1,14,0.998,
KT,umol.L-1,14,0.998,
LOG10PFUML,,14,0.998,
-LOGSW,,14,0.998,
GAMMACMC,mN/meter,14,0.998,
ANTIMICROBIALACTIVITY,,14,0.998,
PLASMAHISTAMINE,umol.L-1,14,0.998,
5-HTSYNDROME,,14,0.998,
ACTIVITY,millimeter/hr,14,0.998,
APA,mV,14,0.998,
EI,,14,0.998,
GROWTHDELAY(T-CC),%,14,0.998,
K,10'-1/min,14,0.998,
LD50,ug/mg,14,0.998,
RELAXEDDNA,%,14,0.998,
MBC=>99,umol.L-1,14,0.998,
DECREASEINBMAX,%,14,0.998,
MIC,ug m/L,14,0.998,
SURVIVORSAT24H,,14,0.998,
ED50,10'-7mol/cm2,14,0.998,
MAXTOLERATEDDOSE,ug.mg-1,14,0.998,
GI,mm2,14,0.998,
KS,L.umol-1,14,0.998,
ACTIVITY,L/s,14,0.998,
CHANGE,umol.L-1,14,0.998,
OFCONTROL,%,14,0.998,
ACTIVITY,pmol/min/ug,14,0.998,
CCH,,14,0.998,
PB,pmolequiv,14,0.998,
EMAX,mV,14,0.998,
ABDOMINALFAT,mg,14,0.998,
ACTIVITY,pmol/min.mg,14,0.998,
GSTCPACTIVITY,,14,0.998,
K,10'-6/M,14,0.998,
30DAYSURVIVORS,,14,0.998,
G0G1,%,14,0.998,
FUNGICIDAL,umol.L-1,14,0.998,
MAXINCREASEINCORONARYFLOW,%,14,0.998,
EC100,mg.ml-1,14,0.998,
LWI,%,14,0.998,
BULLATACININDEX,,14,0.998,
KID,umol.L-1,14,0.998,
ED85,umol.L-1,14,0.998,
MAXRELAXATION,%,14,0.998,
VM,pM min-1,14,0.998,
OUABAIN,ug.mg-1,14,0.998,
ACTIVITY,10'-5OD/s,14,0.998,
INFECTIOUSVIRUS,ffu ml-1,14,0.998,
MAXIMUMRESPONSE,%,14,0.998,
ED50,uM site-1,14,0.998,
CHANGEINBLOODFLOW,,14,0.998,
K,10'3/uM/s,14,0.998,
TUMORBURDEN,mg,14,0.998,
STAININDEX,,14,0.998,
DURATIONOFREVERSAL,s,14,0.998,
CLH,umol.L-1,14,0.998,
LIPIDPEROXIDATION,,14,0.998,
BLOODGLUCOSE,mM (l of whole blood)-1,14,0.998,
PEAKTIME,s,14,0.998,
AUC,nM.hr.kg/mg,14,0.998,
MYOBLASTWITHPARASITES,%,14,0.998,
ACTIVITY,10'-10mol/min,14,0.998,
DRUGUPTAKE(FREE),ng/g,14,0.998,
ACTIVITY,nM g-1,14,0.998,
UD,ug.mg-1,14,0.998,
PLASMAALTAT24H,mU ml-1,14,0.998,
INHIBITIONPOTENCYTII,,14,0.998,
MAXMBP,mmHg,14,0.998,
PCACO2,cm s-1,14,0.998,
INCREASEOVERCONTROL,%,14,0.998,
TPO,%,14,0.998,
ED6,ug.mg-1,14,0.998,
LIVERTG,mg g-1,14,0.998,
DRUGUPTAKE,ug base equiv/g,14,0.998,
CAR,MPK,14,0.998,
ACTIVITY,IU/dl,14,0.998,
RELATIVET12,,14,0.998,
K,M-1 min-1,14,0.998,
ADJUVANTEFFECT,,14,0.998,
K,min-1,14,0.998,
NOOFMICEDEADDAYDIED,,14,0.998,
NOOFMALESMATED,,14,0.998,
HYPOTENSIVEACTIVITY,mmHg,14,0.998,
NOOFMALESFERTILE,,14,0.998,
TIME,10'3s,14,0.998,
PXI50,,14,0.998,
NOOFMALESCOHABITED,,14,0.998,
ACTIVITY,umol.L-1.min-1.,14,0.998,
K-2,10e-3 1/s,14,0.998,
VMAX,uM min-1 mg-1,14,0.998,
DELTAA,mm,14,0.998,
I75,gAi/ha,14,0.998,
AUCT,nM/ml.hr,14,0.998,
NOOFPLAQUES,,14,0.998,
MEANDURATION,s,14,0.998,
MEANDECREASE,%,14,0.998,
THERAPEUTICEFFECT,%,14,0.998,
CT,hr.fmol,14,0.998,
DOSERANGE,ug.mg-1,14,0.998,
AUCP,,14,0.998,
IC35,umol.L-1,14,0.998,
NOOFWRITHINGS,,14,0.998,
THERMODYNAMICSOLUBILITY,ugA/ml,14,0.999,
NETTURNSMIN,,14,0.999,
EQUILIBRIUMOD340,,14,0.999,
VMAX,nM hr-1 mg-1,14,0.999,
REDUCTION,s,14,0.999,
TC90,umol,14,0.999,
ACTIVITY,uS,14,0.999,
NADHOXIDATION,umol.L-1.min-1.mg-1,14,0.999,
AMOUNT,nM (mg of protein)-1,14,0.999,
RATEOFINHIBITION,s-1,14,0.999,
LOGCHANGE,,14,0.999,
TC50,umol,14,0.999,
NETGRAINCOUNTS,,14,0.999,
FAUCMIC,s,14,0.999,
DRUGUPTAKE,ml/min/mg,14,0.999,
POTENTATION,,14,0.999,
ACTIVITY,uM/day,14,0.999,
NLCK,,14,0.999,
VMAX,nM hr-1 (10e6*cells)-1,14,0.999,
PHOTOSENSITIZATION,,14,0.999,
NITRICOXIDE,%,14,0.999,
CONTROLRELAXATION,%,14,0.999,
PIGMENTATIONCAPACITY,,14,0.999,
RATEMAX,beats min-1,14,0.999,
THERAPEUTICINDEX,umol.L-1,14,0.999,
K,10^-5/s,14,0.999,
PROLACTINTREATMENT,umol.L-1,14,0.999,
NOPROTECTEDNODOSED,,14,0.999,
INCREASEINDPM,(mg of protein)-1,14,0.999,
INCREASEINPLASMALIPASE,IU ml-1,14,0.999,
CL,mg ml-1 kg-1,14,0.999,
KO,s-1,14,0.999,
RADIATIONEQUIVALENT,,14,0.999,
COMPLETEREMISSION,%,14,0.999,
AC,,14,0.999,
LOGPMIC,,14,0.999,
INCREASEINBLOODPRESSURE(PR),%,14,0.999,
HYPOCOTYLLENGTH,cm,14,0.999,
KC,10e-3 1/s,14,0.999,
CT10,mM-hr,14,0.999,
RT,s,14,0.999,
DISSOCIATIONRATECONSTANT,s-1,14,0.999,
TONIC-CLONICSEIZURE,,14,0.999,
KA,10'-6/M,14,0.999,
VMAX(APP),pmol/mg.min,14,0.999,
KR,10'-3/min,14,0.999,
EDEMADENSITY,,14,0.999,
REDUCTION,ug.mg-1,14,0.999,
BODYWEIGHTCHANGE,g (100g of body weight)-1,14,0.999,
NOOFSCRATCHES,,14,0.999,
K,10^5/Ms,14,0.999,
VDSS,ml,14,0.999,
HVALEVEL,ug g-1,14,0.999,
ACTIVITY,ul min-1,14,0.999,
POTVIGILANCE,,14,0.999,
PROLACTINCONTROL,umol.L-1,14,0.999,
DOSEBPBP,,14,0.999,
NOOFDOGSUSED,,14,0.999,
NOOFDOGSREVERTED,,14,0.999,
MCCD,ug.mg-1,14,0.999,
ERYTHEMAINDUCTION,,14,0.999,
K,10^3/M/min,14,0.999,
VMAX,nmol/min/mg protein,14,0.999,
AGONISTICACTIVITY,%,14,0.999,
VMAXKM,nM min-1 mg-1 mM-1,14,0.999,
KDISS,10'-2/s,14,0.999,
EXPERIMENTALDPM,,14,0.999,
LOGRATECONSTANT,/mol.L-1.s-1,14,0.999,
SERUMSTABILITY,,14,0.999,
DNACLEAVAGE,%,14,0.999,
HISTOPATHOLOGY,,14,0.999,
AI50,umol.L-1,14,0.999,
SERUMTRIGLYCERIDE,%,14,0.999,
K2,10e-3 1/s,14,0.999,
ACTIVITY,%mol/mol,14,0.999,
HEPATICNECROSISINSURVIVORS,,13,0.999,
CHANGEINCHOLESTEROL,,13,0.999,
BODYWEIGHTLOSSATNADIR,%,13,0.999,
AUC,nM/ml,13,0.999,
D,10'-10m2/s,13,0.999,
MRD,V s-1,13,0.999,
RBP,%,13,0.999,
SURVIVALS,%,13,0.999,
MIC,umol/cm3,13,0.999,
RELATIVESTIMULATORYACTIVITY,%,13,0.999,
EC40,,13,0.999,
MTXRATIO,,13,0.999,
DURATIONTIME,s,13,0.999,
E100,umol.L-1,13,0.999,
MAXSBP,mmHg,13,0.999,
MAP,%,13,0.999,
GPTLEVEL,U l-1,13,0.999,
MTD,mg/m2,13,0.999,
GOTLEVEL,U l-1,13,0.999,
CELLPROLIFERATIONAC50,umol.L-1,13,0.999,
CELLPERMEATION,nm s-1,13,0.999,
MIGRATION,%,13,0.999,
MAXDELTABP,umol.L-1,13,0.999,
MAXENHANCEMENT,,13,0.999,
ECLT,s,13,0.999,
REGRESSIONRESPONSE,%,13,0.999,
QTINTERVAL,ms,13,0.999,
CL,ml.Kg/min,13,0.999,
SOLUBILITY,ug.mg-1,13,0.999,
RADIOACTIVITYLEVEL,ml,13,0.999,
RADIOLIGANDBOUND,%,13,0.999,
CHANGEINTEMPARATURE,Cel,13,0.999,
RATIO,10^4/M/min,13,0.999,
BEHAVIORALRESPONSE,,13,0.999,
REDUCTION,mg,13,0.999,
RELATIVEFLORESCENCE,,13,0.999,
PARASITEMIA,,13,0.999,
EC50,Ke nM-1,13,0.999,
AUC,SUV.min,13,0.999,
C120ED50,,13,0.999,
MNTD,mg.kg-1.d-1,13,0.999,
CACO-2PERMEABILITY,,13,0.999,
MIC,U/ml,13,0.999,
AUC,hr/mL,13,0.999,
REDUCTIONINVIRUSYIELD,pfu/ml,13,0.999,
EC999,umol.L-1,13,0.999,
ALPLEVEL,U l-1,13,0.999,
OPTIMALDOSE,mg uM kg-1 day-1,13,0.999,
DELTAED50,ug.mg-1,13,0.999,
SHUTDOWNTIME,s,13,0.999,
AE,,13,0.999,
EFFECTIVENESS,,13,0.999,
DNAFRAGMENTATION,,13,0.999,
EFFECTIVEDOSE,uM kg-1,13,0.999,
S,%,13,0.999,
AUCTDOSE,nM.hr,13,0.999,
AD50,umol,13,0.999,
EFFECTIVECONCENTRATION,,13,0.999,
BASAL,%,13,0.999,
EXCRETED,%,13,0.999,
ODCACTIVITY,(nM of CO2) 30min-1 (mg of protein)-1,13,0.999,
DELTAA,%,13,0.999,
MED50,mg,13,0.999,
SB,%,13,0.999,
P10MIC,umol.L-1,13,0.999,
SERUMLEVEL,umol.L-1,13,0.999,
MED98,ug.mg-1,13,0.999,
AUCT,umol.L-1,13,0.999,
LOGTUMORCELLKILL,,13,0.999,
RHA,,13,0.999,
AERP,ms,13,0.999,
LOGPC,,13,0.999,
MEC,%w/v,13,0.999,
EQUILIBRIUM,ug/ml,13,0.999,
PKABZ,,13,0.999,
HILLCOEFFICIENT,nH,13,0.999,
CMAX,ug g-1,13,0.999,
MED10,ug.mg-1,13,0.999,
CMAX,uM-1 kg-1,13,0.999,
AVERAGEWEIGHTCHANGE,ug.mg-1,13,0.999,
HORMONALACTIVITY,,13,0.999,
EXPLORATORYACTIVITY,,13,0.999,
AVERAGETUMORVOLUME,T/C,13,0.999,
EMAX,ms,13,0.999,
CT,%ID/cc,13,0.999,
FAUCDOSE,nM.hr/mg/kg,13,0.999,
ROOTGALLINGINDEX,,13,0.999,
I50,gAi/ha,13,0.999,
RSATR,s,13,0.999,
AGONISM,,13,0.999,
CURES,%,13,0.999,
ENHANCEMENTRATIO,,13,0.999,
DIFFERENTIATIONACTIVITYRATIO,,13,0.999,
PHOTOLYSIS,,13,0.999,
MBC>999,,13,0.999,
FMAX,,13,0.999,
TC,umol.L-1,13,0.999,
KMKCAT,,13,0.999,
IC50H,umol.L-1,13,0.999,
ACTIVITY,pmolequiv/mg,13,0.999,
KUP,ml/min/g,13,0.999,
K,10'-4/M/s,13,0.999,
VOLSYN,,13,0.999,
KQ,10'11/M/s,13,0.999,
INDUCTION,fM,13,0.999,
TPI,%,13,0.999,
KDISS,10^-3/s,13,0.999,
VMAX,c.p.m.,13,0.999,
KR,mmol/min,13,0.999,
KD,L.umol-1,13,0.999,
LOGCFUG,,13,0.999,
INCREASEINRESPONSE,%,13,0.999,
KI(KMKCAT),,13,0.999,
KA,/mM,13,0.999,
ACTIVITY,10^6No_unit,13,0.999,
TUMORINHIBITIONRATIO,%,13,0.999,
IPSCORE,,13,0.999,
LOG1IC90,,13,0.999,
LNKT,,13,0.999,
VM,10'-4m3/mol,13,0.999,
ILS(TC),%,13,0.999,
LBF,L/min,13,0.999,
ACTIVITY,L.umol-1,13,0.999,
CL,ml/min.g,13,0.999,
LOG10LT50,,13,0.999,
ACTIVITY,degreeC.hr,13,0.999,
LD100,umol.L-1,13,0.999,
K'',s-1,13,0.999,
INOTROPICPOTENCY,nM kg-1,13,0.999,
KBIND,,13,0.999,
VZ,ml,13,0.999,
LENGTH,mm rat-1,13,0.999,
IC25,,13,0.999,
LBF,ml/min,13,0.999,
LOG10CFU,ml-1,13,0.999,
LD50,mg/m2,13,0.999,
ACTIVITY,mg/g DW,13,0.999,
LESIONCLEARANCE,%,13,0.999,
K2KI,nM-1 min-1,13,0.999,
TISSUELEVELS,umol.L-1,13,0.999,
KD,10^-3/s,13,0.999,
ACTIVITY,(ng of PGE2) (mg of protein)-1,13,0.999,
INH,/mol.L-1.s-1,13,0.999,
LNKP,,13,0.999,
URINEBILE,,13,0.999,
K,10^8/M,13,0.999,
NECROSISRESPONSE,%,13,0.999,
RATECONSTANT,hr-1,13,0.999,
T,s,13,0.999,
ED50,M mouse-1,13,0.999,
PEFF,10'-4 cm/s,13,0.999,
ED50,kg/ha,13,0.999,
LYSISAREA,mm.mm,13,0.999,
CHLORINEUPTAKE,,13,0.999,
ED50,gAi/ha,13,0.999,
NEGATION,%,13,0.999,
ED50,mpk/d,13,0.999,
RATE,nM min-1 (10e6*cells)-1,13,0.999,
LUNGWEIGHT,mg,13,0.999,
BLOCKADEDURATION,s,13,0.999,
BLEEDINGTIME,s,13,0.999,
BEI,kDa-1,13,0.999,
ED90,mg/kg.day,13,0.999,
DRUGDEATHS,,13,0.999,
AMINEFORMED,mg,13,0.999,
BILURUBINLEVEL,mg %,13,0.999,
VAGALRESPONSE,,13,0.999,
RELATIVITY,,13,0.999,
MBIC=>90,umol.L-1,13,0.999,
SPONTANEOUSMOTORACTIVITY,,13,0.999,
WEIGHTCHANGEONDAY5,%,13,0.999,
TRANSCRIPTIONALACTIVITY,%,13,0.999,
RATE,delta OD340 min-1,13,0.999,
LC90,ugAi/L,13,0.999,
KDNB,,13,0.999,
LC50,ugAi/L,13,0.999,
KCATKM,/min/microM,13,0.999,
TO,s,13,0.999,
LOGITP(CONC),,13,0.999,
IC>80,,13,0.999,
KCATKM,10'-3/microM/s,13,0.999,
ACTIVITY,mg.min/dL,13,0.999,
ACTIVITY,10'9CFU/g,13,0.999,
BMD,mg/cm3,13,0.999,
ED50,m equiv [H+] l-1,13,0.999,
LVEDP,mmHg,13,0.999,
PDI,%,13,0.999,
INCREASEINHR,%,13,0.999,
KD,10^-12M,13,0.999,
K,/min/nM,13,0.999,
TMIN,s,13,0.999,
MAXRELEASE,%,12,0.999,
FICINDEX,,12,0.999,
GPGBTENSION,mg,12,0.999,
MEAN,umol.mg-1,12,0.999,
EXCRETION,% of dose,12,0.999,
PL-017SHIFT,,12,0.999,
SBPDECREASE,%,12,0.999,
CHANGEINMST,,12,0.999,
CONTROLGROWTH,,12,0.999,
MYRISTOYLPEPTIDE,%,12,0.999,
CHOLESTROLLEVELS,g l-1,12,0.999,
NA+EXCRETION,m equiv 5hr-1 kg-1,12,0.999,
NEOSTIGMINEREVERSAL,,12,0.999,
RATEOFDECOMPOSITION,,12,0.999,
DRUGUPTAKE,PSL/mm2,12,0.999,
SLOPEOFSCHILDPLOT,,12,0.999,
ACTIVITY,(ng of TXB2) (mg of protein)-1,12,0.999,
TOCED50,umol.L-1,12,0.999,
ACTIVITY,ucat/L,12,0.999,
LOG[-8],,12,0.999,
PDC,,12,0.999,
PC50,,12,0.999,
NOOFANIMALSALIVE,,12,0.999,
TRANSACYLATIONRATE,,12,0.999,
ASATLEVELS,IU/l,12,0.999,
ACTIVITY,mg m-1,12,0.999,
LOG[-5],,12,0.999,
SERUMTG,mg dl-1,12,0.999,
FECALRECOVERY,%,12,0.999,
ACTIVITY,mol.L-1.min-1.Menzyme-1,12,0.999,
FEREMOVED,%,12,0.999,
LOG[-6],,12,0.999,
ACTIVITY,uU/ml,12,0.999,
EXCRETION,m equiv 4hr-1,12,0.999,
LOG[-7],,12,0.999,
TIMEINFLIGHT,%,12,0.999,
MBP(DELTA),%,12,0.999,
PHOSPHOROLYSIS,,12,0.999,
CAMPCONTENT,pmol/mg protein,12,0.999,
RATE,ka/Ks,12,0.999,
REACTIVITY,%,12,0.999,
REGIOSPECIFICITY,,12,0.999,
REDUCINGACTIVITY,%,12,0.999,
CP,mg,12,0.999,
MNTD70,umol.L-1,12,0.999,
CATALYPTICACTION,,12,0.999,
ACTIVITY,10'5/cm'3,12,0.999,
MORTALITYRANGE,d,12,0.999,
EC50,10^3nM,12,0.999,
RATE,beats min-1,12,0.999,
ACTIVITY,10'3/cm2,12,0.999,
VI30,%,12,0.999,
LC50,mg/cm2,12,0.999,
COUNTS30MIN,,12,0.999,
DAP,,12,0.999,
ACTIVITY,10'-9PFU/ml,12,0.999,
ACTIVITY,no. of living cells (10E3) /mL,12,0.999,
VMAX,10'-4deltaA/s,12,0.999,
KSV,L/mol,12,0.999,
ACTIVITY,10'-2k/min,12,0.999,
CITH,,12,0.999,
CHANGEINCELLNUMBER,%,12,0.999,
RAP,,12,0.999,
KOBS11MS,,12,0.999,
DRUGMETABOLISM,ug/L,12,0.999,
DRUGMETABOLISM,pmol/ml,12,0.999,
NOOFANIMALSPROTECTEDNUMBEROFANIMALSTESTED,,12,0.999,
DRUGMETABOLISM,pM,12,0.999,
K,10^4/Ms,12,0.999,
VMAX,pM hr-1,12,0.999,
NOOFANIMALSWITHDAMAGE,,12,0.999,
CL,mg/ml/kg,12,0.999,
QUANTITY,umol.mg-1,12,0.999,
DRUGMETABOLISM,%molar,12,0.999,
K,10e-3 min-1,12,0.999,
QTCDELTA,%,12,0.999,
ALATLEVELS,IU/l,12,0.999,
CT,pmol/ml,12,0.999,
AHINTERVAL,ms,12,0.999,
AUC,hr.sec,12,0.999,
MEANIC50,,12,0.999,
AUC,h·fmol/million cells,12,0.999,
ADJUVANTACTIVITY,,12,0.999,
EXTRACTION,%,12,0.999,
AGE,d,12,0.999,
CT,nmol/g,12,0.999,
GDPACTIVITY,nmol.L-1.min-1.mg-1,12,0.999,
TFREE,ns,12,0.999,
CROPYIELD,%,12,0.999,
EC30,mgAi/L,12,0.999,
LOGPHEP,,12,0.999,
MEANDAYOFDEATHFORTOTALDEAD,,12,0.999,
ACTIVITY,nM stent-1,12,0.999,
AUC,g.hr,12,0.999,
LOGPMW,,12,0.999,
AUCNORMALISED,((ug.h.ml-1)/(mg/kg),12,0.999,
ADDUCTFORMATION,,12,0.999,
IBUPROFEN,%,12,0.999,
MDL,d,12,0.999,
LOGITBIOAVAILABILITY,,12,0.999,
LOGK,L.umol-1,12,0.999,
HVINTERVAL,,12,0.999,
TOTALACIDOUTPUT,%,12,0.999,
PEAKCURRENT,%,12,0.999,
HSLOCURRENT,%,12,0.999,
LOGS,M/m3,12,0.999,
KB,10'3L/mol,12,0.999,
LOG1E100,,12,0.999,
EXCRETION,ug.mg-1,12,0.999,
PEAKCONCENTRATION,umol.L-1,12,0.999,
LOGK'O,,12,0.999,
AE,umol,12,0.999,
TDI,umol.L-1,12,0.999,
ACTIVITYREMANING,%,12,0.999,
THYROIDSTATUS,nM l-1,12,0.999,
LOG10PFU,mg,12,0.999,
FALLING,%,12,0.999,
TI,TD50/MIC50,12,0.999,
HR(DELTA),%,12,0.999,
HBSSOLUBILIZED,%,12,0.999,
TAC,%,12,0.999,
TA,,12,0.999,
LVDPDTMAX(DELTA),%,12,0.999,
ANTICOAGULANTACTIVITY,umol.L-1,12,0.999,
ACTIVITY,pmol/s,12,0.999,
T12INCREASE,%,12,0.999,
FORMALDEHYDE,nM (mg of protein)-1,12,0.999,
SPERMATOGENICINDEX,,12,0.999,
M50,%,12,0.999,
GTRATE,,12,0.999,
TISSUECONCENTRATION,umol.L-1,12,0.999,
%R,%,12,0.999,
ACTIVITY,uM min-1 mg-1,12,0.999,
GPI,umol.L-1,12,0.999,
MAXINTENSITY,,12,0.999,
AHINTERVAL,,12,0.999,
TLM,umol.L-1,12,0.999,
[3H]TDRUPTAKE,c.p.m.,12,0.999,
TBOUND,ns,12,0.999,
IC50,ug.well-1,12,0.999,
TOTAL,%,12,0.999,
TOXTEST,,12,0.999,
ACTIVITY,micrometer,12,0.999,
AMOUNTOFOUABAINUSED,,12,0.999,
STABILITY,%ID,12,0.999,
AUC,pM ml-1,12,0.999,
ACTIVITY,micromol/s,12,0.999,
IC90,ug.well-1,12,0.999,
MAODEAMINATION,%,12,0.999,
ANALGESICRESPONSE,,12,0.999,
MACROPHAGEACTIVATION,,12,0.999,
SPECIFICACTIVITY,dpm,12,0.999,
KCAT,10'-1/s,12,0.999,
TC,mg kg-1 injection-1,12,0.999,
AUCDOSE,hr.microg/ml,12,0.999,
SC,mg dl-1,12,0.999,
STATICTUMORS,%,12,0.999,
KCATKUNCAT,,12,0.999,
EFFECT,mmHg,12,0.999,
TUMORCURE,%,12,0.999,
ACTIVITY,AUC units,12,0.999,
LD50,umol.ml-1,12,0.999,
ACTIVITY,fmol/g,12,0.999,
ACTIVITY,cm/min,12,0.999,
MEINCREASE,nmol.L-1.min-1.mg-1,12,0.999,
RHRL,,12,0.999,
ACTIVITY,cm s-1,12,0.999,
RPP,mmHg beats min-1,12,0.999,
MESTEST,,12,0.999,
TVR,mmHg ml-1 min-1 g-1,12,0.999,
-LOG(1AD50),,12,0.999,
EFFECT,pM (10e6*cells)-1,12,0.999,
LD80,ug/mg,12,0.999,
RESPONSE,RU,12,0.999,
LESIONLENGTH,mm rat-1,12,0.999,
INTENSITYOFERYTHEMIA,,12,0.999,
RELATIVELUCIFERASERESPONSE,,12,0.999,
LESIONS,,12,0.999,
AVERAGECOLONYCOUNT,,12,0.999,
RELATIVITY,c.p.m. mg-1,12,0.999,
RISEHR,%,12,0.999,
AVERAGENOOFMETASTASIS,,12,0.999,
LHCONCENTRATION,mU ml-1,12,0.999,
INH,%/min,12,0.999,
UR,,12,0.999,
EMAX,s,12,0.999,
EMESIS,,12,0.999,
TUBULINPOLYMERIZATION,%,12,0.999,
BMAX,fM assay-1,12,0.999,
PEFF,10^-7 cm/s,12,0.999,
MEANVALUE,,12,0.999,
AVERAGEACTIVITY,,12,0.999,
INFARCTVOLUME,mm**3,12,0.999,
MEANTUMORVOLUME,cm*3,12,0.999,
AV,,12,0.999,
ED,ug/kg,12,0.999,
ED70,,12,0.999,
CELLCYCLEFRACTION,%,12,0.999,
URINEK+,m equiv,12,0.999,
THRESHOLDACTIVEDOSE,ug.mg-1,12,0.999,
RVMAX,,12,0.999,
V0,umol.L-1.s-1,12,0.999,
AUDPC,,12,0.999,
ERP(DELTA),%,12,0.999,
CP,nmol/L,12,0.999,
URINENA+,m equiv,12,0.999,
URINARYVOLUME,ml kg-1 5hr-1,12,0.999,
RELATIVEEFFECT,,12,0.999,
ACTIVITY,log[CFU],12,0.999,
BRONCHOALVEOLARLAVAGES,,12,0.999,
ACTIVITY,10e-4 K s-1,12,0.999,
RELATIVEINHIBITORPOTENCY,,12,0.999,
URINE,ml,12,0.999,
MINCONCENTRATION,umol.L-1,12,0.999,
MIC80,%v/v,12,0.999,
ED25,mM kg-1,12,0.999,
VISCOSITY,%,12,0.999,
ACTIVITY,Torr,12,0.999,
BRAINPENETRATIONINDEX,%,12,0.999,
BIODISTRIBUTIONRATIO,,12,0.999,
CQ,,12,0.999,
RESIDUALCONTRACTILEACTIVITY,,12,0.999,
UNCHANGEDTRACER,%,12,0.999,
UB,,12,0.999,
URINARYLEVEL,mg,12,0.999,
BASELINE,,12,0.999,
RELATIVEBINDINGPOTENCY,,12,0.999,
C5AMAX,%,12,0.999,
MEANRELATIVESURVIVINGFRACTION,,12,0.999,
CP,ug base equiv/g,12,0.999,
BSI,%,12,0.999,
VAGINALACTIVITY,,12,0.999,
URINEVOLUME,,12,0.999,
KAPPX10E-7,L.umol-1,12,0.999,
RELATIVEGROWTH,%,12,0.999,
METABOLICRATE,pM min-1 (mg of protein)-1,12,0.999,
RELATIVEINTENSITY,,12,0.999,
ED,mg,12,0.999,
DELTAS,J/mol/K,12,0.999,
A50,ug.mg-1,12,0.999,
POSITIVE,%,12,0.999,
CLRENAL,,12,0.999,
KI,M-1 min-1,12,0.999,
OD,h-1,12,0.999,
CMAX,mg,12,0.999,
OPTIMALDOSE,%,12,0.999,
PLATELETAGGREGATION,,12,0.999,
CLP,L.h-1.m-2,12,0.999,
KA,10'4/Ms,12,0.999,
CMAX,ngequiv/g,12,0.999,
PLASMALIPIDLEVEL,mg dl-1,12,0.999,
CMAX,pmol/g,12,0.999,
PLASMACORTICOSTERONE,umol.L-1,12,0.999,
CMAX(APP),umol.L-1,12,0.999,
PKAPY,,12,0.999,
2TT,umol.L-1,12,0.999,
CLP,,12,0.999,
OSAV,%,12,0.999,
RATIOCC50IC50,10'5No_unit,12,0.999,
POTENCYVSEKC,,12,0.999,
LAMBDAZ,h-1,12,0.999,
VM,umol.L-1.min-1.mg-1,12,0.999,
LAD,,12,0.999,
MTD,(mg of CPT) kg-1,12,0.999,
RATIOIC50EC50,umol.L-1,12,0.999,
L-T3,%,12,0.999,
EC,uM 15min-1 mg-1,12,0.999,
OBSERVEDAT,umol.L-1,12,0.999,
QT,ms,12,0.999,
KL,,12,0.999,
QH,L/hr/kg,12,0.999,
10E2K1,s-1,12,0.999,
DIURETICACTIVITY,m equiv [Na+] 5hr-1kg-1,12,0.999,
O2PRODUCTION,%,12,0.999,
VOLUME,ml,12,0.999,
KEL,L/hr,12,0.999,
CHANGE,s,12,0.999,
CMAXDOSE,kg.ng/ml/mg,12,0.999,
VMAXKM,10^-9 L min-1,12,0.999,
DOSE(URINARYRECOVERY),%,12,0.999,
CONCENTRATION,nM min-1 (mg of protein)-1,12,0.999,
K-1DECREASE,%,12,0.999,
CONCENTRATION,% dose g-1,12,0.999,
K0,s-1,12,0.999,
DOPAMINELEVEL,ng mg-1,12,0.999,
COMPLETESPONTANEOUSREVERSAL,,12,0.999,
CLH,h-1,12,0.999,
PROGRESSEDTUMORS,%,12,0.999,
DNASINGLESTRANDBREAKS,rad equiv,12,0.999,
ABSORPTION,umol.L-1,12,0.999,
VMAXKM,pl/min,12,0.999,
NRD,mg.kg-1.d-1,12,0.999,
CLH,microM/min/mg,12,0.999,
OSMOLALITY,mOsmol kg-1,12,0.999,
VMAXKM,uL/mg/min,12,0.999,
DEGRANULATINGACTIVITY,,12,0.999,
DNAPHOTO-CROSSLINKING,,12,0.999,
K+EXCRETION,m equiv 5hr-1 kg-1,12,0.999,
NOOFMICEPROTECTEDTESTED,,12,0.999,
KA,10^-6M,12,0.999,
VMAX(APP),%,12,0.999,
CMAXNORMALISED,(ug/ml)/(mg/kg),12,0.999,
VMAXKM,uL/min.mg,12,0.999,
POTENCYMEAN,ng g-1,12,0.999,
DIZ,cm2,12,0.999,
KA,L/hr,12,0.999,
KAPP,10'-7/M,12,0.999,
WEIGHTGAINORLOSS,%,12,0.999,
ACIDOUTPUT,u equiv of [H+] 2hr-1,12,0.999,
PROTECTIVEACTIVITY,%,12,0.999,
NOOFPITS,,12,0.999,
PSI,,12,0.999,
ACETALDEHYDE,nM (mg of protein)-1,12,0.999,
PROTONATED,%,12,0.999,
UNTREATEDCONTROL,%,11,0.999,
FU,ng/g,11,0.999,
AUC,mmHg.hr,11,0.999,
ED30,nmol/Kg,11,0.999,
INFLAMMATIONUNITS,,11,0.999,
STABILITY,uL/mg/min,11,0.999,
LOG1KD,,11,0.999,
RK,,11,0.999,
MIC,pug.ml-1,11,0.999,
MAXIMUMTMAX,h,11,0.999,
BLOODACH,umol.L-1,11,0.999,
ILEALACTIVITY,,11,0.999,
MEANVOLUMEOFHINDPAWS,,11,0.999,
ED20,umol.L-1,11,0.999,
IPA,,11,0.999,
RELATIVECONCENTRATION,,11,0.999,
LD90,g/ha,11,0.999,
ROTOROD,,11,0.999,
MAXSUPPRESSION,%,11,0.999,
ACTIVITY,mm3/day,11,0.999,
FR10TREATED,,11,0.999,
TUMORCURE,,11,0.999,
ACTIVITY,millimeter/sec,11,0.999,
ACTIVITY,KA,11,0.999,
AUC,ng.hr/ml/mg,11,0.999,
FREE,,11,0.999,
NOOFIMPLANTSPREGNANCY,,11,0.999,
BGL,%,11,0.999,
VBETA,l,11,0.999,
DEGRADATIONRATIO,,11,0.999,
VMAX,pmol/uM/min,11,0.999,
PROLONGEDARP,%,11,0.999,
MED90,MKP,11,0.999,
PAPP,10'-2 cm/s,11,0.999,
HAR,,11,0.999,
T-CELLBINDING,%,11,0.999,
NOEL,ug.mg-1,11,0.999,
PHOSPHOR,%,11,0.999,
KPCB,L.umol-1,11,0.999,
NOOFDEADANIMALS,,11,0.999,
AMOUNTINURINE,%,11,0.999,
ALKYLATINGACTIVITY,,11,0.999,
K,M/s,11,0.999,
NOOFVOMITINGEPISODES,,11,0.999,
K+2,s-1,11,0.999,
NOOFMICEALIVE,,11,0.999,
NOOFRATSWITH5-HTSYNDROME,,11,0.999,
DP,,11,0.999,
DPDT,,11,0.999,
K''IAM,,11,0.999,
CLC95,umol.L-1,11,0.999,
K',abs/time,11,0.999,
PROTEININTERACTIONENERGY,kCal M-1,11,0.999,
ACTIVITY,uM/micrometer/s,11,0.999,
PSYCHOTROPICEFFECT,,11,0.999,
KD,um2/s,11,0.999,
TC90,umol.L-1,11,0.999,
K,microM/min,11,0.999,
AUC,ngequiv.hr/g,11,0.999,
EXCLUSIONPARAMETER,,11,0.999,
ACTIVITY,KgAi/ha,11,0.999,
FLUOROSCENCE,%,11,0.999,
AUC,uM h/mpk,11,0.999,
BINDINGAFFINITY,spec bound mg-1,11,0.999,
SC200,umol.L-1,11,0.999,
SBPCHANGE,%,11,0.999,
ED80,mg,11,0.999,
ACTIVITY,IU/g,11,0.999,
CA2+,%,11,0.999,
BINDINGSITEFRACTION,,11,0.999,
INHIBITIONACTIVITY,,11,0.999,
RESPONSE,s-1,11,0.999,
ST,,11,0.999,
SERUMLEVEL,ug dl-1,11,0.999,
MEANTUMORVOLUME,,11,0.999,
MEANRATECONSTANT,,11,0.999,
ULCERINDEX,,11,0.999,
VASCULARRELAXATION,%,11,0.999,
ED20,gAi,11,0.999,
RELATIVEAGONISTICACTIVITY,,11,0.999,
AUC,microM/L.hr,11,0.999,
LOG,%,11,0.999,
SELECTIVEINDEX,,11,0.999,
RELATIVEAGONISTACTIVITY,,11,0.999,
FLUORESCENCEINTENSITY,%,11,0.999,
ENHANCEMENT,umol.L-1,11,0.999,
AVERAGEWEIGHTGAIN,mg,11,0.999,
TUBULINPOLYMERIZATION,,11,0.999,
MI50,,11,0.999,
AUCT,ug/g.min,11,0.999,
BRAINCONCENTRATION,umol.L-1,11,0.999,
%T>MIC,%,11,0.999,
FR10CONTROL,,11,0.999,
FAUCDOSE,ug.h-1.mL-1,11,0.999,
RELEASE,,11,0.999,
TRANSLATION,,11,0.999,
RELATIVERATEMETABOLISM,,11,0.999,
KCAT,umol.min-1,11,0.999,
AUCED90,ug.hr/ml/day,11,0.999,
AUCLASTDOSE,nM.hr,11,0.999,
RELATIVEINHIBITORYACTIVITY,,11,0.999,
BMAX,cpm,11,0.999,
AUCDOSE,ng/mL.hr,11,0.999,
AUCDOSE,ng.hr/ml/mg,11,0.999,
BRAINPLASMA,,11,0.999,
ED60,ug.mg-1,11,0.999,
LESIONFREQUENCY,%,11,0.999,
ED50,ug min-1 kg-1,11,0.999,
MED99,MKP,11,0.999,
BODYWEIGHTGAIN,mg,11,0.999,
ULCERATION,%,11,0.999,
KCAT,10^6/s,11,0.999,
MICEWITHLESIONS,,11,0.999,
AUC,uM hr l-1,11,0.999,
AUMC,ug/ml.hr^2,11,0.999,
EXTENT,,11,0.999,
KCATKM,/min/M,11,0.999,
RESORBINGIMPLANTS,%,11,0.999,
DRUGPERIOD,s,11,0.999,
T129,s,11,0.999,
PHOSPHOROLYSIS,%,11,0.999,
ARTHRITISSCORES,,11,0.999,
LOG1DELTACA,,11,0.999,
CELLSARRESTED,%,11,0.999,
VFT,mA,11,0.999,
COUNT,,11,0.999,
ACTIVITY,10'-6mg/kg,11,0.999,
APOPTOTICINDEX,,11,0.999,
RATIOKI,10^-4No_unit,11,0.999,
TOLERANCE,,11,0.999,
ICL50,umol.L-1,11,0.999,
CELLS,,11,0.999,
K,1/M.sec,11,0.999,
EC50,ng/g,11,0.999,
CGI,,11,0.999,
%OFEFFECT,%,11,0.999,
E2,%,11,0.999,
K,10'-5/M/s,11,0.999,
EC50,ug.cm'-2,11,0.999,
CELLPROLIFERATIONEC70,umol.L-1,11,0.999,
VMAX,10^4M,11,0.999,
CHANGEOFPREDOSE,%,11,0.999,
VMAX,AU/min,11,0.999,
GENERALACTIVITY,,11,0.999,
ACTIVITY,10'-3M,11,0.999,
ACTIVITY,pM of citrulline min-1 (mg of protein)-1,11,0.999,
GR50,umol.L-1,11,0.999,
MNTD,mg,11,0.999,
LOG1CMC,,11,0.999,
MAXDELTABP,mmHg,11,0.999,
LOG1ISA,,11,0.999,
CAMP,pM well-1,11,0.999,
CA2+,umol.L-1.ml-1,11,0.999,
ACTIVITY,uA.cm'-2,11,0.999,
CA2+BINDINGPROTEIN,ug (100mg of duodenum)-1,11,0.999,
MINIMUMTMAX,h,11,0.999,
ATTTACKS,%,11,0.999,
K,10^-4/M,11,0.999,
RATIO,M/s,11,0.999,
DECREASEINHEARTRATE,beats min-1,11,0.999,
KS,,11,0.999,
CT10RATIO,air/N2,11,0.999,
CHANGEINNOOFTROPHOZOITESX10E-5,,11,0.999,
ID50,nM (mg SR protein)-1,11,0.999,
PE,10e-6 cm s-1,11,0.999,
PAPP,10-6 cm/s,11,0.999,
CONTROLPERIOD,,11,0.999,
GLUCOSE,%,11,0.999,
VMAX,deltaA/min,11,0.999,
ND,ug.mg-1,11,0.999,
CA2+FLUX,,11,0.999,
PFE3,,11,0.999,
MAXCFRESPONSE,,11,0.999,
RATING,beats min-1,11,0.999,
CD90,,11,0.999,
KQ,10^13L/mol/s,11,0.999,
PAPP,10'-6cm/min,11,0.999,
COUNTS,s-1,11,0.999,
SUBSTRATESPECIFICITY,,11,0.999,
CAMPPRODUCTION,pM min-1 mg-1,11,0.999,
CA2+ELEVATION,umol.L-1,11,0.999,
KM,10^4M,11,0.999,
AD50,nM mouse-1,11,0.999,
TG,,11,0.999,
DELTAMMHG,,11,0.999,
PLASMAHALFLIFE,s,11,0.999,
KEQ,,11,0.999,
PLASMALEVEL,pg ml-1,11,0.999,
IC40,umol.L-1,11,0.999,
7-DAYWEIGHTCHANGE,%,11,0.999,
KHO,/mol.L-1.s-1,11,0.999,
TI,hr-1,11,0.999,
2XTT,umol.L-1,11,0.999,
LOGP',,11,0.999,
TI50,umol.L-1,11,0.999,
PLATELETCOUNT,ul,11,0.999,
ONSETTIME,s,11,0.999,
K1,10e-3 min-1,11,0.999,
HGBLEVELS,g dl-1,11,0.999,
LOW,%,11,0.999,
VASODILATORYRATE,%,11,0.999,
ACTIVEDOSERANGE,mg uM  kg-1 day-1,11,0.999,
CT10,,11,0.999,
KML,umol.L-1,11,0.999,
KN,L.umol-1,11,0.999,
K,10^6/Ms,11,0.999,
DRUGMETABOLISM,[ppm],11,0.999,
CL,microM/min/mg,11,0.999,
K,10^-5/M,11,0.999,
IC50,ug/mol,11,0.999,
KEL,,11,0.999,
DELTACA,umol.L-1,11,0.999,
OTHERS,,11,0.999,
ABSAC047UM,umol.L-1,11,0.999,
[EA],umol.L-1,11,0.999,
KB,L/mol,11,0.999,
CLP,ml min-1,11,0.999,
VSS,,11,0.999,
KI',,11,0.999,
VPF,l,11,0.999,
DIURESIS,ml kg-1,11,0.999,
KIA,umol.L-1,11,0.999,
ABERRANTCELLS,%,11,0.999,
DISTRIBUTIONRATIO,,11,0.999,
CLH,umol.min-1,11,0.999,
CHANGEOFSIZE,%,11,0.999,
AGONISTEFFECT,%,11,0.999,
[A],umol.L-1,11,0.999,
LOGGEOMETRICMEAN,pfu mg-1,11,0.999,
VMAXKM,mM-1 min-1,11,0.999,
"PKA,2",,11,0.999,
"PKA,1",,11,0.999,
LOGPION,,11,0.999,
TD100,umol.L-1,11,0.999,
CLUF,L/hr/kg,11,0.999,
%HEPATICBLOODFLOW,%,11,0.999,
HIND-PAWLICKLATENCYTIME,s,11,0.999,
AHV,%,11,0.999,
CLH,ml/(min.mg),11,0.999,
KE,h-1,11,0.999,
LC50,ug/cm2,10,0.999,
%OFGROWTHRATE,%,10,0.999,
UTEROTROPICACTIVITY,,10,0.999,
CAMPINCREASE,%,10,0.999,
IRONMOBILIZATION,%,10,0.999,
MICEINFI,,10,0.999,
CA,%,10,0.999,
KB,/M,10,0.999,
CTP,mg/L.hr,10,0.999,
ID50,quanta,10,0.999,
MAXFALLINIOP,mmHg,10,0.999,
SUBSTRATE,umol.L-1,10,0.999,
PARASITESUPPRESSION,%,10,0.999,
RELATIVEABILITY,,10,0.999,
GASTRICLESIONSCORE,umol.L-1,10,0.999,
RELATIVEACTIVITY,c.p.m.,10,0.999,
V0,umol.min-1,10,0.999,
D50,quanta*10e-18,10,0.999,
CARBOXYLASEACTIVITY,dpm,10,0.999,
MAXDELTAHR,%,10,0.999,
LC80,,10,0.999,
VMAX,IU mg-1,10,0.999,
MINLETHALDOSE,ug.mg-1,10,0.999,
ACTIVITY,pM of cGMP (min)-1 (mg of protein)-1,10,0.999,
MICE,%,10,0.999,
PARASITEMIACLEARANCEAFTERTREATMENT,%,10,0.999,
Z,%,10,0.999,
MNCC,,10,0.999,
GELLARCOOKACTIVITY,,10,0.999,
PERMEABILITY,10'-6cm/min,10,0.999,
PARASITEMIACLEARANCEAFTERIMMUNOSUPPRESSION,%,10,0.999,
ACTIVITY,10'6No_unit,10,0.999,
C20,,10,0.999,
ACTIVITY,nM.min,10,0.999,
CATALEPSYSCORE,,10,0.999,
SUPPRESSIONOFPARASITEMIA,%,10,0.999,
RECOVERY,s,10,0.999,
-LOGALPHA,,10,0.999,
CELLULARUPTAKE,pCi cell-1,10,0.999,
MAXIMALDECREASEINIOP,,10,0.999,
LAMBDA-Z,L.h-1,10,0.999,
KCAT,10'-2/s,10,0.999,
VMAX,10'5mmol/min/mg,10,0.999,
TMSW,%,10,0.999,
STABILITY,[ppm],10,0.999,
K,10'4No_unit,10,0.999,
MIC,ug m1 l-1,10,0.999,
CHANGEINBODYWEIGHT,mg,10,0.999,
CELLTOXICITY,umol.L-1,10,0.999,
PERMEABILITY,ml/min,10,0.999,
CC50,10^1 uM,10,0.999,
KCATKM,uM-1 s-1,10,0.999,
RELATIVECYTOTOXICITY,,10,0.999,
ACTIVITY,nM min-1 ml-1,10,0.999,
RD1000,ug.mg-1,10,0.999,
FT50,s,10,0.999,
KP,cm hr-1,10,0.999,
INTENSITY,%,10,0.999,
CT10,umol.L-1,10,0.999,
CAACTIVITY,%,10,0.999,
CELLULARUPTAKE,uCi ml-1,10,0.999,
D,10^-7cm2/sec,10,0.999,
SUBSTRATEMETABOLIZEDAT1HR,%,10,0.999,
JSS,nM hr-1 cm**-2,10,0.999,
EC50,M 50ul-1,10,0.999,
FUNCTION,,10,0.999,
LOG1E50,,10,0.999,
C10N2,umol.L-1,10,0.999,
AQUEOUSSOLUBILITY,,10,0.999,
K,10'3/mol,10,0.999,
STABILITY,mmol/min,10,0.999,
ED5,mg,10,0.999,
GMSACTIVITY,,10,0.999,
RELATIVEIONOTROPICACTIVITY,,10,0.999,
RATIOEC50,umol.L-1,10,0.999,
PERMEABILITY,d,10,0.999,
BRAINCONCENTRATION,nM kg-1,10,0.999,
KP,10^-3cm/min,10,0.999,
K,10'8/M/s,10,0.999,
DECREASEINMEANARTERIALPRESSURE,%,10,0.999,
CONCENTRATIONPLASMA,nM ml-1,10,0.999,
MAXTOLERATEDDOSE,mg.kg-1.d-1,10,0.999,
MAXVASOCONSTRICTION,,10,0.999,
MACREDUCTION,%,10,0.999,
K,10^-1/min,10,0.999,
KA-,/mol.L-1.s-1,10,0.999,
ACTIVITY,Counts 30min-1,10,0.999,
GTPASEACTIVITY,,10,0.999,
SURVIVORSTOTAL,%,10,0.999,
KACT,/mol.L-1.s-1,10,0.999,
DRUGUPTAKE,pmol/mg/min,10,0.999,
MA,,10,0.999,
BODYWEIGHTINFI,mg,10,0.999,
ED50,mg/m2,10,0.999,
MICE,,10,0.999,
RELPOTENCY,,10,0.999,
MBC99,umol.L-1,10,0.999,
VMAX,U/ms,10,0.999,
GROWTHRATE,%,10,0.999,
CKI,umol.L-1,10,0.999,
M-AGONISTINDEX,,10,0.999,
MYRISTOYLCOA,%,10,0.999,
RATING,s,10,0.999,
AUC,uM min l-1,10,0.999,
PH12,,10,0.999,
INITIALMEANARTERIALPRESSURE,mmHg,10,0.999,
FOLDSHIFT,,10,0.999,
LD50,umol,10,0.999,
ACTIVITY,KA Units,10,0.999,
ED50,U.ml-1,10,0.999,
UPTAKESELECTIVITY,,10,0.999,
TISSUEPLASMARATIO,,10,0.999,
DRUGUPTAKE,a.u.,10,0.999,
M2M1INDEX,,10,0.999,
PERMEABILITY,ng/uL,10,0.999,
DRUGUPTAKE,nmol/hr,10,0.999,
DELTAHEARTRATE,,10,0.999,
MBC995,,10,0.999,
ACTIVETOTAL,,10,0.999,
PHOSPHORYLATINGACTIVITY,pM min-1 assay-1,10,0.999,
DRUGRECOVERY,umol.L-1,10,0.999,
RELATIVESEMINALVESICLEWEIGHT,,10,0.999,
RATEMAX,,10,0.999,
BMAX,disintegrations/minute,10,0.999,
FOLDACTIVATION,umol.L-1,10,0.999,
SPECIFICBINDING,fM mg-1,10,0.999,
HARELEASE,,10,0.999,
ACTIVITY,millipolarization,10,0.999,
CI,mg/kg uM h,10,0.999,
RADIOACTIVITYLEVEL,%,10,0.999,
KD,10^6/M,10,0.999,
INHIBITORYPOTENTIAL,,10,0.999,
MFC>99,umol.L-1,10,0.999,
MFC995,,10,0.999,
LOG2(RATIO),,10,0.999,
RESIDUALACTIVITY,c.p.m.,10,0.999,
ACTIVITY,pmol/uL,10,0.999,
NOAEL,,10,0.999,
WRITHES,,10,0.999,
T>MIC90,s,10,0.999,
ED50,ug day-1 kg-1,10,0.999,
DRUGMETABOLISM,ml/min/g,10,0.999,
BK,,10,0.999,
INHIBITIONTYPE,,10,0.999,
ACTIVITY,Min-1,10,0.999,
KMX10E3,hr-1,10,0.999,
K,10^7/M/s,10,0.999,
HEARTWEIGHT,mg 10g-1,10,0.999,
METD,%,10,0.999,
ANALGESICEFFICACYCOMPAREDTOMORPHINE,%,10,0.999,
RELATIVEINFLUX,,10,0.999,
ANALGESICEFFICACYCOMPAREDTOEPIBATIDINE,%,10,0.999,
KM,10'5mM,10,0.999,
VMAX,pmol.min.mg-1,10,0.999,
AMOUNTOFMETABOLITE,nM ml-1,10,0.999,
R%,,10,0.999,
FREL,,10,0.999,
ED99,mg.kg-1.d-1,10,0.999,
MAXPOTENTIATION,%,10,0.999,
BBC50,umol.L-1,10,0.999,
B,%,10,0.999,
CP,ngequiv/ml,10,0.999,
KCAT,10^-4/s,10,0.999,
AUCDOSE,nM.hr/mg,10,0.999,
LOGTCID50MG,,10,0.999,
CLBLOOD,mL/min/kg,10,0.999,
KA,10^8/M,10,0.999,
K'K'+1,,10,0.999,
INDUCTIONNUMBER,,10,0.999,
K'O,/mol.L-1.s-1,10,0.999,
ACCUMULATION,umol.L-1,10,0.999,
DOSEPERORGAN,%,10,0.999,
CONCENTRATION,pmol/10E6 cells,10,0.999,
CLF,,10,0.999,
CPMX1000,,10,0.999,
BATWEIGHT,mg,10,0.999,
DNAUNWINDINGCONCENTRATION,umol.L-1,10,0.999,
KI,10'1/M,10,0.999,
ALPHA-LIPOPROTEINCHOLESTEROL,mg dl-1,10,0.999,
EMESISCMAX,umol.L-1,10,0.999,
HVINTERVAL,ms,10,0.999,
A50,mg,10,0.999,
VSS,L.m-2,10,0.999,
A50,,10,0.999,
INFLECTIONPOINT,,10,0.999,
CLP,ml.min-1,10,0.999,
CLRATIO,%,10,0.999,
LOG,k,10,0.999,
MEANEFFECT,mg,10,0.999,
KDISS,10^3/M/s,10,0.999,
KI,10^3nM,10,0.999,
P50DP50C,mmHg,10,0.999,
CMPH,,10,0.999,
INFECTEDERYTHROCYTES,%,10,0.999,
FAFG,%,10,0.999,
AVERAGE,umol.L-1,10,0.999,
CONCENTRATION,nM ml-1,10,0.999,
VMAX,umol.mg-1,10,0.999,
LOGP16,,10,0.999,
TRANSACTIVATION,fold,10,0.999,
NOOFTUMORSMOUSE,,10,0.999,
INH,mole fraction,10,0.999,
CONCENTRATION,nM min ml-1,10,0.999,
VMAXKM,10'6/min,10,0.999,
PPB,umol.L-1,10,0.999,
SERUMTOTALCHOLESTEROL,mg dl-1,10,0.999,
ACTIVITY,fM ml-1,10,0.999,
TIMECONSTANTT4,,10,0.999,
CTT2,umol.L-1,10,0.999,
ACTIVITY,mg/dl/g,10,0.999,
DELTACORONARYFLOW,,10,0.999,
TRANSACETYLATIONRATE,nM/mg*min,10,0.999,
TUMORWEIGHT,,10,0.999,
SIGMAP,,10,0.999,
NOOFUNTREATEDCELLS,%,10,0.999,
MST,%,10,0.999,
ACTIVITY,ug mouse-1,10,0.999,
DOSEGTISSUE,%,10,0.999,
TP,,10,0.999,
CLF,L/min,10,0.999,
AMOUNT,pM (10e6*cells)-1,10,0.999,
TC50,10'4nM,10,0.999,
INHIBITIONEFFECT,,10,0.999,
BINDINGACTIVITY,umol.L-1,10,0.999,
ACT,umol.L-1,10,0.999,
AMOUNT,%,10,0.999,
PB,pmolequiv/mg,10,0.999,
DRUGABSORPTION,umol.L-1,10,0.999,
IC50,mmol/Kg,10,0.999,
PTZ,,10,0.999,
LOGCMC,,10,0.999,
PCRCURERATE,%,10,0.999,
ACIDOUTPUT,u equiv hr-1,10,0.999,
CONCENTRATION,uCi ml-1,10,0.999,
RESPONSEUNIT,umol.L-1,10,0.999,
CYTOPLASMICVACUOLIZATION,,10,0.999,
INDUCTION,%,10,0.999,
TCID50,,10,0.999,
PC30,,10,0.999,
OCC50,ng/g,10,0.999,
CLOGP-LOGP,,10,0.999,
K2C,s-1,10,0.999,
K3K1,/mol.L-1.s-1,10,0.999,
RMAX,umol.L-1,10,0.999,
TUMORHALFGROWTH,,10,0.999,
TUMORGROWTHDELAY,d,10,0.999,
ACTIVITY,mU m l-1,10,0.999,
POSTDRUGBLOODPRESSURE,mmHg,10,0.999,
INH,10'-5 mol/L,10,0.999,
AUCLASTDOSE,ng.hr/ml/mg/kg,10,0.999,
AAD,,10,0.999,
CLONAZEPAM,%,10,0.999,
ACTIVITY,um2/s,10,0.999,
K21,hr-1,10,0.999,
EMAX,fmol/mg,10,0.999,
K12,hr-1,10,0.999,
INH,10'-4 mol/L,10,0.999,
KA,10^4/Ms,10,0.999,
K13+K23,hr-1,10,0.999,
CYTOTOXICITYINDEX,,10,0.999,
DELTAMABP,%,10,0.999,
MAXPROTECTION,%,10,0.999,
MAXREDUCTIONINMEANARTERIALPRESSURE,mmHg,10,0.999,
INTRINSICACTVITY,,10,0.999,
STABILITY,nM/min,10,0.999,
ED37,umol.L-1,10,0.999,
ACTIVITY,AU.min,10,0.999,
K,10'-9M,10,0.999,
NTD,ug.mg-1,10,0.999,
KAH,/mol.L-1.s-1,10,0.999,
ARTERIALPRESSURE,% mmHg min,10,0.999,
CL,ml/min/m2,10,0.999,
R50,umol.L-1,10,0.999,
CLH,ug/(min.mg),10,0.999,
EMAX,log10[CFU].ml-1,10,0.999,
DISTRIBUTIONPERCENT,,10,0.999,
MED,umol.mg-1,10,0.999,
O2CONSUMPTION,%,10,0.999,
I50,mg,10,0.999,
DELTALV,,10,0.999,
TTO,s,10,0.999,
KCAT,min-1,10,0.999,
MEANGRAFTSURVIVAL,d,10,0.999,
LIVERWEIGHT,g 100g-1,10,0.999,
RSRATIO,,10,0.999,
INDUCEDCONVULSION,number convulsed,10,0.999,
LOGKGSH(S-1),,10,0.999,
MEANINCREASEDLIFESPAN,%,10,0.999,
KASS,,10,0.999,
LIVERWEIGHT,mg 10g-1,10,0.999,
MEANINHIBITION,%,10,0.999,
%BOUND,none,10,0.999,
TRIGLYCERIDELEVEL,mg dl-1,10,0.999,
LNK,,10,0.999,
RIC50,umol.L-1,10,0.999,
OXYGENUPTAKE,nM min-1,10,0.999,
DELTARBF,%,10,0.999,
SEC50,umol.L-1,10,0.999,
FC,10'5No_unit,10,0.999,
SERUMCHOLESTEROL,mg %,10,0.999,
DNAALKYLATION,%,10,0.999,
DNAALKYLATION,,10,0.999,
HORIZONTALSCREEN,number passed,10,0.999,
AUCLASTDOSE,hr.ng/ml,10,0.999,
RICESTEMLENGTH,cm,10,0.999,
VRT,hr2,10,0.999,
EFFLUXKI,s-1,10,0.999,
LOGSENSITIVITY,,10,0.999,
AVERAGELATENCY,%,10,0.999,
KK,/mol.L-1.s-1,10,0.999,
K2',M-1 min-1,10,0.999,
LEVEL,ug of tissue,10,0.999,
PC25,uM kg-1,10,0.999,
POSTANTIBIOTICEFFE,s,10,0.999,
HMGRACTIVITY,,10,0.999,
BINDINGCOMPETITION,%,9,0.999,
AUC,nM.hr/L,9,0.999,
BINDINGACTIVITY,%,9,0.999,
DRUGUPTAKE,micromol/min,9,0.999,
DRUGUPTAKE,mg-1.g-1,9,0.999,
CLH,ml.kg-1,9,0.999,
KA,10'10/M,9,0.999,
DRUGUPTAKE,pg,9,0.999,
ACTIVITY,A570 min-1,9,0.999,
APPROXPKA,,9,0.999,
DRUGUPTAKE(FREE),nmol/L,9,0.999,
IONOTROPICACTIVITY,,9,0.999,
DSB,,9,0.999,
AUC,micromol.hr/L/mg/kg,9,0.999,
ACTIVITY,Amax nM-1,9,0.999,
CLZF,ml/min.kg,9,0.999,
CLFREE,10^3uL/min,9,0.999,
AC30,umol.L-1,9,0.999,
DURATIONTIME,,9,0.999,
DRUGRECOVERY,mg,9,0.999,
APD70,ms,9,0.999,
K,/ms,9,0.999,
K,/nM/s,9,0.999,
C10AIR,umol.L-1,9,0.999,
BODYTEMPERATURE,%,9,0.999,
AP,mV,9,0.999,
CL,ul.min.nmol-1,9,0.999,
INHIBITION(ATCONCENTRATIONM),%,9,0.999,
ECAUC02,,9,0.999,
DISTRIBUTION,l kg-1,9,0.999,
K,10'3L/mol,9,0.999,
DIRECTLYMEASUREDTHICKNESS,umol.L-1,9,0.999,
ACTIVITY,10^-6No_unit,9,0.999,
INHIBITION,c.p.m./Abs,9,0.999,
E,-V,9,0.999,
AUC,uM L,9,0.999,
K,10'-1/s,9,0.999,
BINDINGDECREASE,%,9,0.999,
K,1/M,9,0.999,
CLONICSEIZURES,,9,0.999,
E,%,9,0.999,
ED50,fmol,9,0.999,
ACIDSECRETION,,9,0.999,
ED40,10^-5 mol/L,9,0.999,
2XAPPT,umol.L-1,9,0.999,
DECAY-TIMECONSTANT,ms,9,0.999,
AFC50,[ppm],9,0.999,
INCREASEINCONCENTRATION,,9,0.999,
INHIBITION,(nM of H202) min-1 (ug of protein)-1,9,0.999,
CMAXDOSE,ng/mL/(mg/kg),9,0.999,
ACTIVITY,gAi/ha,9,0.999,
AUC(APP),umol.h.L-1,9,0.999,
INH,min-1,9,0.999,
ABC,mmHg hr-1,9,0.999,
INH,IU/mg,9,0.999,
ED50,10'-8mol/cm2,9,0.999,
ED50,10'-9 ug/ml,9,0.999,
DERIVEDTRABECULARTHICKNESS,umol.L-1,9,0.999,
ANTICONFLICTACTIVITY,,9,0.999,
INH,10'5L/mol/s,9,0.999,
ANTIAMNESICACTIVITY,,9,0.999,
CLAST,ng/g,9,0.999,
DECREASEINPRESSURE,mmHg,9,0.999,
K2,1/M*s,9,0.999,
CHANGETC,,9,0.999,
ERH,s,9,0.999,
INCREASEINCBF,,9,0.999,
K,10'8/M/min,9,0.999,
CMAXNORMALISED,nM.kg/mg,9,0.999,
AUCDOSE,ng.hr/g/mg/kg,9,0.999,
IMPLANTS,,9,0.999,
EICOSANOIDPRODUCTION,pM 2hr-1,9,0.999,
IMMOBILITYTIME,%,9,0.999,
KA,10'3/M.s,9,0.999,
AHA,delta mmHg,9,0.999,
DELTAG,cal/mol,9,0.999,
K2,10e3 s-1,9,0.999,
CHRONICTI,,9,0.999,
ENDOSTEALERODEDSURFACE,%,9,0.999,
IE100,,9,0.999,
ENDOSTEALMINERALIZINGSURFACE,%,9,0.999,
CHELATOR,%,9,0.999,
DELTA,,9,0.999,
DNADAMAGE,10e7 exchanged dCps (ng of DNA),9,0.999,
ACTIVITY,mg.equiv,9,0.999,
DOM,,9,0.999,
CELLSSICKLED,%,9,0.999,
CYTOTOXICCONCENTRATION,,9,0.999,
CC10,,9,0.999,
CC50,%,9,0.999,
ACTIVITY,pmol/mg.min,9,0.999,
CONNECTIVITYDENSITY,mm**-3,9,0.999,
GRAFTSURVIVAL,d,9,0.999,
CONTENTOFCELLCYCLE,%,9,0.999,
CONTRACTILITY,,9,0.999,
CONTRACTILITY,mmHg s-1,9,0.999,
HR,delta beats min-1,9,0.999,
ACTIVITY,nM min-1 (10e-6*cells)-1,9,0.999,
CREATININECL,ml min-1 kg-1,9,0.999,
CPDOSE,umol.L-1,9,0.999,
HEMOLYSIS,,9,0.999,
HHP,mg,9,0.999,
ACTIVITY,ng/dl,9,0.999,
K,L/mol/s,9,0.999,
CONTROLDEATHDAY,,9,0.999,
GASTRICULCERINDEX,,9,0.999,
COF,c.p.m. (mg of protein)-1,9,0.999,
ACTIVEDOSERANGE,,9,0.999,
K,10^-6/M/s,9,0.999,
CYTOTOXICITY,M dm-3,9,0.999,
FLAKINGSCORE,,9,0.999,
DC,,9,0.999,
IC>80,umol.L-1,9,0.999,
DAUTILIZATION,,9,0.999,
DELTAT,,9,0.999,
AD50,nmol/kg,9,0.999,
FIRSTADVERSEEFFECT,,9,0.999,
ID30,umol.L-1,9,0.999,
ACTIVITY,10'-8mol/L,9,0.999,
FDOSE,%,9,0.999,
ID50,10'-6 mol/L,9,0.999,
FIC30,umol.L-1,9,0.999,
FIC20,umol.L-1,9,0.999,
ACUTETOXICITY,M dm-3,9,0.999,
ID25,ug.mg-1,9,0.999,
ACUTETI,,9,0.999,
HYPOTENSION,%,9,0.999,
CONTROLTUMORVOLUME,,9,0.999,
INHIBITORYRATE,%,9,0.999,
DPDTMAX,mmHg s-1,9,0.999,
CONCENTRATION,ug ml-1 ml-1,9,0.999,
IC50,10'-4nM,9,0.999,
ACTIVITY,uL/min,9,0.999,
CA2+SERUM,,9,0.999,
AE,% ID/g,9,0.999,
EMAX,mg,9,0.999,
DD,uM mM-1,9,0.999,
EC25,%,9,0.999,
EC30,M kg-1,9,0.999,
ACTIVITY,pM min-1 (mg of protein)-1,9,0.999,
ABRASIONSCORE,,9,0.999,
ACTIVITY,M kg-1,9,0.999,
EC50,M kg-1,9,0.999,
ACETYLCHOLINELEVEL,umol.L-1,9,0.999,
AT1AFFINITY,nM l-1,9,0.999,
CMAX,ng/kg,9,0.999,
AUG,ng ml-1 hr-1,9,0.999,
AREA,mm**2,9,0.999,
K,10^5/M.s,9,0.999,
ACTIVITY,mm.mg-1.ml-1,9,0.999,
GEOMETRICMEAN,umol.L-1,9,0.999,
IC50,10^-10mol/L,9,0.999,
K,10^7/M,9,0.999,
AUCT,hr/ng.ml,9,0.999,
GLUCURONIDATION,umol.min-1.mg-1,9,0.999,
CAC,,9,0.999,
FORMATION,,9,0.999,
IC50,umol,9,0.999,
FRE,,9,0.999,
IC50,uM tube-1,9,0.999,
IC50,s,9,0.999,
IC50,mol,9,0.999,
CUTANEOUSTOXICOLOGYSCORE,,9,0.999,
FT>MIC,,9,0.999,
ACTIVITY,microg/cm2,9,0.999,
ACTIVITY,microg/cm2/h,9,0.999,
KAPP,10^-3/hr,9,0.999,
ACTIVITY,umol.mg-1.hr-1,9,0.999,
K+OUTPUT,uM kg-1,9,0.999,
CMAX,ugequiv/g,9,0.999,
DEGREEOFACTIVATION,fold,9,0.999,
DELTAS,cal/mol,9,0.999,
VZF,ml,9,0.999,
LOGRATIO,,9,0.999,
TD50,micromol/kg,9,0.999,
TIMECONSTANTT4,ms,9,0.999,
LOGD55,,9,0.999,
TCCORR,%,9,0.999,
TC50,umol.ml-1,9,0.999,
TISSUEAREA,umol.L-1,9,0.999,
LOGGTI,,9,0.999,
SOCIALINTERACTION,,9,0.999,
TDI,min-1,9,0.999,
SIMULATION,%,9,0.999,
MINIMUMSINGLEDOSE,ug.mg-1,9,0.999,
VD,kg-1,9,0.999,
MINED,ug.mg-1,9,0.999,
VASODILATION,,9,0.999,
VASCULARACCUMULATIONRATIO,,9,0.999,
RELATIVEADRENALWEIGHT,mg 100g-1,9,0.999,
LD10,mg/m2,9,0.999,
TOXICTOTAL,,9,0.999,
TE50,,9,0.999,
STYSEIZURE,,9,0.999,
MAXBINDING,%,9,0.999,
SUBG0,%,9,0.999,
MAXI-KCURRENT,,9,0.999,
TOTALPERIPHERALRESISTANCE,mmHg ml-1 min-1,9,0.999,
SUMMATIONMABP,,9,0.999,
MAXDELTA,umol.L-1,9,0.999,
TOTALACTIVITY,,9,0.999,
MAXCHANGE,%,9,0.999,
MAXBLOODPRESSUREFALL,%,9,0.999,
TOCED50,,9,0.999,
TETRAMER,%,9,0.999,
MARROWAREA,umol.L-1,9,0.999,
SUV,g/ml,9,0.999,
T,,9,0.999,
T12LAMBDA,s,9,0.999,
TAI,,9,0.999,
THERAPEUTICINDEX,%,9,0.999,
THERAPEUTICEFFICACY,,9,0.999,
LOGMEC,,9,0.999,
URINEOUTPUT,ml kg-1,9,0.999,
MIC90,%v/v,9,0.999,
LD50,10'-1 ug/ml,9,0.999,
PA,,9,0.999,
THRESHOLDCONCENTRATION,umol.L-1,9,0.999,
KBB,,9,0.999,
PERIOSTEALMINERALIZINGSURFACE,%,9,0.999,
PEAKEFFECT,,9,0.999,
PDR,,9,0.999,
[ALP]MAX,UI l-1,9,0.999,
PA2,%,9,0.999,
PKA5,,9,0.999,
PDD50,,9,0.999,
MIC,10^3nM,9,0.999,
PERMEATED,%,9,0.999,
PERMEABILITYCOEFFICIENT,,9,0.999,
PAPP,10'-6cm/s,9,0.999,
XL50,umol.L-1,9,0.999,
PERMEABILITY,mole fraction,9,0.999,
KCATKM,10^-6 microM/s,9,0.999,
KCATKI,M-1 min-1,9,0.999,
K,10'6/uM/s,9,0.999,
PLASMA,umol.L-1,9,0.999,
RS,nM min-1 kg-1,9,0.999,
RESTINGPOTENTIAL,mV,9,0.999,
RF,delta beats min-1,9,0.999,
RELATIVETHYMUSWEIGHT,mg 100g-1,9,0.999,
LD50,ug fly-1,9,0.999,
RESPONDERS,,9,0.999,
TZ,s,9,0.999,
TW,,9,0.999,
MDD,mean day of death,9,0.999,
MDHREACTIVATION,%,9,0.999,
SENSITISATION,,9,0.999,
MEANCHANGE,umol.L-1,9,0.999,
SECONDARYRESPONSE,,9,0.999,
MEANSURVIVAL,time day-1,9,0.999,
SMAX,nM min-1 kg-1,9,0.999,
RS,ul min-1 kg-1,9,0.999,
TUMORFREESURVIVORS,,9,0.999,
MED,ug/kg,9,0.999,
MED100,ug.mg-1,9,0.999,
MEDIAN,d,9,0.999,
MAXIMALBINDING,,9,0.999,
UNWINDING,,9,0.999,
REDUCTIONOFHEARTRATE,%,9,0.999,
MUTATIONFREQUENCY,,9,0.999,
NA+RESTORATION,%,9,0.999,
NA+OUTPUT,uM kg-1,9,0.999,
NA+INACTIVATION,,9,0.999,
RATIO,/min/mM,9,0.999,
NA,umol.L-1,9,0.999,
RATIO,10'-4No_unit,9,0.999,
RATIO,L/min/umol,9,0.999,
NOOFANIMALS,%,9,0.999,
KSV,10'3L/mol,9,0.999,
MOTORACTIVITY,Counts,9,0.999,
MTS50,umol.L-1,9,0.999,
KT4,L.umol-1,9,0.999,
KX10E-5,L.umol-1,9,0.999,
MTC50,ug.mg-1,9,0.999,
LATENCYTIME,%,9,0.999,
MST,s,9,0.999,
MPR,%,9,0.999,
MPCMIC,,9,0.999,
NADHOXIDATION,nM min-1,9,0.999,
KQ,10^4/M,9,0.999,
KQ,10^12/M,9,0.999,
RATEOFDEATH,%,9,0.999,
ED50,ug/Kg/min,9,0.999,
VDSSDOSE,L/Kg,9,0.999,
INFECTIONSCORE,,9,0.999,
A50,mM kg-1,9,0.999,
ED6,,9,0.999,
AVERAGEWEEKLYWEIGHTCHANGE,%,9,0.999,
ANIMALSDEAD,,9,0.999,
ED80,umol.mg-1,9,0.999,
AMYLASESTIMULATION,max,9,0.999,
CL,mL/min,9,0.999,
AMPLITUDE,mV,9,0.999,
ED97,ug.mg-1,9,0.999,
CORPORALUTEA,,9,0.999,
[LDH]MAX,UI l-1,9,0.999,
PD50,mM kg-1,9,0.999,
RATE,nM min-1 (nM of cytochrome P450)-1,9,0.999,
NONRGS-EC50(UM),umol.L-1,9,0.999,
RD500,ug rat-1,9,0.999,
RATEOFROTATION,,9,0.999,
REACTION,%,9,0.999,
KINASEACTIVITY,pM min-1*ml-1,9,0.999,
VMAX(APP),umol.L-1.min-1,9,0.999,
NOPARTIAL,,9,0.999,
NOOFFERRETS,,9,0.999,
VMAX,uM hr-1 mg-1,9,0.999,
VMAX,uM/min,9,0.999,
PTEXTENSION,umol.L-1,9,0.999,
VMAX,umol.mg-1.min-1,9,0.999,
VEHICLECONTROL,%,9,0.999,
VMAX(APP),M/min,9,0.999,
NOPREGNANTMATED,,9,0.999,
PRODUCTION,ng 2hr-1,9,0.999,
NOOFSTRAINS,,9,0.999,
PRL,umol.L-1,9,0.999,
PRIMARYRESPONSE,,9,0.999,
PREGNANT,%,9,0.999,
RECOVEREDINURINE,%,9,0.999,
PROPIOALDEHYDEGENERATED,umol.L-1,9,0.999,
MNTD,,9,0.999,
PREDRUG,ug.mg-1,9,0.999,
PT,cm s-1,9,0.999,
ORALDURATION,s,9,0.999,
ODMAX,mg,9,0.999,
MUDELTARATIO,,9,0.999,
RANGEOFSURVIVAL,,9,0.999,
RANGEOFDEATHS,d,9,0.999,
NOOFAXONALBRANCHPOINTSCELL,,9,0.999,
PLASMAINSULIN,pM l-1,9,0.999,
MORTALITYNUMBER,,9,0.999,
KHYDR,s-1,9,0.999,
PMLD,,9,0.999,
ONSETSEIZURE,,9,0.999,
ODCACTIVITY,(nM of CO2) hr-1 (mg of protein)-1,9,0.999,
KI,10e2 M-1 s-1,9,0.999,
KI,app,9,0.999,
POSTDRUG,ug.mg-1,9,0.999,
VOLUMEOFURINE,ml,9,0.999,
POTENCY,MU,9,0.999,
VMAXH,umol.min-1,9,0.999,
RATEOFREDUCTION,umol.L-1.min-1.mg-1,8,0.999,
TAD,%,8,0.999,
ARRHYTHMIASCORE,,8,0.999,
KSV,10^3/M,8,0.999,
ANTILIPIDPEROXIDATION,,8,0.999,
K1,M-1 min-1,8,0.999,
BINDING,M of drug (M of BSA)-1,8,0.999,
CMT,umol.L-1,8,0.999,
ED50,mpk day-1,8,0.999,
KA,10'-5/M/s,8,0.999,
LH,,8,0.999,
ED50,10'-3mmol/kg,8,0.999,
LEVEL,units/mL,8,0.999,
TUMORUPTAKE,uM kg-1,8,0.999,
ED50,mg/kg/hr,8,0.999,
ED50,mg kg-1 (day in diet)-1,8,0.999,
TUMORRESPONSE,,8,0.999,
MID,ug.mg-1,8,0.999,
LEVEL,mequiv/L,8,0.999,
MICROSOMALSTABILITY,pg min-1 (mg of protein)-1,8,0.999,
T,umol.L-1,8,0.999,
QTINTERVAL,,8,0.999,
CL(APP),uL/min,8,0.999,
K-2,s-1,8,0.999,
CA2+ELEVATION,,8,0.999,
PM,10'-5 cm/min,8,0.999,
RESERPINEHYPOTHERMIA,,8,0.999,
TURNOVER,%,8,0.999,
VMAX,nmol/hr/microg,8,0.999,
CLH,L/hr,8,0.999,
CMAXNORMALISED,(umol/L)/(mg/kg),8,0.999,
R+V,90 min,8,0.999,
CHANGE,beats min-1,8,0.999,
RT3PRODUCTION,pM tube-1,8,0.999,
RATIO,10^5/s/M,8,0.999,
QUENCHING,%,8,0.999,
RATIOOFDEPOLARIZINGACTIVITY,,8,0.999,
COCAINE,%,8,0.999,
WEIGHTATTERM,mg,8,0.999,
K2,min-1 M-1,8,0.999,
CHANGEINLVDPDT,%,8,0.999,
KDISS,1/s,8,0.999,
AAL,,8,0.999,
KA,10'-2/M,8,0.999,
KINA,s-1,8,0.999,
KD,1/ks,8,0.999,
ACTIVITY,%Idose,8,0.999,
LDLCHOLESTEROL,ug.mg-1,8,0.999,
DRUGUPTAKE,ng/kg,8,0.999,
ED50,nmol/mouse,8,0.999,
LD40,umol.L-1,8,0.999,
URINARYEXCRETION,mg,8,0.999,
DT50,d,8,0.999,
NADHOXIDIZED,nM min-1,8,0.999,
DRUGUPTAKE,nmolequiv/g,8,0.999,
DW,,8,0.999,
DRUGUPTAKE,nmol.hr/g,8,0.999,
ITIACTIVITY,,8,0.999,
ITP,,8,0.999,
AUC,nM.hr/mg/kg,8,0.999,
DRUGUPTAKE,cpm/uL,8,0.999,
DRUGUPTAKE,RFU,8,0.999,
JMAX,umol.min-1,8,0.999,
JSS,ug/cm2.hr,8,0.999,
MTD,%,8,0.999,
INTERFERONRESPONSE,ml,8,0.999,
ACTIVITY,Kcal/kg/day,8,0.999,
APPARENTBINDINGCONSTANT,L.umol-1,8,0.999,
EC50,ucm,8,0.999,
ACTIVITY,RU^2,8,0.999,
SURVIVORS,N.total-1,8,0.999,
RELATIVETODA,%,8,0.999,
DU,,8,0.999,
LD50,%,8,0.999,
ED50,pg/ml,8,0.999,
LDAPP,mM kg-1,8,0.999,
ED70,umol.L-1,8,0.999,
TRNAPEAKEXCLUSION,%,8,0.999,
EMESIS,vomiting/tested,8,0.999,
EMAX,pg/ml,8,0.999,
ALKALINEPHOSPHATASEACTIVITY,U l-1,8,0.999,
TCMAX,%,8,0.999,
EFFECTIVEDOSE,mg,8,0.999,
TUMORAREA,mm**2,8,0.999,
INCREASE(EMAX),%,8,0.999,
ALT,U l-1,8,0.999,
EEMAX,,8,0.999,
EDMAX,uM kg-1,8,0.999,
INCREASEINBLOODPRESSURE,%,8,0.999,
EDEMA,ul,8,0.999,
MEDIANRETENSIONLATENCY,,8,0.999,
AMOUNTINCORPORATED,M (M of tubulin)-1,8,0.999,
INCREASEINLD50,%,8,0.999,
LIPOPROTEINLEVEL,%,8,0.999,
LDL-C,%,8,0.999,
MEANTOTALRESORPTION,um2,8,0.999,
ANTITUMOURACTIVITY,,8,0.999,
CMAXNORMALISED,(ng/mL)/(mg/kg/day),8,0.999,
CAVG,pg/mL,8,0.999,
CMAXMETABOLITE,umol.L-1,8,0.999,
RESTORATION,%,8,0.999,
VMAX(APP),pmol/min.mg,8,0.999,
CONTRACTILITY(LVDPDT),,8,0.999,
BASALCONTROL,%,8,0.999,
PERMEABILITY,microg/cm2/h,8,0.999,
RBI,%,8,0.999,
RATE,nM min-1,8,0.999,
K,pM,8,0.999,
K,s,8,0.999,
PERMEABILITY,pmol/min/cm2,8,0.999,
CONTROLOFP-450MARKER,%,8,0.999,
KCATKM,10'-2/microM/s,8,0.999,
RBCX10E3,ul-1,8,0.999,
CALCULATEDRATIO,,8,0.999,
PROPORTIONOFSURVIVORS,,8,0.999,
KD,10^-5/s,8,0.999,
PROTECTION,umol.L-1,8,0.999,
PROPERTY,,8,0.999,
KD,10^-6/s,8,0.999,
BMAX1,%,8,0.999,
AUMC,%,8,0.999,
RATIO,uL/min/pmol,8,0.999,
KINACT,10^6nM,8,0.999,
RELATIVEPOTENCYRATIO,,8,0.999,
REDUCTIONINTG,%,8,0.999,
CARBONYLGROUP,,8,0.999,
MOLECULARELLIPTICITY,deg.cm2/dmol,8,0.999,
RELATIVEMETABOLICRATE,,8,0.999,
VSS,l hr-1 kg-1,8,0.999,
KD,10^5/s,8,0.999,
KCAT,umol.L-1,8,0.999,
AUMC,ng.hr/ml,8,0.999,
BLOODCLEARANCE,umol.L-1,8,0.999,
PROLONGEDVRP,%,8,0.999,
CHOLESTEROL,%,8,0.999,
AVERAGEPROPORTION,,8,0.999,
BLOODGLUCOSE,umol.L-1.ml-1,8,0.999,
C0,ug/L,8,0.999,
WBCX10E-3,ul-1,8,0.999,
VOCALIZATIONTIME,s,8,0.999,
CAMPPRODUCTION,N,8,0.999,
PROGESTERONEPRODUCTION,ng 2hr-1 (10e5*cells)-1,8,0.999,
-LN(MIC),,8,0.999,
CLH,g/ml/min,8,0.999,
BPR,10'-3/hr,8,0.999,
RELATIVEPOTENCY,umol.L-1,8,0.999,
KINACT,10^3/min,8,0.999,
AUMC,hr2.ng/ml,8,0.999,
KDSS,umol.L-1,8,0.999,
AC,umol.L-1,8,0.999,
KA,10^3/M.s,8,0.999,
RECEPTOROCCUPIED,%,8,0.999,
ROR,%,8,0.999,
CL,umol.min-1,8,0.999,
VOLUMEOFAIR,ml,8,0.999,
K5,min-1,8,0.999,
CL,uL/min/pmol,8,0.999,
KA,10'9/M/min,8,0.999,
CELLULARUPTAKE,pM ul-1,8,0.999,
K6,s-1,8,0.999,
RATIOIP,,8,0.999,
ACTIVECULTURE,%,8,0.999,
K2,10e-3 min-1,8,0.999,
KALKYL,s-1,8,0.999,
K6,min-1,8,0.999,
KI(18X10E-11),umol.L-1,8,0.999,
RATIO,10^3/uM/s,8,0.999,
REVERSION,,8,0.999,
REVERTANTCOLONIESPERPLATE,,8,0.999,
KA,/mM.s,8,0.999,
RRI,,8,0.999,
KI,kcat/Km,8,0.999,
REDUCEDBP,%,8,0.999,
CHANGEINMABP,%,8,0.999,
[CA2+]INCREASE,,8,0.999,
PLASMALEVEL,,8,0.999,
BRAINLEVEL,pM forebrain-1,8,0.999,
KAPPRATIO,,8,0.999,
BRAINLEVEL,ug weight-1,8,0.999,
CMAXDOSE,,8,0.999,
CC50%,umol.L-1,8,0.999,
BW,%,8,0.999,
KHYDROL,s-1,8,0.999,
PLASMACONCENTRATION,uM l-1,8,0.999,
VZF,(mg/kg)/(ug/ml),8,0.999,
KD,10^1 uM,8,0.999,
BINDING,dpm mg-1,8,0.999,
PHOTOTOXICITY,,8,0.999,
KDMPG,L.umol-1,8,0.999,
PLATELETSX10E-3,ul-1,8,0.999,
BORONCONCENTRATION,ug g-1,8,0.999,
KII,,8,0.999,
KENALOXONE,umol.L-1,8,0.999,
RATIOCIC95IC50,,8,0.999,
ABC,,8,0.999,
RP,mV,8,0.999,
ROTATIONS10H,,8,0.999,
EC50,ppb,8,0.999,
ED30,MPK,8,0.999,
ACTIVITY,OD.mm2-1,8,0.999,
KRELATIVE,,8,0.999,
AUCLASTDOSE,umol.h.L-1,8,0.999,
DELTAMEANBLOODPRESSURE,,8,0.999,
SERUMCONCENTRATION,nM l-1 hr-1,8,0.999,
ACTIVITY,10'5No_unit,8,0.999,
SMAX,,8,0.999,
PBBB,10'-6 cm/s,8,0.999,
VM,%,8,0.999,
CYSTEINEREACTION,s-1,8,0.999,
OPTIMALDOSE,uM kg-1,8,0.999,
KOFF,L.umol-1,8,0.999,
ONSETOFBLOCK,s,8,0.999,
CYTOTOXITY,%,8,0.999,
DENSITY,mg/cm3,8,0.999,
CV,,8,0.999,
DELTAK,,8,0.999,
OLIGOMODIFIED,%,8,0.999,
DELTAII,mV,8,0.999,
OFNON-HDL-C,%,8,0.999,
OFHDL-C,%,8,0.999,
AUCNORMALISED,((ng/mL).hours)/(mg/kg/day),8,0.999,
AUCDOSE,ng.hr.kg/ml.mg,8,0.999,
VMAX,/mol.L-1.s-1,8,0.999,
PC50,mg,8,0.999,
SELECTIVITYRATING,,8,0.999,
DOSEELEVATION,ug.mg-1,8,0.999,
SKINSCALING,,8,0.999,
SKINRESPONSE,,8,0.999,
K,10^4No_unit,8,0.999,
VK,,8,0.999,
KX10E-3,s-1,8,0.999,
NSVT,ug.mg-1,8,0.999,
PC95,mg,8,0.999,
CUMULATIVEAMOUNT,mg,8,0.999,
NSRSURVIVALRATE,,8,0.999,
CTAU,umol.L-1,8,0.999,
NORMALWEIGHTGAIN,%,8,0.999,
D-2,%,8,0.999,
ACTIVITY,10'4 /uL,8,0.999,
DOBS,,8,0.999,
SPECIFICACTIVITY,ukat kg-1,8,0.999,
CT,umol,8,0.999,
SELECTIVITY,uM s-1,8,0.999,
CT,ms,8,0.999,
DELTAFFA,,8,0.999,
DELTALOGS,,8,0.999,
DELTACP,kcal/mol/K,8,0.999,
AUC,ug.min/g,8,0.999,
DFMBMD,mg/Ecm,8,0.999,
KOBSCONCENTRATION,,8,0.999,
DIAZEPAMANTAGONISM,,8,0.999,
V0,,8,0.999,
DRUGEXCRETION,ug.mg-1,8,0.999,
KM(UNBOUND),umol.L-1,8,0.999,
PERMEABILITY,a.u.,8,0.999,
KMKI,,8,0.999,
DAMAGESCORE,,8,0.999,
DOSENORMALIZEDCLEARANCE,ml/min.kg,8,0.999,
LATENCYTIME,,8,0.999,
DPDT(MAX),%,8,0.999,
NOOFPROTECTEDTESTED,,8,0.999,
PA2,mg,8,0.999,
LATENCYTOSTEPTHROUGH,s,8,0.999,
AUCT,ngequiv.hr/g,8,0.999,
NOOFPITSSLICE,,8,0.999,
NOOFKILLEDORPARALYZED,,8,0.999,
AUEC,%,8,0.999,
ACTIVITY,/uM,8,0.999,
PAPP,cm min-1,8,0.999,
DELTAAPD90,%,8,0.999,
PERMEABILITY,10^-5cm/s,8,0.999,
COUNTS30,s,8,0.999,
MORPHOLOGY,,8,0.999,
PEMR,,8,0.999,
PERMEABILITY,*10e6,8,0.999,
AUCNORMALISED,(umol.h/L)/(mg/kg),8,0.999,
K,10'-5/nM/min,8,0.999,
K,10^-6M,8,0.999,
DELTAF,%,8,0.999,
DOSEMODIFICATION,,8,0.999,
DRUGEXCRETION,umol.L-1,8,0.999,
DEIODINATION,%,8,0.999,
AUC,pmol.min,8,0.999,
VMAX,M min-1 mg-1,8,0.999,
AUC,pM kg-1,8,0.999,
CP(F)MAX,umol.L-1,8,0.999,
PERMEABILITY,10'-7nmol/cm2/min,8,0.999,
PAPPE-6,cm s-1,8,0.999,
KM,/uM,8,0.999,
ACTIVITY,10'-3dpm,8,0.999,
STABILITY,%Idose,8,0.999,
ACTIVITY,10^3No_unit,8,0.999,
ACTIVITY,10'1/mm2,8,0.999,
SCAVENGINGACTIVITY,,8,0.999,
DRUGMETABOLISM,nmol.min,8,0.999,
DRUGMETABOLISM,mmol/L/hr,8,0.999,
DRUGMETABOLISM,mol,8,0.999,
PAPP,10'-6cm/s2,8,0.999,
DIFFUSIONANALYSIS,,8,0.999,
VD,L,8,0.999,
SEVERITY,,8,0.999,
ACTIVITY,mutants (10e4*survivors)-1,8,0.999,
ACTIVITY,mmHg.hr,8,0.999,
MAXDELTAFC,%,8,0.999,
MAXDELTAFRP,,8,0.999,
MAXDELTAMABP,mmHg,8,0.999,
GR10,gAi/ha,8,0.999,
LZ,s-1,8,0.999,
I80,umol.L-1,8,0.999,
HCMVYIELD,pfu/ml,8,0.999,
LOGPTA,,8,0.999,
HUMANPOTENCY,MU,8,0.999,
HYPERACTIVITY,%,8,0.999,
HYPERMOTILITY,,8,0.999,
HYPOCALCEMICACTIVITY,IU mg-1,8,0.999,
HSASHIFT,,8,0.999,
HPB,,8,0.999,
LOGPE,cm2/sec,8,0.999,
ACTIVITY,ng/mL.hr,8,0.999,
TOTALCHOLESTEROL,ug.mg-1,8,0.999,
ACTIVITY,nmol/mg.hr,8,0.999,
LOGTCI,,8,0.999,
HIGHESTNONTOXICDOSE,mg kg-1 (day in diet)-1,8,0.999,
GID75,mg/m2,8,0.999,
GLUCURONIDATIONRATE,nmol.L-1.min-1.mg-1,8,0.999,
LSD,%,8,0.999,
TISSUELEVEL,umol.L-1,8,0.999,
DIFFUSION,%,8,0.999,
ATHEROGENICINDEX,,8,0.999,
SURVIVALRATIO,%,8,0.999,
AUC,0-24hr,8,0.999,
SURVIVALEXTENSION,,8,0.999,
MPD,ug.mg-1,8,0.999,
ACTIVITY,L/min,8,0.999,
SUPRESSIVEEFFECT,umol.L-1,8,0.999,
LD50,mg kg-1 (day in diet)-1,8,0.999,
ANTIUTEROTROPHICACTIVITY,,8,0.999,
K,/day,8,0.999,
ENANTIOMERICCOMPOSITION,%,8,0.999,
IE,,8,0.999,
IC0,umol.L-1,8,0.999,
IC05,umol.L-1,8,0.999,
ACTIVITY,pg/ml/hr,8,0.999,
IC12,mg,8,0.999,
ACTIVITY,nM/hr,8,0.999,
IC27,umol.L-1,8,0.999,
ACTIVITY,pmol/million cells,8,0.999,
ACTIVITY,nM/ml,8,0.999,
LOGP(100-P),,8,0.999,
MT,,8,0.999,
HDLCHOLESTEROL,ug.mg-1,8,0.999,
ID40,,8,0.999,
TIDALVOLUME,%,8,0.999,
LOGEFFECT,,8,0.999,
ACTIVITY,microL/min/kg,8,0.999,
MAXLOWERINGMABP,mmHg,8,0.999,
FREQUENCY,beats min-1,8,0.999,
FREQUENCY,%,8,0.999,
LOGCFUGOFTISSUE,,8,0.999,
FREEC,umol.L-1,8,0.999,
MAXUTERINEWEIGHT,mg,8,0.999,
MAXWEIGHTLOSS,%,8,0.999,
MBBC,umol.L-1,8,0.999,
ACTIVITYMABP,%,8,0.999,
THERMSOLUBILITY,mg,8,0.999,
IC50[E],nM milliunit-1,8,0.999,
FICI90,,8,0.999,
FG,%,8,0.999,
ACTIVITY,umol.L-1.ml-1,8,0.999,
UTEROTONICACTIVITY,IU mg-1,8,0.999,
HDL-CCHANGE,%,8,0.999,
ED50,ug ear-1 dose-1,8,0.999,
UTEROTROPHICACTIVITY,,8,0.999,
THERAPEUTICINDEX,ug.mg-1,8,0.999,
FICI50,,8,0.999,
FEVERRESPONSE,Cel,8,0.999,
FAUC,nM.hr.kg/mg,8,0.999,
MAXFALLINMAP,mmHg,8,0.999,
EXTENSION,%,8,0.999,
MEANTIMETOSEIZURE,,8,0.999,
MAXFALL,mmHg,8,0.999,
TIDALVOLUME,ul,8,0.999,
MDACONTENT,uM (g of tissue)-1,8,0.999,
ADD,s,8,0.999,
ACTIVITY,mM-1,8,0.999,
FAUCDOSE,microM.hr/mg/kg,8,0.999,
ID50,ng/kg,8,0.999,
VMAX,cpm,8,0.999,
ID50,uL/L,8,0.999,
AFFINITY,L.umol-1,8,0.999,
ID50,10'-6M,8,0.999,
MEANPITSIZE,um2,8,0.999,
ID95,uL/L,8,0.999,
EUDISMICRATIO,,8,0.999,
TRIGLYCERIDELEVEL,,8,0.999,
LOG10CFUMLDAY,,8,0.999,
MEANRESPONSE,,8,0.999,
MEANREACTION,,8,0.999,
CELLSATURATION,pM (10e5*cells)-1,7,0.999,
KCAT,-1/min,7,0.999,
PCB50,,7,0.999,
ACTIVITY,%.min,7,0.999,
ZONEOFSTIMULATION,,7,0.999,
ACTIVITY,%/mmol,7,0.999,
PIC30,,7,0.999,
DAMAGEDAREA,%,7,0.999,
GROUPTOXICITY,,7,0.999,
I50,%,7,0.999,
SELECTIVITYRATIO,umol.L-1,7,0.999,
PAPPS,cm s-1,7,0.999,
SELECTIVITYRATIO,%,7,0.999,
K,10^3/M,7,0.999,
D2DURATION,s,7,0.999,
RATIOKI,No unit,7,0.999,
CELLKILLACTIVITY,,7,0.999,
TISSUESWELLING,ul g-1,7,0.999,
VIRUSYIELDREDUCTION,,7,0.999,
VMAX,pM s-1 mg-1,7,0.999,
AUCLAST,ng.min/g,7,0.999,
CONCENTRATION,ug of B g-1,7,0.999,
DECREASE,umol.L-1,7,0.999,
DECREASEINNOOFAVOIDENCERESPONSES,%,7,0.999,
AVOIDANCETIME,s,7,0.999,
K,10^4L/mol,7,0.999,
AUMC,ug/ml.hr'2,7,0.999,
KB,10'4No_unit,7,0.999,
KCAT,10'4/s,7,0.999,
CMEDIA,ug of B/ml,7,0.999,
KQ,10'5L/mol,7,0.999,
KB,10'8/M,7,0.999,
AUCDOSE,uM.min.kg/mg,7,0.999,
AUCDOSE,uM.hr.mg/kg,7,0.999,
DBP-20,ug.mg-1,7,0.999,
AUCLAST,hr.nmol/ml,7,0.999,
CURE,%,7,0.999,
HCMVYIELDREDUCTION,pfu/ml,7,0.999,
K,10^-8M,7,0.999,
CZ,umol.L-1,7,0.999,
VMAX,rel,7,0.999,
RN,,7,0.999,
ACTIVITY,omegacm2,7,0.999,
NOAEL,ug/L,7,0.999,
RECEPTORBINDING,,7,0.999,
ACTIVITY,10'5/mm3,7,0.999,
LOGKI,%,7,0.999,
K2,m M-1 hr-1,7,0.999,
ACTIVITY,10'5AU/sec,7,0.999,
SIGMAH,%,7,0.999,
KII,uM kg-1,7,0.999,
DELTAHEARTRATE,beats min-1,7,0.999,
DELTAHR,min-1 hr-1,7,0.999,
DELTAI,%,7,0.999,
OXYGENCONSUMED,nM min-1,7,0.999,
CMAXNORMALISED,microM/mg/kg,7,0.999,
CBF-ID75,ug.mg-1,7,0.999,
PHOSPHOLIPIDOSISMEC,,7,0.999,
AVERAGESURVIVED,d,7,0.999,
K,10^4/M/min,7,0.999,
DELTAMA,s,7,0.999,
MAP,delta %,7,0.999,
SIGMAL,%,7,0.999,
"KC,U",hr-1,7,0.999,
VMAX,pmol/s,7,0.999,
AUCDOSE,min.uM,7,0.999,
AUCDOSE,hr.nM,7,0.999,
CONCENTRATIONOFMAXRESPONSE,,7,0.999,
TIMETOONSET,s,7,0.999,
GID75,mg/me2,7,0.999,
CATALEPSY,,7,0.999,
CFU,10^7/g,7,0.999,
PLASMAGLUCOSELEVEL,mg dl-1,7,0.999,
CMVYIELD,pfu/ml,7,0.999,
OFFSETTIME,s,7,0.999,
ACTIVITY,10'7CFU/g,7,0.999,
HYDROLYSIS,nmol.L-1.min-1.mg-1,7,0.999,
DEPRESSION,%,7,0.999,
MAXCONTRACTILEFORCE,,7,0.999,
GLUCOSEUPTAKE,nM hr-1 (mg of worm),7,0.999,
CONCENTRATION,ug rat-1 hr-1,7,0.999,
AUCDOSE,min.ug/ml/(mg/kg),7,0.999,
AVERAGEBODYWEIGHTCHANGE,%,7,0.999,
CLTOTAL,ml s-1,7,0.999,
PAPP,10^-5 cm/s,7,0.999,
ACTIVITY,10'-3 mol/L,7,0.999,
PFCSPLEEN,,7,0.999,
KM(APP),,7,0.999,
CREATININECL,ml/min,7,0.999,
PEC20,,7,0.999,
KA,1/M*1/S,7,0.999,
DNABINDING,L.umol-1,7,0.999,
LACTATEPRODUCED,nM hr-1 (mg of worm),7,0.999,
VDF,,7,0.999,
PERMEABILITY,umol/cm2/hr,7,0.999,
VIRALTITER,PFU.mL-1,7,0.999,
ACTIVITY,10^-3/min/uM,7,0.999,
IC50,10^3 uM,7,0.999,
DRUGMETABOLISM,mol%,7,0.999,
ACTIVITY,nmol/hr/L,7,0.999,
DRUGMETABOLISM,nanomol/min,7,0.999,
HYPNOSISPOTENTIATION,%,7,0.999,
LOGRATE,,7,0.999,
CLRENAL,ml s-1,7,0.999,
NTD50,ug.mg-1,7,0.999,
VMAX,ug/min.kg,7,0.999,
KUN,s-1,7,0.999,
KAPP,h-1,7,0.999,
EMAX,uM kg-1,7,0.999,
PERTURBATIONS,,7,0.999,
LAMBDA-EX,mm,7,0.999,
CPI,mN/meter,7,0.999,
LALTEST,,7,0.999,
PLATELET,10e6 ul-1,7,0.999,
MAXEFFICACY,%,7,0.999,
LAMBDA-EM,mm,7,0.999,
LOGIC50,%,7,0.999,
CNSACTIVITY,,7,0.999,
DNAPEAKEXCLUSION,%,7,0.999,
MAXDELTABP,,7,0.999,
K,10'4/M/min,7,0.999,
VDSS,L/hr,7,0.999,
ACTIVITY,ng/kg/day,7,0.999,
DIFFERENTIATEDCELLS,%,7,0.999,
KI05,,7,0.999,
DRUGMETABOLISM,nmol/J,7,0.999,
ACTIVITY,mgequiv/g,7,0.999,
SAQ,,7,0.999,
AUC,uM hr-1 ml-1,7,0.999,
RATIO,ug.mg-1,7,0.999,
DRUGDEGRADATION,nmol/J,7,0.999,
HR,delta %,7,0.999,
GABAAGONISM,,7,0.999,
G1,%,7,0.999,
CMAX,%,7,0.999,
KINACTKI,mM-1 min-1,7,0.999,
LOGDMAX,,7,0.999,
ACCELERATION,,7,0.999,
VAGUS,delta %,7,0.999,
AUCT,nmol.hr/g,7,0.999,
VMAX,uM min-1 unit-1,7,0.999,
VMAX,nM min-1 (mg of protein)-1,7,0.999,
KIN,10^-4ml/g/s,7,0.999,
DEADTREATED,,7,0.999,
K,10^-5/M/s,7,0.999,
LT999,s,7,0.999,
VBETA,L/hr,7,0.999,
CHANGE,ug.mg-1,7,0.999,
CLRENAL,ml min-1,7,0.999,
SPREAD,%,7,0.999,
WRITHINGNUMBER,,7,0.999,
KB,10^6L/mol,7,0.999,
DRUGRESPONDING,,7,0.999,
STABILITY,microM/min,7,0.999,
MAXINTENSITY,rotations min-1,7,0.999,
TD50ED50,,7,0.999,
MAXLOWERING,,7,0.999,
LOGDIAM,,7,0.999,
PERMEABILITYCOEFFICIENT,nm s-1,7,0.999,
AUCTDOSE,nM.hr/mg,7,0.999,
[CA2+]VARIATION,umol.L-1,7,0.999,
RATIOCC50EC50,10'3No_unit,7,0.999,
RETENTION,,7,0.999,
SPONTANEOUSACTIVITY,,7,0.999,
VMAX,min-1,7,0.999,
DRUGABSORPTION,ug.mg-1,7,0.999,
VMAX,U/min,7,0.999,
IC30,10'-6M,7,0.999,
TIMETOOFFSET,s,7,0.999,
UTEROTROPICEFFECT,,7,0.999,
DRUGUPTAKE,umol.min-1.mg-1,7,0.999,
MITOGENICEFFECT,,7,0.999,
EC50,10^-4nM,7,0.999,
IRONMOBILIZED,%,7,0.999,
IRONCLEARENCE,ug.mg-1,7,0.999,
PRATIO,,7,0.999,
LD10,mg/me2,7,0.999,
DRUGUPTAKE,uL,7,0.999,
AUC,ml/min.kg,7,0.999,
UNREACTEDDRUG,%,7,0.999,
FLT,%,7,0.999,
DRUGUPTAKE(FREE),ug.mg-1,7,0.999,
REPOLARIZATIONTIME,,7,0.999,
MUTATIONFREQUENCY,10e6 F,7,0.999,
REPELLENCY,,7,0.999,
DTTINHIBITION,,7,0.999,
IC50REDUCTION,%,7,0.999,
DURATIONOFIMMOBILITY,,7,0.999,
KCATKM,10^-5/nM/s,7,0.999,
RATIO,10^-3/min/uM,7,0.999,
MELANOTROPICPOTENCY,,7,0.999,
ERYTHEMAINTENSITY,,7,0.999,
TC(SURVIVAL),%,7,0.999,
RATEOFREDUCTION,nmol.L-1.min-1.mg-1,7,0.999,
KA,10^6/Ms,7,0.999,
INH,10'-6 mol/L,7,0.999,
"KD,APP",umol.L-1,7,0.999,
A50,umol.mg-1,7,0.999,
ED50,uM g kg-1,7,0.999,
ANTAGONISTACTIVITY,ug min-1 kg-1,7,0.999,
ED50,ug embryo-1,7,0.999,
LIGHTTRANSMISSION,%,7,0.999,
VSS,L,7,0.999,
BPI,%,7,0.999,
ED50MGKG,,7,0.999,
INFARCTVOLUME,umol.L-1,7,0.999,
CL,mg/min/kg,7,0.999,
INDUCEDFREQUENCY,,7,0.999,
ID50MGKG,,7,0.999,
CL,mg min-1 kg-1,7,0.999,
INTRINSICVASORELAXATION,umol.L-1,7,0.999,
PROCONVULSANTACTION,,7,0.999,
ACTIVITY,fg,7,0.999,
VMAXKM,uL,7,0.999,
LD,uM kg-1,7,0.999,
KEL,10^-3/min,7,0.999,
MODIFICATIONOFADSORBEDDRUG,%,7,0.999,
VMAXKM,uL/min/U,7,0.999,
EC30,L.mol-1,7,0.999,
MTD,mpk,7,0.999,
STROKEVOLUME,ul,7,0.999,
ABSOLUTERATIO,,7,0.999,
AUC,mM.min,7,0.999,
DRUGUPTAKE,nmol/L,7,0.999,
MPE,ug.mg-1,7,0.999,
PRODUCTION,,7,0.999,
FKI,umol.L-1,7,0.999,
BLOODPRESSURE,,7,0.999,
MBEC999,umol.L-1,7,0.999,
PROFILE,,7,0.999,
AUC,cm2,7,0.999,
CAMP,,7,0.999,
DRUGUPTAKE,mmol/Kg,7,0.999,
NEPHROTOXICITY,mg dl-1,7,0.999,
NEPHROTOXICITY,umol.L-1,7,0.999,
CLH,micromol/min,7,0.999,
AUC,microM/hr/mg,7,0.999,
IRREVERSIBLEBINDING,,7,0.999,
RATIO,L.umol-1,7,0.999,
LC50,umol/dm'2,7,0.999,
BINDINGINTENSITY,%,7,0.999,
CLM,ml min-1,7,0.999,
AUC,ng.min/g,7,0.999,
KCATKM,10'-5/M/s,7,0.999,
CLINT,uL min-1 mg-1,7,0.999,
NO2-(MOLMOL),%,7,0.999,
FREERADICALSCAVENGING,%,7,0.999,
IC50,nM/unit,7,0.999,
IC50,ppm g dm**-3,7,0.999,
-LOGKD50,,7,0.999,
CHANGEINDPDT,%,7,0.999,
BLOCKTIME,ms,7,0.999,
MAXREV,%,7,0.999,
RELATIVERATEOFDECOMPOSITION,(nM of drug) min-1 ml-1,7,0.999,
MAXUOSM,mOsmol kg-1,7,0.999,
ANTI-INFECTIOUSEFFECT,,7,0.999,
KCATKM,10^7/M/s,7,0.999,
LETHALTOXICITY,,7,0.999,
BORONINCORPORATION,ug/10e6,7,0.999,
ANTIUTEROTROPICEFFECT,,7,0.999,
ED50,10'-9M,7,0.999,
LDHRELEASE,%,7,0.999,
MITC95,,7,0.999,
ACTIVITY,meter/s,7,0.999,
CHANGEINMEANAORTICFLOW,%,7,0.999,
RELKO,,7,0.999,
APPARENTPKA,,7,0.999,
EC50,pmol/L,7,0.999,
FH,%,7,0.999,
KA,10^1/Ms,7,0.999,
LD84,ug.mg-1,7,0.999,
CLB,ml min-1,7,0.999,
CLB,%,7,0.999,
KAPP,10'-2/s,7,0.999,
SAFTEYMARGIN,,7,0.999,
LETHALITY,ug.mg-1,7,0.999,
VOMITINGFREQUENCY,,7,0.999,
FAUC,ng.hr/g,7,0.999,
MEANAORTICFLOW,ml min-1,7,0.999,
VOLUME,ml 2hr-1,7,0.999,
LEVEL,ug g-1,7,0.999,
VOLUME,ml 4hr-1,7,0.999,
PTZSEIZURE,,7,0.999,
CHANGEINSTROKEVOLUME,%,7,0.999,
CHANGEINTIDALVOLUME,%,7,0.999,
PUPILSIZE,umol.L-1,7,0.999,
RELATIVESUBSTRATEVELOCITY,%,7,0.999,
CHANGEINTIDALVOLUME,ul,7,0.999,
ED20,mg,7,0.999,
ED25,L.mol-1,7,0.999,
ED25,ug/kg,7,0.999,
ED250,,7,0.999,
LESIONINDEX,umol.L-1,7,0.999,
PYROGENICEFFECT,,7,0.999,
ANTIDIURETIC,mg,7,0.999,
ED5,umol.L-1,7,0.999,
EC50,uL/L,7,0.999,
2APTT,10'-3M,7,0.999,
LD95,microg/cm2,7,0.999,
RADIOLABELRECOVERY,umol.L-1,7,0.999,
C0,,7,0.999,
EFFICACY,number ul-1,7,0.999,
INCIDENCEOFOCCLUSION,,7,0.999,
ACTIVITY,m/3h,7,0.999,
MED,uM.kg/diet,7,0.999,
MED,mpk,7,0.999,
TDI,/min/M,7,0.999,
CICIC50,umol.L-1,7,0.999,
AGONIST,,7,0.999,
MED,(mg of base) 20g-1,7,0.999,
CIC90,,7,0.999,
ILS40,mg.kg-1.d-1,7,0.999,
LLRMSAD,ug.mg-1,7,0.999,
AEACTIVITY,,7,0.999,
KA1,,7,0.999,
EC50,umol.g-1,7,0.999,
MELANOTROPICACTIVITY,,7,0.999,
INCREASEDLIFESPAN,,7,0.999,
MEC,mg.ml-1,7,0.999,
RELATIVELIVERWEIGHT,%,7,0.999,
ATPCONTENT,pM (mg of protein)-1,7,0.999,
CHANGEINRESPIRATORYFREQUENCY,%,7,0.999,
MCD,mg.kg-1.d-1,7,0.999,
IE1,eV,7,0.999,
KDL,umol.L-1,7,0.999,
CHANGEINRESPIRATORYFREQUENCY,beats min-1,7,0.999,
RESOWING,%,7,0.999,
LOG1ED30,uM kg-1,7,0.999,
ECAUC02,umol.L-1,7,0.999,
AD50,MPK,7,0.999,
KDH,umol.L-1,7,0.999,
WBC,10e3 ul-1,7,0.999,
RADIOLABELRECOVERY,ng/g,7,0.999,
BRAINBLOODCONCENTRATION,,7,0.999,
MEDIANLIFESPAN,,7,0.999,
AMOUNTFORMED,pM,7,0.999,
T>EC99,s,7,0.999,
KA(T4),%,7,0.999,
HYDROLYSIS,nM min-1,6,0.999,
EAUC50,hr.ng/ml,6,0.999,
RC50,,6,0.999,
SURVIVAL,number,6,0.999,
MSC,umol.L-1,6,0.999,
BMAX,MFU,6,0.999,
PROLONGATIONEFFECT,,6,0.999,
CLF,ml/hr,6,0.999,
EARTHICKNESS,umol.L-1,6,0.999,
E12,mV,6,0.999,
CLF,umol.h.L-1,6,0.999,
DURATIONOFPLATEAU,s,6,0.999,
CLEAVAGERATE,umol.L-1.min-1.mg-1,6,0.999,
BLOODPLASMARATIO,,6,0.999,
REMAININGAT40MIN,%,6,0.999,
AREA,AU mm-1,6,0.999,
BMAX,fM g-1,6,0.999,
MORTALITY,number of descendants/number of tested,6,0.999,
EC50,mh/kg,6,0.999,
PROTEINCONTENT,%,6,0.999,
BMAX2,%,6,0.999,
MOLARPRIMAQUINEINDEX,,6,0.999,
MODIFICATIONOFHEMOGLOBIN,,6,0.999,
BODYTEMPDROP,Cel,6,0.999,
RELATIVEUTEROTROPHICACTIVITY,,6,0.999,
APPROXIMATECOLONYFORMATIONUNIT,gkidney-1,6,0.999,
EC50,umol.h.L-1,6,0.999,
APD75,ms,6,0.999,
LDL,ug.mg-1,6,0.999,
SUSCEPTIBILITY,nmol/mg protein/h,6,0.999,
CLFREE,L/hr,6,0.999,
ACTIVITY,/cm,6,0.999,
ACTIVITY,/10'3mm'-3,6,0.999,
ACTIVITY,10'2/M,6,0.999,
VMAX,nmol/min/U,6,0.999,
ACETYLATION,%,6,0.999,
VOLUME,ml min-1,6,0.999,
KA,10^2/Ms,6,0.999,
VMAX,pmol/min/pmol,6,0.999,
ACTIVITY,W,6,0.999,
LOG(1C50),,6,0.999,
ULCERINDEX,umol.L-1,6,0.999,
TRANS,%,6,0.999,
IMMUNOSUPRESSIVEACTIVITY,%,6,0.999,
INHIBITORYACTIVITYRATIO,,6,0.999,
KAPP,uM-1,6,0.999,
VMAX,mM min-1,6,0.999,
BLOODLOSS,ug.mg-1,6,0.999,
IC20,L.mol-1,6,0.999,
INHIBITION,uM kg-1,6,0.999,
INHIBITION,umol,6,0.999,
KW,s-1,6,0.999,
KINACT,10^-2/min,6,0.999,
K,10^2/M/s,6,0.999,
ABERRANTCELLS,,6,0.999,
TRABECULARTHICKNESS,mm,6,0.999,
KINACTKI,uM-1 min-1,6,0.999,
KAPP,1/M,6,0.999,
IC50,10'-4g/L,6,0.999,
ACCUMULATIONCOUNTS,Counts,6,0.999,
KA,mm,6,0.999,
LDHRELEASE,MU,6,0.999,
K,10^-4/M/s,6,0.999,
KCATKM,/M/min,6,0.999,
V0,10^-8M/s,6,0.999,
VZ,uL/g,6,0.999,
CLFREE,uL/min/nmol,6,0.999,
MEMBRANEINTEGRITY,%,6,0.999,
DRUGUPTAKEDOSE,nM/mg/kg,6,0.999,
MED,ug/L,6,0.999,
RADIOACTIVITY,nM equiv (ml of blood)-1,6,0.999,
MEQUIVOFHCL,,6,0.999,
RADIOACTIVITY,nM equiv (ml of urine)-1,6,0.999,
ED90,mg/kg,6,0.999,
RADIOACTIVITY,nM equiv mg-1,6,0.999,
MEDIANTUMORALVOLUME,cm*3,6,0.999,
AMOUNTOF[3H]THYMIDINE,c.p.m.,6,0.999,
RELATIVEPERMIABILITY,,6,0.999,
RELATIVEMETABOLICSTABILITY,,6,0.999,
AMOUNT,pM,6,0.999,
TC50,10'5nM,6,0.999,
MED90,mg monkey-1 day-1,6,0.999,
RELATIVEKM,,6,0.999,
EFFECT,pM g-1,6,0.999,
BRAINLEVEL,umol.L-1,6,0.999,
ED80,umol.L-1,6,0.999,
ALPHA50,molar fraction,6,0.999,
TCT,s,6,0.999,
EFFLUX,umol.L-1,6,0.999,
EGGREDUCTION,%,6,0.999,
RAPP,,6,0.999,
MED,(mg of base) kg-1,6,0.999,
TD50,mg,6,0.999,
ED50,ug mg-1 kg-1,6,0.999,
MFC>99,,6,0.999,
BPI,,6,0.999,
ED50,nM day-1 kg-1,6,0.999,
RELATIVETHRESHOLDDOSE,,6,0.999,
ED100,[ppm],6,0.999,
ACTIVITY,Ratio,6,0.999,
CL,mL/min/m2,6,0.999,
ANTAGONISMEFFECTS,,6,0.999,
CLP,ug hr ml-1,6,0.999,
NEURITEBEARINGCELLSTOTALCELLS,%,6,0.999,
STABILITY,nmol/g,6,0.999,
BINDINGCONSTANT,l M-1,6,0.999,
CLM,l hr-1,6,0.999,
AUC,ng.hr.kg/ml/mg,6,0.999,
BITTERTASTEINTENSITY,0-15 scale,6,0.999,
RESIDUALRRACTIVITY,%,6,0.999,
STABILITY,pmol/ml,6,0.999,
DRUGUPTAKE,cpm/mm2,6,0.999,
NITRITE,umol.L-1,6,0.999,
BLOCK,,6,0.999,
NITRATE,umol.L-1,6,0.999,
AUC,ng.eq.h.ml-1,6,0.999,
EC90,ug.mg-1,6,0.999,
DRUGUPTAKE,kBq/cm3,6,0.999,
NETSWELLING,,6,0.999,
ANTITUMORACTIVITY,mg,6,0.999,
DRUGUPTAKE,microL/min/mg,6,0.999,
CLH,microL/ml/min,6,0.999,
AUC,nM.hr/g,6,0.999,
NEPHROTOXICITY,,6,0.999,
NED,ug.mg-1,6,0.999,
PPB,pmolequiv/mg,6,0.999,
DRUGUPTAKE,pg/mg,6,0.999,
PRCF,,6,0.999,
NA+RATIO,,6,0.999,
STATICREMISSION,%,6,0.999,
CLH,10'-6uL/min,6,0.999,
CLH,uM/min.mg,6,0.999,
NOCUREDTOTAL,,6,0.999,
EC90MIC,,6,0.999,
%PFU,%,6,0.999,
ABSORBANCE,%,6,0.999,
K-1APP,hr-1,6,0.999,
IRONBINDING,m equiv kg-1,6,0.999,
IDORGAN,,6,0.999,
LD50,10'-2 ug/ml,6,0.999,
KHYDROL,,6,0.999,
KA,10'4/M.s,6,0.999,
VMAXKM,U/mg/uM,6,0.999,
KELIM,hr-1,6,0.999,
LOGPALK,,6,0.999,
VMAXREL,,6,0.999,
ZONESIZE,,6,0.999,
ACTIVITY,Kb M-1,6,0.999,
LD50,J/cm2,6,0.999,
KA,10'5/Ms,6,0.999,
VMAX,delta A/min,6,0.999,
TOTALDPM,,6,0.999,
ACTIVITY,J,6,0.999,
IFN,,6,0.999,
K,10'6/M.s,6,0.999,
TRIGLYCERIDES,mg dl-1,6,0.999,
3DPSA,,6,0.999,
ACTIVITY,m equiv l-1,6,0.999,
KM,umol.mg-1,6,0.999,
LD,Gy,6,0.999,
ID50,fmol,6,0.999,
VMAX,pM,6,0.999,
LOG(ACTIVITY),ml-1,6,0.999,
LOGMRI,,6,0.999,
KB,10'-5L/mol,6,0.999,
KB,10'4mol/L,6,0.999,
LD,g/Kg,6,0.999,
KB,10'5L/mol,6,0.999,
INTRINSICEFFICACY,%,6,0.999,
TRANSPORTRATE,umol.L-1.min-1.mg-1,6,0.999,
ACTIVITY,KA/dl,6,0.999,
IRRITATIONOFEYES,arbitrary units,6,0.999,
HYPOCHROMICSHIFT,%,6,0.999,
ANTIPROLIFERATIVEEFFECT,umol.L-1,6,0.999,
WBCCHANGE,%,6,0.999,
KALKYL,,6,0.999,
ACTIVITY,nm s-1,6,0.999,
TOTALBINDING,pCi mg-1,6,0.999,
K2,L.umol-1,6,0.999,
TOTALRADIOACTIVITY,,6,0.999,
K05,,6,0.999,
UOSM,mOsmol kg-1,6,0.999,
ILC,%,6,0.999,
KH,,6,0.999,
ACTIVITY,AU/mm,6,0.999,
IOGP,,6,0.999,
LOG10CELLKILL,,6,0.999,
KCAT,Min-1,6,0.999,
KIN,uL/g.min,6,0.999,
VMAXH,pmol/min/g,6,0.999,
ABORTION,%,6,0.999,
ACTIVEDOSERANGE,mg uM kg-1 day-1,6,0.999,
ACTIVITY,10'6/100microL,6,0.999,
LD50,pmol/g,6,0.999,
VMAXKM,10'3ml/min,6,0.999,
ACTIVITY,Momega,6,0.999,
KCAT,L.umol-1,6,0.999,
KS,s-1,6,0.999,
50%NAPROXENFORMED,%,6,0.999,
VMAX,amol/cell.min,6,0.999,
IDGFEMUR,%,6,0.999,
%OFINHIBITIONORSTIMULATION,%,6,0.999,
ID50,mg.ml-1,6,0.999,
"KCS,APP",umol.L-1,6,0.999,
KAFF,umol.L-1,6,0.999,
LD,[ppm],6,0.999,
KINACT,M/s,6,0.999,
K,10'-7/hr,6,0.999,
1KREL,,6,0.999,
LEVEL,ng g-1,6,0.999,
KQ,10'13/M/sec,6,0.999,
VD,%,6,0.999,
TUMORVOLUME,%,6,0.999,
VMAX,nM min-1 g-1,6,0.999,
LATENCY,ms,6,0.999,
KQ,,6,0.999,
LOGD50,umol.L-1,6,0.999,
VRT(T),hr2,6,0.999,
KQ,10'11L/mol/s,6,0.999,
IC50,ug.cm-3,6,0.999,
IC50,10^2pM,6,0.999,
KINACT,10e-3 s-1,6,0.999,
1MIC,L/mg,6,0.999,
KQ,10^13/M/sec,6,0.999,
VOLUME,umol.L-1,6,0.999,
ACTIVITY,U/uM,6,0.999,
ACTIVITY,U l-1,6,0.999,
KA,10'-6/M/s,6,0.999,
INCORPORATED,%,6,0.999,
KOBSX10E2,s-1,6,0.999,
ACTIVITY,kU,6,0.999,
KOBSCONCENTRATION,/mol.L-1.s-1,6,0.999,
TRANSCRIPTIONALACTIVATION,%,6,0.999,
TPO(MAX),%,6,0.999,
ACTIVITY,mV/ms,6,0.999,
LC50,ppb,6,0.999,
INCREASECONTRACTILITY,%,6,0.999,
IC50,nA,6,0.999,
KA,10^9/M,6,0.999,
KINACT,/ms,6,0.999,
IC50(APP),,6,0.999,
TUMORSIZE,umol.L-1,6,0.999,
ACTIVITY,RFU/min,6,0.999,
K,10'-6M,6,0.999,
TOXICLEVEL,mg.ml-1,6,0.999,
K,10^-5/nM/s,6,0.999,
TUMORGROWTHINHIBITION,%,6,0.999,
KDISS,10'-1/s,6,0.999,
K,10'-6/s,6,0.999,
WEIGHT,(mg of prostate) (100g of body weight)-1,6,0.999,
VIRUSTITER,pfu/ml,6,0.999,
VIRUSYIELD,ffu ml-1,6,0.999,
KIAPP,umol.L-1,6,0.999,
ACTIVITY,million,6,0.999,
ACTIVITY,cmH2O/ms,6,0.999,
KCATKM,10'-4/uM/s,6,0.999,
VMAX,ug/ml/min,6,0.999,
TRABECULARNO,mM-1,6,0.999,
TUMORGROWTHDELAY,,6,0.999,
K+2K,/mol.L-1.s-1,6,0.999,
VLDL,ug.mg-1,6,0.999,
LOGK,hr-1,6,0.999,
KD,10^2/s,6,0.999,
K3,min-1 M-1,6,0.999,
K,10^-7M,6,0.999,
-LOG(1HC50),,6,0.999,
-TDELTAS,cal/mol,6,0.999,
VT50,,6,0.999,
IC50,ucm,6,0.999,
ACTIVITY,eggs/g,6,0.999,
LATENCYTOEXIT,,6,0.999,
SYNERGYWITHMETHICILLIN,,6,0.999,
KX10E3,s-1,6,0.999,
ANTINOCICEPTION,%,6,0.999,
CELLNODISHX10E5,,6,0.999,
GROWTHRATE,umol.L-1,6,0.999,
CELLSURVIVAL,,6,0.999,
RATFERTILITY,%,6,0.999,
FALLENTREATED,,6,0.999,
FACOACTIVITY,%,6,0.999,
TESTOSTERONE,umol.L-1,6,0.999,
MEANED50,ug.mg-1,6,0.999,
THRUPTAKE,,6,0.999,
GSH,uM g-1,6,0.999,
TESTOSTERONE,,6,0.999,
C10AIRC10N2,,6,0.999,
RATEOFTURBIDITYCHANGE,,6,0.999,
ADDUCTFORMATION,%,6,0.999,
FAUCLAST,hr.nM,6,0.999,
CHANGEINTUMORAREA,%,6,0.999,
MABPCHANGE,,6,0.999,
MEANARTERIALBLOODPRESSURE,%,6,0.999,
CELLULARCONTENT,pM (10e6*cells)-1,6,0.999,
CHANGEINTPR,%,6,0.999,
CELLULARGROWTH,%,6,0.999,
FAUCDOSE,nM.hr,6,0.999,
GSTACTIVITY,nM min-1 (mg of protein)-1,6,0.999,
TIMEOFLICKING,s,6,0.999,
GI50,%,6,0.999,
GABAENHANCEMENT,,6,0.999,
REDUCTION,beats min-1,6,0.999,
FUNGICIDALCONCENTRATION,umol.L-1,6,0.999,
ACTIVITY,umol/mol,6,0.999,
FORMATION,pM/10e9,6,0.999,
FPTASEACTIVITY,fM ug-1 min-1,6,0.999,
CHANGEINFVR,%,6,0.999,
TIMEOVER100NGML,s,6,0.999,
GRI,,6,0.999,
FINALPLASMACONCENTRATION,umol.L-1,6,0.999,
MAP,beats min-1,6,0.999,
CMAX,ug/hr,6,0.999,
DEVELOPEDTENSION,%,6,0.999,
BASISMOTILITY,,6,0.999,
BATHOCHROMICSHIFT,mm,6,0.999,
OCCLUSIONS,,6,0.999,
OCC80,ug.mg-1,6,0.999,
OCC50,,6,0.999,
DISTRIBUTION,% dpm,6,0.999,
CMAX,pmol.hr/g,6,0.999,
DISTRIBUTIONOFEXCRETEDFE,%,6,0.999,
DMF,,6,0.999,
CMAX,ug/kg,6,0.999,
AGONISTINDEX,,6,0.999,
CONVULSIONTHRESHOLD,ug.mg-1,6,0.999,
AD99,ug.mg-1,6,0.999,
TIMETOPEAKTENSION,s,6,0.999,
AD50,pM,6,0.999,
CHANGEINTC,%,6,0.999,
CHANGEINSENSITIVITY,,6,0.999,
RELATIVEBINDING,,6,0.999,
CBFINCREASINGACTIVITY,%,6,0.999,
RATIO,10'-5/M,6,0.999,
RELATIVEANALGESICPOTENCY,,6,0.999,
GLYCINEANTAGONISM,,6,0.999,
RELATIVEAMPLITUDE,,6,0.999,
RATIOIC50,10'4No_unit,6,0.999,
RATIO,10'3/M.s,6,0.999,
CAVERAGE,umol.L-1,6,0.999,
FIBERSPREPARATIONS,,6,0.999,
C24,,6,0.999,
ACTIVITYINDEX,mg-1.g-1,6,0.999,
MAXRESPOSE,,6,0.999,
DERIVEDTRABECULARNUMBER,umol.L-1,6,0.999,
ACTIVITY,pM (2*10e6*cells)-1,6,0.999,
RATECONSTANTAPP,s-1,6,0.999,
HEPATOCYTESTABILITY,uL/min/10e6 cells,6,0.999,
BUNCHANGEBY,%,6,0.999,
CELL,%,6,0.999,
AGGREGATION,,6,0.999,
RCI,%,6,0.999,
RATIO[3H]:TUBULIN,,6,0.999,
ACTIVITY,units/assay,6,0.999,
MEANLOGGI50,,6,0.999,
CELLNODISHX10E3,,6,0.999,
HEXOBARBST,s,6,0.999,
CDYN,%,6,0.999,
TOPOISOMERASE-IACTIVITY,,6,0.999,
RATEOFHYDRIDETRANSFER,s-1,6,0.999,
CELLAGGREGATES,,6,0.999,
HDT,ug.mg-1,6,0.999,
AGONISTACTIVITY,IU mg-1,6,0.999,
HIGH,%,6,0.999,
RATTURNING,%,6,0.999,
RD100,ug.mg-1,6,0.999,
RELATIVEFLUORESCENTUNIT,,6,0.999,
EXTAUC,%,6,0.999,
CC90,,6,0.999,
REACTIONRATE,,6,0.999,
CC50,[ppm],6,0.999,
CELLGROWTH,number of cells ml-1,6,0.999,
AGONISTICEFFECT,%,6,0.999,
EP22,mV,6,0.999,
EXPLORATIONMOTILITY,,6,0.999,
RELATIVEDISSOCIATIONRATE,,6,0.999,
MIDPOINTDOSE,ug.mg-1,6,0.999,
TEMPERATUREDECREASE,degrees F,6,0.999,
LOSSOFINACTIVATION,%,6,0.999,
CHANGEOFHEMOCONCENTRATION,,6,0.999,
GHPEAK,umol.L-1,6,0.999,
FREEFRACTION,%,6,0.999,
REDUCTIONINRESPIRATORYVOLUME,ml,6,0.999,
MAXPLATELETRESPONSE,,6,0.999,
ACTIVITY(UMOLGOFLIVER75MIN),%,6,0.999,
THYROIDSTATUS,umol.L-1,6,0.999,
CAIACTIVITY,,6,0.999,
CHANGEINHEMATOLOGY,,6,0.999,
MBIC,,6,0.999,
THRESHOLDCURRENT,nA,6,0.999,
ACTIVITY,um3/um2/day,6,0.999,
MAXDELTAAPD95,,6,1,
RATIO,10^2/M/s,6,1,
CHANGEINMAP,%,6,1,
CFU,10^8/g,6,1,
GHAUC0-180,ug min l-1,6,1,
RATE,pM min-1 (g dry weight)-1,6,1,
MBEC2,umol.L-1,6,1,
RECOVERYRATE,%,6,1,
CARDIACOUTPUT,ml min-1,6,1,
FLUINTENSITY,RU,6,1,
GFR,ml min-1 kg-1,6,1,
MAXDVDT,V s-1,6,1,
CFUG,,6,1,
FLUORESCENCE,a.u,6,1,
ACTIVITYREGAINED,%,6,1,
GASTRICSCORE,,6,1,
RATIOCC50IC50,10'3No_unit,6,1,
REDUCTIONOFIOP,mmHg,6,1,
CELLSPOSITIVE,%,6,1,
THYMIDYLATESHIFT,,6,1,
AUCDOSE,Kg.mg.hr/L.mg,6,1,
EXCRETION,mg dl-1,6,1,
OMNIMED,ug.mg-1,6,1,
AVERAGE,c.p.m.,6,1,
DECREASEINTONE,,6,1,
CMIN,fmol,6,1,
PANCREATICRESPONSE,,6,1,
DEATHDOSE,ug.mg-1,6,1,
PAPP,ucm,6,1,
PAPP,umol/L/s,6,1,
RRT,,6,1,
SC50,%,6,1,
CMINSS,nmol/g,6,1,
PARASITECLEARANCETIME,s,6,1,
D2SELECTIVITY,,6,1,
SERUMGLUCOSE,mg dl-1,6,1,
RRT,mean,6,1,
AUCLAST,nmol/hr/L,6,1,
DECREASEOFSBP,mmHg,6,1,
AVERAGEFORSKINREACTION,,6,1,
ROI,,6,1,
PA1,,6,1,
PKH,,6,1,
CONCENTRATION,uM 100ml-1,6,1,
PHOSPHORYLATIONRATE,umol.L-1,6,1,
PC95,umol.L-1,6,1,
CULTURENEGATIVE,%,6,1,
CONVERSIONRATE,,6,1,
PERMEABILITY,Papp* 10E6 cm/s,6,1,
AUCUNITS,,6,1,
CONTROLOFGROWTH,%,6,1,
PERMEABILITY,10'-4 cm/min,6,1,
"S20,W",Svedberg,6,1,
PERMEABILITY,umol cm2/hr,6,1,
PERIOSTEALMINERALAPPOSITIONRATE,mm day-1,6,1,
COI,%,6,1,
AUCLASTDOSE,mg.hr/ml,6,1,
PICSEIZURE,ug.mg-1,6,1,
BP,umol.L-1,6,1,
DELTAG,Cel,6,1,
T,ns,6,1,
CL,uL/mg/min,6,1,
CL,uL.ml-1,6,1,
ANTIGENP24CONTENT,umol.L-1,6,1,
T-C,days (optimal dose)-1,6,1,
ED250,umol.mg-1,6,1,
ED50,(ug of misoprostol) kg-1,6,1,
BODYTEMPERATUREDROP,Cel,6,1,
ED50,10'-10M,6,1,
ANTICONULSANTACTIVITY,%,6,1,
RELATIVERESPONSE,%,6,1,
QKD,umol.L-1,6,1,
MIC,L.umol-1,6,1,
T>EC50,s,6,1,
CYTOCHROMELOSS,,6,1,
QT,,6,1,
ANTIBODYTITER,,6,1,
MHPGSO4,ug g-1,6,1,
CL,ml/hr/mg,6,1,
CL,ml min-1,6,1,
ANTI-FXAACTIVITY,%,6,1,
RELATIVESELECTIVITY,,6,1,
CI95,,6,1,
AUC,nmol.hr,6,1,
RESPIRATORYSYSTEMRESISTANCE,,6,1,
CONCENTRATION,pM (10e6*cells)-1,6,1,
RTACTIVITY,%,6,1,
PC20,,6,1,
CONCENTRATION,mg dl-1,6,1,
AUCTDOSE,min.kg/L,6,1,
T>FEC50,s,6,1,
AUCTDOSE,microM.hr/mg/kg,6,1,
NOOFWRITHES,,6,1,
SSAT,pM min-1 mg-1,6,1,
AUC,u-1 hr-1 ml-1,6,1,
RESTINGPOTENTIAL,-mV,6,1,
DRUGEXCRETION,umol,6,1,
DRUGMETABOLISM,10'-2/hr,6,1,
CLZF,ml/hr/kg,6,1,
AUC,pmol.hr/g,6,1,
RESPONSE,ug.mg-1,6,1,
CLUP,ml/min,6,1,
BINDINGCONSTANT,,6,1,
DRUGMETABOLISM,nmol/L,6,1,
AUC,pM hr-1 g-1,6,1,
DRUGMOLBASEPAIR,,6,1,
REVERSIBILITY,,6,1,
NORELEASE,,6,1,
NOOFFOCIPERDISH,,6,1,
CMAX,ng/mL.hr,6,1,
P24,umol.L-1,6,1,
SLOPE,g dl-1M-1,6,1,
SLOPE,mutants ug-1,6,1,
PLAQUEINHIBITIONRESULT,,6,1,
SMT,,6,1,
SNA,%,6,1,
AVOIDANCERESPONSE,,6,1,
DELTAS,cal/mol/K,6,1,
DENATURATIONRATECONSTANT,s-1,6,1,
ONSETFORSLEEP,s,6,1,
CMAX,umol.mg-1,6,1,
CONTROLCELLNUMBER,%,6,1,
DEPLETION,%,6,1,
BINDING,fM uterus-1,6,1,
AVERAGETURNSFIRST15MIN,,6,1,
NOOFINFECTEDCELLS,%,6,1,
CROPYIELD,Kg,6,1,
CONCENTRATION,ul,6,1,
PD2APP,,6,1,
CONCENTRATIONINBRAIN,umol.L-1,6,1,
SECRETION,uM hr-1 kg-1,6,1,
CRSECRETION,%,6,1,
CROPYIELD,mg,6,1,
PEAKRADIOACTIVITYINBLOOD,% injected dose cm**-3,6,1,
PCOCT,,6,1,
SD50,ug.mg-1,6,1,
CR,%,6,1,
SCORE,%,6,1,
SCMET,ug.mg-1,6,1,
SR,,6,1,
PKINACT,,6,1,
PCPACTIVITY,cysts g-1,6,1,
PEAKINHIBITION,%,6,1,
SPERMIDINECONCENTRATION,nM (10e6*cells)-1,6,1,
DRUGDEGRADATION,10'-8mol/min,6,1,
AUC,uM.h. kg/mg,6,1,
RETRACTIONTIME,s,6,1,
NOOFRELAPSES,,6,1,
NOOFMICEDEAD,,6,1,
SPECIFICITY,%,6,1,
REVERSEPOTENTIAL,,6,1,
NOOFSHOCKSACCEPTED5MIN,,6,1,
NOOFSPIKES,,6,1,
PKL,,6,1,
AVERAGERATIO,,6,1,
NON-HDL-C,mg dl-1,6,1,
CPMMILLIONCELLS,,6,1,
DECREASEINCVR,%,5,1,
CONCENTRATION,pmol/E109 cells,5,1,
DECREASEINHYPOTHALAMUSNOREPINEPHRINE,%,5,1,
DECREASEINHEARTNOREPINEPHRINE,%,5,1,
CARBAMOYLATINGACTIVITY,,5,1,
SGPTACTIVITY,units/mL,5,1,
X,s,5,1,
LOGAC50,,5,1,
FOODINTAKE,%,5,1,
PHOSPHORYLATION,%,5,1,
MAXTOLERATEDDOSE,uM kg-1,5,1,
IC50L,umol.L-1,5,1,
VIRUCIDAL,,5,1,
FOODINTAKE,,5,1,
MBC100,,5,1,
AUCED90,umol.h.L-1.d-1,5,1,
SERUMT4,ug dl-1,5,1,
IC50,liposomes ml-1,5,1,
CARBONYLGROUP,nM mg-1,5,1,
S-GOTLEVEL,Karmen units,5,1,
KAPP,10'8/M,5,1,
GI50,10^4M,5,1,
RATIO,10'5/M/min,5,1,
TOXICEFFECT,,5,1,
1N,,5,1,
RATIO,10^3/s/M,5,1,
SGOTACTIVITY,units/mL,5,1,
CA2+ANTAGONISTICACTIVITY,%,5,1,
LOSSOFAFFINITY,,5,1,
KC,umol.L-1,5,1,
TIMECONSTANTT3,,5,1,
HEPATICTRIGLYCERIDE,mg g-1,5,1,
CP,pg/mg,5,1,
PEFF,10'-3cm/min,5,1,
I40,umol.L-1,5,1,
C20FRP,,5,1,
TINH,,5,1,
AUCLASTDOSE,hr.kg.ng/ml/mg,5,1,
TPE,toxicity,5,1,
FRS50,umol.L-1,5,1,
DBPUPRATIO,,5,1,
K+EXCRETION,ml 6hr-1 100g-1,5,1,
C8H,,5,1,
MAXPROTECTION,,5,1,
MAXPROTECTIVEEFFECT,%,5,1,
FRACTIONRECOVEREDINURINE,%,5,1,
PHOSPHOLIPIDOSIS,umol.L-1,5,1,
THY-1EXPRESSION,,5,1,
PHOSPHOLIPIDOSISINDEX,,5,1,
MAXSCORE,,5,1,
DECREASE,mmHg,5,1,
AUCLAST,pmol.hr/g,5,1,
ANTIFUNGALACTIVITY,%,5,1,
RATIO,ml/g,5,1,
ED100,nM kg-1,5,1,
LC50,%,5,1,
INH,umol.mg-1,5,1,
BEHAVIORALSYNDROME,,5,1,
ED200,,5,1,
PLATELETCOUNTUL,,5,1,
MIC=<90,,5,1,
MIC999,,5,1,
BC,umol.L-1,5,1,
NOOFESCAPEFAILURE,,5,1,
ED30,mg.kg-1.d-1,5,1,
BICARBONATELEVEL,,5,1,
AUC,uM hr ml-1,5,1,
NOOFAVOIDANCE,,5,1,
DRUGMETABOLISM,nmol/min/nmol,5,1,
EC80,,5,1,
LDED80,,5,1,
LDH,,5,1,
AUC,nmol/g.min,5,1,
ACCUMULATION,nM g-1,5,1,
INHIBITIONAT5NM,%,5,1,
VMREL,%,5,1,
VMAX,M min-1,5,1,
EC90,ppb,5,1,
ABD50,ug.mg-1,5,1,
UD50,,5,1,
REDUCTIONINAUC,,5,1,
DRUGMETABOLISM,microM/min/mg,5,1,
PARTITIONCOEFFICIENT,s,5,1,
MAXDELTAVMAX,%,5,1,
AUMC,microM.hr^2,5,1,
GATEDCURRENT,%,5,1,
LOGIC50,log(1/M),5,1,
WEIGHTDIFFERENCE,T-C,5,1,
RATIO,10^6/M/min,5,1,
LOGDSF,,5,1,
PAPP,um.s-1,5,1,
KPOL,s-1,5,1,
CONCENTRATIONPLASMA,umol.L-1,5,1,
S-GPTLEVEL,Karmen units,5,1,
MAXIMALCHANGE,%,5,1,
VIRUSINACTIVATION,%,5,1,
MAXFALLINIOP,,5,1,
DAMAGEREDUCTION,%,5,1,
ACTIVITY,ml/cm3,5,1,
ACTIVITY,ml/cm3/min,5,1,
K+2KI,umol.L-1.min-1.,5,1,
MAXIMALACTIVATION,,5,1,
EXUDATEVOLUME,ml,5,1,
STERILITY,%,5,1,
AVERAGE14-DAYMGR,,5,1,
HEPATICCHOLESTEROL,mg g-1,5,1,
ACTIVITY,mM hr-1,5,1,
MAXAPD90(DELTA),%,5,1,
PIC35,,5,1,
ACTUALDURACTION,,5,1,
SLEEPRATIO,,5,1,
PK4,,5,1,
2PT,10'-3M,5,1,
LOG1KL,,5,1,
OXYTOCICACTIVITY,U mg-1,5,1,
CONCENTRATION,ng day-1,5,1,
RATIO,1/M.sec,5,1,
ID50,mg ear-1,5,1,
AUMCT,ng.hr/ml,5,1,
MEANBLOODPRESSURE,umol.L-1,5,1,
CHANGEINTC,,5,1,
MD,%,5,1,
AVBLOCK,,5,1,
DELTACPP,mmHg,5,1,
DELTAH,10^4cal/mol,5,1,
MBEC80,umol.L-1,5,1,
FCMAX,nmol/g,5,1,
AUCED50,ug.mg-1,5,1,
RATIO,No unit,5,1,
CONCENTRATION,pmol/10E9 cells,5,1,
ACTIVITY,pM hr-1 mg-1,5,1,
AUCT,pmol.hr,5,1,
COMPOUNDRECOVERY,s,5,1,
DELTAH-V,ms,5,1,
SDL,,5,1,
LOG1I50,,5,1,
KA,10^2/M/s,5,1,
C2,ug g-1,5,1,
TG2XLAG,umol.L-1,5,1,
THERMSOLUBILITY,%,5,1,
MEAIBUPTAKE,,5,1,
PITURNOVER,%,5,1,
TRANSPORT,pM min-1 (mg of protein)-1,5,1,
FLUINTENSITY,10^9/s/cm2,5,1,
FNOAEL,umol.L-1,5,1,
AUCDOSE,umol/l.hr,5,1,
RELATIVEANTITUMORACTIVITY,,5,1,
1VMAX,deltaA/s,5,1,
ME,%,5,1,
AUCDOSE,ng.hr.kg/mg/ml,5,1,
C10APD90,umol.L-1,5,1,
KCATKM,uM-1 min-1,5,1,
ICA,,5,1,
ACTIVITY,mJ,5,1,
CONCENTRATION,ml,5,1,
CONCENTRATION,dpm,5,1,
FAUC,nmol/g/min,5,1,
ID50,mg.kg-1.d-1,5,1,
AUCDOSE,uM.hr/mg,5,1,
I50M,,5,1,
COVALENTBINDING,%,5,1,
HELICITY,%,5,1,
ACTIVITY,pM 10min-1,5,1,
ACTIVITY,nanometer2/sec,5,1,
VMAX,area/min/mg,5,1,
[I]05,umol.L-1,5,1,
TOTALBINDINGINHIBITED,%,5,1,
KIX,umol.L-1,5,1,
HTSDATA,,5,1,
CP,ug.hr.ml-1,5,1,
CP,umol.h.L-1,5,1,
HYPOGLYCEMICACTIVITY,,5,1,
PEFF,10^-6nanometer/s,5,1,
RBC,10e6 ul-1,5,1,
KB,10^4L/mol,5,1,
I,,5,1,
KBETA,umol.L-1,5,1,
CP,pmol/g,5,1,
LOGPCYC,,5,1,
PERIPHERALRESTRICTIONINDEX,,5,1,
HFRATIO,,5,1,
AUCTDOSE,ug.hr/mL/mg/kg,5,1,
KCAT,10'-3/hr,5,1,
KB,10'9/M,5,1,
PEC5,,5,1,
PEC50,umol.L-1,5,1,
%OFACTIVITYREMAINING,%,5,1,
AUCT,hr.ng/g,5,1,
RATIOIC50EC50,10'5No_unit,5,1,
S-PHASE,%,5,1,
CROSSREACTION,%,5,1,
LYSISTIME,s,5,1,
K,10^8/M/min,5,1,
CFRRATING,,5,1,
KMKCAT,uM s-1,5,1,
PD50,umol.mg-1,5,1,
KN,,5,1,
CORRELATIONCOEFFICIENT,,5,1,
CC100,,5,1,
PD200,umol.mg-1,5,1,
ACTIVITY,pmol/(s.cm2),5,1,
ACTIVITY,pmol/Kg,5,1,
%RELEASEOFNITRICOXIDE,uM uM-1,5,1,
KINETICSOLUBILITY,10'-5mg/ml,5,1,
KOBS,/ms,5,1,
KINETICSOLUBILITY,10'-4mg/ml,5,1,
K,umol.min-1,5,1,
MAXACHIEVABLEBIOAVAILABILITY,,5,1,
KINACTKM,/mol.L-1.s-1,5,1,
KCATKM,/M/hr,5,1,
CHALLENGEDOSE,,5,1,
RATIOAUC,ml/g,5,1,
MAXAGONISTACTIVITY,%,5,1,
MLC,ug.mg-1,5,1,
CHANGEINBLOODFLOW,%,5,1,
EC95,[ppm],5,1,
INCREASEIN[CA+2],umol.L-1,5,1,
LOAEL,ug.mg-1,5,1,
EPINEPHRINELEVEL,,5,1,
LMA,%,5,1,
EDDELTA,ug.mg-1,5,1,
NOSURVIVED,,5,1,
AMOUNTRECOVEREDINURINE,mg,5,1,
B-AA-B,,5,1,
EPOXIDEFORMATION,umol.L-1,5,1,
LIVERWEIGHT,g (100g of body weight)-1,5,1,
88Y-SERUM,%,5,1,
LIVERTG,,5,1,
KA,uM kg-1,5,1,
REMISSION,%,5,1,
LD100,[ppm],5,1,
AUCDOSE,hr.kg.ug/ml/mg,5,1,
DILATION,,5,1,
VZF,(mg/kg)/(uM),5,1,
BUI,,5,1,
RATE,nM-1 min-1 (mg of protein)-1,5,1,
SOLUBILITY,mg/uL,5,1,
AUCDOSE,M.hr.kg/mg,5,1,
TUBULIN,,5,1,
TD,umol.L-1,5,1,
C,mg.ml-1,5,1,
OLIGOSHIFTED,%,5,1,
MED999,ug.mg-1,5,1,
DELTAWEIGHT,,5,1,
VDSS,ml/min.kg,5,1,
CLF,L/Kg,5,1,
EC50,10'11PFU,5,1,
MI05,,5,1,
VMAXK,,5,1,
STABILITY,pmolequiv/mg,5,1,
EC50,10^-2nM,5,1,
RESPONDING,,5,1,
ABSOLUTE,%,5,1,
EC50,10^2 uM,5,1,
BMAX,disintegrations/min,5,1,
VMAX(APP),umol.L-1.s-1,5,1,
CLF,(mg)/(ug/ml)/hr,5,1,
MHC10,,5,1,
T12,ml/min.kg,5,1,
EMIN,,5,1,
C0,ng/L,5,1,
MED50,umol.L-1,5,1,
AMBULATIONSCORE,,5,1,
TC50IC50,,5,1,
TS,Cel,5,1,
VMAX,pmol/min/ug,5,1,
ACTIVITY,mAU ml-1,5,1,
ENANTIOSELECTIVITYCOEFFICIENT,,5,1,
IMPAIRED,%,5,1,
DFM,mg/cm2,5,1,
VDSS,Not_given,5,1,
EXCRETED,,5,1,
INFECTED,%,5,1,
KA,l mol-1,5,1,
ACTIVITY,10^-10No_unit,5,1,
NOOFVIRUSFREEMICE,,5,1,
AUC,ug h/g,5,1,
ED50,umol.h.L-1,5,1,
K,10'10/M/s,5,1,
ACQUISITIONTIME,,5,1,
KI2,umol.L-1,5,1,
AUC,ug.ml-1,5,1,
MEANLOGLC50,,5,1,
ACTIVITY,g/mm,5,1,
LIVERCHLEVELS,,5,1,
AUCDOSE,nM/hr,5,1,
RATEOFFORMATION,nM (mg of protein)-1,5,1,
CHANGEOFWEIGHT,%,5,1,
ANIMALSAFFECTED,,5,1,
ANESTHETICEFFECT,%,5,1,
DELTAS-H,ms,5,1,
EXTENTOFDNABINDING,,5,1,
ANIMALSAFFECTED,%,5,1,
AOC,mmHg.hr,5,1,
MEANNOOFDAYSPOST-INFECTIONTODEATH,,5,1,
KD,10'-8/s,5,1,
SPECIFICRADIOACTIVITY,Ci/M,5,1,
OFDOSEEXCRETED,%,5,1,
ANIMALSWITHPALPABLETUMOR,,5,1,
CI,%,5,1,
MEC,mg,5,1,
AGONISTRESPONSE,,5,1,
LOG(1MEC),,5,1,
ACTIVITY,log10RLU,5,1,
AUC100,ug.mg-1,5,1,
ILS,d,5,1,
K,10'4/Ms,5,1,
KD,10^-4/s,5,1,
PKR+,,5,1,
IL-1PRODUCTION,pg ml-1,5,1,
AUC,umol.hr/kg,5,1,
EFFICIENCY,uM-1 s-1,5,1,
LIVERCHOLESTEROL,mg (g of tissue)-1,5,1,
VD,ml/min.kg,5,1,
BRAINCONCENTRATION,,5,1,
K,10'4/s,5,1,
NOOFRATSDISPLAYINGDASYNDROME,,5,1,
TED,nM kg-1,5,1,
KI1,umol.L-1,5,1,
NOOFSURVIVORSTOTAL,,5,1,
RATEOFFORMATION,pM min-1,5,1,
MFED,,5,1,
POSITIVEPAWS,%,5,1,
RELATIVELOSSOFPOTENCY,,5,1,
UPTAKE,fM cell-1,5,1,
PLASMAMIC,umol.L-1,5,1,
NOOFINVADEDCELLS,,5,1,
INH,pM,5,1,
QH,L/hr.Kg,5,1,
NOOFLUNGLESIONS,,5,1,
LESIONSCORE,,5,1,
DRUGDEGRADATION,pmol/min/mg,5,1,
DRUGDEGRADATION,a.u.,5,1,
T12,umol.L-1,5,1,
PLASMATOTALCHOLESTEROL,mg dl-1,5,1,
VR,ml,5,1,
ED50,10'-4umol/ml,5,1,
T12H,,5,1,
AUC,uM min uM-1,5,1,
CL,ml/min.mg,5,1,
INH,L.mol-1,5,1,
KA,10^10/M,5,1,
UTERUSEFFECT,,5,1,
CMAX,%ID,5,1,
PRESSORRESPONSE,%,5,1,
MTD,mg/day,5,1,
CLINT,,5,1,
UPTAKERATE,nM min-1 cm**-2,5,1,
SUBSTRATEEFFICIENCY,%,5,1,
CL,ml/mm/kg,5,1,
NOOFMICESURVIVING>6MONTHS,,5,1,
CLF,ug/ml.hr,5,1,
K,10'-6/M/s,5,1,
MITOTICFIGURES,,5,1,
SURFACEINVOLVEMENT,%,5,1,
AOC,,5,1,
AUC,nmol/g/min,5,1,
SWO,,5,1,
EC70,umol.L-1,5,1,
CL,nL/pmol/min,5,1,
AAC,Deltalog10[CFU].ml-1.h-1,5,1,
CL,ml mg-1 kg-1,5,1,
KA,10^5L/mol,5,1,
DR20,ug.mg-1,5,1,
T2,s,5,1,
NOOFNEWTUMORS,,5,1,
ACTIVITY,deltalog10pfu/g,5,1,
T3,%,5,1,
RELATIVERATE,%,5,1,
BPDECREASE,,5,1,
NOOFOPENARMENTRIES,,5,1,
ED50,Ug/ml,5,1,
BAV,%,5,1,
ACTIVITY,dyn/cm,5,1,
ED50,mg kg-1 dose-1,5,1,
NOOFMICEWITHOUTTUMORS,,5,1,
VMAXKM,ml/min/mg,5,1,
NOOFGUINEAPIGSPROTECTED,,5,1,
CLF,ug.mg-1,5,1,
BLOODLEVEL,,5,1,
ISOMETRICCONTRACTION,%,5,1,
KI,1/M.s,5,1,
AUC,h-1,5,1,
ACTIVITY,N/mm,5,1,
MORBIDITY,%,5,1,
SURVIVALTIME,s,5,1,
PROTECTION,d,5,1,
VMAXL,pmol/min/g,5,1,
CLUF,ml/min.kg,5,1,
ACTIVITY,Pmol,5,1,
MOLARPOTENCY,,5,1,
ULCERINDEX,mm,5,1,
EC50,uL.ml-1,5,1,
DRUGUPTAKE,%Idose/kg,5,1,
MNTD>75,umol.L-1,5,1,
INHIBITORYACTIVITY,%,5,1,
DRUGUPTAKE,%ID.m^-2,5,1,
INHIBITIONOFINCREASEINWEIGHT,%,5,1,
ACTIVITY,10^5No_unit,5,1,
PROGRESSEDREMISSION,%,5,1,
NECROSIS,,5,1,
BINDINGAFFINITY,L.umol-1,5,1,
INITIALHEARTRATE,bts min-1,5,1,
KEQ,umol.L-1,5,1,
INHIBITORYRATIO,%,5,1,
KA,10'5/uL,5,1,
DRUGUPTAKE,umol.h.L-1,5,1,
ISC,,5,1,
RESCUEDNEURONS,%,5,1,
NEGATIVEIONOTROPICACTIVITY,%,5,1,
AUC,hr.kg.ng/ml/mg,5,1,
IPOL,umol.L-1,5,1,
KI,/nM,5,1,
CLONICSEIZURES,%,5,1,
KA,10'5/M.s,5,1,
LD50,10'-3 ug/ml,5,1,
IOPLOWERING,mmHg,5,1,
PRODRUGREMAINS,%,5,1,
POTENTIATIONINFLECTIONPOINT,umol.L-1,5,1,
IP+SCSCORE,,5,1,
PPM,,5,1,
IP3-SENSITIVECA2+STORES,%,5,1,
DRUGUPTAKE,ug/kg,5,1,
KHD,,5,1,
NEGATIVECHRONOTROPICACTIVITY,%,5,1,
RESIDUALAMINE(EE),%,5,1,
AUC,min.sec,5,1,
NA+EXCRETION,ml 6hr-1 100g-1,5,1,
CLH,mg/min/g,5,1,
ACTIVITY,pS,4,1,
ZONEREDUCTION,%,4,1,
KB,10^5L/mol,4,1,
HYPOKINESIA,Counts,4,1,
RD50,umol.L-1,4,1,
LOG[-10],,4,1,
[3H]-UPTAKE,,4,1,
RATSTURNING,%,4,1,
LOG[-9],,4,1,
TOTALINFARCTVOLUME,mm,4,1,
KCAT,/mol.L-1.s-1,4,1,
KAPPX10E6,L.umol-1,4,1,
RATIOOFDOSE,,4,1,
TMED,ug.mg-1,4,1,
KCAT,1/s,4,1,
CC50,10'3ug/ml,4,1,
TOTALPROTEIN,mg 100g-1 24hr-1,4,1,
ACTIVITY,pM/mg,4,1,
LV,dP/dtmax,4,1,
%CHANGE,%,4,1,
LVDPDTMAX,%,4,1,
HEARTWEIGHTABSOLUTE,mg,4,1,
RATIOCC50EC50,10^5No_unit,4,1,
ACTIVITY,ngequiv,4,1,
TOTALUPTAKE,,4,1,
CATALASE,mg of protein,4,1,
KCAT,ms-1,4,1,
CFU,%,4,1,
HC5,,4,1,
CARTILAGESPACE,,4,1,
IC12,,4,1,
TOTALTRITIUM,%,4,1,
IC20,10'-6M,4,1,
CAROTIDFLOWDECREASE,%,4,1,
CFU-GEMM,%,4,1,
MASSINDEX,%,4,1,
HYDROXYPROLINERELEASE,umol.L-1,4,1,
MASSINDEX,mg/10g body weight,4,1,
KCATKM,%,4,1,
TOTALURINEACTIVITY,%,4,1,
IC37,umol.L-1,4,1,
RATIOCC50EC50,10^4No_unit,4,1,
LOGKP,ucm.s-1,4,1,
LYSISTIME,,4,1,
C6H,umol.L-1,4,1,
RATIOOFSTIMULATION,,4,1,
ACTIVITY,nmol of MDA/mg of LDL,4,1,
HC90,umol.L-1,4,1,
ACTIVITY,uL/L,4,1,
HAPTOGLOBIN,g l-1,4,1,
ACTIVITY,mg/mm3,4,1,
ACTIVITYINANIMALS,,4,1,
IC50,nM kg-1,4,1,
THYMIDINEREVERSAL,,4,1,
THYLPOSITIVECELLSSPLEEN,%,4,1,
FRACTIONOFLIVERBLOODFLOW,%,4,1,
THYLPOSITIVECELLS,%,4,1,
C70,umol.L-1,4,1,
FRACTIONCHANGE,%,4,1,
FRACTION,,4,1,
IC50,10^-1microM,4,1,
-LOGIC50IC50,,4,1,
MAXEFFECT,Counts 10min-1,4,1,
CACO-2PERMEABILITY,% hr-1,4,1,
IC50,10'-10 uM,4,1,
CHALLENGEDOSE,cells mouse-1,4,1,
CHALLENGETIME,,4,1,
RATIO(CICE),,4,1,
RATIO,umol.min-1,4,1,
RECOVERY,dpm ml-1,4,1,
KAPP,10^-5/M,4,1,
GLUCOSE,mg day-1,4,1,
TPL,umol.L-1,4,1,
ACTIVITYFACTOR,,4,1,
ACTIVITY,pfu/ml,4,1,
IC50,mg.min/m3,4,1,
RECEPTORSTATE,,4,1,
RATIOCC50EC50,10^3No_unit,4,1,
RATIOCC50EC50,10^2No_unit,4,1,
GLUCOSEUPTAKE,uM mg-1,4,1,
FT12,,4,1,
-LOGKI,,4,1,
GASTRICDAMAGE,%,4,1,
ACTIVITY,umol.L-1.h-1,4,1,
CHANGEINFOOT-LICKINGLATENCY,%,4,1,
KCATKM,10'4/Ms,4,1,
ACTIVITY,milliosmole,4,1,
MAXIMALDECREASEINIOP,mmHg,4,1,
IC50,10^2 nM,4,1,
ACTIVITY,umol/min/kg,4,1,
REFLEX,,4,1,
CA2+FLUX,nM mg-1,4,1,
FUNCTIONALSELECTIVITY,,4,1,
ACTIVITY,units ml-1,4,1,
ACTIVITY,mg/uM,4,1,
1KMAX,s,4,1,
RELATIVE,g %,4,1,
TOTALRELEASE,%,4,1,
BRAINLESION,mm,4,1,
TM,s,4,1,
RATECHANGE,%,4,1,
ILSDAYS,%,4,1,
EMAX,deltalog10[CFU].ml-1,4,1,
EMAX,bpm,4,1,
MEC50,umol.L-1,4,1,
ALBUMIN,mg 100g-1 24hr-1,4,1,
IMPDHACTIVITY,(nM of XMP formed) hr-1 (mg of protein)-1,4,1,
ALKYLATINGACTIVITY,10e3*k,4,1,
BRAINUPTAKE,%,4,1,
VZF,(mg/kg)/(ng/ml),4,1,
CI25,,4,1,
AGONISTICPOTENCY,%,4,1,
TUBULINCONTENT,umol.mg-1,4,1,
TCMIN,,4,1,
ACTIVITY,kcps,4,1,
MED,umol,4,1,
MED100,,4,1,
TCI,%,4,1,
RELATIVEINITIALRATE,,4,1,
RELATIVEINITIALSLOPE,,4,1,
CL,%ID/cc,4,1,
TUMORBLOODRATIO,,4,1,
ALBCHANGE,,4,1,
C,ng/mL,4,1,
TC50,mg/m3,4,1,
ACTIVITY,l kg-1,4,1,
ID50,%,4,1,
ACTIVITY,mmol/m2/s,4,1,
FMAX,pg/ml,4,1,
THERMOGENESIS,,4,1,
IC70,,4,1,
ACTIVITYSCORE,,4,1,
IC95,,4,1,
RATIO,1/M 1/s,4,1,
ACTUALCLEARANCE,ml min-1 kg-1,4,1,
ICMAX,%,4,1,
ID100,ug/kg,4,1,
C12H,ng g-1,4,1,
ID30,mg,4,1,
ACUTELETHALTOXICITY,,4,1,
RATIO,/min/nM,4,1,
FERRETEMESIS,,4,1,
TEWL,,4,1,
F34,,4,1,
ACTIVITY,inches,4,1,
IMRATIO,,4,1,
ILS(MGKG),%,4,1,
AMNESIAREVERSAL,,4,1,
TC50,10^3uM,4,1,
%OFNORELEASE,,4,1,
IDG,,4,1,
EPSMED,ug.mg-1,4,1,
N20FORMED,umol.L-1,4,1,
EOSINHIBITION,%,4,1,
WATERINTAKE,ml 20min-1,4,1,
AG80,%,4,1,
CHOLESTEROLCONTENT,,4,1,
CHOLESTEROLLEVEL,mg g-1,4,1,
IH50,umol.L-1,4,1,
RELATIVEACTIVITYOFACHE,,4,1,
RATIO,10^-4/uM/min,4,1,
MAXRESPONSE,uV,4,1,
MAD,,4,1,
RATIOIC50,10^6No_unit,4,1,
GROWTHRESPONSE,%,4,1,
TOTALRATE,g-1 min-1 ml-1,4,1,
RATIOIC50,10^3No_unit,4,1,
RATIOIC50,10^2No_unit,4,1,
TOTALRATE,min-1,4,1,
RATIOIC50,10^-4No_unit,4,1,
GROSSMORPHOLOGY,,4,1,
TM(APP),Cel,4,1,
KD,10'3/s,4,1,
RELATIVEEFFICIENCY,,4,1,
VZF,mg,4,1,
CHOLCHANGE,,4,1,
5-HTPACCUMULATION,ug g-1,4,1,
F12,,4,1,
ID80,micromol/kg/min,4,1,
C10,air/N2,4,1,
ACTIVITY,mIU/ml,4,1,
F%T>MIC,,4,1,
TREMOROLYTICDOSE,,4,1,
TEST,,4,1,
RATEOFOXIDATION,nM min-1 ml-1,4,1,
EXTERNALNUCLEOSIDE,nM g-1,4,1,
TRIGCHANGE,,4,1,
CHANGESINAIRWAYRESISTANCE,RL,4,1,
CHANGESINDYNAMICCOMPLIANCE,Cdyn,4,1,
LOG10CFU,mg,4,1,
2XTG,umol.L-1,4,1,
AFFINITYCONSTANT,L.umol-1,4,1,
LOG10CCID50G,,4,1,
ERYTHEMAFORMATION,,4,1,
AGGREGATIONRATIO,,4,1,
EROSIONS,,4,1,
MEANPAWDIAMETER,umol.L-1,4,1,
ACTIVITY,uM/kg,4,1,
MRTINF,s,4,1,
RATIO,nmol/g/uM,4,1,
ACTIVITY,Karmen,4,1,
RENALCLEARANCE,ml min-1 kg-1,4,1,
AUC,hr/L.kg,4,1,
ED50ED50(TAXOL),,4,1,
ACTIVITY,hr-1,4,1,
ANTAGONIST,,4,1,
ED50,ugAi/ml,4,1,
MTDRATIO,,4,1,
LD16,ug.mg-1,4,1,
DTH,,4,1,
ED50,pM,4,1,
DURATION,d,4,1,
IC50,10'-8mg/ml,4,1,
PP2ASELECTIVITY,,4,1,
LD50,10'-4M/ml,4,1,
MEDTUMORWEIGHT,mg,4,1,
KD,kcal.mol-1,4,1,
ANALOGUELEVEL,pM (10e6*cells)-1,4,1,
ED50,umol/kg.min,4,1,
TAILFLICK,%,4,1,
RELATIVEPHOSPHORYLATIONRATE,,4,1,
KD,10^7/M,4,1,
ED50,uM mouse-1,4,1,
APOPTOSISINDUCTION,%,4,1,
MLD,g/Kg,4,1,
UI,mm2,4,1,
MLC50,%,4,1,
KDS,,4,1,
CL(APP),L/hr,4,1,
EC50,10'-7mol,4,1,
SYNAPTICSITE,,4,1,
AUC,hr.%ID/ml,4,1,
AUC,fmol,4,1,
INSULINRELEASE,%,4,1,
EC50,10'-2ppm,4,1,
ED,U mg-1,4,1,
BODYTEMPERATURE,Cel,4,1,
CLF,g/min,4,1,
ANTIVIRALACTIVITY,,4,1,
LDHRELEASE,,4,1,
SWIMMINGACTIVITY,T/C,4,1,
UD50,uM kg-1,4,1,
ECAR,%,4,1,
UD50,umol.mg-1,4,1,
BLOODUREANITROGEN,,4,1,
ANTIVIRALSELECTIVITY,,4,1,
ACTIVITY,U/g.Hb,4,1,
ACTIVITY,U/dl,4,1,
VSS,l,4,1,
TUMORLIVERRATIO,,4,1,
MFC50,,4,1,
TUMORSIZE,mg,4,1,
ACTIVITY,fmol/mg,4,1,
AMPAEFFECT,%,4,1,
SUBCUTANEOUSSCORE,,4,1,
INCREASEINHR,,4,1,
LD50,L.mol-1,4,1,
POW,,4,1,
VMAXKM,ml min-1 kg-1,4,1,
ACTIVITY,AU/L,4,1,
MTD,ug/kg/day,4,1,
LEVELOFCGMP,pM,4,1,
PRESSORACTIVITY,,4,1,
KA,mM-1,4,1,
INTRAPERITONALSCORE,,4,1,
CLFREE,uL/hr/10^6cells,4,1,
VSS,kg-1,4,1,
AMOUNTOFTXB2FORMATION,umol.L-1,4,1,
ED90,umol.mg-1,4,1,
LH,umol.L-1,4,1,
A,%,4,1,
ED50,dp/dt,4,1,
MBC100,umol.L-1,4,1,
CL,L/hr/1.73 m2,4,1,
KA,10'6/M/min,4,1,
RC10,,4,1,
PRESSORRESPONSE,IU mg-1,4,1,
UREANITROGENCONCENTRATION,mg dl-1,4,1,
LIVERCONCENTRATION,nM kg-1,4,1,
ANTAGONISTACTIVITY,pA2,4,1,
INCREASEINTEMPERATURE,,4,1,
INCREASEINLIFE-SPAN,,4,1,
INFERTILITYACTIVITY,,4,1,
LIMITINGT12,s,4,1,
AUC,microg.hr/mL.g,4,1,
DTH,umol.L-1,4,1,
ED50,ug rat-1,4,1,
MTDTGI50,,4,1,
DURATIONOFSEIZURE,s,4,1,
TC(D),%,4,1,
CL,mg/kg/min,4,1,
ED60,umol.L-1,4,1,
PRESSORRESPONSE,mmHg,4,1,
CL,mg/ml/g,4,1,
ED50MGANIMALDAY,,4,1,
ED50,mg kg-1 hr-1,4,1,
ANTIBODYRESPONSE,,4,1,
LIPIDPEROXIDATION,nM MDA (mg LDL)-1,4,1,
MND,14-21 day,4,1,
ATPCONTENT,umol.mg-1,4,1,
UNMETABOLIZED,%,4,1,
ABSORPTION,u equiv min-1,4,1,
CL,ng.hr/ml,4,1,
ANTIDIURETICACTIVITY,IU uM-1,4,1,
CL,pmol/min/mg,4,1,
CLF,ml.min-1,4,1,
INH,ugequiv,4,1,
T-CELL,umol.L-1,4,1,
ANTIDIURETICACTIVITY,U mg-1,4,1,
VOLUMECHANGE,%,4,1,
CLF,mg/(ng/ml)/min,4,1,
LESION,%,4,1,
CL,uL/min.ml,4,1,
PVCS,number min-1,4,1,
PUNISHMENTTESTMSAD,ug.mg-1,4,1,
ED15,mg kg-1 i.d.,4,1,
RELATIVETOCONTROL,%,4,1,
ANTIHYPERTENSIVEACTIVITY,mmHg hr-1,4,1,
UC50,umol.L-1,4,1,
INSULINRELEASE,ng/islet/1h,4,1,
ED10HR,,4,1,
UD50,%,4,1,
EC30,10'-6M,4,1,
PRODRUGREMAINS,,4,1,
ED300,,4,1,
KA,10^3(1/Ms),4,1,
CL,nM/min,4,1,
MAXCONTRACTILITY,%,4,1,
KCATKM,/nM/s,4,1,
TIMEOFHALFINACTIVATION,s,4,1,
RATIO,ml/min/uL,4,1,
ACTIVITY,mmHg/L.min,4,1,
IC50,10'5mM,4,1,
ACTIVITY,ug.h-1.mL-1,4,1,
TIMECONSTANTT2,,4,1,
ACTIVITY,mmHg hr-1,4,1,
TIMECONSTANTT1,,4,1,
CHANGEINBLOODPRESSURE,,4,1,
LOGINHIBITION,,4,1,
ACTIVITY,ml/s/g,4,1,
REDUCTIONINEOSCOUNT,,4,1,
MAXDOSE,mM kg-1,4,1,
ACTIVITY,um.s-1,4,1,
REDUCTIONINPROSTATEWEIGHT,%,4,1,
ACTIVITY,ml/kg/hr,4,1,
BRAINCONTENT,nM g-1,4,1,
EPS,,4,1,
TUMORFREETOTAL,,4,1,
PRODRUGRECONVERSION,%,4,1,
ED30DBP,,4,1,
CLEAVAGERATE,nM U-1 hr-1,4,1,
KEFF(REL),,4,1,
AUC,10^4nM.min,4,1,
VMAXL,umol.min-1,4,1,
INHIBITIONPERIOD,s,4,1,
INHIBITIONRATE,,4,1,
CLF,L.h-1,4,1,
CLF,(mg/kg)/(ng/ml)/hr,4,1,
LD50,mmol/L,4,1,
LD90,mg,4,1,
CLD,L/hr,4,1,
REMAINS,,4,1,
INHIBITORYBINDING,%,4,1,
ACTIVITY,RFU/ug/min,4,1,
MOLARCONTENT,Molecules (LDL particle)-1,4,1,
ACTIVITY,M/uL,4,1,
ARP,m/M,4,1,
KE,10'8/M,4,1,
MONOCATIONSPECIES,%,4,1,
RELT,,4,1,
ACTIVITY,1/s,4,1,
INITIALCONCENTRATION,%,4,1,
SURVIVALRANGE,d,4,1,
CL,min.kg/L,4,1,
RELATIVETS,%,4,1,
T34,,4,1,
T1,,4,1,
EBD20,ug.mg-1,4,1,
KA,10^6/M.s,4,1,
T2,,4,1,
RENALCLEARANCE,ml min-1,4,1,
CL,ml.min-1,4,1,
ED50,10'-6M,4,1,
ED50,10'-5umol/ml,4,1,
KDHYDRO,umol.L-1,4,1,
MIC,ug/mg,4,1,
ANTICONVULSANT,,4,1,
INTIMAAREA,10e3 um2,4,1,
ATRIALMAPD90,ms,4,1,
AUC,hr.nmol/ml,4,1,
ED50,10'-14 ug/ml,4,1,
CL,ml/min/hr,4,1,
INTERNALISATION,%,4,1,
AB,%,4,1,
VOMITS,,4,1,
ED5,nM kg-1,4,1,
MTA,,4,1,
CL,ml/min/nmol,4,1,
THERMOGENESIS,%,4,1,
NRD,,4,1,
KCATKM,m M-1 min-1,4,1,
DRUGUPTAKE,ml/min,4,1,
LCE,,4,1,
DRUGUPTAKE,microg/g,4,1,
VENOM,%,4,1,
PEAKSTRIATALUPTAKE,,4,1,
ACTIVITY,10e-6*s cm-1,4,1,
KMAPP,,4,1,
K,l mol-1,4,1,
DRUGUPTAKE,mgequiv/ml,4,1,
IUP,,4,1,
OFRATSTURNING,%,4,1,
ACTIVITY,10'-4AU/sec,4,1,
URINE,%,4,1,
CP,cps,4,1,
POSTANITBIOTICEFFECT,,4,1,
DRUGUPTAKE,mBq,4,1,
PEAKEFFECTTIME,s,4,1,
AUCTDOSE,umol.h.L-1,4,1,
AUCDOSE,mg.hr/ml,4,1,
NB,,4,1,
DELTATCID50,,4,1,
AUCTDOSE,ng.hr/ml/mg/kg,4,1,
DRUGUPTAKE,ml/g,4,1,
SOLUBILITY,/mM,4,1,
IRREVERSIBILITY,%,4,1,
K2,10e-3 s-1,4,1,
KKMAX,h-1,4,1,
KS,10^4/M,4,1,
ROTORODINDEX,ROI,4,1,
DELTALOGP50,,4,1,
VMAX,pMl hr-1,4,1,
STELEVATION,delta mV,4,1,
PKA6,,4,1,
K,L/mol,4,1,
ACTIVITY,AU.min/L,4,1,
KA,10'6/M.s,4,1,
ORALDURATION,,4,1,
AUCTDOSE,mg.hr/ml,4,1,
DRUGUPTAKE,uL/cm2,4,1,
URINARYRECOVERY,,4,1,
AVERAGEBODYWEIGHT,mg,4,1,
AUCDOSE,mmol.L/hr,4,1,
DELTALOG10CFU,ml-1,4,1,
KS,h-1,4,1,
%,%,4,1,
RESIDUEFRACTION,%,4,1,
OPTIMALDOSE,mg.kg/inj,4,1,
CMIN,mg,4,1,
DRUGUPTAKE,nmol.min,4,1,
AUCDOSE,min.ug/ml,4,1,
AUC,ug .h/g,4,1,
KQ,10'-12/M/s,4,1,
SEVERITYMEAN,,4,1,
ACTIVITY,(nM of CO2) hr-1 mg-1,4,1,
PHOSLPDCHANGE,,4,1,
ACTIVITY,10^-2No_unit,4,1,
BASALGH,umol.L-1,4,1,
AUCGLU,mM min,4,1,
ACTIVITY,10^-11No_unit,4,1,
PAPP,10^-6/cm,4,1,
CMAX,ug/10^6 cells,4,1,
DOSECONVERTED,%,4,1,
KIH,fM,4,1,
K2,mM-1 min-1,4,1,
KQ,/mol.L-1.s-1,4,1,
NOOFSURVIVORS,%,4,1,
PAPP,cm'-6/s,4,1,
CMAXTMAX,,4,1,
KIK'I,,4,1,
AUCLAST,hr.nmol/g,4,1,
CMAX,ng/ml/mg,4,1,
ACIDOUTPUT,u equiv 2hr-1,4,1,
NOOFRATSWITHLESIONS,,4,1,
DPDT,1/Pmax,4,1,
SCXRATIO,,4,1,
DC50,nmol/L,4,1,
BIOLOGICALACTIVITY,,4,1,
DRUGUPTAKE,ngequiv/ml,4,1,
CLONES,%,4,1,
DRUGUPTAKE,ng.hr/ml,4,1,
CP,ng.hr/ml,4,1,
VDSS,umol.L-1,4,1,
KA,10'3L/M,4,1,
AUCT,pmol.hr/g,4,1,
AUCTDOSE,uM.hr.Kg/mg,4,1,
KIMUTKIWT,,4,1,
CREATCHANGEBY,%,4,1,
CREATININECL,mL/min,4,1,
BINDINGPOTENCY,,4,1,
KSOLV,hr-1,4,1,
VMAX,/RU/s,4,1,
NOOFANIMALSPROTECTEDNOANIMALSTESTED,100mg kg-1,4,1,
RETCHES,,4,1,
CONCENTRATION,ng mg-1,4,1,
PKX,,4,1,
DPDT,1/Pmax s,4,1,
PLASMAINTEGRAL,uCi min ml-1,4,1,
PENETRATION,,4,1,
DRUGUPTAKE,pmol/mm3,4,1,
VMAX,pmol/min/10^6cells,4,1,
SELECTIVITYRATIO,Ratio,4,1,
ACTIVITY,%/hr,4,1,
CONTROLRETCHES,,4,1,
KSV,/uM,4,1,
RESPONDER,%,4,1,
NMDAEFFECT,%,4,1,
CORTEXCLEARANCE,ml s-1 (10e4*g)-1,4,1,
RESPONSEVALUE,uM kg-1,4,1,
SELECTIVITYINDEX,%,4,1,
KB,M-1 min-1,4,1,
BINDING,umol.L-1,4,1,
CONVULSIONS,%,4,1,
KO,min-1 s-1,4,1,
POLYAMINE,,4,1,
CTE,,4,1,
DRUGUPTAKE,10'-8mol,4,1,
AUC,ng/mL.kg,4,1,
CT10,uM hr,4,1,
AUC,nmol/L.min,4,1,
BINDING,ug g-1,4,1,
K,10^-1/M/s,4,1,
CT50,,4,1,
K,10^8/M/s,4,1,
KI,10^4/M,4,1,
CT50,d,4,1,
VMAX,microM/microg/sec,4,1,
ACTIVITY,10^6CFU,4,1,
SALURETICACTIVITY,,4,1,
CMC,10'-3 mol/L,4,1,
K,/M/hr,4,1,
SA,umol.L-1,4,1,
STABILITY,pmol/mg,4,1,
CONTROLVOMITS,,4,1,
AUC,ng.hr,4,1,
KIRR,s-1,4,1,
NOAEL,mgAi/L,4,1,
SDS,mg/kg,4,1,
KI,10'7/M/min,4,1,
AUGMENTATION,%,4,1,
ACTIVE,,4,1,
AUPAP,%,4,1,
MBC,mmol/L,4,1,
AUCT,nmol/g.hr,4,1,
ACTIVITY,10^9(p/s)(uW/cm^2),4,1,
KIN,uL/sec/g,4,1,
IVR,beats min-1,4,1,
LC95,[ppm],4,1,
DRUGUPTAKE,%Idose,4,1,
AUC,nmol.hr/kg,4,1,
SCEREBRATIO,,4,1,
AUC,nM.min/ml,4,1,
AUCTDOSE,hr.kg.ng/ml/mg,4,1,
CMIN(84HR),pg/mL,4,1,
DELTALATENCYTIME,,4,1,
CMINPBMC,pmol/10^6cells,4,1,
AUCTDOSE,ng.hr/g/mg/kg,4,1,
NAD+LEVEL,%,4,1,
CP(F)SS,umol.L-1,4,1,
KSAPP,umol.L-1,4,1,
CLH,uL,4,1,
AUCTDOSE,hr.Kg/L,4,1,
CRITICALCONCENTRATION,umol.L-1,4,1,
NADHOXIDATION,umol.L-1.min-1.,4,1,
PEFF,%,4,1,
VELOCITY,umol.L-1.min-1.mg-1,4,1,
VELOCITYRELATIVETOATP,,4,1,
IR,,4,1,
NAPROXENPRODUCED,umol.L-1,4,1,
CP,nmol/g,4,1,
AUCT,ug.hr/g,4,1,
OXIDATION,umol.L-1.min-1.,4,1,
CLH,min/mL,4,1,
DRUGUPTAKE,pmol/ml,4,1,
LC99,mgAi/L,4,1,
CTC50,umol.L-1,4,1,
DRUGUPTAKE,IU/ml,4,1,
ACTIVITY,10'6uL,4,1,
COOPERATIVEEFFECT,,4,1,
DRUGTRANSPORT,ug.mg-1,4,1,
POLYAMINE,nM (mg of protein)-1,4,1,
STABILITY,ng/ml/hr,4,1,
AUCT,min.ng/L,4,1,
PD50,uM kg-1,4,1,
BINDINGAFFINITY,1/M,4,1,
CT,%ID,4,1,
DRUGTRANSPORT,nmol/hr.cm2,4,1,
VENTRICULARMAPD90,ms,4,1,
K,10'6/Ms,4,1,
BINDINGACTIVITY,fM mg-1,4,1,
VMAX,mAU/min/uM,4,1,
VMAX,pM U-1 min-1,4,1,
VMAX(APP),pmol/min.ml,4,1,
PERMEABILITY,10e4*cm min-1,4,1,
VMAX,10'-5 uM/s,4,1,
VMAXKM,%,4,1,
PERMEABILITY,AB cm/s,4,1,
SKINTHICKNESS,,4,1,
OCCED50,ug.mg-1,4,1,
VMAX,10'4OD/sec,4,1,
OCC90,ug.mg-1,4,1,
PLASMAMAGNESIUMCHANGEBY,%,4,1,
PG,,4,1,
AVERAGELATENCY,,4,1,
K,10^-7/s,4,1,
BEHAVIORALOBSERVATION,,4,1,
LC30,,4,1,
CMAX,ng/hr,4,1,
PASSIVITY,,4,1,
CZ,ug/L,4,1,
VASODILATION,%,4,1,
VASODILATORYRATE,,4,1,
AUC,uM h/(mg/kg),4,1,
KSV,10^5L/mol/s,4,1,
VMAX,umol.L-1.h-1,4,1,
KINACT,s,4,1,
SERUMCREATININE,,4,1,
DRUGDISSOLUTION,%,4,1,
SERUMCREATININECONC,mg dl-1,4,1,
DRUGDEGRADATION,umol.min-1.mg-1,4,1,
DESENSITISATION,%,4,1,
PFCSPLLEEN,,4,1,
AUMCT,hr2.ng/ml,4,1,
VASOPRESSORACTIVITY,U mg-1,4,1,
CONCENTRATIONURINE,umol.L-1,4,1,
KB,s-1,4,1,
ACTIVITY,10'-8mol/kg,4,1,
PBBB,,4,1,
SIGNFREEDOSE,ug.mg-1,4,1,
KA,1/M,4,1,
AVERAGEMAX,%,4,1,
PA2,IU mg-1,4,1,
AUCLAST,ng.hr,4,1,
RT50,,4,1,
KRKMAX,M-min,4,1,
VBETA,,4,1,
AVERAGELUNGWEIGHT,mg,4,1,
ACTIVITY,10'-7mol/L,4,1,
DRUGCONC(SERUM),umol.L-1,4,1,
DRUGCONC(LDL),umol.L-1,4,1,
PARAPARETICMICE,%,4,1,
VC,kg-1,4,1,
NOOFMICEINFECTEDTOTAL,,4,1,
CONSUMPTION,%,4,1,
DANERATIO,,4,1,
AUMCLAST,hr.hr.ng/ml,4,1,
DASTIM,%,4,1,
KP,umol.L-1,4,1,
ACTIVITY,(nM of vector) (ug of DNA)-1,4,1,
PERCENTREMAINING,%,4,1,
K,10'-3M,4,1,
ADPFORMATION,%,4,1,
KAEFFECT,%,4,1,
MEANAXONALAREA,,4,1,
KACT,s-1,4,1,
MEANBODYWEIGHT,%,4,1,
CHANGEOFAREA,%,4,1,
LOG10REDUCTION,,4,1,
FECALWEIGHT,mg,4,1,
FECES,%,4,1,
ADRENOCHROMEFORMATION,nM min-1 (mg of protein)-1,4,1,
FOLDSTIMULATION,,4,1,
C5AAFFINITY,%,4,1,
C24H,umol.L-1,4,1,
RATIO,10'6/M/min,4,1,
FORMATIONOFCOMPOUND,umol.L-1,4,1,
LOGA50,,4,1,
MAXUTEROTONICRESPONSE,%,4,1,
FOODINTAKE,g kg-1,4,1,
IC50,umol/dm3,4,1,
RATIO,10'2No_unit,4,1,
ACTIVITYINDEX,ug.mg-1,4,1,
KI(APP),mole fraction,4,1,
ADRENOCHROMEFORMATION,,4,1,
MEANACTIVITY,umol.L-1,4,1,
DRUGUPTAKE(FREE),nmol/g,4,1,
CHANGEINVOLUME,%,4,1,
MEAN,%,4,1,
ACTIVITY,mU.nmol/h,4,1,
AD50,%,4,1,
FEC50,,4,1,
ACTIVITY,mU ml-1,4,1,
FD,%,4,1,
TRANSPORT,%,4,1,
FCMAX,ug.mg-1,4,1,
AD50,mM kg-1,4,1,
TGI50,,4,1,
FC,umol.L-1,4,1,
FC,log10RLU,4,1,
RELATIVEBIOAVAILABILITY,%,4,1,
MDS,,4,1,
FBA,((mmol/day)/100g),4,1,
MEAN,nM hr-1 mg-1,4,1,
CHANGEINSPERMATOGENESIS,,4,1,
AD50,umol.L-1,4,1,
KAKRKR,umol.L-1,4,1,
KAKR,,4,1,
FAUCDOSE,nM.hr.kg/mg,4,1,
AUCDOSE,hr.kg.L,4,1,
FORMATIONOFNO3-,umol.L-1,4,1,
DRUGMETABOLISM,nmol/hr,4,1,
DNAONFILTER,,4,1,
RINGIMMOBILITY,%,4,1,
ACTIVITY,10'9uL,4,1,
DECREASEINMEANARTERIALPRESSURE,,4,1,
DNADAMAGE,,4,1,
K,10'2/s,4,1,
AXONALREGENERATIONRATE,,4,1,
DL50,ug.mg-1,4,1,
CMAXDOSE,microM/mg/kg,4,1,
PLASMACONCENTRATION,pg ml-1,4,1,
AUMC,ug.hr/g,4,1,
KINACT,10^-1/s,4,1,
VMAX,uM min-1 ml-1,4,1,
VMAX,pmol/min/g,4,1,
DOSE,nM kg-1,4,1,
DOSE,mg.mouse-1,4,1,
BASALBINDING,%,4,1,
KINACT,10^3nM,4,1,
PAPP,10'-8m/s,4,1,
NOOFUPTAKESITES,,4,1,
SPAV3,umol.L-1,4,1,
NOOFWDS60MIN,,4,1,
DNAFRACTION,,4,1,
CMAXDOSE,kg.mg/L.mL,4,1,
DISPLACEMENTOFDP,,4,1,
K,10'2/mol/s,4,1,
VCF,,4,1,
PBBB,10'-3cm/min,4,1,
OCC90,nmol/g,4,1,
CMAX,pmol/10^6cells,4,1,
CMAX,uM.kg/mg,4,1,
DBPCHANGE,%,4,1,
PAPP,nM s-1,4,1,
PHDEPENDENCE,,4,1,
K,10'3No_unit,4,1,
KQ,/kM/s,4,1,
ACIDTITER,m equiv l-1,4,1,
PLASMAHALF-LIFE,s,4,1,
CONCENTRATION,nM (g of tissue)-1,4,1,
SHR,,4,1,
VMAX,nM/min/mg,4,1,
VMAX,nmol/ mL h,4,1,
LACTOSEPRODUCTION,uM mg-1,4,1,
SPECIFICACTIVITY,pM hr-1 (mg of protein)-1,4,1,
ACTIVITY,10'9/s/cm2,4,1,
PAPP,10'-3cm/min,4,1,
DECREASEINMAP,,4,1,
DOSE,M kg-1,4,1,
PAE,d,4,1,
KINACT,10^3/s,4,1,
COMPETITIVEPROTECTION,,4,1,
CYTOTOXICITYIC50,umol.L-1,4,1,
ACTIVITY,10'-6 cm/s,4,1,
BEHAVIORRESPONSE,,4,1,
CYTOCHROMELOSS,%,4,1,
VACUOLERESPONSE,umol.L-1,4,1,
VMAX,nM hr-1 (mg of protein)-1,4,1,
PM,10e-5*cm/min,4,1,
K'I,umol.L-1,4,1,
DRUGMOBILITY,,4,1,
K,10^3(1/Ms),4,1,
AUCDOSE,nmol.hr,4,1,
VMAX,nmol/min/ug,4,1,
K,10'5No_unit,4,1,
CMAXTUMOR,umol.L-1,4,1,
DRUGMETABOLISM,ug/ml.hr,4,1,
KI,10e3* M-1 s-1,4,1,
AUC,ug/g.hr,4,1,
KSV,10'5L/M,4,1,
ACTIVITY,10'-5AU/sec,4,1,
PAH,,4,1,
DRUGMETABOLISM,pg/ml/min,4,1,
AUMC,hr.hr.ug/ml,4,1,
NOOFANIMALSPROTECTEDNOANIMALSTESTED,300mg kg-1,4,1,
BG,umol.L-1,4,1,
K,10^-3/M/s,4,1,
K3',L (M min)-1,4,1,
ACTIVITY,10'1/M,4,1,
ACTIVATION,fold,4,1,
AUCED90,umol.h.L-1,4,1,
SERUMPROLACTINLEVEL,mg.ml-1,4,1,
VDSS,L/m2,4,1,
CMAX,umol.h.L-1,4,1,
PB,umol.L-1,4,1,
CMAX,nM l-1 hr-1,4,1,
CYCLASESTIMULATION,%,4,1,
DELTAERP,ms,4,1,
SERUMCONC,umol.L-1,4,1,
LC50,10'-1ppm,4,1,
AUCLAST,ug.hr/g,4,1,
ACTIVITY,10'3kdyun/cm3,4,1,
BGREDUCTION,%,4,1,
LC50,10'-3ppm,4,1,
K,10'5/M/min,4,1,
DEPOLARISATION,mV,4,1,
PERMEABILITYRATE,nm s-1,4,1,
DRUGMETABOLISM,L/mol/min,4,1,
ID50,pg,3,1,
FAUCLAST,nM.hr,3,1,
FANA,,3,1,
ACTIVITY,mM kg-1,3,1,
TRAPSTAINING,,3,1,
MEANAUC,,3,1,
ID50,mg kg-1 hr-1,3,1,
MEAN%OFCONTROL,%,3,1,
ACTIVITY,mN/meter,3,1,
AGGREGATE,%,3,1,
FC,10'6No_unit,3,1,
TGIR,,3,1,
LOG1EC50,,3,1,
TRANSFECTIONACTIVITY,RLU (mg of protein)-1,3,1,
ID30,ug.mg-1,3,1,
LOG10CFUDAY,,3,1,
AFFECTEDANIMALS,%,3,1,
MEANINCREASEINSURVIVAL,d,3,1,
EMAX,mg.kg-1.d-1,3,1,
MEANFREEPLASMACONCENTRATION,umol.L-1,3,1,
LS,s,3,1,
ACTIVITY,mIU/L,3,1,
LOWERINGACTIVITY,%,3,1,
TMIN,,3,1,
LVDPDT,%,3,1,
MEC,10'-6M,3,1,
LUI,%,3,1,
HDL,,3,1,
HDL,%,3,1,
HDL,ug.mg-1,3,1,
I50,(ug of base) ml-1,3,1,
TOTALNOOFTURNS,,3,1,
HEARTWEIGHT,,3,1,
ACTIVITY,mEq/dL,3,1,
TOTALLIVERWEIGHT,mg,3,1,
LRR,s,3,1,
LPS,s,3,1,
ACTIVITY,pKi,3,1,
HELICITY,,3,1,
MAXDISPLACEMENT,%,3,1,
MAXEFFECT,s,3,1,
MEC,umol,3,1,
ACTIVITY,ml/hr,3,1,
TTO,,3,1,
ACTIVITYEC50,umol.L-1,3,1,
TSHCHOL,,3,1,
ACTIVITY,mg.s.L-1,3,1,
FU,nmol/g,3,1,
MAXIMUMINHIBITION,%,3,1,
ACTIVITY,umol/min/ml,3,1,
ACTIVITY,microm2/micrometer/d,3,1,
IC50,10^-4nM,3,1,
ACTIVITY,um3/um2/yr,3,1,
TIME,pS,3,1,
FRACTIONCLEAREDRENALLY,%,3,1,
LOGBETA,,3,1,
FOODINTAKE,g day-1,3,1,
MEANULCERINDEX,umol.L-1,3,1,
TRACTIONTEST,score,3,1,
FLUINTENSITY,10^3No_unit,3,1,
FLUINTENSITY,10^4No_unit,3,1,
MBC<=999,umol.L-1,3,1,
TRABECULARTHICKNESS,,3,1,
MBC50,,3,1,
FOLDSTIMULATION,%,3,1,
TMED50,,3,1,
LOGA,s-1,3,1,
MAXRESPONSE,delta mmHg,3,1,
ACTIVITY(NMOLMGOFPROTEINMIN),%,3,1,
FT12,s,3,1,
THYMUSWEIGHTCHANGE,mg,3,1,
EMIN,umol.L-1,3,1,
EMPTY,%,3,1,
MEANTOTALPLASMACONCENTRATION,umol.L-1,3,1,
MEANINDEX,,3,1,
IDTHYROID,%,3,1,
ENOYL-COAHYDRATASE,umol.L-1.min-1.mg-1,3,1,
EOSINOPHILS,%,3,1,
AFFINITYSTATE2,%,3,1,
AFFINITYSTATE1,%,3,1,
TDSRATIO,,3,1,
TED,microg/cm2/h,3,1,
ID25,mg kg-1 p.o.,3,1,
THERAPEUTICINDICES,TI,3,1,
ICL5,umol.L-1,3,1,
ACTIVITY(UMOLMGOFPROTEINMIN),%,3,1,
IC50,nmol/Kg,3,1,
ACTIVITYINANIMALS,ug.mg-1,3,1,
IC50,ml,3,1,
MAXJUMPINGRATE,%,3,1,
HEARTBEAT,beats min-1,3,1,
MAC,uM/L,3,1,
ACTIVITY,pIC50,3,1,
AUC,mg.hr/kg,3,1,
MTD,g/Kg,3,1,
SUCCEEDEDTESTED,,3,1,
EC25(UNBOUND),umol.L-1,3,1,
SUPEROXIDEANION,umol.L-1,3,1,
MST,months,3,1,
ELEVATIONOFTHRESHOLD,%,3,1,
MECHANISTICREFERENCE,,3,1,
TD50,microM/Kg,3,1,
GD200[D],%,3,1,
IC30,L.mol-1,3,1,
MARGINBEFOREONSETOFTACHYCARDIA,,3,1,
ACTIVITY,pmol/min.ug,3,1,
MARGINBEFOREONSETOFHYPOKALEMIA,,3,1,
GR50,KgAi/ha,3,1,
IC2X,,3,1,
ACTIVITY,nM min-1 unit-1,3,1,
GRACTIVITY,U.mg-1,3,1,
ACTIVITY,pmol adducts/mg DNA,3,1,
ACTIVITY,pgequiv/ml,3,1,
AUC,mg,3,1,
AUC,hr.ng/L,3,1,
IC10,,3,1,
MTD,mmol/Kg,3,1,
TRABECULARNO,,3,1,
SURVIVALEXTENSION,%,3,1,
MOTORACTIVITY,accumulated counts 30min-1,3,1,
MOTORACTIVITY,Counts hr-1,3,1,
EC50,10^3 uM,3,1,
MORTALITYTHRESHOLD,ug.mg-1,3,1,
EC50,mM kg-1,3,1,
EC50,mg.kg-1.d-1,3,1,
AUC,hr.fmol,3,1,
ACTIVITY,Kg/hr.m2,3,1,
MTXEQUIVALENT,,3,1,
AUC,mg/dl.hr,3,1,
STIMULATIONS,%,3,1,
STOICHIOMETRY,,3,1,
MTD8,ug.mg-1,3,1,
MTD4,ug.mg-1,3,1,
MTD2,ug.mg-1,3,1,
AUC,microM.hr.kg/umol,3,1,
E2:E1,,3,1,
GRIPSTRENGTH,mg,3,1,
IC02,umol.L-1,3,1,
ACTIVITY,ng.hr/ml,3,1,
MAXACTIVATION,umol.L-1,3,1,
LYSOZYMERELEASE,%,3,1,
GSTACTIVITY,U.mg-1,3,1,
HOMOVANILLICACIDCONCENTRATION,nM g-1,3,1,
ACTIVITY,pD2,3,1,
HEPATICEXTRACTION,,3,1,
LOSS,,3,1,
TOPICALIRRITATIONSCORE(0-21),,3,1,
HIND-PAWLICKLATENCYTIME,,3,1,
TOTALCOENZYME,%,3,1,
HISTAMINERELEASE,%,3,1,
HOURSABOVEEC90,,3,1,
HEMATOCRIT,mg,3,1,
ACTIVITY,ng/min,3,1,
HRCHOL,,3,1,
HSFACTIVITYX10E2,ml,3,1,
ACTIVITY,nmol/mg LDL,3,1,
TOTALCELLS,number ul-1,3,1,
HVA,,3,1,
ACTIVITY,nmol of acetaldehyde(AcH) oxide per minute per mg of protein,3,1,
I90,g/ha,3,1,
ACTIVITY,uM J-1,3,1,
TMAX,%,3,1,
MAXAGGREGATION,,3,1,
GSH,,3,1,
GSHREACTIVITY,,3,1,
GLUTATHIONELEVELS,umol/g tissue,3,1,
GLUTATHIONE,nM mg-1,3,1,
ACTIVITY,nM (nM of NOS),3,1,
GI90,,3,1,
TOXICITY(DEATHS),%,3,1,
GFR,ml min-1,3,1,
TIMECONSTANT,,3,1,
IC50,10'5pM,3,1,
ACTIVITY,uM/min/uL,3,1,
TOXICINDEX,,3,1,
TIMEINLIGHT,%,3,1,
IC50,10'-3g/L,3,1,
ACTIVITY,uL/g/min,3,1,
ACTIVITY,ms/s1/2,3,1,
GLUCOSELEVEL,g day-1,3,1,
GLUCOSELEVEL,g dl-1,3,1,
GLUCOSELEVEL,ml d-1,3,1,
TPR,%,3,1,
K,10^8No_unit,3,1,
MAXTC,ug.mg-1,3,1,
DECREASEDTRIGLYCERIDE,,3,1,
PAPP,10-6 cm s-1,3,1,
PAPP,10^-5 cm/min,3,1,
KQ,10'11L/mol,3,1,
KQ,10'-5L/mol,3,1,
DDTMSAD,ug.mg-1,3,1,
KQ,10'-4L/mol,3,1,
SERUMTSH,ug 100ml-1,3,1,
AUCGLUREDUCTION,%,3,1,
PAPP,umol.s-1,3,1,
DAYOFVAGINALOPENING,,3,1,
AUCLAST,nM.hr/L,3,1,
K,10^4/M.s,3,1,
PAR,ug.mg-1,3,1,
PARALYSIS,s,3,1,
ACTIVITY,10'-6microL,3,1,
AUCLAST,ng/g.hr,3,1,
KONOO-,/mol.L-1.s-1,3,1,
D,10'-6cm2/s,3,1,
K,10^-8/s,3,1,
AUCFIRSTTREATMENT,,3,1,
AUCED90,ug.hr.ml-1,3,1,
PAWWEIGHT,mg,3,1,
DECREASEINEXITLATENCY,%,3,1,
CSS,ng/mL,3,1,
AUCNPO,uM x h/dose,3,1,
CSS,mcg/mL,3,1,
AUCT,ng.hr2/ml,3,1,
ACTIVITY,10'-4/s,3,1,
CR2,block/treat,3,1,
KM,pmol/uL,3,1,
VMAX,FU uM-1,3,1,
KM,10^3/M,3,1,
ACTIVITY,10'-2nmol,3,1,
CPDOSE,nM/mg/kg,3,1,
VMAX,RFU/s,3,1,
CPCC,,3,1,
CP(F)DOSE,umol.L-1,3,1,
PEFF,10'-8cm/s,3,1,
ACTIVITY,10'-4nmol,3,1,
CUMULATIVEURINEVOLUME,,3,1,
AUCED90,ug.h-1.mL-1,3,1,
DAYOFDEATH,,3,1,
VM,,3,1,
VM,umol.L-1,3,1,
VMAX,10'-5deltaA/s,3,1,
DRUGMETABOLISM,mg.equiv,3,1,
NOOFOCCLUSIONS,,3,1,
DR2,,3,1,
DPT,umol.L-1,3,1,
DRUGMETABOLISM,ml/min/mg,3,1,
AUC,nmol/g,3,1,
AUC,nmol/hr,3,1,
NOOFDEPOLARIZATIONS,,3,1,
SPECIFICINCORPORATION,c.p.m. (mg of melanin)-1,3,1,
VASOPRESSORRESPONSES,,3,1,
ACTIVITY,10^3CFU/mg,3,1,
AUC,nmol/100.000 cells x h,3,1,
VD,ml/hr.kg,3,1,
DRUGDEGRADATION,s,3,1,
LC20,,3,1,
DRUGUPTAKE,%Idose/L,3,1,
DOPAC,,3,1,
AUC,uA.cm'-2,3,1,
AUC,uM h/dose,3,1,
DRUGDEGRADATION,%molar,3,1,
SPLEENWEIGHT,,3,1,
DOSE,mM kg-1,3,1,
CYOTOXICITY,,3,1,
DR2,ug min-1 kg-1,3,1,
KOFF,*10e6/s,3,1,
K,10^3/min,3,1,
VMAX,10'-3OD/min,3,1,
LACTONE,,3,1,
SOLUBILITY,s,3,1,
DOPACCONCENTRATION,nM g-1,3,1,
DRUGMETABOLISM,10^-3L/mol/min,3,1,
NOOFPROTECTEDANIMALSTOTAL,,3,1,
DPDT20,,3,1,
ACTIVITY,10^-4No_unit,3,1,
ACTIVITY,10^-4/hr,3,1,
ACTIVITY,10^-10M,3,1,
DOPALEVEL,ug g-1,3,1,
DOSAGE,mg,3,1,
STABILITY,mg-1.g-1,3,1,
VAREA,,3,1,
STABILITY,Cel,3,1,
NOOFDEADMICE,ug.mg-1,3,1,
DOSE,mg uM (kg of body weight)-1,3,1,
AUCT,nM.hr.kg/mg,3,1,
AUCT,hr.nmol/g,3,1,
THRESHOLDVALUE,ug.mg-1,3,1,
OUABAINDOSE,ug.mg-1,3,1,
P74,,3,1,
SIGMASH,%,3,1,
DELTABP,,3,1,
ACTIVITY,10'3cm,3,1,
KQ,10^12L/mol.s,3,1,
KQ,10^12L/mol,3,1,
ACTIVITY,10'3/min,3,1,
K,10^-4 uM/s,3,1,
KQ,10^11/M/s,3,1,
DEGREESCENTIGRADE,Cel,3,1,
SI,ml beat-1 kg-1,3,1,
AUCDOSE,uM.hr/mg.kg,3,1,
ACTIVITY,10'3/M,3,1,
SHRDELTABLOODPRESSURE,dec,3,1,
PALMITOYL-COAOXID,umol.L-1.min-1.mg-1,3,1,
KQ,10'13L/mol,3,1,
KRED,/mol.L-1.s-1,3,1,
DELTALOG10CCID50,,3,1,
KS,10^3/M,3,1,
K,10^-3/M/min,3,1,
OVERTBEHAVOIUR,,3,1,
DLBT,ug.mg-1,3,1,
KREACT,,3,1,
THROMBINTIME,s,3,1,
FPGSACTIVITY,nM hr-1 mg-1,3,1,
THROMBOXANEB2LEVEL,%,3,1,
TPR,mmHg ml-1 min-1 kg-1,3,1,
NOCURED,,3,1,
INOTROPICPOTENCY,,3,1,
AUC,ng/g,3,1,
DELTAH,10^5cal/mol,3,1,
SKINGRAFTSURVIVAL,,3,1,
K,10^-2/M/s,3,1,
KQ,10^4L/mol,3,1,
VENTRICULARRELATIVEREFRACTORYPERIOD,ms,3,1,
P24SYNTHESIS,umol.L-1,3,1,
K,10^-1/s,3,1,
AUCDOSE,ng/(hr.mL.mg.kg),3,1,
VD,ml/min.Kg,3,1,
DELTAH1,cal/mol,3,1,
KR,min1 M1,3,1,
KR,s,3,1,
OCCLUSIONS,ug min-1 kg-1,3,1,
SPECIFICACTIVITY,nM Pi min-1 (mg of protein)-1,3,1,
PD100,mg.kg-1.d-1,3,1,
AUCDOSE,microg.min/mL,3,1,
KSH,,3,1,
EC50,10'7pM,3,1,
SN,,3,1,
SMAX,umol.L-1.min-1.mg-1,3,1,
DELTAPLASMACHOLESTEROL,%,3,1,
PAOACTIVITY,pM min-1,3,1,
ACTIVITY,10'-9M,3,1,
AUCED90,,3,1,
AUCT,nM/ml.min,3,1,
SELECTIVITYINDEX,10^4No_unit,3,1,
KOBS,/mol.L-1.s-1,3,1,
AUCSECONDTREATMENT,,3,1,
K,10^5L/mol,3,1,
AUCT,g/hr,3,1,
KO,/M,3,1,
CT,umol.g-1,3,1,
PD,,3,1,
VMAX,10'-4umol/min/U,3,1,
PD10,,3,1,
K,10'6/s,3,1,
DELTATG,,3,1,
K,10'3/M.s,3,1,
DELTATG,%,3,1,
DISTRIBUTION,l,3,1,
NUCLEICACIDS,mg mg-1,3,1,
AUC,uh ml-1,3,1,
VDRAFFINITY,umol.L-1,3,1,
DIOXYGENUPTAKERATE,umol.L-1.min-1.,3,1,
ACTIVITY,10'8CFU/g,3,1,
AUC,umol,3,1,
KTM,L.umol-1,3,1,
KTM,,3,1,
DIFFERENCEINRETENTIONTIME,s,3,1,
ACTIVITY,10'7CFU/ml,3,1,
VDSS,g/Kg,3,1,
DELTAPKA,,3,1,
DERIVEDTRABECULARNUMBER,mM-1,3,1,
VDSS,mL,3,1,
OLIGOSHIFTED,,3,1,
VDSS,mg/ng/ml,3,1,
VDSS,ml/hr.kg,3,1,
ONSETOFBLOCK,,3,1,
EC300,umol.L-1,3,1,
CL,ml.kg-1,3,1,
SURVIVAL,10'5CFU/ml,3,1,
AURC,s,3,1,
C100,,3,1,
C0DOSE,umol.L-1,3,1,
RPE,,3,1,
CL,microL/ml/min,3,1,
CL,mg/ng/ml/hr,3,1,
K5,,3,1,
2XTG,,3,1,
C1,ml min-1 kg-1,3,1,
RNAFRACTION,,3,1,
CMC,10'-4 mol/L,3,1,
RATECONSTANTAPP,/mol.L-1.s-1,3,1,
CL,% ID/g,3,1,
VZ,ug.mg-1,3,1,
BRAINLEVELS,,3,1,
KD,10^-6 mol/L,3,1,
CIT,ml min-1 kg-1,3,1,
PL,,3,1,
KIH,pM,3,1,
KIH,,3,1,
CL,ml kg-1,3,1,
KACT,,3,1,
AVERAGESAMPLEINTAKE,mg.kg-1.d-1,3,1,
K1,pM,3,1,
KD,uL/OD/min,3,1,
ROTATIONALBEHAVIOR,turns hr-1,3,1,
BAT,mg,3,1,
KA,M/M,3,1,
CMAX,ug.h-1.mL-1,3,1,
VMAX,pmol/OD/min,3,1,
CL,mL/mg/kg,3,1,
VMAX,pmol/h,3,1,
AVERAGEFOODINTAKE,g mouse-1 day-1,3,1,
RADIOACTIVITY,nCi g-1,3,1,
BPRATIO,,3,1,
VMAX,pmol/mg.min,3,1,
PKAVALUE,,3,1,
CHOLESTEROL,mg dl-1,3,1,
C0(UNBOUND),umol.L-1,3,1,
VSS,L/hr,3,1,
ACTIVEDOSE,,3,1,
VSS,L.kg-1,3,1,
CMINSS,nmol/L,3,1,
VZF,,3,1,
ACTIVATIONFACTOR,,3,1,
QTCINTERVAL,ms s-1,3,1,
KDERROR,umol.L-1,3,1,
RW,s,3,1,
CMAX,ng/mg prot.,3,1,
RATIO,10^4/s/M,3,1,
WEIGHTDIFFERENCE,%,3,1,
PSA,%,3,1,
BMD,mg cm**-2,3,1,
ABOLITION,,3,1,
AUMC,ng/mL.hr'2,3,1,
RATIO,10^1/M/s,3,1,
ABILITY,%,3,1,
KIAPP(INACT),umol.L-1,3,1,
BINDING,dpm,3,1,
C5MIN,umol.L-1,3,1,
KINACT,10^4/M/min,3,1,
PHOSPHOLIPIDOSISMEC,umol.L-1,3,1,
KCATKM,10^3/M/s,3,1,
KCATKM,10^6/s/M,3,1,
RELATIVITY,%,3,1,
PROTEIN,mg.ml-1,3,1,
K6,,3,1,
K2,d se-1,3,1,
88Y-SERUM,,3,1,
CL,g/hr/kg,3,1,
VZ,mg/ng/ml,3,1,
CL,10'-6uL/min,3,1,
PLASMACLEARANCE,ml min-1,3,1,
CMAXPTH,pM,3,1,
BRAINLEVELS,umol.L-1,3,1,
WALKINGBEHAVIOUR,%,3,1,
RATE,nM min-1 (unit XOD)-1,3,1,
CMC,10'-2 mol/L,3,1,
CHOLINEUPTAKE,pM (4 min)-1 (mg of protein)-1,3,1,
RELATIVEPHOSPHORYLATION,,3,1,
BASALACTIVITY,%,3,1,
AVERAGEIOP,mmHg,3,1,
ACT,s,3,1,
CI,l kg-1,3,1,
CL,L/hr/m2,3,1,
BACTERIALGROWTH,,3,1,
PKIC,,3,1,
BRAINUPTAKE,nM g-1,3,1,
A,,3,1,
PKAAPP,,3,1,
PROSTAGLANDINE2LEVEL,%,3,1,
CLDF,L/hr,3,1,
KBAPP,10'-9M,3,1,
RATIO,s,3,1,
RATIOCC50EC50,10'4No_unit,3,1,
RD1000,,3,1,
CLF,(mg/kg)/(ug/ml).hr,3,1,
KAPP,10^4/M,3,1,
RBADATA,,3,1,
VMAX,min uM-1,3,1,
%INHIBITION,"%,%",3,1,
RBA,h/min,3,1,
RATIOPLASMACONCENTRATIONIC50,,3,1,
PERMEABILITY,10'-5cm/hr,3,1,
K,kcal.mol-1,3,1,
KINX,hr-1,3,1,
KINETICSOLUBILITY,uL,3,1,
CLH,uL/min/pmol,3,1,
VMAXKM,U/min/nM,3,1,
PREGNANCYINDEX,,3,1,
KA,10'9/M/s,3,1,
CORONARYFLOW,%,3,1,
CLRATIO,,3,1,
PROLONGEDVRP,,3,1,
KEQ,L.umol-1,3,1,
CC50IC50,,3,1,
EC50,10'-4 ug/cm2,3,1,
PROLACTINRELEASERATE,ng mg-1 hr-1,3,1,
BLOODLACTATE,mg dl-1,3,1,
RATIOTUMOURPLASMA,,3,1,
KI,10'-16M,3,1,
%INHIBITIONOFCONTROLSPECIFICBINDING,%,3,1,
RESIDUALACTIVITY,umol.L-1,3,1,
K,mol/L/min,3,1,
BINDINGCONSTANT,1E4/M,3,1,
REDUCEDPARASITEMIA,,3,1,
ACTIVITY,/M,3,1,
PERIOSTEALMINERALAPPOSITIONRATE,%,3,1,
KE,L/hr,3,1,
RC50,10'-1mg/ml,3,1,
PROOFOFPRINCIPLE,,3,1,
KA,10^-6/M/s,3,1,
CD90,umol.L-1,3,1,
PERTURBATIONS,%,3,1,
VMAXKM,uL/OD/min,3,1,
CLP,L.h-1,3,1,
AUEC,%.hr,3,1,
ACTIVITY,(mM of AZT) (mg k-carrageenan)-1,3,1,
POSTANITBIOTICEFFECT,s,3,1,
KF,s-1,3,1,
AUIC,%.hr,3,1,
CONTROLSURVIVALSTOTAL,,3,1,
POTENCY,mg,3,1,
REACTIONRATE,nM hr-1,3,1,
CLH,ml.min/kg,3,1,
VMAXKM,nmol/min.uM,3,1,
PERMEABILITY,nanometer/sec,3,1,
KISO,,3,1,
CP,g/ml,3,1,
CONVERSION,,3,1,
([I][S]05),,3,1,
RATIOLIVERBLOOD,umol.L-1,3,1,
KA,10E3*1/M,3,1,
KCATKINACT,,3,1,
CARNITINEACETYLTRANSFERASE,mg of protein,3,1,
CELLULARCONCENTRATION,umol,3,1,
CLP,kg-1 hr-1,3,1,
REDUCTIONINAUC,%,3,1,
CFUML,ml-1,3,1,
VMAXKM,FU min-1 uM-1,3,1,
PERMEABILITY,cm (10e3*hr)-1,3,1,
PERMEABILITY,s,3,1,
AUCTOTAL,,3,1,
RATIOIC50,10'3No_unit,3,1,
PERMEABILITY,mg,3,1,
PERMEABILITY,10^6m/s,3,1,
KEL,min-1,3,1,
RATIOIC50EC50,10'4No_unit,3,1,
VMAX,deltaA/s,3,1,
PRESUMEDDRUG-RELATEDDEATHS,,3,1,
RATIOIC50,10^4No_unit,3,1,
KIS,uM/L,3,1,
RATIOIC50,10^5No_unit,3,1,
CORTICALINFARCTVOLUME,%,3,1,
COUNTSOFROTATION,turns hr-1,3,1,
KASS,10E3*1/M*1/s,3,1,
ZINCFINGERREACTIVITY,RFU min-1,3,1,
BLOODLACTATE,umol.L-1,3,1,
PRODUCTION,pM (mg of protein)-1,3,1,
CC50,10^4 uM,3,1,
CELLPLATINGEFFICIENCY,%,3,1,
CONDUCTION,mm/m/s,3,1,
KA,10'3L/mol,3,1,
RATIO,mM-1s-1,3,1,
ED50,nmol/kg/day,3,1,
T50,,3,1,
MIC,10'-1nmol,3,1,
MIC,(ug of base) ml-1,3,1,
ED50,L/ha,3,1,
LEVEL,mg.ml-1,3,1,
MGDHGI50,,3,1,
INFUSIONRATE,ug min-1 kg-1,3,1,
ANIMALSPROTECTED,,3,1,
ACTIVITY,g-1,3,1,
INFLECTIONPOINT,nm/s,3,1,
ED50,pmg.kg-1,3,1,
ED50,ug hr-1 kg-1,3,1,
TUMORLATENCY,d,3,1,
TUMORINCIDENCE,%,3,1,
ED70,ug/kg,3,1,
UNBOUNDPLASMA,%,3,1,
EC50,pH,3,1,
SURVIVALSTOTAL,,3,1,
ACTIVITY,Mequiv,3,1,
T4,umol.L-1,3,1,
ED85,,3,1,
DRUGUPTAKE,pmol/OD,3,1,
ANALGESIA,,3,1,
T12SS,s,3,1,
AMOUNTOFUNREACTEDSUBSTRATE,,3,1,
TUMORFREESURVIVAL,,3,1,
LOCOMOTION,cm,3,1,
ACTIVITY,kN/m2,3,1,
TUMORBURDEN,,3,1,
EF200,,3,1,
EFF,%,3,1,
TUMOR,number,3,1,
MED10,,3,1,
ALPHAKI,,3,1,
ALPHAC,,3,1,
TCMAX,s,3,1,
ACTIVITY,kg/ha,3,1,
EFFLUX,%,3,1,
TCS50,,3,1,
IMPROVED,,3,1,
TCX100,ug.mg-1,3,1,
TUMORGROWTH,%,3,1,
NADHOXIDN,umol.L-1.min-1.,3,1,
NADHCONTENT,,3,1,
TUMORWEIGHTREDUCTION,%,3,1,
UTERINEWEIGHT,mg cm-1,3,1,
NKA,M/M,3,1,
AUC,mmol/L,3,1,
STABILITY,uL.ml-1,3,1,
ACTIVITY,10^9CFU/ml,3,1,
NEUTROPHILS,%,3,1,
AUC,nM.hr/ml,3,1,
NETLOGCHANGEINTUMORBURDEN,,3,1,
LD,,3,1,
NEGATION,,3,1,
MUD,,3,1,
ACTIVITY,EU/mg,3,1,
DURATIONOFINCREASEINSLA,s,3,1,
PEI,,3,1,
EC5,,3,1,
EC50,%molar,3,1,
EC50,(mg/kg)/day,3,1,
AUC,g/hr,3,1,
EC50,10'-3mol%,3,1,
CLEAVAGE,,3,1,
ACTIVITY,10^7No_unit,3,1,
DRUGUPTAKE,L.mol-1,3,1,
NADCONTENT,M (M of enzyme)-1,3,1,
UTERINEWEIGHTEFFECT,,3,1,
NAD+CONTENT,%,3,1,
NAD+CONTENT,,3,1,
NAD,%,3,1,
NACLCONCENTRATION,umol.L-1,3,1,
DRUGUPTAKE,s,3,1,
NA+EXCRETION,ug.mg-1,3,1,
DRUGUPTAKE(FREE)DOSE,umol.L-1,3,1,
LD100,microg/cm2,3,1,
DRUGUPTAKEDOSE,umol.L-1,3,1,
IONENHANCEMENT,,3,1,
ACTIVITY,Counts/minute,3,1,
AUC,microM/mg/kg,3,1,
DURATIONOFANESTHESIA,s,3,1,
DRUGUPTAKE,pg/ml,3,1,
IRONCLEARENCE,,3,1,
DRUGUPTAKE,SUV.min,3,1,
STABILITY,mol%,3,1,
AUC,ng/10^6 cells × hr,3,1,
K,10'-13/s,3,1,
UTEROTROPHICEFFECT,%,3,1,
LD,ug/kg,3,1,
T12REGEN,s,3,1,
CL(%Q),%,3,1,
KDISS,10E-2*1/s,3,1,
QH,ml/min.Kg,3,1,
PINHIBITION,%,3,1,
CO,%,3,1,
PLASMATG,mg dl-1,3,1,
PLASMATC,mg dl-1,3,1,
QMAX,%,3,1,
KA,/min/nM,3,1,
KINACT,10'5nM,3,1,
KDISS,10^-4/s,3,1,
RELATIVESUBSTRATEVELOCITY,,3,1,
CHANGEINMYOCARDIALCONDUCTION,,3,1,
WEIGHTCHANGEATNADIR,,3,1,
K-1,hr-1,3,1,
PLEURALVOLUME,ml,3,1,
KI,TS,3,1,
KAMINE,/mol.L-1.s-1,3,1,
2*APTT,,3,1,
CONCBRAIN,umol.L-1,3,1,
C16,,3,1,
COMPETITION,,3,1,
C120,umol.L-1,3,1,
PLASMA[5-FU],nmol/mL,3,1,
ACTIVITY,%/min,3,1,
PROTECTEDMICE,,3,1,
LEARNINGTIME,s,3,1,
RATIO,g/cm,3,1,
PROTECTIONRATIO,,3,1,
AUMC,microg.min/mL,3,1,
CACO-2A-B,cm s-1,3,1,
BINDING,pCi mg-1,3,1,
CONSUMPTION,ml d-1,3,1,
CONSUMPTION,g day-1,3,1,
PROTECTIVERATIO,,3,1,
WEIGHTREDUCTION,%,3,1,
KCATKM,10^-2/mM/s,3,1,
RATIO,10^7/M/s,3,1,
BINCORPORATION,mg,3,1,
C50K,umol.L-1,3,1,
REVERSINGACTIVITY,,3,1,
PIC50(MM),,3,1,
KCATKM,umol.L-1,3,1,
KDISS,10'-6M,3,1,
ACETYLCHOLINERELEASE,%,3,1,
VMAX,nM/mgM,3,1,
KCATKM,s-1,3,1,
APD90,%,3,1,
ACTIVITY,dB,3,1,
ED15,nmol/kg/day,3,1,
ED15,nM day-1 kg-1,3,1,
ACTIVITY,a.u.L/mol.cm,3,1,
APD50,%,3,1,
LD90,Gy,3,1,
MOBILIZATION,%,3,1,
ULCERATION,ug.mg-1,3,1,
APOPTOTICCELL,%,3,1,
EC90,(mg/kg)/day,3,1,
MIC,ug/cm2,3,1,
APD30,%,3,1,
ED13,,3,1,
MINPLAGUEINHIBITORY,%,3,1,
ECMAX,pM,3,1,
LDL,%,3,1,
MINERALIZINGAPPOSITIONRATE,mm day-1,3,1,
BONEMINERALDENSITY,mg/cm3,3,1,
ED10,uM kg-1,3,1,
INHIBITION,units ml-1,3,1,
ED50,10'-6umol/ml,3,1,
SUSCEPTIBILTYRATIO(LIVERINTESTINE),,3,1,
ACTIVITY,cps/nM,3,1,
ACTIVITY,bpm.hr,3,1,
LOGPOCTC,,3,1,
CLEARANCE,mg kg-1 uM-1 hr-1,3,1,
ED50,10'-15 ug/ml,3,1,
BONEMINERALDENSITY,mg/cubic cm,3,1,
KKIN,L.umol-1,3,1,
TUMOUR[5-FU],nmol/g,3,1,
ED200,mg,3,1,
LESIONCOVERAGE,,3,1,
LESIONCOVERAGE,%,3,1,
TWI,,3,1,
ACTIVITY,cmH2O,3,1,
ED30,nmol/kg/day,3,1,
ED35,uM kg-1,3,1,
ED37,,3,1,
T12,s-1,3,1,
MIC50,%v/v,3,1,
ED5,,3,1,
IC50,10^-5 ug/ml,2,1,
MAXDELTAFC,,2,1,
MAXDELTAMABP,,2,1,
IC50,10^-3mg/ml,2,1,
MAXDELTAMAP,,2,1,
MAXFALLINMAP,,2,1,
IC50,10^-6nmol,2,1,
GAG,%,2,1,
MAXFOLDINCREASE,,2,1,
GAMMACMC,,2,1,
IC50,10'8nM,2,1,
LOGEMAX,,2,1,
GRADE,,2,1,
IC50,10'6uM,2,1,
MAX,umol.L-1,2,1,
IC50,10'6pM,2,1,
GI,cm/day,2,1,
MAXDELTA,,2,1,
LOGK,obs,2,1,
IC50,10'3pM,2,1,
MAXBSR,%,2,1,
GLUCURONIDATIONRATE,,2,1,
IC20,10'-3M,2,1,
GR50,gAe/L,2,1,
GR50,ppb,2,1,
MEANKD,umol.L-1,2,1,
LEVEL,ng dl-1,2,1,
MAD,10'-3microL,2,1,
EXCRETION,,2,1,
EC50,umol,2,1,
MAD,10'-6microL,2,1,
GROUPPERFORMANCETIME,s,2,1,
LOGPOCTN,,2,1,
HK,,2,1,
FE,%,2,1,
FEC50,nmol/L,2,1,
ED50,10'-11 ug/ml,2,1,
FEC85,umol.L-1,2,1,
FUNGICIDAL,%,2,1,
G30MIN,,2,1,
ID50,pKi,2,1,
LVDRXHR,%,2,1,
I50,M kg-1,2,1,
GROSSKILL,,2,1,
MAC,ug.mg-1,2,1,
GROSSLOGKILL,,2,1,
GROWTHINHIBITION,umol.L-1,2,1,
GROWTHINHIBITON,%,2,1,
GROWTHZONE,,2,1,
LZ,h-1,2,1,
H2ACTIVITY,,2,1,
HC>=50,umol.L-1,2,1,
LV,,2,1,
IC,ug.mg-1,2,1,
LOGPDODN,,2,1,
I14,umol.L-1,2,1,
HEARTRATE,mmHg,2,1,
HED,ug.mg-1,2,1,
LOGPLOGD,,2,1,
LOSSOFACTIVITY,%,2,1,
HF2,,2,1,
HG,,2,1,
HIGHESTNONTOXICDOSE,,2,1,
INHIBITION,(ul of blood) (2ml BALF)-1,2,1,
INHIBITORYRATIO,,2,1,
LEFTATRIALPRESSURE,mmHg,2,1,
MLD,10^-8mol,2,1,
LD50X110,,2,1,
MINORALDOSE,,2,1,
LD50X140,,2,1,
INHIBITION(ALPHA=001),%,2,1,
MINID,uM kg-1,2,1,
ED10,nmol/Kg,2,1,
ED100,MPK,2,1,
LD80,mmol/Kg,2,1,
LD80,umol.L-1,2,1,
ED13,umol.L-1,2,1,
LD90,g/hm2,2,1,
INHIBITIONAT1UM,%,2,1,
ED200,umol.mg-1,2,1,
INHIBITION(AT100UM),%,2,1,
ED50,ug/L,2,1,
LL,,2,1,
EXCRETEDGLUCOSE,mg,2,1,
CCIC50,,2,1,
ILS,s,2,1,
MED,mg/kg/hr,2,1,
EIC50,umol.L-1,2,1,
EIR,,2,1,
ELEVATION,%,2,1,
LOG(ACTIVITY),%,2,1,
ELIMINATION,,2,1,
MEC20,umol.L-1,2,1,
MEC15,,2,1,
ICDATP-50,umol.L-1,2,1,
LOG(ACTIVITY),PFU/ml,2,1,
INHIBITORYZONE,,2,1,
LD50,ml,2,1,
ED50,10'-13 ug/ml,2,1,
INSULINLOWERINGEFFECT,%,2,1,
INH,ngequiv,2,1,
INH,mol,2,1,
MIC,ug cm**-3,2,1,
LEVEL,fM mg-1,2,1,
ED50,10'-9mol/cm2,2,1,
LEVEL,mg g-1,2,1,
ED50,KgAi/ha,2,1,
LEVEL,nmol ofpHB/min/mgof protein,2,1,
INHIBITION,s-1,2,1,
LEVEL,pg ml-1,2,1,
MIC,10'-2nmol,2,1,
ED50,gAe/L,2,1,
MI,umol.L-1,2,1,
INFUSIONRATE,uM min-1 kg-1,2,1,
LIGHTTRANSMISSION,,2,1,
ED50,nM hr-1 kg-1,2,1,
ED50,nM kg,2,1,
ED50,ng/kg,2,1,
INDUCTIONOFCATALEPSY,,2,1,
MFC90,,2,1,
MIC60,umol.L-1,2,1,
MIC90,%,2,1,
INCREASEIN[CA+2],,2,1,
LD50X120,,2,1,
LD50,gAe/L,2,1,
INTAKE,%,2,1,
INTACT,,2,1,
EC5X,,2,1,
MMC,,2,1,
FCMAXDOSE,umol.L-1,2,1,
PA2APP,,2,1,
ICL50,,2,1,
P50,umol.L-1,2,1,
P10MIC,,2,1,
K,10'6Lmol,2,1,
DELTAH,cal/mol.K,2,1,
OXYTOCICACTIVITY,,2,1,
KSECOND,/mol.L-1.s-1,2,1,
OTINTERVAL,,2,1,
DELTALOGDOCT-DOD74,,2,1,
DELTALOGPOCT-DOD,,2,1,
K,10'6/mol,2,1,
DELTAS,,2,1,
DELTAS,10^2cal/mol/degree,2,1,
DELTAS,10^3cal/mol/degree,2,1,
LOGPOCTZ,,2,1,
DELTAS,KJ/(mol.K),2,1,
K,10'6/min,2,1,
KSV,10'4M,2,1,
KSV,10^5L/mol,2,1,
KSV,10^6/M,2,1,
PA2,ug.mg-1,2,1,
DEGREEOFCROSSRESISTANCE,,2,1,
KON,1/M1/S,2,1,
PAPP,umol.L-1,2,1,
PAWSWELLING,,2,1,
PAWEDEMA,%,2,1,
PARENTREMAININGATTIME,%,2,1,
D,10'-7cm2/sec,2,1,
D,10^-10m2/s,2,1,
D,10^-20No_unit,2,1,
D,kHz,2,1,
K,10'7/s/microM,2,1,
DELTACP,kcal/mol.K,2,1,
KP,10^-4cm/hr,2,1,
PA,ml/s/g,2,1,
LOG(ACTIVITY),s-1,2,1,
PERMEABILITY,nmol/cm2/hr,2,1,
CONTROLST,,2,1,
K,mole fraction,2,1,
PERMEABILITY,cm/hr,2,1,
CORRECTRESPONSES,%,2,1,
PERMEABILITY,10^4cm2/sec,2,1,
PERMEABILITY,10^-3cm/min,2,1,
KKMAX,log10[CFU].ml-1.h-1,2,1,
CP,fmol/uL,2,1,
K,L/min.mmol,2,1,
K,L/hr,2,1,
PEC50,%,2,1,
KM,10'-3mol/mol,2,1,
KM,10'-5M/min,2,1,
K,10^9No_unit,2,1,
CP,ug.h-1.mL-1,2,1,
KM,Me-3,2,1,
PEFF,10^-8cm/s,2,1,
PEFF,10^-5cm/s,2,1,
CPA,,2,1,
CPD50,ug.mg-1,2,1,
CPM,%,2,1,
KM,uM kg-1,2,1,
PB,umol.mg-1,2,1,
PB,pmol/mg.hr,2,1,
KSV,10^6L/mol,2,1,
OT,,2,1,
K,10'9/s,2,1,
DALEVEL,pg 5ul-1,2,1,
DAMAGESCORE,0-10,2,1,
ID100,ug.mg-1,2,1,
MAXREV,,2,1,
IC50,ucm.s-1,2,1,
MAXPLASMALEVEL,umol.L-1,2,1,
MAXPI,,2,1,
MAXMEANWEIGHTLOSS,%,2,1,
FRP,,2,1,
MAXINHIBITIONCONCENTRATION,umol.L-1,2,1,
FU,10'-5No_unit,2,1,
IC50,10^4 uM,2,1,
MC100,umol.L-1,2,1,
FEMURWEIGHT,%,2,1,
IC50,10^-8nmol,2,1,
FAUC,umol.L-1,2,1,
EXHAL+B1718ATIONOF14CO2,%,2,1,
EXHALATIONOF14CO2,% of dose,2,1,
EXTRACTIONRATIO,,2,1,
EXUDATE,ml,2,1,
F,umol.L-1,2,1,
ID50,mg kg-1 b.i.d.,2,1,
ID50,fM,2,1,
MEANDAYSURVIVAL,d,2,1,
FA,hr.ng/ml,2,1,
FABS,h-1,2,1,
MEANDAY,,2,1,
MEANACTIVITY,,2,1,
FEC90,nmol/L,2,1,
ID50,10'-8mol/L,2,1,
FB,,2,1,
MEAN,umol.L-1,2,1,
FC,10'7No_unit,2,1,
FRACTIONEXCRETEDUNCHANGED,%,2,1,
FPTMSAD,ug.mg-1,2,1,
DAYSTOTUMORDOUBLING,,2,1,
MCC,ucm,2,1,
DBP,,2,1,
KQ,10^14L/mol/s,2,1,
DBP15,ug.mg-1,2,1,
KP,nm/s,2,1,
K,10^-5/nM/min,2,1,
K,10^-5/mM/s,2,1,
K,10^-4No_unit,2,1,
PAPP,10'-6m/s,2,1,
PAPP,10'-6cm,2,1,
DECREASEINLIFESPAN,d,2,1,
KQ,10'7No_unit,2,1,
K,10^-3/nM/min,2,1,
DECREASEOFSPONTANEOUSFIRINGRATE,umol.L-1,2,1,
MNTD>90,umol.L-1,2,1,
INTINSICACTIVITY,%,2,1,
EC50,ug.hr.ml-1,2,1,
FPKI,,2,1,
FI50,[ppm],2,1,
IC50RATIO,%,2,1,
IC50EC50,,2,1,
FLOAEL,umol.L-1,2,1,
FMEC,umol.L-1,2,1,
MBC,ug.mg-1,2,1,
MBC,ug cm**-3,2,1,
MAXWEIGHTLOSS,,2,1,
FOS,%,2,1,
FP,,2,1,
FPEC50,,2,1,
MAXREVERSINGRATE,%,2,1,
LOG(ACTIVITY),[CFU].g-1,2,1,
RATE,nM min-1 (mg of protein)-1,2,1,
MED,pmol/hr,2,1,
KB,10^2/M,2,1,
RATIOIC50EC50,10'6No_unit,2,1,
KB,10^-4/M,2,1,
RATIOIC50,10^-3No_unit,2,1,
CFU,10'9/g,2,1,
CFU,10^5/g,2,1,
CHANGEINDENSITYOFUTERINEGLAND,,2,1,
KCATKM,10'6/Ms,2,1,
RATIO,CC/OC,2,1,
CI,l min-1,2,1,
KD,10^-10mol/L,2,1,
RATECONSTANT,umol.L-1,2,1,
CHOLINEUPTAKE,,2,1,
RATEACCELERATION,,2,1,
RATE,pM min-1 (mg of protein)-1,2,1,
RATE,pM min-1,2,1,
RATE,nl min-1,2,1,
PERMEABILITY,10'-6cm/s,2,1,
RATE,nM (mg of protein)-1,2,1,
RATIO,10^6No_unit,2,1,
CL,%ID,2,1,
KD,10^-8mol/L,2,1,
CL,(mg/kg)/(ng/ml)/hr,2,1,
KD,10^2/M,2,1,
KD,10^3/M,2,1,
RANGE,%,2,1,
CL,L (min mg)-1,2,1,
CL,L.h-1,2,1,
RATEOFHYDRIDETRANSFER,,2,1,
RATEOFHYDROLYSIS,nM min-1,2,1,
CENTRALSELECTIVITY,,2,1,
KBS,umol.L-1,2,1,
RATEOF[CA+2]INCREASE,nM min-1,2,1,
KASSAPP,l uM-1,2,1,
RATIOAUC(INF),,2,1,
KAPP,10^7/M,2,1,
KAPP,10^6/M,2,1,
RATIO,umol.L-1.s-1,2,1,
CHANGEINBLOODGLUCOSE,%,2,1,
RATIO,ng/kg,2,1,
RATIO,ml/min/nmol,2,1,
KCAT,mol/dm3,2,1,
KCATKM,10'-4/M/s,2,1,
KCATKM,10'-5/s/uM,2,1,
RATIO,mg-1.g-1,2,1,
RATIO,mL/min.umol,2,1,
RATIO,m M-1 min-1,2,1,
CHANGEINBODYWEIGHT,,2,1,
CHANGEINDASYNTHESIS,%,2,1,
RATIO,U M-1 s-1,2,1,
KCAT,umol.L-1.min-1.mg-1,2,1,
KAPPX10E6,,2,1,
CL,L.h/kg,2,1,
RATIOPIC50,s,2,1,
CDOG,,2,1,
CDYN,% delta,2,1,
KBAPP,L.mol-1,2,1,
CELLCYCLEEFFECT,,2,1,
RBA,umol.L-1,2,1,
CELLDEATH,,2,1,
KB,10^3L/mol,2,1,
CELLPERMEATION,,2,1,
CELLSARRESTED,,2,1,
RATEOFRECOVERY,s-1,2,1,
RATIO,10^6/s/M,2,1,
IDGFEMUR,,2,1,
COMPOUNDRECOVERY,ug.h-1.mL-1,2,1,
KIN,ml/min/g,2,1,
PLASMACONC,umol.L-1,2,1,
KIDNEYVDR,fM (mg of protein)-1,2,1,
KIK0KI,uM-1 min**-2,2,1,
KIEQ,pM,2,1,
KIN,umol.L-1,2,1,
KINACT,10^-1/min,2,1,
CMT,,2,1,
"K(P,UU,BRAIN)",umol.L-1,2,1,
PKADECREASE,,2,1,
COMPLETESURVIVALDOSE,ug.mg-1,2,1,
PFE3+,,2,1,
CONTRACTILEFORCE,,2,1,
CONCENTRATIONOFMAXRESPONSE,umol.L-1,2,1,
K(ON)K(OFF),,2,1,
CMIN,ng/dL,2,1,
PLASMACA2+,mg dl-1,2,1,
CMINRATIO,,2,1,
K10E4,L.umol-1,2,1,
CMAXTUMOR,nmol/L,2,1,
K'',,2,1,
KIAM',,2,1,
K,nM/min,2,1,
K,umol.L-1.s-1,2,1,
K3,M-1 min-1,2,1,
KIC,L.mol-1,2,1,
KINACT,1/minute,2,1,
PKIH,,2,1,
COLONICWEIGHT,mg cm-1,2,1,
PKIL,,2,1,
KINACT,U s-1,2,1,
KCATKM,10^-6/nM/s,2,1,
CMAXRATIO,(null),2,1,
RATIO,10^-4/uM/s,2,1,
RATIO,10^-3No_unit,2,1,
RATIO,10^-3/uM/min,2,1,
RATIO,10^-2No_unit,2,1,
RATIO,10'8/M/min,2,1,
RATIO,10'7/M/min,2,1,
RATIO,10'4/M/min,2,1,
KAPP,10'-6M,2,1,
KCATKM,mM s-1,2,1,
KCATKM,microM/min,2,1,
KCATKUNCAT,/mol.L-1.s-1,2,1,
RATIO,10'-4/min.mol%'-4,2,1,
RATIO,/nM/s,2,1,
RATIO,/mM.s,2,1,
KAAPP,umol.L-1,2,1,
KIACT,s-1,2,1,
HYDROLYSISRATECONSTANT,s-1,2,1,
K2,1/M,2,1,
CMAXPTH,pg/ml,2,1,
K2KS,/mol.L-1.s-1,2,1,
CMINSS,ng/mL,2,1,
K1,1/M,2,1,
CONTROL,uM kg-1,2,1,
KINACT,10^3/M.s,2,1,
PKAB3,,2,1,
CMAX(RATIO),umol.L-1,2,1,
CONCENTRATION,ug 100ml-1,2,1,
KIN,Min-1,2,1,
CMAX,ul ml-1,2,1,
RATIOCC50EC50,10'5No_unit,2,1,
CFU,g-1,2,1,
KCATKM,1/(M*min),2,1,
MED90,,2,1,
LOG(1C),umol.L-1,2,1,
EFFECTIVEMOLARITY,,2,1,
EFFICACY,No. of mice tumor free,2,1,
LOG(1K),,2,1,
MED,ug/Kg/min,2,1,
K,ms,2,1,
OPTIMUMTC,%,2,1,
KINETICSOLUBILITY,ug/ml/min,2,1,
KGMAX,log10[CFU].ml-1.h-1,2,1,
KA,10^-4/s,2,1,
KE(APP),,2,1,
KE(APP),/M/min,2,1,
KEL,10'-3/hr,2,1,
PROMINENZ,umol.L-1,2,1,
KA,10'7/M.s,2,1,
KESELECTIVITYRATIO,,2,1,
KF,L.umol-1,2,1,
CLF,g/hr/kg,2,1,
KA,10^-5M,2,1,
PRODUCTION,ng (g of tissue)-1,2,1,
KH,%,2,1,
KA,10'4mol/L,2,1,
CLFREE,umol.min-1.mg-1,2,1,
CLH,/min/uL,2,1,
CLH,10^3uL/min,2,1,
KI,/min/M,2,1,
PR,%,2,1,
PROTECTIVEDOSE,ug.mg-1,2,1,
PROTECTIVEDOSE,umol.L-1,2,1,
MED50,ug/kg,2,1,
EF90,,2,1,
PLASMAINSULIN,uU ml-1,2,1,
MED999,,2,1,
MEC,10'-6 mol/L,2,1,
ID50,umol/kg/h,2,1,
ID50,umol.ml-1,2,1,
EMESISED,,2,1,
MEANTUMORDELAY,d,2,1,
MEANTUMORATENCY,d,2,1,
MEANTIMETODEATH,d,2,1,
LOG10EID50G,,2,1,
EU,g-1,2,1,
EXCESSMST,%,2,1,
MED,nmol/Kg,2,1,
MED,uM/g,2,1,
ED75,mg.kg-1.d-1,2,1,
EDDELTA5,,2,1,
ED75,umol.L-1,2,1,
ED80,mg.kg-1.d-1,2,1,
METABOLICRATE,nmol/min*mg of protein,2,1,
METABOLICRATE,%,2,1,
ED90,%,2,1,
INCREASEINCAMP,fold,2,1,
ED90,KgAi/ha,2,1,
ED90,g/ha,2,1,
MEMREC,%,2,1,
MEDIANTUMOR,d,2,1,
EDDELTA20,,2,1,
MEDIAAREA,10e3 um2,2,1,
EFFLUX,,2,1,
EDP,mmHg,2,1,
LOG,L.umol-1,2,1,
RADIOLABELRECOVERY,s,2,1,
CL,s,2,1,
CL,hr/L/kg,2,1,
RADIOACTIVITYINURINE,% of dose,2,1,
CMAX,ng/hr/ml,2,1,
PLASMA[14C]CHOLESTEROL,dpm dl-1,2,1,
K5,hr-1,2,1,
CMAX,pg/g,2,1,
K4,s-1,2,1,
CMAX,ug hr ml-1,2,1,
CLZF,l/hr.kg,2,1,
CLZF,L/kg/hr,2,1,
POCT,,2,1,
POESCORE,,2,1,
CLH,ug/ml/hr,2,1,
CLH,umol/min/ml,2,1,
CLINT,uL/(min.pmol),2,1,
CLONIC,,2,1,
CLP,M min-1 kg-1,2,1,
KI,10'7nM,2,1,
KI,10'8/M/min,2,1,
CLP,mg min-1 kg-1,2,1,
KI,10^-12M,2,1,
CLP,ng hr ml-1,2,1,
CLR,l/hr,2,1,
CLT,,2,1,
KI,10^2 nM,2,1,
POLYMORPHONUCLEARCELLS,,2,1,
CLTF,uL/min,2,1,
CLZF,L.hr/kg,2,1,
CLZF,L/Kg,2,1,
KA,micromol/min,2,1,
RADIOLABELRECOVERY,ugequiv.hr/ml,2,1,
CMAX,ng.hr/g,2,1,
KI,nM-1 min-1,2,1,
CLH,mL/mg/kg,2,1,
PS,,2,1,
RADIOACTIVITYINURINE,%,2,1,
RADIOACTIVEABSORPTION,%,2,1,
KD,umol/dm3,2,1,
QUENCH,%,2,1,
QH,ml/hr.kg,2,1,
KA,10^4M,2,1,
CL,s-1,2,1,
KE,10^-6M,2,1,
KA,10^3/min,2,1,
KDISS,10^-4M,2,1,
KDISS,10^-7M,2,1,
KDISS,10^2/M/s,2,1,
KA,10^3/Ms,2,1,
CLB,ml/hr,2,1,
KA,10'-5/RU/s,2,1,
KDPPH,,2,1,
CLH,L/hr/mg,2,1,
KI,10'-3/min,2,1,
PPB,umol,2,1,
CMAX,nM g-1,2,1,
CMAX,L/hr,2,1,
CMAX,U,2,1,
KA,10'1/M,2,1,
KI,10^8M,2,1,
CMAX,kg/L,2,1,
PMAX,,2,1,
CMAX,microM.hr,2,1,
PM,umol.L-1,2,1,
PERMEABILITY,omegacm2,2,1,
GH,%,2,1,
CYTOSTATICCONCENTRATION,umol.L-1,2,1,
ACTIVITY,10^4CFU,2,1,
TMED,,2,1,
SALDIURETICACTIVITY,pM equiv kg-1 6hr-1,2,1,
ACTIVITY,/min/M,2,1,
YA,,2,1,
TMAX,ug.hr.ml-1,2,1,
TMAX,ng.hr/ml,2,1,
STABILITYOFBSR,%,2,1,
AUCT,hr.ng/L,2,1,
V0,mg/ml/hr,2,1,
CAVG,ng/dL,2,1,
ACTIVITY,A% min-1,2,1,
ACTIVITY,pg/mm2,2,1,
XL50,,2,1,
VMAX,umol.min,2,1,
VMAX,10'-4 uM/s,2,1,
AUC,nM l-1 hr-1,2,1,
TISSUEWEIGHT,mg,2,1,
SF50,,2,1,
AD50,ug brain-1,2,1,
ACIDOUTPUT,m equiv [H+] l-1,2,1,
ACTIVITY,L/hr,2,1,
T12RATIO,,2,1,
SOLUBILITY,10^-3mg/ml,2,1,
ANTICONULSANTACTIVITY,ug.mg-1,2,1,
VRT,ha2,2,1,
SURVIVALAFTER30DAYS,,2,1,
AVERAGEGROSSPATHOLOGYSCORES+-SE,,2,1,
VDSS,kg/L,2,1,
REMAININGRATE,,2,1,
URINARYVOLUME,ml min-1,2,1,
ACTIVITY,nanometer,2,1,
TURNS1ST,,2,1,
ACTIVITY,/min/nM,2,1,
ACCUMULATION,nM/mg of dry wt,2,1,
ACTIVITY,10^4L/mol,2,1,
STAINING,%,2,1,
ACTIVITY,10^3L/mol,2,1,
AUCNPO,uM.h/dose,2,1,
(KCATKM)KUNCAT,L.umol-1,2,1,
CARDIACOUTPUT,,2,1,
XFOLD,100uM,2,1,
VMAXKM,/M,2,1,
BILEFLOW,ml hr-1,2,1,
AUC,mmHg.day,2,1,
ACTIVITY,pmolequiv,2,1,
VMAX,10'-3deltaA/s,2,1,
ACTIVITY,ppm/g/hr,2,1,
%OFKINASEACTIVITY,%,2,1,
ACTIVITY,rat,2,1,
ACTIVITY,nM min-1,2,1,
REDUCEDCIRCADIANOSCILLATION,,2,1,
REDUCEDCYP7A1GENEEXP,,2,1,
VMAXKM,/nM.min,2,1,
ACTIVITY,mg hr-1 kg-1,2,1,
AUCNOM,uM*h*kg/mg,2,1,
VMAX,%/min,2,1,
SA,%,2,1,
ACTIVITY,/M/min,2,1,
CAROTIDFLOWREDUCTION,%,2,1,
BIOAVAILABILITYINCREASE,%,2,1,
VMAX,10'-3umol/min/U,2,1,
AUC,nM hr-1 ml-1,2,1,
T12,nanoseconds,2,1,
BOUND,,2,1,
ACCUMULATION,mU ml-1,2,1,
ACTIVITY,dpm (mg of protein)-1,2,1,
VDSS,s,2,1,
AUC,0-infinity,2,1,
RELATIVESTIMULATIONINDEX,%,2,1,
ACTIVITY,10'-9/min,2,1,
AVERAGEUTERINEWEIGHT,,2,1,
AUC,ug/g.min,2,1,
BMAXL,umol.mg-1,2,1,
ACTIVATION,mU ml-1,2,1,
BMAXH,umol.mg-1,2,1,
APOPTOTICCELLS,%,2,1,
SURVIVORSATDAY28,,2,1,
ACTIVITY,U (g of tissue)-1,2,1,
RELATIVEVMAX,%,2,1,
SURVIVORS,umol.L-1,2,1,
VMAXL,pmol/min/mg,2,1,
APPTT,umol.L-1,2,1,
RELBRAINEXPOSURE,,2,1,
RI,umol.L-1,2,1,
BMAX,pmol/ml,2,1,
RELK,,2,1,
AUC,ug/L,2,1,
ACTIVITY,PFU/ml,2,1,
VDF,g/Kg,2,1,
UNCHANGEDNDEA,% of dose,2,1,
BMAX,pM g-1,2,1,
SURVIVIALTOTAL,,2,1,
SUSCEPTIBILITY,nM hr-1 (mg of protein)-1,2,1,
VDF,ml,2,1,
RLUNG,% delta,2,1,
ACTIVITY,dg/ml,2,1,
VRT(T),s,2,1,
ACTIVITY,cpm.s-1,2,1,
AUC,L/hr/kg,2,1,
AUCDOSE,%,2,1,
T12,l kg-1,2,1,
TOTALBINDING,,2,1,
SOLUBILITY,ugA/ml,2,1,
VMAX,pmol/min.ug,2,1,
ANTIDIURETICACTIVITY,%,2,1,
RELATIVESIGNAL,relative signal,2,1,
T09,d,2,1,
VMAXKM,pmol/microM,2,1,
AUC,0-tIdc,2,1,
SOLUBILITY,10'-4mg/ml,2,1,
AUC,umol/l.min,2,1,
T3,,2,1,
ANTI-ANALGESIC,,2,1,
ROTATIONALBEHAVIOR,,2,1,
SNGFR,nl min-1,2,1,
VMAX,pmol/(min.ug),2,1,
AUC,ug min g-1,2,1,
SNI,,2,1,
ANTI-EMETIC,,2,1,
VSS,k,2,1,
BLOODPRESSURE,umol.L-1,2,1,
ANTI-FACTORXAACTIVITY,mg,2,1,
ACTIVITY,fmol/ug,2,1,
ACTIVITY,dyn/mg,2,1,
TUMORVOLUMEREDUCTION,%,2,1,
SPECIFICBINDINGPERMGOFPROTEIN,fM mg-1,2,1,
AUC,ug.hr/ml/day,2,1,
AVERAGEGI50,,2,1,
RESORPTION,,2,1,
TOTALGLOMERULI,,2,1,
VOLUMEOFURINE,,2,1,
ACTIVITY,ug/min/cm2,2,1,
TOXIC,ug.mg-1,2,1,
ACTIVITY,mmol/L.min,2,1,
BMAX,fM mg-1 protein,2,1,
CA2+EXCRETION,uM day-1,2,1,
ACTIVITY,umol/min/g,2,1,
WEIGHTRATIO,,2,1,
RVCF,%,2,1,
AUCLAST,hr.mmol,2,1,
RUMAX,RLU,2,1,
AUCLAST,day.ng/ml,2,1,
ACTIVITYINDEX,mm,2,1,
C50G,umol.L-1,2,1,
AUCINF,nM l-1 hr-1,2,1,
AUMC,ng/mL.hr^2,2,1,
C24,ng mL-1,2,1,
ACTIVITY,mg/min/dl,2,1,
AUMC,ug.hr.ml-1,2,1,
STENOSIS,%,2,1,
AUMC,ug.hr/L,2,1,
ACTIVITY,10^1pg/ml,2,1,
ACTIVITY,10^10/M,2,1,
RELATIVEANTIANDROGENICACTIVITY,,2,1,
ACTIVITY,mg/hr/dl,2,1,
VASCULARRELAXATION,,2,1,
VINACT,s-1,2,1,
AUCLAST,hr.ug/g,2,1,
TPR,,2,1,
AUC,pmol·min/mg,2,1,
1KI,L.umol-1,2,1,
VMAX,mol/min/L,2,1,
"S20,W",,2,1,
1-LOGKI,,2,1,
ACTIVITY,mmHg s-1,2,1,
CREATININECL,min/ml/hr,2,1,
VAGUS,,2,1,
AUCLAST,pmol.min,2,1,
ACTIVITY,ml min-1 kg-1,2,1,
TIME,umol.L-1,2,1,
WORMREDUCTION,,2,1,
VMAXKM,10'-4L/min,2,1,
BLOCKADEEFFECT,,2,1,
-DELTAGOBS,kCal mol-1,2,1,
CARDIACCONTRACTILEFORCE,mg,2,1,
VM,10'-5m3/mol,2,1,
AUCLAST,pmol.min/mg,2,1,
ACTIVITY,10'-5/min,2,1,
AUMC,hr.hr.ng/g,2,1,
TIMESPENT,s,2,1,
AUCLAST,uM.min/ml,2,1,
-LOGEC50,,2,1,
TIMEOFPEAKACTION,s,2,1,
AUCN,,2,1,
ACTIVITY,10'-5g,2,1,
TIMETO30%BSR,s,2,1,
VMAX,mol/min,2,1,
ACTIVITY,ug g-1,2,1,
AUCNOM,uM h kg/mg,2,1,
ACTIVITY,ug/min.kg,2,1,
TIMETOMAXBSR,s,2,1,
REDUCTIONINCLRENAL,%,2,1,
REDUCTIONINARTERIALBLOODPRESSURE,,2,1,
ACTIVITY,10^3CFU,2,1,
AUCLAST,nmol.hr/g,2,1,
CAACTIVITY,(ml of NaOH) min-1,2,1,
ACTIVITY,pA2,2,1,
%LBF,%,2,1,
SEIZURESTAGE,,2,1,
REACTIONTIME,,2,1,
REACTIVATION,,2,1,
AUC,ng min,2,1,
AUCT,mg.hr/kg,2,1,
VMAX,10'-6mM/min,2,1,
SD200,uM kg-1,2,1,
TONICSEIZURES,,2,1,
AUC,mmHg,2,1,
"[A]T,L",10'-8 /no of units.cm'3,2,1,
ACATACTIVITY,%,2,1,
VMAX(APP),abs/hr,2,1,
%BOUNDFRACTION,%,2,1,
VMAX,U mg-1,2,1,
STABILITY,nM/min/mg,2,1,
ACTIVITY,10^5/mm3,2,1,
VMAX(APP),10'-4abs/s,2,1,
AC50,mg,2,1,
SD,,2,1,
TOTALCL,L/hr,2,1,
ACCUMULATEDCOUNTS30,,2,1,
AUCTDOSE,ug.h-1.mL-1,2,1,
"[A]T,L",/mol.dm'3,2,1,
SBP,,2,1,
CC50,mol,2,1,
AUCTDOSE,uM.hr.kg/mg,2,1,
ACTIVITY,ng/cm2,2,1,
CC50,U.mg-1,2,1,
[3H]THYMIDINECPMDISH,,2,1,
UTERUSTOBLOODRATIO,,2,1,
AUEC,,2,1,
ACTIVITY,microM/g,2,1,
ACTIVITY,ng ml-1 hr-1,2,1,
TICKACTION,%,2,1,
AUMC,mg.hr/L,2,1,
BLOCKAGE,%,2,1,
TIMETORIGHTING,s,2,1,
ACTIVITY,microA,2,1,
AUC,pmol.min/mg,2,1,
ACTIVITY,(pM of product) min-1 (mg of protein)-1,2,1,
ACTIVITY,10'-7/M/s,2,1,
AUCLAST,nM/min,2,1,
SERUMLHLEVEL,mg.ml-1,2,1,
BLOCKOFACTIVITY,%,2,1,
WEIGHTCHANGEOFAP-S,mg,2,1,
VARIATION,,2,1,
ACTIVITY,mg/min/kg,2,1,
REDUCEDSREBF1GENEEXP,,2,1,
VMAX,/abs/min,2,1,
REDUCEDSERPINE1GENEEXP,,2,1,
ACTIVITY,10^8No_unit,2,1,
CC50,10^3 uM,2,1,
ACTIVITY,10^8(p/s/cm^2/sr)/(uW/cm^2),2,1,
%INJECTEDDOSECM3,%,2,1,
VMAX,10^-5M/min,2,1,
SD80,ug.mg-1,2,1,
AUCT,nmol/g.min,2,1,
VMAX,10'-7cpm/min,2,1,
VMAX,10'-6mol/min/ug,2,1,
VMAXH,pmol/min/mg,2,1,
SEDATIVEDOSE,ug.mg-1,2,1,
ACTIVITY,pEC50,2,1,
VMAXKM,umol.L-1.min-1.mg-1,2,1,
TONIC,,2,1,
VDSS,%,2,1,
K,10'-8/s,2,1,
DOSE,mg rat-1,2,1,
DOSE,nM min-1 kg-1,2,1,
DOSE,nM mouse-1,2,1,
LAMBDAZ,s-1,2,1,
DOSE,pM kg-1,2,1,
DOSE,ug/embryo,2,1,
DOSEELEVATION,,2,1,
LASTTHERAPYDAY,%,2,1,
DOSENORMALIZEDCLEARANCE,L/hr,2,1,
DOSERANGE,uM kg-1,2,1,
LC25,umol.L-1,2,1,
LC30,[ppm],2,1,
NOACTIVE,,2,1,
EC50,10^-4microM,2,1,
K,/min/M,2,1,
MST,range,2,1,
EC30,10'-9M,2,1,
EC50,10'-2 ug/cm2,2,1,
MPORELEASE,,2,1,
IZ,cm2,2,1,
EC50,10'5pM,2,1,
IUPAD50,ug.mg-1,2,1,
LC99,[ppm],2,1,
EC50,10'9PFU,2,1,
EC50,10^-1microM,2,1,
EC50,10^2 ug/ml,2,1,
EC2,,2,1,
EC50,10^3ug/ml,2,1,
LD10,g/hm2,2,1,
DOPAACCUMULATION,%,2,1,
NORESPANIMALSTOTAL,/ 5,2,1,
INVERSEAGONISM,%,2,1,
OCC,umol.L-1,2,1,
DRUGMETABOLISM,pmol/mg/min,2,1,
LC15,umol.L-1,2,1,
DRUGMETABOLISM,umol.h.L-1,2,1,
NOOFACTIVENOOFTESTED,,2,1,
NON-SPECIFICBINDING,,2,1,
NOL,umol.L-1,2,1,
NOL,ug.mg-1,2,1,
DRUGTRANSPORT,ug/hr,2,1,
NOEFFECTDOSE,,2,1,
DRUGUPTAKE,AU/min,2,1,
NOCHANGE,,2,1,
DRUGUPTAKE,Gy/MBq,2,1,
NOAEL,ug/kg/day,2,1,
NOAEL,ug/kg,2,1,
NOAEL,nmol/Kg,2,1,
DRUGABSORPTION,mg/hr,2,1,
DPMBOUNDTOPROTEIN,,2,1,
DPM,,2,1,
K,10'2/M,2,1,
KUNCAT,M-1 min-1,2,1,
OFTUMORS,%,2,1,
OFF-RATE,s,2,1,
ODMAX,,2,1,
ODCACTIVITY,,2,1,
DI50,[ppm],2,1,
KX10E-5,,2,1,
OCCULATIONS,,2,1,
OCCLUSIONTIME,s,2,1,
DIFFERENCE,,2,1,
IO,,2,1,
LD33,ug.mg-1,2,1,
DRUGMETABOLISM,fmol/mg,2,1,
K,10'-2/Ms,2,1,
KSV,umol.L-1,2,1,
K,10'4/mol,2,1,
PCHANGE,%,2,1,
CRLEAKAGE,,2,1,
CS50,mA,2,1,
CSFLEVELS,umol.L-1,2,1,
K,10^6No_unit,2,1,
CSS-12W,pg/mL,2,1,
CSS-48H,pg/mL,2,1,
CSS-4W,pg/mL,2,1,
K,10^6/M.s,2,1,
CT,mmol/g,2,1,
CT,ug/L,2,1,
CT,umol.mg-1,2,1,
KOBS,10^-3/s,2,1,
CREATININECL,ml/min.kg,2,1,
K,10^5/min/M,2,1,
PC95,microg/cm2,2,1,
K,10^3/Ms,2,1,
PC95,,2,1,
K,10^3/M.s,2,1,
KOFF,1/nM.1/min,2,1,
PC50,microg/cm2,2,1,
KOFF,nM-1 min-1,2,1,
CURES@40MGKG,,2,1,
PBBB,microL/min/g,2,1,
PBBB,%,2,1,
T-CELLBINDING,,2,1,
CRITICALMICELLECONCENTRATION,umol.L-1,2,1,
KT4,,2,1,
LC50,pg,2,1,
LD40,mmol/Kg,2,1,
E50,,2,1,
EC50,nmol/Kg,2,1,
MOLARITY,umol.L-1,2,1,
MOLAREQUIVALENCEBOUND,,2,1,
LD50,10'-3 mol/L,2,1,
MOBILIZATION,,2,1,
K,/nM.min,2,1,
EC16,umol.L-1,2,1,
DRUGUPTAKE,cps/ml,2,1,
DRUGUPTAKE,uM/g,2,1,
DRUGUPTAKE,dpm/ml,2,1,
LC50,10'-2ppm,2,1,
DRUGUPTAKE,fmol/min,2,1,
DRUGUPTAKE,fmol/uL,2,1,
DRUGUPTAKE,mg%,2,1,
DRUGUPTAKE,nCi/cc,2,1,
DRUGUPTAKE,nM/mg,2,1,
DRUGUPTAKE,ng.hr/g,2,1,
NCOR1RECRUITMENT,,2,1,
DRUGUPTAKE,pM,2,1,
DRUGUPTAKE,ug.hr.ml-1,2,1,
EC1000,,2,1,
DTH,10e-3mm,2,1,
DUR,ug.mg-1,2,1,
DURATIONOFACTION,ug.mg-1,2,1,
DURATIONOFPEAKACTION,s,2,1,
LC50,microg/dm2,2,1,
MTD16,ug.mg-1,2,1,
MTD,umol.ml-1,2,1,
MTD,umol,2,1,
DRUGMETABOLISM,g/mol,2,1,
LC50,gAi/L,2,1,
DRUGLEVEL,,2,1,
AUMC,ug/L.hr,2,1,
C0,ug.hr.ml-1,2,1,
AUMCLAST,hr2.ug/g,2,1,
ACTIVITY,mBq,2,1,
AUCDOSE,uM.hr.kg,2,1,
C0,nmol/L,2,1,
AUC,mg.ml-1,2,1,
AUMCT,mg/L.hr,2,1,
ABSORPTION,ug.mg-1,2,1,
AUCDOSE,nmol/ml.hr,2,1,
RS,umol.L-1.min-1.mg-1,2,1,
STROKEVOLUME,ml,2,1,
AED,ug.mg-1,2,1,
RELATIVEPEROXIDATION,,2,1,
TREATMENT,umol.L-1,2,1,
STIMULATIONINDEX,%,2,1,
ACTIVITY,10^-5/s,2,1,
THERAPEUTICINDEX,14 day,2,1,
THERAPEUTICDOSE,ug.mg-1,2,1,
RELATIVEBINDINGAFFINITY,umol.L-1,2,1,
AC30,,2,1,
TRANSPORTERDEGRATECONST(K),day-1,2,1,
ARTERIALOCCLUSION,%,2,1,
BC,,2,1,
TRANSPORTERPRODUCTIONRATE(R),fM mg-1 day-1,2,1,
VBETA,kg-1,2,1,
AUC,uM kg-1,2,1,
RTG,,2,1,
REPORT,,2,1,
VMAXKM,U.mg-1,2,1,
2T11,,2,1,
C0,ug.mg-1,2,1,
AUMCLAST,hr.hr.ug/ml,2,1,
AFFINITYCONSTANT,l M-1,2,1,
TED,,2,1,
VOLUMEDISTRIBUTION,l,2,1,
ANTIFERTILITYACTIVITY,,2,1,
DRUGEXCRETION,umol/hr,2,1,
ABSOPTION,,2,1,
ACTIVITY,abs/uL,2,1,
BACTERICIDAL,umol.L-1,2,1,
BONEDAMAGESCORE,,2,1,
AUC,(umol/L).min,2,1,
VOLUME,mm**3,2,1,
VOLUME,ml min-1 kg-1,2,1,
AUC,%.hr,2,1,
ABC,mmHg.hr,2,1,
ATTACKS,%,2,1,
SPB,%,2,1,
SYNERGY,%,2,1,
VDRAFFINITY,,2,1,
VMAX,pmol/min/ml,2,1,
AVERAGETUMORWEIGHT,mg,2,1,
BACTERIALCOUNTS,,2,1,
ACTIVITY,g/cm3,2,1,
AUC,ug h ml-1 kg-1,2,1,
TUMORINHIBITION,%,2,1,
AUC,microM.hr'2,2,1,
ABSORPTION,ul min-1,2,1,
STROKEWORK,mg,2,1,
TRIGLYCERIDELEVEL,%,2,1,
AFFINITY,/mol.L-1.s-1,2,1,
ACTIVITY,mCi animal-1,2,1,
VFT,,2,1,
RELATIVECYTOTOXICACTIVITY,,2,1,
AUC,uM.h/L,2,1,
TFP,,2,1,
VCF,L/hr/kg,2,1,
SUBLETHALDOSE,ug.mg-1,2,1,
AUMCT,ug/ml.hr^2,2,1,
C,,2,1,
AUC,mU min dl-1,2,1,
ACTIVITY,kiloU/hr,2,1,
BSR,uM kg-1,2,1,
BRDUPOSITIVE,%,2,1,
SUBSTRATEACTIVITY,umol.L-1,2,1,
TD10,ug.mg-1,2,1,
ACTIVITY,kg/kg,2,1,
SLI,,2,1,
AUC,hr.ug/g,2,1,
ALLODYNIASCORE,,2,1,
BRAINPLASMA,%,2,1,
AUCDOSE,ng.hr.kg/ml/mg,2,1,
ALPHAT12,,2,1,
VMAX(APP),abs/min,2,1,
RENALCLEARANCE,L.h-1,2,1,
SLEEPTIME,,2,1,
ACTIVITY,Kcal/kg/hr,2,1,
VMAX,pM assay-1 hr-1,2,1,
K,10'9/M,2,1,
MEC,nmol/Kg,2,1,
KINETICSOLUBILITY(APP),,2,1,
DRUGDEGRADATION,10'-3nmol/min,2,1,
DRUGEXCRETION,%molar,2,1,
2XPT,,2,1,
DRUGEXCRETION,h-1,2,1,
LC10,mgAi/L,2,1,
DRUGEXCRETION,s,2,1,
AUC,hr/ng.ml,2,1,
LBF,ml/min.kg,2,1,
ALPHAT12(APP),s,2,1,
BRAINCONC,ng/g,2,1,
TTC,s,2,1,
AUMCT,ug/L.hr,2,1,
TUMORAREA,,2,1,
VI,ml.kg-1,2,1,
AUCDOSE,nmol.hr/g,2,1,
AHA,,2,1,
ALTGPT,l,2,1,
AUC,uM.min/ml,2,1,
VD,Kg,2,1,
AUC,ug .hr/g,2,1,
ACTIVITY,10'5CFU/ml,2,1,
ACTIVITY,kBq/ml,2,1,
ACTIVITY,L.umol-1.s-1,2,1,
AUCDOSE,ng h/ mL,2,1,
AMOUNT,,2,1,
SPECIFICRADIOACTIVITY,,2,1,
ANIMALS,,2,1,
TC(TUMORVOL),%,2,1,
AUCDOSE,nM.hr/ml,2,1,
BQL,,2,1,
ROTORODINDEX,,2,1,
ANOGENITALDISTANCE,umol.L-1,2,1,
VZ,L/hr/kg,2,1,
VD,L/1.73 m2,2,1,
ACTIVITY,10'5PFU,2,1,
VD,L/hr,2,1,
PPKB,,1,1,
PRESSORACTIVITY,%,1,1,
PRESSORRESPONSE,,1,1,
BMAX,10'-6pmol,1,1,
CLFREE,10^4uL/min/mg,1,1,
PRESSURERESPONSE,%,1,1,
REPLACEMENT,%,1,1,
RESCUEDNEURONS,,1,1,
CLH,mg/kg/min,1,1,
PPB,L/hr/kg,1,1,
PPB,%ID,1,1,
CLH,ml/mg,1,1,
CLH,ml/min/10^6cells,1,1,
CLH,10^-4L/hr/kg,1,1,
PROGRESSEDTUMORS,,1,1,
BLEEDINGTIME,umol.L-1,1,1,
CLH,umol/min/g,1,1,
CLH,uL/hr,1,1,
CLF,ug.hr.ml-1,1,1,
CL,micromol.hr/L/mg/kg,1,1,
REMLATENCY,,1,1,
PROLACTINRELEASE,ng mg-1 hr-1,1,1,
BRAIN,ng g-1,1,1,
BPCHANGE,,1,1,
RADIOACTIVITYREMAINED,%,1,1,
CL,l hr-1,1,1,
CL,lL/min/million,1,1,
CL,mL.min,1,1,
CL,mg/hr/kg,1,1,
BPINCREASE,AUD30min,1,1,
CL,mg/kg/microM.hrs,1,1,
BPINCREASE,%,1,1,
CLF,(mg/kg)/(microg/ml)/hr,1,1,
CL,min.ug/ml,1,1,
CL,ml,1,1,
RELATIVEONCENTRATION,umol.L-1,1,1,
CIP,ug.mg-1,1,1,
BNA,,1,1,
CLAST,ug.hr.ml-1,1,1,
BLOODVOLUME,HB g ml-1,1,1,
PROLONGATION,,1,1,
CLAST,ng/mL.hr,1,1,
CLBILIARY,ml/min.kg,1,1,
CLERANCE,l hr-1 kg-1,1,1,
CLH,umol/min/kg,1,1,
RELATIVEINACTIVATION,,1,1,
CATALEPTICEFFECT,,1,1,
RATIOGI50,10'4No_unit,1,1,
CFU,10^6/g,1,1,
RATIOED50MIC50,,1,1,
RECOVERYRATE,,1,1,
RATIOEC50,No unit,1,1,
RATIOEC50,10^-6No_unit,1,1,
RATIOEC50,10^-4No_unit,1,1,
RATIOEC50,10^-2No_unit,1,1,
RATIOCMAXBRAINPLASMA,,1,1,
CAV(SS),nmol.L-1,1,1,
CFU,ml,1,1,
REDUCEDFOODINTAKE,%,1,1,
CHANGE,uM kg-1,1,1,
RATIO,ms,1,1,
RATIO,mole fraction,1,1,
RATIO,umolequiv/umol,1,1,
BRAIN,weight,1,1,
CI50,umol.L-1,1,1,
BMAX,pmol/g,1,1,
BMAX2,fM (mg of protein)-1,1,1,
BMAX,fM,1,1,
PROTEINBOUND,%,1,1,
RELATIVEVMAXKM,rel,1,1,
RELATIVEWEIGHTLOSS,%,1,1,
BMAX2,,1,1,
CLBILIARY,%,1,1,
BMAX1,fM (mg of protein)-1,1,1,
PROTEIN,,1,1,
BMAX1,,1,1,
BMAX,sites cell-1,1,1,
PROLONGEDQT,,1,1,
CLEARANCE,l hr-1,1,1,
BMAX,pg/mm2,1,1,
PROTECTION,ug.mg-1,1,1,
BMAX,fmol/ug,1,1,
CLEARANCE,l kg-1,1,1,
REMAINED,%,1,1,
CLEARANCE,ml min-1,1,1,
CLEARANCEBLOOD,Not_given,1,1,
BMAX,fM bound (mg of protein)-1,1,1,
CL,kg-1 hr-1,1,1,
MEC,nmol/L,1,1,
CL,h-1,1,1,
F,ml/min.kg,1,1,
ADVERSEEFFECT,,1,1,
F%T>MIC,%,1,1,
FAUCDOSE,hr.Kg/L,1,1,
ERPR,,1,1,
MEC,pM,1,1,
ALDHACTIVITY,nM min-1,1,1,
MEQUIVOFNA+KG,,1,1,
MEDIANTOXICITY,ug.mg-1,1,1,
ED97,,1,1,
EDAREC,,1,1,
EDEMA,umol.L-1,1,1,
EDEMAINHIBITION,,1,1,
MEDIAN,%,1,1,
EDUCTION,%,1,1,
AMINEFORMED,,1,1,
TC@20MGKG,%,1,1,
TC@30MGKG,%,1,1,
TC@40MGKG,%,1,1,
TC@50MGKG,%,1,1,
MEANEFFECTIVEDOSE,,1,1,
TERMINALT12,s,1,1,
RADIOLABELRECOVERY,ugequiv/ml,1,1,
TERMINALELIMINATIONT12,s,1,1,
ED90,1/mg.1/kg.1/day,1,1,
ANABOLICACTIVITY,,1,1,
RATIO,ml g-1,1,1,
ED90,kg/ha,1,1,
MEC,L.mol-1,1,1,
EMAX,s-1,1,1,
EMAX,ug/kg,1,1,
EMAXH,%,1,1,
TDELTAS,10^2kJ/mol,1,1,
EMAXL,%,1,1,
AGONISMINFLECTIONPOINT,umol.L-1,1,1,
EMESISED,ug.mg-1,1,1,
AFLCL,ms,1,1,
EQUIEFFECTIVEDOSE,,1,1,
MEC,g/ml,1,1,
ERH,umol.L-1,1,1,
ET-1LEVEL,pg ml-1,1,1,
MEANMAXIMUMTEMPDROP,Cel,1,1,
TEMPERATURECHANGE,(degrees C)-1,1,1,
EFF+-SD,%,1,1,
EFFECTIVEDOSE,umol.L-1,1,1,
TCID50,log10/ml,1,1,
EFFLLUX,s-1,1,1,
CL,ug.hr.ml-1,1,1,
BODYWEIGHT,kg,1,1,
CL,ug.mg-1,1,1,
CL,ug/hr,1,1,
CL,ug/ml/hr,1,1,
CL,umol.h.L-1,1,1,
CL(APP),L/min,1,1,
CL-,,1,1,
BODYTEMPERATURE,,1,1,
CL-RENAL,L/hr,1,1,
BODYWEIGHTCHANGE,,1,1,
CL-RENAL,mL/min,1,1,
BP(ED50),%,1,1,
CL,ml hr-1,1,1,
RANGEOFMIC,umol.L-1,1,1,
CL,(ml/min)/kg,1,1,
RANGE,ug ul-1,1,1,
BRAINLEVEL,%,1,1,
BRAINLEVEL,,1,1,
PVCS,,1,1,
QMAX,10^10L/mol/s,1,1,
PWEIGHTCHANGE,,1,1,
DELTAH,10^3kJ/mol,1,1,
MED,ug min-1 kg-1,1,1,
ALPCHANGETO,,1,1,
MED,mmol/Kg,1,1,
EGGS,,1,1,
TCVALUE,,1,1,
MED,g/Kg,1,1,
AUCDOSE,ng/hr.ml,1,1,
TOTALACIDOUTPUT,,1,1,
AUCDOSE,ngequiv.hr/ml/mg,1,1,
CL,ng/ml/hr,1,1,
QH,ml/min,1,1,
BORONINMEDIAAT0H,ug of B/ml,1,1,
QH,L/min,1,1,
QH,L/Kg,1,1,
BORONINCORPORATION,mg,1,1,
QA,,1,1,
CL,nM/min/mg,1,1,
CL,ng/min/kg,1,1,
RATIO,ml/min/umol,1,1,
CP,ug/hr.ml,1,1,
RATIO,microL/min/mg,1,1,
SALDIURETICACTIVITY,(m equiv) 6hr-1 kg-1,1,1,
PERMEABILITY,10^-6m/s,1,1,
PERMEABILITY,10^-6cm/min,1,1,
CP,L/Kg,1,1,
PERMEABILITY,10'-6cm2/s,1,1,
PERMEABILITY,10'-6/s,1,1,
CP,mg/min/kg,1,1,
SCWREDUCTION,%,1,1,
CP,microg.min/mL,1,1,
AUCTDOSE,ngequiv.hr/ml/mg,1,1,
CP,nmol/Kg,1,1,
AUCTDOSE,ng.hr/ml/mg,1,1,
CP,pg/ml,1,1,
PERFORMANCE,,1,1,
CP,uM/g,1,1,
CP(F),nmol/L,1,1,
CP(F)DOSE,nM/mg/kg,1,1,
AUCTDOSE,,1,1,
CP,ml.kg-1,1,1,
PERMEABILITY,ug/cm2.hr,1,1,
SALINECONTROL,,1,1,
PERMEABILITY,cm/min,1,1,
REDUCTIONINARTERIALBLOODPRESSURE,%,1,1,
PERMEABILITY,microg/cm2,1,1,
SEC50,10'-10M,1,1,
AUCT,ng/nL.hr,1,1,
SECONDORDER,M s-1,1,1,
PEC50,10^-6No_unit,1,1,
PDELTAIOP,mmHg,1,1,
AUCT,ml/min.kg,1,1,
CSSMIN,ng/mL,1,1,
PD50,pmg.kg-1,1,1,
CT,pg/ml,1,1,
CT,uM/L,1,1,
AUCSS(TAU)NORMALISED,(nmol.h.L-1)/(mg/kg),1,1,
SELECTIVITYINBINDING,,1,1,
PCB,,1,1,
PCACO-2,cm s-1,1,1,
SELECTIVITYINDEX,10^3No_unit,1,1,
CSSMIN,mcg/mL,1,1,
SELECTIVITYINDEX,10^5No_unit,1,1,
CPMAX,,1,1,
PED50,ug.mg-1,1,1,
SELECTIVITYINDEX,Monkey,1,1,
AUCNPO,,1,1,
DC50,uM/L,1,1,
DCMAX,%,1,1,
PAPP,cm2/sec,1,1,
PAPP,microg/cm2,1,1,
CURATIVEINDEX,%,1,1,
CURES,d,1,1,
CURES@10MGKG,,1,1,
CURES@20MGKG,,1,1,
CURES@80MGKG,,1,1,
PBBB,cm/s,1,1,
PBBB,10'-3cm/s,1,1,
AUCLASTDOSE,ug.hr.ml-1,1,1,
AUCLAST,umol.L-1,1,1,
AUCLAST,ug.min/g,1,1,
AUCGLUREDUCTION(MMXMIN),%,1,1,
PB,equiv,1,1,
PAWWEIGHTINCREASE,,1,1,
PAWVOLUME,ml,1,1,
AUCLAST,ngequiv.hr/g,1,1,
ED50,10^-5 ug/ml,1,1,
AUCLAST,ng/hr,1,1,
CUMULATIVEDOSE,mM kg-1,1,1,
AUCDOSE,uM/hr/Kg/mg,1,1,
DELTAG,10^2kJ/mol,1,1,
DC50,mmol/L,1,1,
PAPP,10^-6cm2/s,1,1,
DECREACEINBP,umol.L-1,1,1,
PAPP,10'-9cm/s,1,1,
DECREASEINARTERIALBLOODPRESSURE,,1,1,
DECREASEINARTERIALBLOODPRESSURE,%,1,1,
PAPP,10'-6/s,1,1,
PAPP,10'-3cm/s,1,1,
PAP,umol.L-1,1,1,
PAOACTIVITY,pM min-1 mg-1,1,1,
DELTAF75,,1,1,
DECREASEINRFU,umol.L-1,1,1,
DECREASEOFSPONTANEOUSFIRINGRATE,,1,1,
AUCDOSE,uM.hr/ml,1,1,
DEGREEOFACTIVATION,,1,1,
PACTIVITY,,1,1,
DELTAA,Cel,1,1,
DELTABEATSMIN,,1,1,
DELTACP,,1,1,
CS50,,1,1,
SDS,,1,1,
PEAKCONCENTRATION,%,1,1,
CHANGEOFWEIGHT,g mouse-1,1,1,
CFC20,,1,1,
CBRAIN,ng g-1,1,1,
CFR,ug.mg-1,1,1,
RATIOIC50EC50,10'7No_unit,1,1,
RECOVEREDINBILE,%,1,1,
CC50,10'5uM,1,1,
BSABINDING,,1,1,
REDUCTIONINHEARTRATE,%,1,1,
CHANGEINCORPORALUTEA,,1,1,
RATIO,/microsec/nM,1,1,
RATIO,%ID,1,1,
RELATIVEBIOAVAILABILITY,nM ml-1,1,1,
CHANGENONHDL-C,,1,1,
RELATIVECONTRACTILEPOTENCY,,1,1,
RATEOFROTATION,turns 5min-1,1,1,
RATEOFREDUCTION,,1,1,
C10,,1,1,
CHANGEOFBODYWEIGHT,,1,1,
RATEOFMETABOLISM,pM/mg/minute,1,1,
RATIOKI,10'-5No_unit,1,1,
RATIOKI,10'4No_unit,1,1,
CC50,10'10uM,1,1,
RBC,10e3 ul-1,1,1,
RATIO,mg/mm,1,1,
RATIOCC50EC50,10^10No_unit,1,1,
REDUCTIONINBLOODPRESSURE,%,1,1,
"CAVE,SS",umol.L-1,1,1,
RATIOIC50EC50,10'3No_unit,1,1,
CCID50,PuM,1,1,
RC50,10'-5mg/ml,1,1,
CCONTROL,%,1,1,
RBC,10e-6ul-1,1,1,
RATIOKI,10'7No_unit,1,1,
RBC,10E6/mm3,1,1,
CC50,ucm,1,1,
CELLDENSITY,cells ml-1,1,1,
CC50,10'7uM,1,1,
RATIOOFDISTRIBUTION,,1,1,
RATIOIC50,10^7No_unit,1,1,
RATIOKI,10^-6No_unit,1,1,
CELLULARUPTAKEOFBORONAT16H,ug of B (g of cells)-1,1,1,
CHANGEINSYSTOLICPRESSURE,,1,1,
CHEMOSENSITIZINGACTIVITY,umol.L-1,1,1,
PEAKEFFECT,%,1,1,
CHOLESTEROL,,1,1,
RATIO,10'-2/s,1,1,
RATIO,10^3/mM/s,1,1,
CA,,1,1,
C90,,1,1,
RATIO,10^-6No_unit,1,1,
RATIO,10^-4No_unit,1,1,
RATIO,10'7/s/M,1,1,
RATIO,10'5/min/M,1,1,
RATIO,10'-6cm/min,1,1,
RATIO,10'-6/nM/s,1,1,
RATIO,10'-5/min.mol%'-4,1,1,
RATIO,10'-5/M/s,1,1,
RELATIVE,umol.L-1,1,1,
CLINICALREFERENCE,,1,1,
CLP,l kg-1,1,1,
RESISTANCERATIO,,1,1,
CREATININECL,umol.L-1,1,1,
PEAKGH,umol.L-1,1,1,
SD90,,1,1,
RELATION,%,1,1,
RATIO,10^3No_unit,1,1,
RATIO,10^4No_unit,1,1,
RATEOFFORMATION,,1,1,
CHOLESTEROL,mg kg-1 diet,1,1,
C0,ng.hr,1,1,
C(24H),mcg/mL,1,1,
RATECONSTANT,M s-1,1,1,
CI,10'6No_unit,1,1,
CI,10'7No_unit,1,1,
RATE,ul min-1,1,1,
CI,No unit,1,1,
REDUCTIONINMOVEMENT,,1,1,
RATIO,10^5No_unit,1,1,
RATIO,1/M1/s,1,1,
CHANGEINOVARIANFOLLICULARATRESIA,,1,1,
CHANGEINENTRYLATENCY,,1,1,
CAC,10^-5M,1,1,
RATIO,KB 7d-1,1,1,
RATIO,CPP/GLY,1,1,
REDUCTIONOFPROSTATEWEIGHT,%,1,1,
RATIO,10^8/M/s,1,1,
T12DOSE,s,1,1,
EC91,umol.L-1,1,1,
ED50,10'1 ug/ml,1,1,
SOLUBILITY,ug/kg,1,1,
OCC50,uM/g,1,1,
SOLUBILITY,10'-8mol,1,1,
DISPACEMENT,%,1,1,
DISSOCIATION,,1,1,
AUC,ug/mg/day,1,1,
DIURETICACTIVITY,(m equiv [Na+]) 5hr-1 kg-1,1,1,
DIURETICACTIVITY,(m equiv [Na+]) kg-1,1,1,
DIZ,umol.L-1,1,1,
DMAX,%,1,1,
DNASINGLESTRANDBREAKS,,1,1,
SPECIFICACTIVITY,uM Pi/min/mg protein,1,1,
SPECIFICBINDING,,1,1,
AUC,ug min/mL,1,1,
DISPLACEMENT,umol.L-1,1,1,
NOOFSURVIVORS,48h,1,1,
SOLUBILITY,10'-7mol,1,1,
DELTATM,°C,1,1,
DELTAH,10^6cal/mol,1,1,
P-450LOSS,umol.L-1,1,1,
AUC(0-24)NORMALISED,(nmol.h.L-1)/(mg/kg),1,1,
OCCUPANCY,ug.mg-1,1,1,
MIC,ucm,1,1,
DIAMETEROFINHIBITIONZONE,diameter mm,1,1,
EC80,mgAi,1,1,
EC90,nmol/L,1,1,
MLC,pug.ml-1,1,1,
MLC,ml/min.kg,1,1,
APD,%,1,1,
SUV,nCi/cc,1,1,
APA,ms,1,1,
SUVMAX,kBq/cm3,1,1,
EC98,umol.L-1,1,1,
EC986,umol.L-1,1,1,
MLD,ug/kg,1,1,
ED25,pmg kg-1 day-1,1,1,
STIMULATORYACTIVITY,%,1,1,
STIMULATION,umol.L-1,1,1,
SOLUBILITY,10'3ug/ml,1,1,
OFVIABILITY,%,1,1,
OD,umol.L-1,1,1,
SOLUBILITY,mmol.ml-1,1,1,
SOLUBILITY,ppb,1,1,
P(EI),Ei,1,1,
SLEEPLATENCY,%,1,1,
P,pcm s-1,1,1,
OXIDATION,%,1,1,
NOAEL,mg,1,1,
DRUGUPTAKE,L/Kg,1,1,
NN,/ 7,1,1,
NKA,mM-1,1,1,
AUC,ng.h-1.ml-1,1,1,
AUC,ng.Eq/ml,1,1,
AUC,ng ml kg-1,1,1,
AUC,ng hr g-1,1,1,
AUC,ng/L,1,1,
AUC,nM/L.hr,1,1,
NETCELLKILL,,1,1,
NETBODYWEIGHTDELTA,mg,1,1,
STABILTY,months,1,1,
DRUGUPTAKE,ng/cm2/h,1,1,
NBTREDUCTION,%,1,1,
DRUGUPTAKE,uM/L,1,1,
DRUGUPTAKE,ug.h-1.mL-1,1,1,
DRUGUPTAKE,ug.min/g,1,1,
DRUGUPTAKE,umol.ml-1,1,1,
STABILITY,pM/mg/hr,1,1,
NOAEL,ng/kg,1,1,
DOSENONRENALLYCLEARED,%,1,1,
DELTASBP,,1,1,
DELTAIOP,,1,1,
DELTANONHDL-C,%,1,1,
SMAX,IU/ml/hr,1,1,
ORALDOSE,ug.mg-1,1,1,
"ONSETFORSLEEP,MIN",,1,1,
ORALACTIVITY,ml min-1,1,1,
DELTAS,J/mol,1,1,
DELTAS,kcal/mol.K,1,1,
AUCDOSE,min.g/L,1,1,
SPECIFICINCORPORATION,,1,1,
DELTAT,K,1,1,
OPTIMALDOSAGE,,1,1,
OPSINSHIFTACTIVITY,,1,1,
SOLUBILITY,10'-1mg/ml,1,1,
SOLUBILITY,10'-1mol/L,1,1,
SOLUBILITY,10'-2g,1,1,
ORALACTIVITY,%,1,1,
DURATIONOFBLOCK,,1,1,
ANXIOLYTICACTIVITY,,1,1,
MLD50,,1,1,
APD95,,1,1,
MTC,%,1,1,
ASORBANCE,,1,1,
EC50,10^-6nmol,1,1,
MONOMER,%,1,1,
EC50,10'-3 ug/cm2,1,1,
EC50,10'-2mg/ml,1,1,
MTT,umol.L-1,1,1,
MTL,,1,1,
E2,,1,1,
MTD,ug/m2/day,1,1,
EA,kcal.mol-1,1,1,
EAUC50,ng.hr/ml,1,1,
EAUC50,ug.hr.ml-1,1,1,
AUC,mg.hr,1,1,
MTD,mg-1.g-1,1,1,
EBD20,,1,1,
EC50,10'-2mol%,1,1,
EC10,,1,1,
EC14,umol.L-1,1,1,
EC200,,1,1,
AT1AFFINITY,,1,1,
EC50,nM g-1,1,1,
EC50,mmol/Kg,1,1,
EC50,10'6pM,1,1,
PARASITECLEARANCETIME,,1,1,
EC50,10'-6microg/cm2,1,1,
SURVIVAL,[CFU].ml-1,1,1,
AUC,L/hr.Kg,1,1,
AUC,10^6nM,1,1,
EC50,10'10PFU,1,1,
MPE,umol.L-1,1,1,
AUC,0-tldc,1,1,
EC50,10'8PFU,1,1,
EC50,mgAi,1,1,
SURVIVALDOSE,,1,1,
MRC,ug.mg-1,1,1,
MPA,,1,1,
AUBC,ng.hr/ml,1,1,
EC50,PuM,1,1,
MORTALITYRATIO,,1,1,
EC50,mM/L,1,1,
MORTALITY,umol.L-1,1,1,
EC24,umol.L-1,1,1,
AUC,hr.nmol/g,1,1,
APD95,umol.L-1,1,1,
MST,MST,1,1,
ANTIHYPERTENSIVE,,1,1,
ED195,ug/kg,1,1,
ED2,Na2,1,1,
ED2,umol.L-1,1,1,
ED20,ug/kg,1,1,
ED25,10'-11M,1,1,
T-CELL,,1,1,
ED25,10'-9M,1,1,
ED145,ug/kg,1,1,
MOLARRATIO,,1,1,
EC996,umol.L-1,1,1,
ANXIOLYTICAFFECT,,1,1,
SURVIVORS,ug.mg-1,1,1,
EC50,ucm.s-1,1,1,
EC50,ug hr ml-1,1,1,
EC50H,umol.L-1,1,1,
EC50L,umol.L-1,1,1,
EC59,umol.L-1,1,1,
EC70,ug.mg-1,1,1,
ED15,%,1,1,
T,degree,1,1,
ANTIHYPERTENSIVEACTIVITY,ug.mg-1,1,1,
ECG,,1,1,
SUPPRESSIONOFPARASITEMIA,,1,1,
EC37,%,1,1,
MRT,umol.L-1,1,1,
EC50,10'-1ppm,1,1,
EC10X,,1,1,
STIMULATORYEFFECT,nM min-1 (mg of protein)-1,1,1,
EC50,nM kg-1,1,1,
EC50,pnM,1,1,
ECMAX,ug.mg-1,1,1,
MINLYTICCONCENTRATION,,1,1,
ED,umol.mg-1,1,1,
SYNERGISTICEFFECT,,1,1,
ED10,,1,1,
ANTIPSYCHOTIC,,1,1,
MINCONCENTRATION,,1,1,
ED100,ug day-1 kg-1,1,1,
ED100,umol,1,1,
SYSTOLICBLOODPRESSURE,SBP,1,1,
AUC,min.ng/g,1,1,
DRUGUPTAKE,mg/L.hr,1,1,
DOSEG,,1,1,
T50,mg,1,1,
GLUCOSE,mg dl-1,1,1,
GLUCOSELEVEL,%,1,1,
MAXAPD95,%,1,1,
MAD,10'-2microL,1,1,
ACTIVITY,uM kg-1 s.c.,1,1,
GLUCOSELOWERINGRELATIVETOPOSITIVECONTROL,%,1,1,
MAXACTIVATION,umol,1,1,
MAXACTIVATION,pmol/mg/min,1,1,
ACTIVITY,uCi/ml,1,1,
GMOUSE,,1,1,
MARGINBEFOREONSETOFTACHYCARDIA,ug.mg-1,1,1,
TISSUELEVELS,,1,1,
MARGINBEFOREONSETOFHYPOKALEMIA,ug.mg-1,1,1,
TISSUESWELLING,uM g-1,1,1,
MAD,10'-4microL,1,1,
GLUCOSELOWERINGOBOBDOSE,ug.mg-1,1,1,
TG,mg kg-1 diet,1,1,
AD90,ug/kg,1,1,
FAUCLAST,umol.h.L-1,1,1,
MAXCAMP,,1,1,
GITOLERANCE,,1,1,
GICLEARENCE,,1,1,
TOPICALDOSAGE,umol.L-1,1,1,
TMSHIFTDEGREEC,Cel,1,1,
HD50,umol.mg-1,1,1,
HDL-CCHANGE,,1,1,
ACTIVITY,pKa,1,1,
LOWERINGACTIVITY,,1,1,
HEMELOSS,umol.L-1,1,1,
HEPATICBLOODFLOW,L.h.Kg-1,1,1,
LOSSOFACTIVITY,,1,1,
HISTAMINERELEASE,,1,1,
GI75,umol.L-1,1,1,
HSFRELEASE,,1,1,
HD40,ug.mg-1,1,1,
GI50,10'-8cm/s,1,1,
GRCONTROL,%,1,1,
TLAST,,1,1,
GI50,PuM,1,1,
GI50EC50,umol.L-1,1,1,
MAXCONTRACTILEACTIVITY,mg,1,1,
MIC,10^-3micromol/ml,1,1,
MIC,10'-4nmol,1,1,
ACTIVITY,pM/min/mg,1,1,
ANTICOAGULANTACTIVITY,mg kg-1 hr-1,1,1,
ED35,mg,1,1,
MIC65,umol.L-1,1,1,
T12,microsec,1,1,
ED5,umol.mg-1,1,1,
ANTICONVULSANTACTIVITYANTICONVULSANTACTIVITY,,1,1,
T12,ug.hr.ml-1,1,1,
T12,ug.mg-1,1,1,
ED50,10'-13mol,1,1,
T12(APP),,1,1,
ED50,10'-1umol/L,1,1,
MIC,IU/ml,1,1,
T12BETA,,1,1,
T12EFF,,1,1,
MIC,ug.hr.ml-1,1,1,
T12HMIN,,1,1,
T12HS,,1,1,
ED50,10'-8mol,1,1,
T12IV,,1,1,
MIC,ucm.s-1,1,1,
ED50,DIUR,1,1,
T4,,1,1,
ANESTHESIADURATION,,1,1,
ED50,nM animal-1,1,1,
ANTICANCERACTIVITY,,1,1,
ED50,mg g-1 day-1,1,1,
T>IC50,umol.L-1,1,1,
ED50,mg/cm2,1,1,
ED50,ml.kg-1,1,1,
MHC,10'-6M,1,1,
MIC,10^-4 ug/ml,1,1,
ANTI-HIVACTIVITY,,1,1,
ANTI-ARHYTHMIC,,1,1,
ED50,mmol,1,1,
ED50,uM ear-1,1,1,
ANTAGONISTEFFICACY,%,1,1,
ED50,ug animal-1,1,1,
ED50,umol.g-1,1,1,
ED50ED50(TAXOL),umol.L-1,1,1,
ED58,,1,1,
ED75,,1,1,
TC,log10,1,1,
ACTIVITY,pg/ug,1,1,
ACTIVITY,pM/min/ml,1,1,
NOEFFECTIVENOTESTED,,1,1,
TIMEAFTERDOSE,,1,1,
DRUGTRANSPORT,%ID,1,1,
DRUGDEGRADATION,s-1,1,1,
MIC97,umol.L-1,1,1,
ANTIDIURETICACTIVITY,IU mg-1,1,1,
MIC82,umol.L-1,1,1,
FU,%ID,1,1,
FU,nmol/Kg,1,1,
FU,ug.h-1.mL-1,1,1,
FULLINHIBITION,umol.L-1,1,1,
G1,,1,1,
TID20,ug.mg-1,1,1,
MAXIMALACTIVATION,umol.L-1,1,1,
GAIN,,1,1,
TIME,10'11min,1,1,
GASTRICCONCENTRATION,,1,1,
MAXINHIBITION,umol.L-1,1,1,
GASTRICEMPTYING,,1,1,
ACTIVITY,um3.um2/day,1,1,
GC200[D],%,1,1,
DRUGMETABOLISM,uM/g,1,1,
DRUGMETABOLISM,fmol/ug,1,1,
STABILITY,%/min,1,1,
DRUGABSORPTION,ml/hr/kg,1,1,
STABILITY,microg.min/mL,1,1,
DOSEPERORGAN,,1,1,
AUC,uN h kg/mg,1,1,
NOOFRATSDIED,,1,1,
AUC,uM.hr/mg,1,1,
AUC,uM.hr.kg,1,1,
DRUG,nM (mg of protein)-1,1,1,
DRUGABSORPTION,microg/cm2,1,1,
SPONTANEOUSREPERFUSION,%,1,1,
DRUGMETABOLISM,10'-4/s,1,1,
DRUGABSORPTION,umol,1,1,
DRUGUPTAKE,%ID/mg/ml,1,1,
DRUGDEGRADATION,10'-6/hr,1,1,
DRUGEXCRETION,U,1,1,
DRUGEXCRETION,mg/day,1,1,
DRUGEXCRETION,ml/hr/kg,1,1,
DRUGEXCRETION,ml/min.kg,1,1,
DRUGMETABOLISM,10'-2/s,1,1,
GENERALIZATION,,1,1,
ACTIVITY,ul g-1,1,1,
TMIN,d,1,1,
GI,%/hr,1,1,
MBIC100,umol.L-1,1,1,
ACTIVTY,%,1,1,
FLUOROSCENCE,,1,1,
FMEAN,%,1,1,
FOLDIC50,,1,1,
THERMSOLUBILITY,10'-1mol/L,1,1,
FOODINTAKE,g 5mice-1 5days-1,1,1,
MAXREDUCTION,ug.mg-1,1,1,
FEZ,%,1,1,
AD50,umol.mg-1,1,1,
TIMEOFDOSINGBEFOREANTIGENCHALLENGE,s,1,1,
GI50,10^3nM,1,1,
ACTIVITY,pg/uL,1,1,
ACTIVITY,pg/dl,1,1,
TMAX,ug.mg-1,1,1,
ACTIVITY,pg.hr/ml,1,1,
TMAXDOSE,s,1,1,
HALFDURATION,,1,1,
HALUCINOGENICACTIVITY,,1,1,
FIC80,umol.L-1,1,1,
ACTVITY,,1,1,
AD,,1,1,
TG2XLAG,,1,1,
ACTIVITY,ug.hr.ml-1,1,1,
GI,10'-6M,1,1,
MAXDELTABP,mg kg-1 p.o.,1,1,
GI,L.mol-1,1,1,
GASTRICLESIONS,,1,1,
ACTIVITY,ug cm**-2 hr-1,1,1,
MAXIOPREDUCTION,,1,1,
MAXMBP,,1,1,
FC,10'-4No_unit,1,1,
FRPAT10MICROM,%,1,1,
FCMAX,mg L-1,1,1,
MDHREACTIVATION,,1,1,
TGI,10^5uM,1,1,
AD50,mg,1,1,
FCMAX,ng/g,1,1,
FCMAX,nmol/L,1,1,
AD50,d,1,1,
AD100,ug.mg-1,1,1,
PARASITES,,1,1,
ID50,10'-3M,1,1,
PARASITECLEARANCE,,1,1,
IC90,%,1,1,
WEIGHTINCREASE,%,1,1,
KINACT,10^4/s,1,1,
VMAX,10'7U/min,1,1,
IC90,Gy,1,1,
IC90,PuM,1,1,
12KCATKM,/mol.L-1.s-1,1,1,
IC50REDUCTION,,1,1,
KCATKM,10'5/Ms,1,1,
KMAPP,rel,1,1,
KINACT,M-1 min-1,1,1,
KAPP,10'5L/mol,1,1,
KINACT,mV,1,1,
K+2KI,,1,1,
KM,mg/min/microL,1,1,
KCATKM,10'2/Ms,1,1,
K,10^9/M/min,1,1,
KCATKM,10'3/M.s,1,1,
ACTIVITY,10'-3 ug/ml,1,1,
IC50,ug cm**-2,1,1,
KAPP,10'4M,1,1,
IC75,ug.mg-1,1,1,
LC50,10'-13 ug/ml,1,1,
VMAX,nM/hr,1,1,
KCAT,h-1,1,1,
VMAX,L/Kg,1,1,
KCAT,hr-1,1,1,
IC50,10^-4 ug/ml,1,1,
ACTIVITY,ml/cm,1,1,
LOGGEOMETRICMEAN,ppfu mg-1,1,1,
IC50,10^-4mg/ml,1,1,
IC50,10^-5mg/ml,1,1,
ACTIVITY,10'-2M,1,1,
ACTIVITY,micromol/dl,1,1,
IC50,10^-3umol/L,1,1,
IC50,10'7nM,1,1,
KCATKM,1/M*s,1,1,
KCATKM,1/M.s,1,1,
KINACT,10^4nM,1,1,
IC60,10'-2 ug/ml,1,1,
-TDELTAS,J/mol.K,1,1,
KD,10^4/M,1,1,
KCATKM,10'7M/s,1,1,
IC50,ug/kg,1,1,
IC50,umol.g-1,1,1,
-LOGLC50,,1,1,
IC50,umol.h.L-1,1,1,
K,fM,1,1,
I16,umol.L-1,1,1,
VMAX,mOD/minute,1,1,
KIOBS[I],/mol.L-1.s-1,1,1,
KB,10^7L/mol,1,1,
LOGPOCTA,,1,1,
HYDROLYSISRATECONSTANT,t/2,1,1,
%AUC,%,1,1,
LOGPN,cyh,1,1,
%BOUNDALBUMIN,%,1,1,
HYPNOSISDURATION,,1,1,
%DOSE,%,1,1,
ACTIVITY,ng/min/dl,1,1,
VMAX,mM/hr,1,1,
HYPOGLYCEMIC,,1,1,
I10,umol.L-1,1,1,
LOGPE,10^-6 cm/s,1,1,
KBAPP,L.umol-1,1,1,
%CLEARED,%,1,1,
KBP,,1,1,
KB,10^3/M,1,1,
I5,umol.L-1,1,1,
I23,umol.L-1,1,1,
ACTIVITY,mg/kg/hr,1,1,
ACTIVITY,10'-3nmol,1,1,
IC50,umol.min-1,1,1,
KCATKM,10'4/M/min,1,1,
KCAT,10'7/s,1,1,
%MAX,umol.L-1,1,1,
KCAT,10'2/s,1,1,
I20,umol.L-1,1,1,
I28,umol.L-1,1,1,
KINACTKI,10e4 M-1 s-1,1,1,
KINACTKIAPP,M-1s-1,1,1,
I30,umol.L-1,1,1,
LOGP,c.p.m.,1,1,
K,No unit,1,1,
[CA2+],umol.L-1,1,1,
LOGP,10'-2No_unit,1,1,
I42,umol.L-1,1,1,
LOGOFINHIBITORYZONE,umol.L-1,1,1,
ACTIVITY,10'-1microM,1,1,
KCAT,10^4/s,1,1,
ACTIVITY,10'-10s,1,1,
K,10'-7/M,1,1,
VARIATIONOFEDEMAVOLUME,%,1,1,
AC30,%,1,1,
KI,10'11mM,1,1,
K,10'-6/hr,1,1,
KQ,10'6No_unit,1,1,
VASOPRESSORACTIVITY,mg,1,1,
LC100,,1,1,
ACTIVITY,10^-6M,1,1,
VMAX(APP),pmol/mg/min,1,1,
VMAX,pmol/min/U,1,1,
ACTIVITY,10'2pg/ml,1,1,
VMAX,pmol/min/cm2,1,1,
LC10,[ppm],1,1,
LC1,umol.L-1,1,1,
K,10^-3No_unit,1,1,
KI,10^-2/min,1,1,
KI,10^-4microM,1,1,
LBF,ml/min.Kg,1,1,
LBF,ml/hr,1,1,
ACTIVITY,10^3pg/ml,1,1,
VMAXKM,10'-4min,1,1,
VMAXKM,10'-5L/min,1,1,
KILLED,%,1,1,
ACTIVITY,10^2CFU/ml,1,1,
KP,ml/min/g,1,1,
LC50,10^5uM,1,1,
V1,ml,1,1,
K,10'-5/s/nM,1,1,
ACTIVITY,10^4CFU/mg,1,1,
K,10'-2M,1,1,
V0,10^-3/s,1,1,
V0,10^-5/s,1,1,
VMAXKM,10'-5min,1,1,
AC200,,1,1,
K,10'-3/M/s,1,1,
K,10'-53No_unit,1,1,
KGMAX,umol.L-1,1,1,
K,10'-3No_unit,1,1,
ACTIVITY,10^3log10CFU/ml,1,1,
K,10^-6/mM/s,1,1,
K,10'-5/hr,1,1,
VMAX(APP),nM/min,1,1,
KQ,10'4No_unit,1,1,
TOXICITYINDEX,,1,1,
KQ,10'4L/mol,1,1,
"K(P,UU,BRAIN)",%,1,1,
K,10e4min-1,1,1,
LOGEC50(UM),,1,1,
LOGD75,,1,1,
KINACTI,/mol.L-1.s-1,1,1,
IC50,10^5uM,1,1,
IC50,mg.kg-1.d-1,1,1,
KINACT,umol,1,1,
IC50,mg/cm3,1,1,
IC50,microA,1,1,
K+2,,1,1,
IC50,uL.ml-1,1,1,
KCATKM,/min.uM,1,1,
IC50,10^-6 ug/ml,1,1,
KCAT,umol/min/nmol,1,1,
%REDUCTION,%,1,1,
%REDUCTION,,1,1,
%OFCONTROLAGONISTRESPONSE,%,1,1,
LOGIC50(UM),,1,1,
KAPP,L.mol-1,1,1,
KM,10'-4M/min,1,1,
INH,10'-9mol/L,1,1,
AC50,g/dl,1,1,
KQ,10'12L/mol.s,1,1,
KI,10'2/M/min,1,1,
KI,10'22mM,1,1,
KA,10'2L/mol,1,1,
ACTIVITY,10^1/mm2,1,1,
VMAX(UM),%,1,1,
KQ,10'13/mol/s,1,1,
KIINACT,s-1,1,1,
ACTIVITY,10^-7/hr,1,1,
TUMOURINHIBITION,,1,1,
KA,10'2/Ms,1,1,
AC50,hr.nmol/L,1,1,
KQ,10'14/M/s,1,1,
LC25,[ppm],1,1,
KA,10'10M,1,1,
K,10'-5L/mol,1,1,
ACTIVITY,10^-9M,1,1,
LEVEL,nmol of pHB/min/mg of protein,1,1,
I13,umol.L-1,1,1,
KB1,,1,1,
K,M-2,1,1,
KMAX,s-1,1,1,
INCREASEINMAP,%,1,1,
ACTIVITY,10'-5 mol/L,1,1,
LIVERCATALASE,mg of protein,1,1,
KINACT,10'-8/s,1,1,
KD,10^3/s,1,1,
KD,10^3/M/s,1,1,
KNA,L.umol-1,1,1,
5-HTLEVEL,%,1,1,
WEIGHTCHANGEATNADIR,%,1,1,
WEIGHT(MGG),%,1,1,
KD,10'-10L/mol,1,1,
VMAX,nanomol/min,1,1,
KMAXKS,/mol.L-1.s-1,1,1,
KMAX,h-1,1,1,
ID50,10'-9mol/L,1,1,
ID50,ug kg-1 min-1,1,1,
KACT,mV,1,1,
KCATKM,10^1/M/s,1,1,
ID50,pug.ml-1,1,1,
VMAX,nmol/min/ml,1,1,
KINACT,10'-9M,1,1,
KD,10^3 uM,1,1,
LOAEL,ml.kg-1,1,1,
VSV,,1,1,
INH,10'-7mol/kg,1,1,
A05,,1,1,
VSSF,L,1,1,
INH,10'-8mol/kg,1,1,
VSSF,,1,1,
ACTIVITY,fM,1,1,
LEVELINSERUM,mg dl-1,1,1,
LIPHOPHILICITY,sigma pi,1,1,
KINACT,10'-7/s,1,1,
INCREASES,%,1,1,
K,10^3L/mol,1,1,
VMAX,10'-2umol/min/U,1,1,
INCREASEINHEARTRATE,,1,1,
VMAX,nmol/min/kg,1,1,
INCREASEINHEARTRATE,%,1,1,
INCREASEINHEARTRATE,beats min-1,1,1,
KOBSS,,1,1,
KCATKM,10^2/M/s,1,1,
VMAX,10'3mmol/min/mg,1,1,
ACTIVITY,g/hr,1,1,
KINACT,10^3/M/s,1,1,
VMAX,10'-6deltaA/s,1,1,
WCC999,umol.L-1,1,1,
KCATKM,10^-4/M/s,1,1,
KD,10'-5 cm/s,1,1,
KD,10'-29M,1,1,
VMAX,10'-8M/s,1,1,
K-1,min-1,1,1,
ID50,10'-3microM,1,1,
IDANIMAL,%,1,1,
ID60,ug.mg-1,1,1,
ID50,10'-7mol/L,1,1,
KD,10'-2(1/s),1,1,
KD,10'-11/M,1,1,
ACTIVITY,mCi/M,1,1,
ID50,ug/hr.kg,1,1,
KINACT,10^-4/min,1,1,
ID50,microg/cm2,1,1,
VMAX,10'-7mol/s,1,1,
VMAX,10'-6mol/s,1,1,
ID50,10'-1microM,1,1,
ID100,umol.L-1,1,1,
WCC90,umol.L-1,1,1,
VMAX,10'-8cpm/min,1,1,
ID50,pmg.kg-1,1,1,
ID50,pg kg-1,1,1,
ID50,pM,1,1,
ID50,mg/kg/hr,1,1,
KD,/nM/min,1,1,
ID50,mg kg-1 day-1 b.i.d.,1,1,
ACTIVITY,%mg,1,1,
KCATKM,10^8/M/s,1,1,
ACTIVITY,mN,1,1,
KD,10'-7/s,1,1,
WEIGHTCHANGE,T-C,1,1,
KAPP,10'3L/mol,1,1,
K,10^7No_unit,1,1,
KCATKM,10^-4/nM/s,1,1,
LOG10CFUML,umol.L-1,1,1,
33,umol.L-1,1,1,
1KM,10'2/M,1,1,
KD,10'-9/M,1,1,
LEVELINSERUM,umol.L-1.ml-1,1,1,
INH,10'-7mol/L,1,1,
ACTIVITY,10'-1 ug/ml,1,1,
INCC50,%,1,1,
%INHIBITIONINLIVER,%,1,1,
I7,umol.L-1,1,1,
LOGKZ,,1,1,
KC,s-1,1,1,
LOGKP,10'-6 cm/s,1,1,
%INHIBITIONINSPLEEN,%,1,1,
IC25,PuM,1,1,
%INHIBITIONOFCONTROLAGONISTRESPONSE,%,1,1,
KB,10^1/M,1,1,
KB,10^-5L/mol,1,1,
IC100,mg.kg-1.d-1,1,1,
IC15,L.mol-1,1,1,
ACTIVITY,/10^6mm3,1,1,
ACTIVITY,nM/10e6,1,1,
ACTIVITY,/10^3mm3,1,1,
IC05,,1,1,
ACTIVITY,mean,1,1,
VMAX,uM hr-1,1,1,
TRANSCRIPTIONALACTIVITY,,1,1,
ACTIVITY,nanometer2,1,1,
KCAT,*10e-3,1,1,
LOGKI,uM.hr/L,1,1,
LOGKE,L.umol-1,1,1,
%INHIBITIONINBONE-MARROW,%,1,1,
IC33,umol.L-1,1,1,
IC40,mm,1,1,
IC50,/mol.L-1.s-1,1,1,
IC50,10'-11uM,1,1,
LOGK4,,1,1,
IC50,10'-13 ug/ml,1,1,
KB,10'6/mol,1,1,
ACTIVITY,mol/g,1,1,
135,umol.L-1,1,1,
IC50,10'13nM,1,1,
ACTIVITY,mmol.h/L,1,1,
IC50,10'16 uM,1,1,
IC50,10'20 uM,1,1,
TOXICITY,number of dead animals,1,1,
IC50,10'5uM,1,1,
ACTIVITY,10'-1/M/s,1,1,
IC50,10'-4umol/L,1,1,
INCC50,,1,1,
KD,10^-1M,1,1,
KD,10^4 uM,1,1,
INCORPORATED,,1,1,
K,10^5No_unit,1,1,
IMAX,s,1,1,
VMAX,nmol/cm2/s,1,1,
ACTIVITY,l hr-1 kg-1,1,1,
ACTIVITY,10'-4g,1,1,
WASHOUT,%,1,1,
KA,uM l-1,1,1,
KD,10^-15M,1,1,
LOG(1ID50),umol.L-1,1,1,
K,10^5/s,1,1,
KCATKM,10^-3/M/s,1,1,
IFNGAMMACONCENTRATION,pg ml-1,1,1,
ACTIVITY,kJ/cm2,1,1,
KD,10^-52M,1,1,
VV,,1,1,
K,10^2No_unit,1,1,
INFECTIONSCOREMEAN,,1,1,
VM,umol.L-1.ml-1,1,1,
LIFESPAN,%,1,1,
ILS(SUR),%,1,1,
KD,10'1/s,1,1,
WBC,10E3/mm3,1,1,
INCREASED,%,1,1,
KD,10^-2M,1,1,
KD,10^-4 mol/L,1,1,
KD,10^-4/M,1,1,
IN,,1,1,
KINACT,10'4nM,1,1,
LOG,(degrees C)-1,1,1,
INCREASE,ml min-1,1,1,
KINACT,10'2/s,1,1,
INCREASEINBLOODPRESSURE,,1,1,
ACTIVITY,log10pfu/g,1,1,
LOCOMOTOR,Counts,1,1,
K,10^3No_unit,1,1,
ACTIVITY,kT/e,1,1,
KD,10^-5 mol/L,1,1,
KD,10^-17M,1,1,
ILSMAXOD,,1,1,
KD,10'-9L/mol,1,1,
ILA,,1,1,
K,10'-51No_unit,1,1,
KQ,10'11L/mol.s,1,1,
PAPP,ug.cm-3,1,1,
KA,10^1/M,1,1,
KA,10^1 uM,1,1,
LD100,ug/kg,1,1,
LD100,mg,1,1,
IP,nm/s,1,1,
LD10,ug/uL,1,1,
KE,10^-4M,1,1,
KE,10^-5M,1,1,
LD,mg,1,1,
LCC999,umol.L-1,1,1,
KA,10^-7M,1,1,
LCC99,umol.L-1,1,1,
KA,10^-7/M,1,1,
KIN,10^-3/s,1,1,
LD30,ug.mg-1,1,1,
KDSPR,umol.L-1,1,1,
KDSPA,umol.L-1,1,1,
INTRINSIC,,1,1,
LD50,microM/g,1,1,
LD50,mg-1 kg-1,1,1,
ACTIVITY,Ci/mmol,1,1,
KDNONIONIC,umol.L-1,1,1,
KIKI,umol.L-1,1,1,
CCELLULAR,ug of B (g of cells)-1,1,1,
PKABN,,1,1,
PKAAZ,,1,1,
PKAAN,,1,1,
CMIN,ng/g,1,1,
AVERAGEBILEFLOW,ml hr-1,1,1,
CMIN,nmol/L,1,1,
CMIN,ug.mg-1,1,1,
CMIN(1),nmol.L-1,1,1,
CMIN(80HR),pg/mL,1,1,
CMIN(SS),nmol.L-1,1,1,
PKA(1),,1,1,
PKA,L.umol-1,1,1,
PK3',,1,1,
CMINSS,umol.L-1,1,1,
PINCREASE,,1,1,
AUMCT,ug.hr2/L,1,1,
PICSEIZURE,,1,1,
DELTAH,10'4cal/mol,1,1,
HSLOCURRENT,,1,1,
UPTAKE,nM 3s-1 (mg of protein)-1,1,1,
KDISS,10^-6M,1,1,
KDISS,10^-8M,1,1,
VMAX,pM hr-1 mg-1,1,1,
LC50,ug.cm'-2,1,1,
K,10'-2/nM/min,1,1,
KIN,10'-3ml/s/g,1,1,
UV,ml kg-1,1,1,
ACTIVITY,10^5/Ms,1,1,
KA,10'7(1/Ms),1,1,
ACTIVITY,10^4log10CFU/ml,1,1,
K,10'-10No_unit,1,1,
KA,10'8M,1,1,
KEL,L/Kg,1,1,
KA,10^-3/M,1,1,
IZAARAARLV,,1,1,
ACTIVITY,10^7cm/s,1,1,
IZAARAARLV,%,1,1,
ACTIVITY,10^7IFU/ml,1,1,
ACTIVITY,10'-7 cm/s,1,1,
ACTIVITY,10^7CFU/g,1,1,
ACTIVITY,10^7CFU,1,1,
K,10^-8/M/s,1,1,
K,10^-6No_unit,1,1,
K,10'-18No_unit,1,1,
KA,10'7/Ms,1,1,
VMAX,deltaOD/hr,1,1,
K,10^10No_unit,1,1,
LC95,ug.mg-1,1,1,
KDISS,L.mol-1,1,1,
LD50,10'2umol/kg,1,1,
INTRAPERITONEALSCORE,,1,1,
KDISS,umol.L-1.s-1,1,1,
KA,10^2/M,1,1,
K,10^1/s,1,1,
K,10^1/M/s,1,1,
ACTIVITY,10^5CFU/ml,1,1,
KDISS,h-1,1,1,
KDISS,10^-5M,1,1,
KIN,10'-5ml/s/g,1,1,
ACTIVITY,10^8CFU/ml,1,1,
K,10'-11M,1,1,
KEL,s,1,1,
VMAXKM,ml min-1 mg-1,1,1,
K,10'-12/min,1,1,
PKAE2,,1,1,
CMEDIA,ug of B g-1,1,1,
CMC,umol/dm3,1,1,
BBBIMPERMEABLE,,1,1,
PLASMACLEARANCE,Clp,1,1,
PLASMACLEARANCE,,1,1,
PLASMACHOLESTEROL,%,1,1,
CMAXDOSE,ng/ml/mg,1,1,
CMAXDOSE,ngequiv/ml/mg,1,1,
AVERAGESCORE,%,1,1,
PLASMACONCENTRATION,%,1,1,
CMAXDOSE,umol,1,1,
BBB,s,1,1,
PLASMANEFA,%,1,1,
CLP,ml hr-1,1,1,
CLP,ml mg-1 kg-1,1,1,
CLR,L/hr,1,1,
CLRENAL,l/h,1,1,
BINDINGCONSTANT,1/M,1,1,
CLRENAL,mL/min/1.73 m2,1,1,
CLTF,,1,1,
CLTF,L/hr,1,1,
BINDING,ug.mg-1,1,1,
AVERAGEWEIGHTGAIN,,1,1,
PLASMACLEARANCE,hkg,1,1,
PLASMACLEARANCE,mg.ml-1,1,1,
BAV,,1,1,
PAPP,uL/min.mg,1,1,
PAPP,nanometer/sec,1,1,
CYTOTOXICENDPOINT,,1,1,
AUMC,,1,1,
"S20,W",s,1,1,
CONTROLLEVEL,umol.L-1,1,1,
BBB,%,1,1,
BBB,,1,1,
PLASMALEPTIN,%,1,1,
PLASMACLEARANCE,ug.mg-1,1,1,
CMAX,ug m-1 min-1,1,1,
BASALGLUCOSE,mg dl-1,1,1,
PLASMAINSULIN,%,1,1,
PLASMAIL-6,%,1,1,
CMAX,ug/ml.hr,1,1,
PLASMAGLUCOSE,%,1,1,
BBB,10'-3cm/min,1,1,
PLASMACONCENTRATION,ug equiv ml-1,1,1,
PMEC,,1,1,
CMAX,hr.ng/ml,1,1,
CMC,mmol/dm3,1,1,
PM,ml-1,1,1,
PHARMACOKINETIC,%,1,1,
CONCBRAIN,,1,1,
CONCENTRATIONOFCL-,m equiv 6hr-1 kg-1,1,1,
PH,ml 4hr-1,1,1,
CONTRACTILITY,ug.mg-1,1,1,
CONTROL,pfu/ml,1,1,
CONTROL,umol.L-1,1,1,
CONTROLATTHEDOSEOF500MICROGMOUSE,%,1,1,
PERMEABILITYLIMITED,,1,1,
CONTROLATTHEDOSEOF50MICROGMOUSE,%,1,1,
PERMEABILITY,umol.s-1,1,1,
PERMEABILITY,umol.min-1,1,1,
CONTROLCURRENT,,1,1,
PH50,,1,1,
COMPOUNDRECOVERY,umol.L-1,1,1,
COMPOUNDRECOVERY,ml/hr,1,1,
COMPOUNDINURINE,%,1,1,
CMAXTRIPHOSPHATE,umol.L-1,1,1,
PKB(APP),,1,1,
CONCENTRATIONINSERUM,,1,1,
CONCENTRATIONINBRAIN,,1,1,
CONCENTRATION,ug of B/ml,1,1,
PLASMATRIGLYCERIDE,%,1,1,
PM,10^-6 cm/s,1,1,
CMAX,ng kg-1,1,1,
PLT,10E3/mm3,1,1,
BETAT12,%,1,1,
CMAX,ng.hr,1,1,
CMAX,ng/10^6 cells,1,1,
CMAX,ng/10^6 cells in 4 h,1,1,
PLATELETCOUNT,10e3 ul-1,1,1,
PM,ucm.s-1,1,1,
AUMC,ug.hr2/L,1,1,
CMAXTMAX,s,1,1,
AVERAGELOGGI50,umol.L-1,1,1,
CMAXTRIPHOSPHATE,pmol/10^6cells,1,1,
CONCENTRATION,PuM,1,1,
CONCENTRATION,mequiv/L,1,1,
PHOTOXICREACTION,mg,1,1,
PHOTOTOXICITY,ug.mg-1,1,1,
CONCENTRATION,ug min-1 kg-1,1,1,
ACTIVITY,10^7.99CFU/g,1,1,
ACTIVITY,10^6IFU/ml,1,1,
KA,10^-4/M,1,1,
VDSS,ml/hr/kg,1,1,
KA,10'1/M/s,1,1,
ACTIVITY,10'9CFU/ml,1,1,
ACTIVITY,10^-3/hr,1,1,
KQ,10^14/M/s,1,1,
K,10'1/M/s,1,1,
K2KI,,1,1,
K,10'1/mol/s,1,1,
ACTIVATION,umol.L-1,1,1,
VENTRICULARTACHYCARDIA,,1,1,
KI,10^2/M/s,1,1,
KQ,10^13L/mol,1,1,
KI,Kg,1,1,
L,%,1,1,
K,10'8Lmol,1,1,
"KI,APP",umol.L-1,1,1,
KI0,umol.L-1,1,1,
ACTIVITY,10'6PFU,1,1,
VMAX,uM/L.min,1,1,
VDU,,1,1,
K,10'-7/nM/min,1,1,
KQ,10^13/M,1,1,
ACTIVITY,10^-3/s,1,1,
VDAREA,ug.mg-1,1,1,
K,10'10/s,1,1,
K,10'11/M,1,1,
VD,ml/mg,1,1,
K,10'1mol/dm3/s,1,1,
KICOMP,umol.L-1,1,1,
VD(APP),L,1,1,
VD(APP),L/hr,1,1,
VDAPP,L,1,1,
K,10'2/M/min,1,1,
ACTIVITY,10^-3No_unit,1,1,
VELREM,%,1,1,
LA,,1,1,
K,10^-11/min,1,1,
K,10'10/M,1,1,
K,10'1/s,1,1,
K,10^-12/min,1,1,
LBF,L/hr,1,1,
K21,h-1,1,1,
KSV,10'-4L/M,1,1,
KSV,10'4/mol,1,1,
K,10^-1(1/Ms),1,1,
KI50,,1,1,
K,10'3mol/dm3/s,1,1,
VDSS,L/hr.Kg,1,1,
KA,/nM/min,1,1,
KA,/nM,1,1,
KI'UNCOMP,umol.L-1,1,1,
KUNCAT,/mol.L-1.s-1,1,1,
VMAX,pM 0.5hr-1,1,1,
LBF,L/hr/kg,1,1,
KI,10^-9/min,1,1,
KA,10'4 /uL,1,1,
V2,ml,1,1,
LC50,10'5uM,1,1,
ACTIVITY,10^3/cm2,1,1,
VMAXKM,/mol.L-1.s-1,1,1,
ACTIVITY,10^3/M,1,1,
LC50,10'-4ppm,1,1,
KIKM,umol.L-1,1,1,
K,10^-5/min,1,1,
ACTIVITY,10^2pg/ml,1,1,
ACTIVITY,10'7PFU/ml,1,1,
VELOCITY,,1,1,
ACIDOUTPUT,(equiv of [H+]) 2hr-1,1,1,
VCF,L/hr,1,1,
VDSS,ml/mg,1,1,
K3KI,,1,1,
K,10'6/nM/min,1,1,
VMAX,uM g-1,1,1,
VMAX,uM mg-1,1,1,
VDSS(APP),ml/min.kg,1,1,
K3K1,umol.L-1,1,1,
KS,10^6/M,1,1,
K,10'7/mol,1,1,
K,10'5/mol,1,1,
ACTIVITY,10'5L/mol,1,1,
KUP,ml/min,1,1,
KUNCAT,s-1,1,1,
K,10'7L/mol,1,1,
ACTIVITY,10'9/ml,1,1,
KI,PuM,1,1,
KI,ml/min/g,1,1,
ACIDHYDROLYSIS,mol/mol,1,1,
LAMBDAZ,L/min,1,1,
ACTIVITY,10^-11M,1,1,
UTERINEACTIVITY,,1,1,
INH,L/hr/kg,1,1,
INHIBITION(500ΜM),%,1,1,
INH,s-1,1,1,
KA,L.mol-1,1,1,
VSS,L/m2,1,1,
LETHALDOSE,umol.L-1,1,1,
K,10^2/Ms,1,1,
INH,10^-10mol/L,1,1,
ACTIVITY,dyn.s.cm'-5.10'4,1,1,
LEVEL,mg/gof liver,1,1,
KD,10^6uM,1,1,
KD,microL/min/mg,1,1,
INH,10^-8mol/L,1,1,
KA,10^5/Ms,1,1,
KA,L.umol-1.s-1,1,1,
INH,AU/sec,1,1,
VDSS(APP),l,1,1,
INH,E^-1%,1,1,
ACTIVITY,deltalog10/ml,1,1,
INH,E^1%,1,1,
LDLO,ug.mg-1,1,1,
ACTIVITY,U/ml/min,1,1,
KD2,,1,1,
INH,ug/kg,1,1,
ACTIVITY,10^6CFU/ml,1,1,
JMAX,pmol/min/mg,1,1,
ACTIVITY,10^6/100microL,1,1,
ACTIVITY,10^5PFU/g,1,1,
ACTIVITY,10^7.67CFU/g,1,1,
ACTIVITY,L/Kg,1,1,
UPTAKE,% injected dose cm**-3,1,1,
KDISS,10^-3M,1,1,
INH,umol,1,1,
VM,rel,1,1,
KD,umol.L-1.s-1,1,1,
KOH-,,1,1,
KA,10^7/M/s,1,1,
KA,10^7/M.s,1,1,
TWITCHTENSION,,1,1,
KD1,,1,1,
INHIBITION,c.p.m. 50ul-1,1,1,
INHIBITION,cm,1,1,
LETHALTOXICITY,ug.mg-1,1,1,
K1,,1,1,
KP,10^-5cm/hr,1,1,
ACTIVITY,U/min/ml,1,1,
LDH50,umol.L-1,1,1,
INHIBITIONAT10NM,%,1,1,
KA,10^5/M.s,1,1,
LDH,U g-1,1,1,
INHIBITIONCONCENTRATION,umol.L-1,1,1,
INHIBITIONINDEX,10'27No_unit,1,1,
LD95,,1,1,
ULTRAFILTRATION,,1,1,
ULCERINCIDENCE,,1,1,
INHIBITORYDOSE,ug.mg-1,1,1,
ABAANALOGUERATIO,,1,1,
VPF,L/hr,1,1,
KA,10^4/M.s,1,1,
LD70,umol.L-1,1,1,
KDISS,10'-6/s,1,1,
VOLUMEREDUCTION,%,1,1,
KA,10^4/s,1,1,
K,10'-2/s/M,1,1,
KA,10'6/Ms,1,1,
ACTIVITY,PbU,1,1,
LD60,ug.mg-1,1,1,
K12,h-1,1,1,
INITIALHEARTRATE,,1,1,
KDHYDRO,,1,1,
ACTIVITY,10'-5nmol,1,1,
K,10^2/M/min,1,1,
KDISS,10^-1/s,1,1,
KDISS,10^-10M,1,1,
KDISS,10^-1M,1,1,
UNCHANGEDNDEA,%,1,1,
KDISS,10^-2/Ms,1,1,
ACTIVITY,Osm/kg,1,1,
INITIALINHIBITION,umol.L-1,1,1,
LD50,ug/uL,1,1,
INJECTED,,1,1,
UNTREATEDCONTROL,,1,1,
INJECTEDDOSE(G),%,1,1,
LD50,po,1,1,
LD50,ng/kg,1,1,
UP,,1,1,
K,10^2/M,1,1,
PERMEABILITY,10^-8cm/s,1,1,
